original_value,curated_ontology,match_level,stage,top1_match,top1_score,top2_match,top2_score,top3_match,top3_score,top4_match,top4_score,top5_match,top5_score
nan,nan,1,1,nan,1.0,nan,1.0,nan,1.0,nan,1.0,nan,1.0
1-ERG,ERG Gene,1,2,ERG Gene,0.9439,Ewing Sarcoma<;>ERG Gene Rearrangement,0.9174,AML1-ETO Fusion Protein Expression,0.9069,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9040,ETV1 Gene,0.9019
2-ETV1,ETV1 Gene,1,2,ETV1 Gene,0.9570,ETV4 Gene,0.9398,AML1-ETO Fusion Protein Expression,0.9265,Estrogen Receptor Positive<;>HER2/Neu Positive,0.9139,Estrogen Receptor Negative<;>HER2/Neu Positive,0.9134
20% DYSGERMINOMA AND 80% YOLK SAC TUMOR,Ovarian Dysgerminoma<;>Yolk Sac Tumor,1,2,Ovarian Dysgerminoma<;>Yolk Sac Tumor,0.9738,Ovarian Dysgerminoma,0.9435,Yolk Sac Tumor<;>Seminoma,0.9429,Nongerminomatous Germ Cell Tumor<;>Yolk Sac Tumor,0.9408,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9363
25-30% DUCTAL COMPONENT,Prostate Ductal Adenocarcinoma,99,2,Ductal,0.9479,Breast Ductal Carcinoma,0.9336,Breast Mixed Ductal and Lobular Carcinoma,0.9332,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.9316,Pancreatic Ductal Adenocarcinoma,0.9302
3-ETV4,ETV4 Gene,1,2,ETV4 Gene,0.9477,ETV1 Gene,0.9399,Extraventricular Neurocytoma,0.9127,AML1-ETO Fusion Protein Expression,0.9126,Supratentorial Ependymoma<;>Subependymoma,0.9085
4-FLI1,FLI1 Gene,1,2,FLI1 Gene,0.9538,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9286,Myelodysplastic Syndrome with Isolated del(5q),0.9074,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9055,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9055
5-SPOP,SPOP Gene,1,2,SPOP Gene,0.9337,Myelodysplastic Syndrome with Isolated del(5q),0.9122,Myelodysplastic Syndrome with del(5q),0.9108,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.8901,"Astrocytoma, IDH-Mutant, Grade 4",0.8878
6-FOXA1,FOXA1 Gene,1,2,FOXA1 Gene,0.9409,PAX3/FOXO1 Fusion Gene,0.9178,"Astrocytoma, IDH-Mutant, Grade 4",0.9078,CBFB-MYH11 Fusion Protein Expression,0.9071,"Astrocytoma, IDH-Mutant, Grade 3",0.9048
7-IDH1,IDH1 Gene,4,2,"Astrocytoma, IDH-Mutant, Grade 4",0.9296,"Astrocytoma, IDH-Mutant, Grade 3",0.9281,"Astrocytoma, IDH-Mutant, Grade 2",0.9265,IDH1 Gene,0.9227,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9226
82463 NEUROENDOCRINE CARCINOMA NOS,Neuroendocrine Carcinoma,1,2,Neuroendocrine Carcinoma,0.9564,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.9537,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.9521,High Grade<;>Small Cell Neuroendocrine Carcinoma<;>Small Cell Adenocarcinoma,0.9519,Head and Neck Neuroendocrine Carcinoma,0.9493
AB,Thymoma Type AB,1,2,Thymoma Type AB,0.9123,B-Lymphocyte,0.9051,Thymoma Type A<;>Thymoma Type AB,0.9014,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.8973,Activated B-Cell Positive,0.8967
ABC,Activated B-Cell Positive,2,2,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9047,Activated B-Cell Positive,0.9037,"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",0.8999,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.8997,Chondroblastoma,0.8980
ABDOMEN,Abdomen,1,2,Abdomen,1.0000,Abdominal Wall,0.9500,Stomach,0.9233,Peritoneum,0.9208,Intestine,0.9163
ABDOMINAL WALL,Abdominal Wall,1,2,Abdominal Wall,1.0000,Abdomen,0.9500,Peritoneum,0.9210,Omentum,0.9054,Peritoneal Mesothelioma,0.9025
ACANTHOLYTIC,Skin Acantholytic Squamous Cell Carcinoma,1,2,Skin Acantholytic Squamous Cell Carcinoma,0.9402,Desmoplastic,0.9171,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9020,Anaplastic Pleomorphic Xanthoastrocytoma,0.8995,Neoplastic Fibroblast-Like Cell,0.8989
ACC,Adrenal Cortical Carcinoma,99,2,Cerebral Cortex,0.9003,Anaplastic Astrocytoma,0.8988,Ascending Colon,0.8947,Colon,0.8940,Anaplastic Carcinoma,0.8926
ACINAR,Acinar Cell,1,2,Acinar Cell,0.9682,Acinar Cell Carcinoma,0.9465,Prostate Acinar Adenocarcinoma,0.9461,Lung Acinar Adenocarcinoma,0.9459,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.9353
ACINAR ADENOCARCINOMA 85513,Lung Acinar Adenocarcinoma,1,2,Lung Acinar Adenocarcinoma,0.9585,Prostate Acinar Adenocarcinoma,0.9560,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.9559,Acinar Cell Carcinoma,0.9428,Pancreatic Acinar Cell Carcinoma,0.9412
ACINAR AND CRIBRIFORM,Prostate Acinar Adenocarcinoma<;>Cribriform,1,2,Prostate Acinar Adenocarcinoma<;>Cribriform,0.9669,Cribriform,0.9575,Cribriform<;>Solid<;>Tubular,0.9509,Breast Tubular Carcinoma<;>Cribriform,0.9486,Breast Tubular Carcinoma<;>Cribriform Pattern,0.9453
ACINAR AND DUCTAL,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,2,2,Ductal,0.9572,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.9509,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.9471,Acinar Cell,0.9466,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9431
ACINAR CELL CARCINOMA,Acinar Cell Carcinoma,1,2,Acinar Cell Carcinoma,1.0000,Pancreatic Acinar Cell Carcinoma,0.9886,Acinar Cell Carcinoma<;>Papillary,0.9728,Acinar Cell,0.9711,Lung Acinar Adenocarcinoma,0.9578
ACINAR CELL CARCINOMA OF THE PANCREAS,Pancreatic Acinar Cell Carcinoma,1,2,Pancreatic Acinar Cell Carcinoma,0.9939,Acinar Cell Carcinoma,0.9912,Acinar Cell Carcinoma<;>Papillary,0.9718,Acinar Cell,0.9677,Prostate Acinar Adenocarcinoma,0.9606
"ACINAR CELL CARCINOMA, NOS",Acinar Cell Carcinoma,1,2,Acinar Cell Carcinoma,0.9823,Pancreatic Acinar Cell Carcinoma,0.9736,Acinar Cell Carcinoma<;>Papillary,0.9626,Acinar Cell,0.9558,Lung Acinar Adenocarcinoma,0.9494
ACINAR/ PAPILLARY,Acinar Cell Carcinoma<;>Papillary,1,2,Acinar Cell Carcinoma<;>Papillary,0.9703,Papillary,0.9677,Papillary Adenocarcinoma,0.9474,Acinar Cell,0.9456,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.9415
ACINIC CELL CARCINOMA,Acinar Cell Carcinoma,1,2,Acinar Cell Carcinoma,0.9820,Pancreatic Acinar Cell Carcinoma,0.9743,Acinar Cell Carcinoma<;>Papillary,0.9632,Carcinoma,0.9488,Prostate Squamous Cell Carcinoma,0.9475
ACRAL,Acral Lentiginous Melanoma,1,2,Acral Lentiginous Melanoma,0.9233,Anaplastic,0.8940,Anaplastic Pleomorphic Xanthoastrocytoma,0.8918,Anaplastic Astrocytoma,0.8916,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.8914
ACRAL LENTIGINOUS,Acral Lentiginous Melanoma,1,2,Acral Lentiginous Melanoma,0.9765,Lentigo Maligna,0.9182,Lentigo Maligna Melanoma,0.9176,Laryngeal,0.9025,Anaplastic Pleomorphic Xanthoastrocytoma,0.8991
ACRAL MELANOMA,Acral Lentiginous Melanoma,1,2,Acral Lentiginous Melanoma,0.9709,Cutaneous Melanoma,0.9287,Melanoma,0.9257,skin appendage carcinoma,0.9200,Mucosal Melanoma of the Head and Neck,0.9195
ACTIVATED B-CELL TYPE,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,2,2,Activated B-Cell Positive,0.9721,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9650,B-Lymphocyte,0.9427,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9367,Mature B-Cell Non-Hodgkin Lymphoma,0.9312
ACUTE BIPHENOTYPIC LEUKEMIA,Acute Biphenotypic Leukemia,1,2,Acute Biphenotypic Leukemia,1.0000,Acute Megakaryoblastic Leukemia,0.9515,Acute Monocytic Leukemia,0.9509,Acute Monoblastic and Monocytic Leukemia,0.9493,Acute Erythroid Leukemia,0.9477
ACUTE ERYTHROID LEUKAEMIA,Acute Erythroid Leukemia,1,2,Acute Erythroid Leukemia,0.9911,Acute Megakaryoblastic Leukemia,0.9648,Acute Myeloid Leukemia,0.9589,Acute Monocytic Leukemia,0.9585,Acute Lymphoblastic Leukemia,0.9570
ACUTE ERYTHROID LEUKEMIA,Acute Erythroid Leukemia,1,2,Acute Erythroid Leukemia,1.0000,Acute Megakaryoblastic Leukemia,0.9714,Acute Lymphoblastic Leukemia,0.9651,Acute Myeloid Leukemia,0.9646,Acute Monocytic Leukemia,0.9638
ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE,Acute Leukemia of Ambiguous Lineage,1,2,Acute Leukemia of Ambiguous Lineage,0.9918,Acute Undifferentiated Leukemia,0.9536,Acute Myeloid Leukemia with MLL Rearrangement,0.9487,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9446,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9446
ACUTE LEUKEMIAS OF AMBIGUOUS LINEAGE,Acute Leukemia of Ambiguous Lineage,1,2,Acute Leukemia of Ambiguous Lineage,0.9975,Acute Undifferentiated Leukemia,0.9608,Acute Myeloid Leukemia with MLL Rearrangement,0.9550,Acute Megakaryoblastic Leukemia,0.9514,Acute Myeloid Leukemia,0.9512
ACUTE LYMPHOBLASTIC LEUKEMIA,Acute Lymphoblastic Leukemia,1,2,Acute Lymphoblastic Leukemia,1.0000,B Acute Lymphoblastic Leukemia,0.9834,T Acute Lymphoblastic Leukemia,0.9822,Acute Myeloid Leukemia,0.9681,Early T Acute Lymphoblastic Leukemia,0.9676
"ACUTE LYMPHOBLASTIC LEUKEMIA ALL, B-CELL",B Acute Lymphoblastic Leukemia,1,2,B Acute Lymphoblastic Leukemia,0.9857,B Lymphoblastic Leukemia/Lymphoma,0.9777,Acute Lymphoblastic Leukemia,0.9750,T Acute Lymphoblastic Leukemia,0.9749,B Acute Lymphoblastic Leukemia with t(9<;>22)(q34.1<;>q11.2)<;> BCR-ABL1,0.9729
"ACUTE LYMPHOBLASTIC LEUKEMIA ALL, T-CELL",T Acute Lymphoblastic Leukemia,1,2,T Acute Lymphoblastic Leukemia,0.9850,B Acute Lymphoblastic Leukemia,0.9787,Acute Lymphoblastic Leukemia,0.9754,T Lymphoblastic Leukemia/Lymphoma,0.9754,B Acute Lymphoblastic Leukemia with t(9<;>22)(q34.1<;>q11.2)<;> BCR-ABL1,0.9736
ACUTE LYMPHOID LEUKEMIA,Acute Lymphoblastic Leukemia,1,2,Acute Lymphoblastic Leukemia,0.9751,Acute Myeloid Leukemia,0.9671,T Acute Lymphoblastic Leukemia,0.9659,Acute Monocytic Leukemia,0.9650,B Acute Lymphoblastic Leukemia,0.9643
ACUTE MEGAKARYOBLASTIC LEUKAEMIA,Acute Megakaryoblastic Leukemia,1,2,Acute Megakaryoblastic Leukemia,0.9936,Acute Monocytic Leukemia,0.9701,Acute Myeloid Leukemia,0.9688,Acute Erythroid Leukemia,0.9644,Acute Myelomonocytic Leukemia,0.9624
ACUTE MEGAKARYOBLASTIC LEUKEMIA,Acute Megakaryoblastic Leukemia,1,2,Acute Megakaryoblastic Leukemia,1.0000,Acute Monocytic Leukemia,0.9747,Acute Myeloid Leukemia,0.9729,Acute Erythroid Leukemia,0.9714,Acute Myelomonocytic Leukemia,0.9676
ACUTE MONOBLASTIC AND MONOCYTIC LEUKAEMIA,Acute Monoblastic and Monocytic Leukemia,1,2,Acute Monoblastic and Monocytic Leukemia,0.9963,Acute Monocytic Leukemia,0.9687,Acute Myeloid Leukemia,0.9531,Acute Megakaryoblastic Leukemia,0.9529,Acute Myeloid Leukemia with Minimal Differentiation,0.9523
ACUTE MONOBLASTIC/MONOCYTIC LEUKEMIA,Acute Monoblastic and Monocytic Leukemia,1,2,Acute Monoblastic and Monocytic Leukemia,0.9975,Acute Monocytic Leukemia,0.9771,Acute Megakaryoblastic Leukemia,0.9611,Acute Myeloid Leukemia,0.9611,Acute Myelomonocytic Leukemia,0.9582
ACUTE MYELOBLASTIC LEUKEMIA,Acute Myeloid Leukemia,2,2,Acute Myelomonocytic Leukemia,0.9841,Acute Myeloid Leukemia,0.9838,Acute Megakaryoblastic Leukemia,0.9805,Acute Monocytic Leukemia,0.9740,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9713
"ACUTE MYELOBLASTIC LEUKEMIA, IN RELAPSE",Recurrent Acute Myeloid Leukemia,1,2,Recurrent Acute Myeloid Leukemia,0.9618,Acute Lymphoblastic Leukemia<;>Recurrent Disease,0.9609,Acute Myeloid Leukemia with Maturation,0.9603,Acute Myeloid Leukemia,0.9602,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.9586
ACUTE MYELOGENOUS LEUKEMIA AML,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.9878,Acute Myelomonocytic Leukemia,0.9813,Acute Monocytic Leukemia,0.9758,Acute Megakaryoblastic Leukemia,0.9730,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9729
"ACUTE MYELOGENOUS LEUKEMIA AML, M2 MYELOBLASTIC",Acute Myeloid Leukemia with Maturation,99,2,Acute Myeloid Leukemia,0.9624,Acute Myelomonocytic Leukemia,0.9623,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9602,Acute Myeloid Leukemia Not Otherwise Specified,0.9600,Acute Monocytic Leukemia,0.9589
"ACUTE MYELOGENOUS LEUKEMIA AML, M3 PROMYELOCYTIC",Acute Promyelocytic Leukemia with PML-RARA,2,2,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.9646,Acute Promyelocytic Leukemia with PML-RARA,0.9618,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9613,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9613,Acute Myelomonocytic Leukemia,0.9610
"ACUTE MYELOGENOUS LEUKEMIA AML, M4 MYELOMONOCYTIC",Acute Myelomonocytic Leukemia,1,2,Acute Myelomonocytic Leukemia,0.9711,Acute Myeloid Leukemia with MLL Rearrangement,0.9622,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9609,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9609,Acute Myeloid Leukemia,0.9590
"ACUTE MYELOGENOUS LEUKEMIA AML, M5 EOSINOPHILIC/MONOCYTIC",Acute Monoblastic and Monocytic Leukemia,2,2,Acute Monocytic Leukemia,0.9662,Acute Monoblastic and Monocytic Leukemia,0.9644,Acute Myeloid Leukemia,0.9626,Acute Myelomonocytic Leukemia,0.9622,Acute Myeloid Leukemia with MLL Rearrangement,0.9613
"ACUTE MYELOGENOUS LEUKEMIA AML, M5 MONOCYTIC",Acute Monoblastic and Monocytic Leukemia,3,2,Acute Monocytic Leukemia,0.9712,Acute Myeloid Leukemia,0.9642,Acute Monoblastic and Monocytic Leukemia,0.9640,Acute Myelomonocytic Leukemia,0.9627,Acute Myeloid Leukemia with MLL Rearrangement,0.9588
"ACUTE MYELOGENOUS LEUKEMIA AML, M6 ERYTHROLEUKEMIA",Acute Erythroid Leukemia,99,2,Acute Monoblastic and Monocytic Leukemia,0.9612,Acute Monocytic Leukemia,0.9573,Acute Myelomonocytic Leukemia,0.9570,Acute Myeloid Leukemia,0.9556,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9546
"ACUTE MYELOGENOUS LEUKEMIA AML, M7 MEGAKARYOBLASTIC",Acute Megakaryoblastic Leukemia,1,2,Acute Megakaryoblastic Leukemia,0.9602,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9563,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9563,Acute Myelomonocytic Leukemia,0.9550,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9547
ACUTE MYELOGENOUS LEUKEMIA M5A,Acute Monoblastic and Monocytic Leukemia,99,2,Acute Myeloid Leukemia,0.9621,Acute Myelomonocytic Leukemia,0.9590,Acute Monocytic Leukemia,0.9581,Acute Myeloid Leukemia with Maturation,0.9517,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9509
ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS,Acute Myeloid Leukemia,99,2,Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,0.9695,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9673,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9669,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9668,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9668
ACUTE MYELOID LEUKAEMIA AML AND RELATED PRECURSOR NEOPLASMS,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.9700,Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,0.9686,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9655,Acute Myeloid Leukemia with MLL Rearrangement,0.9641,Acute Myeloid Leukemia Not Otherwise Specified,0.9636
"ACUTE MYELOID LEUKAEMIA, NOS",Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.9713,Acute Myeloid Leukemia Not Otherwise Specified,0.9675,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9612,Acute Myeloid Leukemia with MLL Rearrangement,0.9609,Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,0.9604
"ACUTE MYELOID LEUKAEMIA, NOS, THERAPY-RELATED MYELOID NEOPLASMS",Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,1,2,Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,0.9820,Therapy-Related Myeloid Neoplasm,0.9675,Acute Myeloid Leukemia Not Otherwise Specified,0.9641,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9629,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9616
ACUTE MYELOID LEUKEMIA,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,1.0000,Acute Monocytic Leukemia,0.9791,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9755,Acute Myelomonocytic Leukemia,0.9741,Acute Megakaryoblastic Leukemia,0.9729
ACUTE MYELOID LEUKEMIA WITH MULTILINEAGE DYSPLASIA,Acute Myeloid Leukemia with Multilineage Dysplasia,1,2,Acute Myeloid Leukemia with Multilineage Dysplasia,1.0000,Myelodysplastic Syndrome with Multilineage Dysplasia,0.9758,Acute Myeloid Leukemia with Minimal Differentiation,0.9706,Acute Myeloid Leukemia with Maturation,0.9688,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9627
"ACUTE MYELOID LEUKEMIA WITH MULTILINEAGE DYSPLASIA, NOT HAVING ACHIEVED REMISSION",Acute Myeloid Leukemia with Multilineage Dysplasia,1,2,Acute Myeloid Leukemia with Multilineage Dysplasia,0.9828,Acute Myeloid Leukemia with Minimal Differentiation,0.9669,Acute Myeloid Leukemia without Maturation,0.9642,Myelodysplastic Syndrome with Multilineage Dysplasia,0.9618,Acute Myeloid Leukemia with Maturation,0.9604
ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA RELATED CHANGES,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,1,2,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.9996,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9745,Acute Myeloid Leukemia with Minimal Differentiation,0.9644,Acute Myeloid Leukemia with MLL Rearrangement,0.9642,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.9635
ACUTE MYELOID LEUKEMIAS,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.9966,Acute Monocytic Leukemia,0.9771,Acute Myelomonocytic Leukemia,0.9742,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9737,Acute Megakaryoblastic Leukemia,0.9726
ACUTE MYELOMONOCYTIC LEUKAEMIA,Acute Myelomonocytic Leukemia,1,2,Acute Myelomonocytic Leukemia,0.9931,Chronic Myelomonocytic Leukemia,0.9711,Acute Myeloid Leukemia,0.9686,Acute Monocytic Leukemia,0.9665,Chronic Myelomonocytic Leukemia-1,0.9627
ACUTE MYELOMONOCYTIC LEUKEMIA,Acute Myelomonocytic Leukemia,1,2,Acute Myelomonocytic Leukemia,1.0000,Chronic Myelomonocytic Leukemia,0.9765,Acute Myeloid Leukemia,0.9741,Acute Monocytic Leukemia,0.9719,Chronic Myelomonocytic Leukemia-1,0.9692
ACUTE PROMYELOCYTIC LEUKAEMIA WITH T(15;17)(Q22;Q12); PML-RARA,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,1,2,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.9912,Acute Promyelocytic Leukemia with PML-RARA,0.9787,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9771,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9734,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9733
ACUTE PROMYELOCYTIC LEUKAEMIA WITH T15;17Q22;Q12;  PML-RARA,Acute Promyelocytic Leukemia with PML-RARA,2,2,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.9835,Acute Promyelocytic Leukemia with PML-RARA,0.9757,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9714,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9664,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9664
ACUTE PROMYELOCYTIC LEUKAEMIA WITH T15;17Q22;Q12; PML-RARA,Acute Promyelocytic Leukemia with PML-RARA,2,2,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.9835,Acute Promyelocytic Leukemia with PML-RARA,0.9757,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9714,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9664,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9664
ACUTE UNDIFFERENTIATED LEUKAEMIA,Acute Undifferentiated Leukemia,1,2,Acute Undifferentiated Leukemia,0.9912,undifferentiated sarcoma,0.9566,Acute Leukemia of Ambiguous Lineage,0.9541,Undifferentiated Carcinoma,0.9532,Undifferentiated,0.9507
ACUTE UNDIFFERENTIATED LEUKEMIA,Acute Undifferentiated Leukemia,1,2,Acute Undifferentiated Leukemia,1.0000,Acute Leukemia of Ambiguous Lineage,0.9608,undifferentiated sarcoma,0.9559,Undifferentiated Carcinoma,0.9523,Undifferentiated,0.9505
ACUTE_BIPHENOTYPIC_LEUKEMIA,Acute Biphenotypic Leukemia,1,2,Acute Biphenotypic Leukemia,0.9942,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9539,Acute Monocytic Leukemia,0.9536,Acute Monoblastic and Monocytic Leukemia,0.9530,Acute Megakaryoblastic Leukemia,0.9529
ACUTE_LYMPHOBLASTIC_B_CELL_LEUKAEMIA,B Acute Lymphoblastic Leukemia,1,2,B Acute Lymphoblastic Leukemia,0.9817,Acute Lymphoblastic Leukemia,0.9782,T Acute Lymphoblastic Leukemia,0.9729,B Lymphoblastic Leukemia/Lymphoma,0.9702,B Acute Lymphoblastic Leukemia with t(9<;>22)(q34.1<;>q11.2)<;> BCR-ABL1,0.9633
ACUTE_LYMPHOBLASTIC_LEUKAEMIA,Acute Lymphoblastic Leukemia,1,2,Acute Lymphoblastic Leukemia,0.9870,B Acute Lymphoblastic Leukemia,0.9733,T Acute Lymphoblastic Leukemia,0.9715,Acute Monocytic Leukemia,0.9643,Acute Myeloid Leukemia,0.9641
ACUTE_LYMPHOBLASTIC_T_CELL_LEUKAEMIA,T Acute Lymphoblastic Leukemia,1,2,T Acute Lymphoblastic Leukemia,0.9845,Acute Lymphoblastic Leukemia,0.9770,B Acute Lymphoblastic Leukemia,0.9725,T Lymphoblastic Leukemia/Lymphoma,0.9689,Early T Acute Lymphoblastic Leukemia,0.9669
ACUTE_MONOCYTIC_LEUKEMIA,Acute Monocytic Leukemia,1,2,Acute Monocytic Leukemia,0.9927,Acute Myeloid Leukemia,0.9777,Acute Monoblastic and Monocytic Leukemia,0.9750,Acute Megakaryoblastic Leukemia,0.9722,Acute Myelomonocytic Leukemia,0.9689
ACUTE_MYELOID_LEUKAEMIA,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.9860,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9703,Acute Monocytic Leukemia,0.9699,Acute Myelomonocytic Leukemia,0.9643,Acute Megakaryoblastic Leukemia,0.9641
ACYC,Adenoid Cystic Carcinoma,99,2,Colon,0.8861,Colorectal,0.8819,Atypical Chronic Myeloid Leukemia,0.8789,Cystadenocarcinoma,0.8776,Adamantinoma,0.8774
ADAMANTINOMA,Adamantinoma,1,2,Adamantinoma,1.0000,Adamantinomatous Craniopharyngioma,0.9631,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9088,Adenocarcinoma,0.9038,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9028
ADCA ACINAR WITH MUCIN PRODUCTION,Lung Colloid Adenocarcinoma,99,2,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.9288,Adenocarcinoma,0.9270,Appendix Goblet Cell Adenocarcinoma,0.9257,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.9256,Adenocarcinoma<;>Moderately Differentiated,0.9251
ADENOCARCINOMA,Adenocarcinoma,1,2,Adenocarcinoma,1.0000,Breast Adenocarcinoma,0.9790,Lung Adenocarcinoma,0.9760,Prostate Adenocarcinoma,0.9717,Pancreatic Adenocarcinoma,0.9699
ADENOCARCINOMA AND MATURE CYSTIC TERATOMA,Adenocarcinoma<;>Dermoid Cyst,99,2,Mature Teratoma,0.9568,Teratoma with Somatic-Type Malignancy,0.9495,Seminoma<;>Mature Teratoma,0.9494,Teratoma,0.9490,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9482
ADENOCARCINOMA OF GALLBLADDER,Gallbladder Adenocarcinoma,1,2,Gallbladder Adenocarcinoma,0.9957,Gallbladder Carcinoma,0.9726,Gastric Adenocarcinoma,0.9666,Gallbladder Adenosquamous Carcinoma,0.9633,Adenocarcinoma,0.9632
ADENOCARCINOMA OF THE GASTROESOPHAGEAL JUNCTION,Gastroesophageal Junction Adenocarcinoma,1,2,Gastroesophageal Junction Adenocarcinoma,0.9928,Esophageal Adenocarcinoma,0.9646,Gastric Adenocarcinoma,0.9595,Gastroesophageal Cancer,0.9557,Adenocarcinoma,0.9547
ADENOCARCINOMA P/MD,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,99,2,Adenocarcinoma,0.9580,Prostate Adenocarcinoma,0.9507,Pancreatic Adenocarcinoma,0.9473,Lung Adenocarcinoma,0.9471,Adenocarcinoma<;>Poorly Differentiated,0.9468
ADENOCARCINOMA PROSTATE WITH PROMINENT DUCTAL DIFFERENTIATION IDENTIFIED,Prostate Ductal Adenocarcinoma,1,2,Prostate Ductal Adenocarcinoma,0.9746,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.9673,Pancreatic Ductal Adenocarcinoma,0.9638,Prostate Adenocarcinoma,0.9595,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.9594
ADENOCARCINOMA WITH FOCAL MUCINOUS FEATURES,Mucinous Adenocarcinoma,2,2,Colon Mucinous Adenocarcinoma,0.9525,Mucinous Adenocarcinoma,0.9498,Lung Mucinous Adenocarcinoma,0.9446,Breast Mucinous Carcinoma,0.9441,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.9437
ADENOCARCINOMA WITH NE FEATURES,Adenocarcinoma with Neuroendocrine Differentiation,1,2,Adenocarcinoma with Neuroendocrine Differentiation,0.9588,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.9486,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.9410,High Grade<;>Small Cell Neuroendocrine Carcinoma<;>Small Cell Adenocarcinoma,0.9376,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9372
"ADENOCARCINOMA, CLEAR CELL",Adenocarcinoma Clear Cell,1,2,Adenocarcinoma Clear Cell,0.9953,Clear Cell Adenocarcinoma,0.9910,Endometrial Clear Cell Adenocarcinoma,0.9770,Clear Cell Renal Cell Carcinoma,0.9734,"Lung Large Cell Carcinoma, Clear Cell Variant",0.9713
"ADENOCARCINOMA, ENDOMETRIOID",Endometrioid Adenocarcinoma,1,2,Endometrioid Adenocarcinoma,0.9869,Endometrial Endometrioid Adenocarcinoma,0.9846,Ovarian Endometrioid Adenocarcinoma,0.9822,Cervical Endometrioid Adenocarcinoma,0.9781,Endometrial Adenocarcinoma,0.9709
"ADENOCARCINOMA, HIGH GRADE SEROUS",Serous Adenocarcinoma<;>High Grade,1,2,Serous Adenocarcinoma<;>High Grade,0.9910,Ovarian High Grade Serous Adenocarcinoma,0.9865,Fallopian Tube High Grade Serous Adenocarcinoma,0.9793,Ovarian Low Grade Serous Adenocarcinoma,0.9792,Serous Adenocarcinoma,0.9713
"ADENOCARCINOMA, LOW GRADE SEROUS",Ovarian Low Grade Serous Adenocarcinoma,1,2,Ovarian Low Grade Serous Adenocarcinoma,0.9868,Serous Adenocarcinoma<;>High Grade,0.9839,Ovarian High Grade Serous Adenocarcinoma,0.9792,Fallopian Tube High Grade Serous Adenocarcinoma,0.9740,Serous Adenocarcinoma,0.9675
"ADENOCARCINOMA, MIXED",Mixed Cell Adenocarcinoma,1,2,Mixed Cell Adenocarcinoma,0.9812,"Lung Adenocarcinoma, Mixed Subtype",0.9789,Endometrial Carcinoma<;>Mixed,0.9625,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9620,Mixed Carcinoma,0.9610
"ADENOCARCINOMA, MIXED SUBTYPES","Lung Adenocarcinoma, Mixed Subtype",1,2,"Lung Adenocarcinoma, Mixed Subtype",0.9872,Mixed Cell Adenocarcinoma,0.9774,Endometrial Carcinoma<;>Mixed,0.9579,Endometrial Clear Cell Adenocarcinoma<;>Mixed,0.9568,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9559
"ADENOCARCINOMA, MUCINOUS",Mucinous Adenocarcinoma,1,2,Mucinous Adenocarcinoma,0.9856,Colon Mucinous Adenocarcinoma,0.9749,Lung Mucinous Adenocarcinoma,0.9737,Appendix Mucinous Adenocarcinoma,0.9721,Gastric Mucinous Adenocarcinoma,0.9698
"ADENOCARCINOMA, NOS",Adenocarcinoma,1,2,Adenocarcinoma,0.9638,Adenocarcinoma<;>Well Differentiated,0.9575,Adenocarcinoma<;>Poorly Differentiated,0.9555,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9540,Lung Adenocarcinoma,0.9521
"ADENOCARCINOMA, NOS 81403",Adenocarcinoma,1,2,Adenocarcinoma,0.9540,Adenocarcinoma<;>Well Differentiated,0.9531,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9519,Adenocarcinoma<;>Poorly Differentiated,0.9498,Adenocarcinoma<;>Moderately Differentiated,0.9486
"ADENOCARCINOMA, SEROUS",Serous Adenocarcinoma,1,2,Serous Adenocarcinoma,0.9856,Ovarian Serous Adenocarcinoma,0.9788,Endometrial Serous Adenocarcinoma,0.9737,Serous Adenocarcinoma<;>High Grade,0.9706,Ovarian High Grade Serous Adenocarcinoma,0.9645
"ADENOCARCINOMA, SIGNET RING CELL",Signet Ring Cell Carcinoma,2,2,Signet Ring Adenocarcinoma Cell,0.9948,Signet Ring Cell Carcinoma,0.9862,Rectal Signet Ring Cell Adenocarcinoma<;>Colon Signet Ring Cell Adenocarcinoma,0.9843,Gastric Signet Ring Cell Adenocarcinoma,0.9838,Appendix Signet Ring Cell Carcinoma,0.9816
"ADENOCARCINOMA, TUBULAR",Tubular Adenocarcinoma,1,2,Tubular Adenocarcinoma,0.9884,Tubular Adenocarcinoma<;>Moderately Differentiated,0.9758,Tubular Adenocarcinoma<;>Well Differentiated Adenocarcinoma Cell,0.9740,Gastric Tubular Adenocarcinoma,0.9733,Breast Tubular Carcinoma,0.9644
ADENOCARCINOMA- MAMMARY GLAND,Breast Adenocarcinoma,1,2,Breast Adenocarcinoma,0.9794,Adenocarcinoma,0.9757,Salivary Gland Adenocarcinoma,0.9626,Lung Adenocarcinoma,0.9613,Prostate Adenocarcinoma,0.9611
ADENOCARCINOMA- MAMMARY GLAND; BREAST; METASTATIC SITE: PLEURAL EFFUSION;,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,1,2,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9864,Breast Ductal Carcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9834,Pleural Effusion<;>Site of Metastasis,0.9712,Bone<;>Site of Metastasis<;>Prostate Adenocarcinoma,0.9498,Breast Adenocarcinoma,0.9455
ADENOCARCINOMA- NOS,Adenocarcinoma,1,2,Adenocarcinoma,0.9650,Adenocarcinoma<;>Well Differentiated,0.9598,Adenocarcinoma<;>Poorly Differentiated,0.9567,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9547,Lung Adenocarcinoma,0.9534
ADENOCARCINOMA- PROSTATE,Prostate Adenocarcinoma,1,2,Prostate Adenocarcinoma,0.9855,Adenocarcinoma,0.9762,Breast Adenocarcinoma,0.9637,Pancreatic Adenocarcinoma,0.9636,Prostate Ductal Adenocarcinoma,0.9634
ADENOCARCINOMA- PROSTATE; METASTATIC SITE: BONE;,Bone<;>Site of Metastasis<;>Prostate Adenocarcinoma,1,2,Bone<;>Site of Metastasis<;>Prostate Adenocarcinoma,0.9914,Bone<;>Site of Metastasis,0.9698,Prostate Adenocarcinoma,0.9576,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9565,Brain<;>Site of Metastasis,0.9516
ADENOCARCINOMA-MAMMARY GLAND,Breast Adenocarcinoma,1,2,Breast Adenocarcinoma,0.9794,Adenocarcinoma,0.9757,Salivary Gland Adenocarcinoma,0.9626,Lung Adenocarcinoma,0.9613,Prostate Adenocarcinoma,0.9611
ADENOCARCINOMA-MAMMARY GLAND; BREAST; EPITHELIAL; METASTATIC SITE: PLEURAL EFFUSION;,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,1,2,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9782,Breast Ductal Carcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9752,Pleural Effusion<;>Site of Metastasis,0.9631,Bone<;>Site of Metastasis<;>Prostate Adenocarcinoma,0.9448,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.9445
ADENOCARCINOMA-MD,Adenocarcinoma<;>Moderately Differentiated,5,2,Adenocarcinoma,0.9730,Breast Adenocarcinoma,0.9590,Prostate Adenocarcinoma,0.9550,Lung Adenocarcinoma,0.9549,Adenocarcinoma<;>Moderately Differentiated,0.9537
ADENOCARCINOMA-P/MD,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,99,2,Adenocarcinoma,0.9592,Prostate Adenocarcinoma,0.9511,Adenocarcinoma<;>Poorly Differentiated,0.9497,Adenocarcinoma<;>Moderately Differentiated,0.9493,Lung Adenocarcinoma,0.9491
ADENOCARCINOMA-UD,Adenocarcinoma<;>Undifferentiated,4,2,Adenocarcinoma,0.9591,Urethral Adenocarcinoma,0.9580,Bladder Adenocarcinoma,0.9545,Adenocarcinoma<;>Undifferentiated,0.9523,Breast Adenocarcinoma,0.9518
ADENOCARCINOMA-VPD,Adenocarcinoma<;>Poorly Differentiated,4,2,Prostate Adenocarcinoma,0.9547,Adenocarcinoma,0.9501,Vaginal Adenocarcinoma,0.9445,Adenocarcinoma<;>Poorly Differentiated,0.9435,Pancreatic Adenocarcinoma,0.9415
ADENOCARCINOMA-WD,Adenocarcinoma<;>Well Differentiated,3,2,Adenocarcinoma,0.9663,Breast Adenocarcinoma,0.9545,Adenocarcinoma<;>Well Differentiated,0.9544,Adenocarcinoma<;>Poorly Differentiated,0.9519,Lung Adenocarcinoma,0.9497
ADENOCARCINOME-PD,Adenocarcinoma<;>Poorly Differentiated,5,2,Adenocarcinoma,0.9271,Adenocarcinoma<;>Dermoid Cyst,0.9263,Lung Micropapillary Adenocarcinoma,0.9255,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9250,Adenocarcinoma<;>Poorly Differentiated,0.9243
ADENOCARINOMA,Adenocarcinoma,99,2,Adenosarcoma,0.9561,Adenoid Cystic Carcinoma,0.9472,Uterine Corpus Adenosarcoma,0.9452,Breast Adenoid Cystic Carcinoma,0.9414,Lung Adenoid Cystic Carcinoma,0.9406
ADENOID CYSTIC BREAST CANCER,Breast Adenoid Cystic Carcinoma,1,2,Breast Adenoid Cystic Carcinoma,0.9919,Adenoid Cystic Carcinoma,0.9850,Cervical Adenoid Cystic Carcinoma,0.9729,Lung Adenoid Cystic Carcinoma,0.9713,Gallbladder Adenosquamous Carcinoma,0.9492
ADENOID CYSTIC CARCINOMA,Adenoid Cystic Carcinoma,1,2,Adenoid Cystic Carcinoma,1.0000,Breast Adenoid Cystic Carcinoma,0.9889,Cervical Adenoid Cystic Carcinoma,0.9857,Lung Adenoid Cystic Carcinoma,0.9836,Adenosquamous Carcinoma,0.9611
ADENOID CYSTIC CARCINOMA OF THE LUNG,Lung Adenoid Cystic Carcinoma,1,2,Lung Adenoid Cystic Carcinoma,0.9941,Adenoid Cystic Carcinoma,0.9894,Breast Adenoid Cystic Carcinoma,0.9803,Cervical Adenoid Cystic Carcinoma,0.9735,Lung Adenosquamous Carcinoma,0.9707
ADENOSARCOMA,Adenosarcoma,1,2,Adenosarcoma,1.0000,Uterine Corpus Adenosarcoma,0.9686,Chondrosarcoma,0.9581,Angiosarcoma,0.9564,Breast Angiosarcoma,0.9507
ADENOSQUAMOUS,Adenosquamous Carcinoma,1,2,Adenosquamous Carcinoma,0.9793,Lung Adenosquamous Carcinoma,0.9739,Esophageal Adenosquamous Carcinoma,0.9663,Gastric Adenosquamous Carcinoma,0.9660,Endometrial Adenosquamous Carcinoma,0.9639
ADENOSQUAMOUS CARCINOMA,Adenosquamous Carcinoma,1,2,Adenosquamous Carcinoma,1.0000,Lung Adenosquamous Carcinoma,0.9886,Endometrial Adenosquamous Carcinoma,0.9862,Cervical Adenosquamous Carcinoma,0.9850,Gastric Adenosquamous Carcinoma,0.9838
ADENOSQUAMOUS CARCINOMA OF GALLBLADDER,Gallbladder Adenosquamous Carcinoma,1,2,Gallbladder Adenosquamous Carcinoma,0.9975,Gastric Adenosquamous Carcinoma,0.9815,Adenosquamous Carcinoma,0.9778,Pancreatic Adenosquamous Carcinoma,0.9746,Endometrial Adenosquamous Carcinoma,0.9713
ADENOSQUAMOUS CARCINOMA OF THE GALLBLADDER,Gallbladder Adenosquamous Carcinoma,1,2,Gallbladder Adenosquamous Carcinoma,0.9962,Gastric Adenosquamous Carcinoma,0.9829,Adenosquamous Carcinoma,0.9807,Pancreatic Adenosquamous Carcinoma,0.9755,Endometrial Adenosquamous Carcinoma,0.9743
ADENOSQUAMOUS CARCINOMA OF THE PANCREAS,Pancreatic Adenosquamous Carcinoma,1,2,Pancreatic Adenosquamous Carcinoma,0.9932,Pancreatic Adenosquamous Carcinoma<;>Ductal,0.9845,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.9840,Adenosquamous Carcinoma,0.9840,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland,0.9803
ADENOSQUAMOUS CARCINOMA OF THE STOMACH,Gastric Adenosquamous Carcinoma,1,2,Gastric Adenosquamous Carcinoma,0.9911,Adenosquamous Carcinoma,0.9882,Lung Adenosquamous Carcinoma,0.9802,Gallbladder Adenosquamous Carcinoma,0.9802,Endometrial Adenosquamous Carcinoma,0.9798
ADRENAL,Adrenal Gland,1,2,Adrenal Gland,0.9870,Adrenal Gland Pheochromocytoma,0.9556,Adrenal Gland Carcinoma,0.9399,Adrenal Gland Neoplasm,0.9396,Adrenal Cortical Adenoma,0.9320
ADRENAL GLAND,Adrenal Gland,1,2,Adrenal Gland,1.0000,Adrenal Gland Pheochromocytoma,0.9656,Adrenal Gland Neoplasm,0.9461,Adrenal Gland Carcinoma,0.9445,Adrenal Gland Pheochromocytoma<;>Paraganglioma,0.9373
ADRENAL TUMOR,Adrenal Gland Neoplasm,1,2,Adrenal Gland Neoplasm,0.9775,Adrenal Gland Carcinoma,0.9704,Adrenal Cortical Carcinoma,0.9524,Adrenal Gland Pheochromocytoma,0.9512,Adrenal Cortical Oncocytic Carcinoma,0.9478
ADRENAL_CARCINOMA,Adrenal Gland Carcinoma,1,2,Adrenal Gland Carcinoma,0.9893,Adrenal Cortical Carcinoma,0.9778,Adrenal Gland Neoplasm,0.9693,Adrenal Cortical Oncocytic Carcinoma,0.9637,Adrenal Cortical Myxoid Carcinoma,0.9599
ADRENOCORTICAL ADENOMA,Adrenal Cortical Adenoma,1,2,Adrenal Cortical Adenoma,0.9718,Adrenal Gland Neoplasm,0.9486,Hepatocellular Adenoma,0.9446,Adrenal Gland Carcinoma,0.9401,Adrenal Cortical Oncocytic Carcinoma,0.9388
ADRENOCORTICAL CARCINOMA,Adrenal Cortical Carcinoma,1,2,Adrenal Cortical Carcinoma,0.9732,Adrenal Gland Carcinoma,0.9712,Adrenal Cortical Oncocytic Carcinoma,0.9645,Adrenal Cortical Myxoid Carcinoma,0.9623,Adrenal Gland Neoplasm,0.9540
ADRENOCORTICAL CARCINOMA- MYXOID TYPE,Adrenal Cortical Myxoid Carcinoma,1,2,Adrenal Cortical Myxoid Carcinoma,0.9714,Adrenal Cortical Carcinoma,0.9446,Adrenal Cortical Oncocytic Carcinoma,0.9444,Adrenal Gland Carcinoma,0.9422,Myxoma,0.9412
ADRENOCORTICAL CARCINOMA- ONCOCYTIC TYPE,Adrenal Cortical Oncocytic Carcinoma,1,2,Adrenal Cortical Oncocytic Carcinoma,0.9741,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.9583,Thyroid Gland Oncocytic Carcinoma,0.9582,Adrenal Cortical Carcinoma,0.9517,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.9517
ADRENOCORTICAL CARCINOMA- USUAL TYPE,Adrenal Cortical Carcinoma,3,2,Normal Breast-Like Subtype of Breast Carcinoma,0.9466,Adrenal Gland Carcinoma,0.9459,Adrenal Cortical Carcinoma,0.9449,Adrenal Cortical Myxoid Carcinoma,0.9414,Nasopharyngeal-Type Undifferentiated Carcinoma,0.9410
ADULT T-CELL LEUKEMIA/LYMPHOMA,Adult T-Cell Leukemia/Lymphoma,1,2,Adult T-Cell Leukemia/Lymphoma,1.0000,T Lymphoblastic Leukemia/Lymphoma,0.9676,T Acute Lymphoblastic Leukemia,0.9555,T-Cell Non-Hodgkin Lymphoma,0.9541,B Lymphoblastic Leukemia/Lymphoma,0.9532
ADULT_T_CELL_LYMPHOMA-LEUKAEMIA,Adult T-Cell Leukemia/Lymphoma,1,2,Adult T-Cell Leukemia/Lymphoma,0.9882,T Lymphoblastic Leukemia/Lymphoma,0.9609,T-Cell Non-Hodgkin Lymphoma,0.9529,T Acute Lymphoblastic Leukemia,0.9493,B Lymphoblastic Leukemia/Lymphoma,0.9481
AGGRESSIVE DIGITAL PAPILLARY ADENOCARCINOMA,Digital Papillary Adenocarcinoma,1,2,Digital Papillary Adenocarcinoma,0.9809,Papillary Adenocarcinoma,0.9671,Lung Papillary Adenocarcinoma,0.9581,Acinar Cell Carcinoma<;>Papillary,0.9507,Gastric Papillary Adenocarcinoma,0.9490
ALL,Acute Lymphoblastic Leukemia,99,2,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.8916,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.8913,"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",0.8907,Mature B-Cell Non-Hodgkin Lymphoma,0.8883,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.8876
ALL CELLS WERE TAKEN WHEN PATIENT WAS IN RELAPSE,Acute Lymphoblastic Leukemia<;>Recurrent Disease,2,2,Relapse,0.9401,Acute Lymphoblastic Leukemia<;>Recurrent Disease,0.9245,First Relapse,0.9209,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9208,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.9199
ALVEOLAR,Alveolar,1,2,Alveolar,1.0000,Alveolar Rhabdomyosarcoma,0.9400,Lung Acinar Adenocarcinoma,0.9260,Acinar Cell,0.9192,Lung,0.9116
ALVEOLAR RHABDOMYOSARCOMA,Alveolar Rhabdomyosarcoma,1,2,Alveolar Rhabdomyosarcoma,1.0000,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.9597,Rhabdomyosarcoma,0.9503,Alveolar,0.9400,Pleomorphic Rhabdomyosarcoma,0.9334
ALVEOLAR SOFT PART SARCOMA,Alveolar Soft Part Sarcoma,1,2,Alveolar Soft Part Sarcoma,1.0000,Soft Tissue Sarcoma,0.9547,Sarcoma,0.9430,Soft Tissue Neoplasm,0.9411,Malignant Soft Tissue Neoplasm,0.9391
AMELANOTIC,Amelanotic Melanoma,1,2,Amelanotic Melanoma,0.9815,Atypical Spindle Melanocyte<;>Epithelioid Melanocyte,0.9055,Keratoacanthoma,0.9048,Adamantinoma,0.9037,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells<;>Sarcomatoid Carcinoma,0.9027
AMELANOTIC NODULAR,Cutaneous Nodular Melanoma,2,2,Amelanotic Melanoma,0.9529,Cutaneous Nodular Melanoma,0.9418,Nodular Neoplasm,0.9366,Desmoplastic/Nodular Medulloblastoma,0.9233,"Ganglioneuroblastoma, Nodular",0.9184
AML,Acute Myeloid Leukemia,2,2,Acute Myeloid Leukemia with Mutated RUNX1,0.9463,Acute Myeloid Leukemia,0.9446,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9437,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9425,AML1-ETO Fusion Protein Expression,0.9415
AML WITH BIALLELIC MUTATIONS OF CEBPA,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,1,2,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0.9895,Acute Myeloid Leukemia with Mutated CEBPA,0.9638,Acute Myeloid Leukemia with Mutated RUNX1,0.9386,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.9376,Acute Myeloid Leukemia with Mutated NPM1,0.9358
AML WITH INV(16)(P13.1Q22) OR T(16;16)(P13.1;Q22); CBFB-MYH11,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,1,2,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9882,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9794,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9794,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9728,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9725
AML WITH INV(3)(Q21Q26.2) OR T(3;3)(Q21;Q26.2); RPN1-EVI1,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",2,2,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9863,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9863,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9770,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9713,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9713
AML WITH INV16P13.1;Q22 OR T16:16P13.1:Q22;  CBFB-MYH11,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,1,2,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9779,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9705,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9705,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9644,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9644
AML WITH INV16P13.1Q22 OR T16;16P13.1;Q22; CBFB-MYH11,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,1,2,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9759,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9679,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9679,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9655,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9654
AML WITH INV16P13.1Q22 OR T16;16P13.1;Q22;CBFB-MYH11,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,1,2,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9759,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9679,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9679,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9655,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9654
"AML WITH INV3Q21.3;Q26.2 OR T3;3Q21.3;Q26.2; GATA2, MECOM","Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",1,2,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9762,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9762,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9672,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9640,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9640
"AML WITH INV3Q21.3Q26.2 OR T3;3Q21.3;Q26.2; GATA2, MECOM","Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",1,2,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9758,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9758,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9665,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9636,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9636
AML WITH INV3Q21;Q26.2 OR T3;3Q21;Q26.2; RPN1-EVI1,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",1,2,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9763,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9763,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9675,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9640,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9640
AML WITH INV3Q21Q26.2 OR T3;3Q21;Q26.2; RPN1-EVI1,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",1,2,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9689,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9689,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9646,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9590,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9589
AML WITH MATURATION,Acute Myeloid Leukemia with Maturation,1,2,Acute Myeloid Leukemia with Maturation,0.9684,Acute Myeloid Leukemia without Maturation,0.9589,Acute Myeloid Leukemia with Multilineage Dysplasia,0.9399,Acute Myeloid Leukemia with Minimal Differentiation,0.9391,Acute Myeloid Leukemia without Maturation<;>Auer Rods Present,0.9371
AML WITH MINIMAL DIFFERENTIATION,Acute Myeloid Leukemia with Minimal Differentiation,1,2,Acute Myeloid Leukemia with Minimal Differentiation,0.9794,Acute Myeloid Leukemia with Multilineage Dysplasia,0.9483,Acute Myeloid Leukemia with Maturation,0.9441,Acute Myeloid Leukemia without Maturation,0.9425,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.9372
AML WITH MUTATED CEBPA,Acute Myeloid Leukemia with Mutated CEBPA,1,2,Acute Myeloid Leukemia with Mutated CEBPA,0.9865,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0.9668,Acute Myeloid Leukemia with Mutated RUNX1,0.9586,Acute Myeloid Leukemia with Mutated NPM1,0.9551,AML1-ETO Fusion Protein Expression,0.9355
AML WITH MUTATED NPM1,Acute Myeloid Leukemia with Mutated NPM1,1,2,Acute Myeloid Leukemia with Mutated NPM1,0.9871,Acute Myeloid Leukemia with Mutated CEBPA,0.9613,Acute Myeloid Leukemia with Mutated RUNX1,0.9595,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0.9452,Acute Myeloid Leukemia with MLL Rearrangement,0.9406
AML WITH MUTATED RUNX1,Acute Myeloid Leukemia with Mutated RUNX1,1,2,Acute Myeloid Leukemia with Mutated RUNX1,0.9861,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9602,Acute Myeloid Leukemia with Mutated CEBPA,0.9601,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9586,Acute Myeloid Leukemia with Mutated NPM1,0.9556
AML WITH MYELODYSPLASIA-RELATED CHANGES,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,1,2,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.9866,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9584,Therapy-Related Myelodysplastic Syndrome,0.9570,Myelodysplastic Syndrome,0.9546,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.9544
AML WITH RECURRENT GENETIC ABNORMALITIES,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,1,2,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.9851,Recurrent Acute Myeloid Leukemia,0.9642,Acute Myeloid Leukemia with Mutated RUNX1,0.9539,Acute Lymphoblastic Leukemia<;>Recurrent Disease,0.9513,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9500
AML WITH T(6;9)(P23;Q34); DEK-NUP214,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,2,2,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.9813,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.9807,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9679,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9679,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9645
AML WITH T(8;21)(Q22;Q22); RUNX1-RUNX1T1,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,2,2,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9895,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9895,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9775,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9743,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9743
AML WITH T(9;11)(P22;Q23); MLLT3-MLL,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,1,2,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9903,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9903,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9750,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9749,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9745
AML WITH T6:9P23:Q34.1; DEK-NUP214,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,2,2,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.9687,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.9683,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9579,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9578,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9572
AML WITH T6;9P23;Q34.1;DEK-NUP214,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,2,2,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.9692,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.9681,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9600,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9594,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9586
AML WITH T6;9P23;Q34; DEK-NUP214,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,2,2,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.9696,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.9688,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9591,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9586,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9576
AML WITH T8;21Q22;Q22.1; RUNX1-RUNX1T1,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,1,2,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9696,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9688,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9576,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9576,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9568
AML WITH T8;21Q22;Q22.1;RUNX1-RUNX1T1,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,1,2,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9696,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9688,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9576,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9576,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9568
AML WITH T8;21Q22;Q22; RUNX1-RUNX1T1,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,1,2,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9689,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9679,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9566,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9564,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9564
AML WITH T9;11P22;Q23;  MLLT3-MLL,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,2,2,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9881,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9881,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9741,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9741,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9730
AML WITH T9;11P22;Q23; MLLT3-MLL,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,2,2,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9881,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9881,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9741,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9741,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9730
AML WITHOUT MATURATION,Acute Myeloid Leukemia without Maturation,1,2,Acute Myeloid Leukemia without Maturation,0.9734,Acute Myeloid Leukemia with Maturation,0.9521,Acute Myeloid Leukemia without Maturation<;>Auer Rods Present,0.9423,Acute Myeloid Leukemia with Minimal Differentiation,0.9312,Acute Myeloid Leukemia with Maturation<;>Auer Rods Present,0.9270
"AML, NOS",Acute Myeloid Leukemia Not Otherwise Specified,4,2,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9433,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9418,Acute Myeloid Leukemia with Mutated RUNX1,0.9406,Acute Myeloid Leukemia Not Otherwise Specified,0.9405,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9400
AML-MDS,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,3,2,Acute Myeloid Leukemia with Multilineage Dysplasia,0.9418,Myelodysplastic Syndrome with Excess Blasts-1,0.9405,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9400,Myelodysplastic Syndrome with Excess Blasts-2,0.9393,Acute Myeloid Leukemia with Mutated RUNX1,0.9383
AMLM,Acute Myeloid Leukemia,5,2,AML1-ETO Fusion Protein Expression,0.9387,Acute Myeloid Leukemia with Mutated RUNX1,0.9355,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9340,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9325,Acute Myeloid Leukemia,0.9298
AMPULLARY CANCER,Ampulla of Vater Carcinoma,1,2,Ampulla of Vater Carcinoma,0.9341,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma,0.9287,Medullary Carcinoma,0.9251,Pancreatic Carcinoma,0.9241,Pancreatic Adenocarcinoma,0.9229
AMPULLARY CARCINOMA,Ampulla of Vater Carcinoma,2,2,Medullary Carcinoma,0.9490,Ampulla of Vater Carcinoma,0.9489,Pancreatic Carcinoma,0.9480,Breast Medullary Carcinoma,0.9448,Colon Medullary Carcinoma,0.9417
ANAL CANCER,Anal Carcinoma,1,2,Anal Carcinoma,0.9806,Anal Squamous Cell Carcinoma,0.9588,Anal Glands Adenocarcinoma,0.9428,Rectal Adenocarcinoma,0.9304,Colorectal Adenocarcinoma,0.9239
ANAL GLAND ADENOCARCINOMA,Anal Glands Adenocarcinoma,1,2,Anal Glands Adenocarcinoma,0.9954,Prostate Adenocarcinoma,0.9638,Salivary Gland Adenocarcinoma,0.9615,Anal Carcinoma,0.9588,Adenocarcinoma,0.9584
ANAL SQUAMOUS CELL,Anal Squamous Cell Carcinoma,1,2,Anal Squamous Cell Carcinoma,0.9879,Squamous Cell Carcinoma,0.9638,Prostate Squamous Cell Carcinoma,0.9609,Esophageal Squamous Cell Carcinoma,0.9595,Skin Squamous Cell Carcinoma,0.9583
ANAL SQUAMOUS CELL CARCINOMA,Anal Squamous Cell Carcinoma,1,2,Anal Squamous Cell Carcinoma,1.0000,Squamous Cell Carcinoma,0.9762,Anal Carcinoma,0.9739,Esophageal Squamous Cell Carcinoma,0.9734,Prostate Squamous Cell Carcinoma,0.9731
ANAPLASTIC,Anaplastic,1,2,Anaplastic,1.0000,Anaplastic Astrocytoma,0.9784,Anaplastic Carcinoma,0.9742,Anaplastic Medulloblastoma,0.9706,Anaplastic Oligodendroglioma,0.9689
ANAPLASTIC ASTROCYTOMA,Anaplastic Astrocytoma,1,2,Anaplastic Astrocytoma,1.0000,Anaplastic,0.9784,Malignant Glioma<;>Anaplastic Astrocytoma,0.9727,Anaplastic Oligodendroglioma,0.9714,Anaplastic Medulloblastoma,0.9709
"ANAPLASTIC ASTROCYTOMA, IDH-MUTANT","Astrocytoma, IDH-Mutant, Grade 3",2,2,"Anaplastic Astrocytoma, IDH-Wildtype",0.9840,"Astrocytoma, IDH-Mutant, Grade 3",0.9809,"Astrocytoma, IDH-Mutant, Grade 2",0.9804,"Astrocytoma, IDH-Mutant, Grade 4",0.9784,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9658
"ANAPLASTIC ASTROCYTOMA, IDH-WILDTYPE","Anaplastic Astrocytoma, IDH-Wildtype",1,2,"Anaplastic Astrocytoma, IDH-Wildtype",1.0000,"Glioblastoma, IDH-Wildtype",0.9756,"Astrocytoma, IDH-Mutant, Grade 3",0.9721,"Astrocytoma, IDH-Mutant, Grade 2",0.9719,"Astrocytoma, IDH-Mutant, Grade 4",0.9683
ANAPLASTIC EPENDYMOMA,Anaplastic Ependymoma,1,2,Anaplastic Ependymoma,1.0000,Anaplastic Astrocytoma,0.9696,Anaplastic Medulloblastoma,0.9662,Anaplastic,0.9652,Ependymoma,0.9609
ANAPLASTIC GANGLIOGLIOMA,Anaplastic Ganglioglioma,1,2,Anaplastic Ganglioglioma,1.0000,Ganglioglioma,0.9670,Anaplastic Oligodendroglioma,0.9668,Malignant Glioma<;>Anaplastic Astrocytoma,0.9568,Anaplastic Astrocytoma,0.9556
ANAPLASTIC LARGE CELL LYMPHOMA,Anaplastic Large Cell Lymphoma,1,2,Anaplastic Large Cell Lymphoma,1.0000,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.9698,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.9625,Large Cell/Anaplastic Medulloblastoma,0.9624,Anaplastic,0.9559
ANAPLASTIC LARGE-CELL LYMPHOMA ALK NEGATIVE,"Anaplastic Large Cell Lymphoma, ALK-Negative",1,2,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.9958,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.9819,Anaplastic Large Cell Lymphoma,0.9566,"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",0.9422,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9352
ANAPLASTIC LARGE-CELL LYMPHOMA ALK POSITIVE,"Anaplastic Large Cell Lymphoma, ALK-Positive",1,2,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.9969,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.9863,Anaplastic Large Cell Lymphoma,0.9664,Anaplastic,0.9418,Large Cell/Anaplastic Medulloblastoma,0.9417
ANAPLASTIC MEDULLOBLASTOMA,Anaplastic Medulloblastoma,1,2,Anaplastic Medulloblastoma,1.0000,Anaplastic Astrocytoma,0.9709,Anaplastic,0.9706,Anaplastic Ependymoma,0.9662,Anaplastic (Malignant) Meningioma,0.9610
ANAPLASTIC MENINGIOMA,Anaplastic (Malignant) Meningioma,1,2,Anaplastic (Malignant) Meningioma,0.9868,Anaplastic,0.9779,Anaplastic Astrocytoma,0.9773,Anaplastic Medulloblastoma,0.9694,Anaplastic Oligodendroglioma,0.9680
ANAPLASTIC OLIGOASTROCYTOMA,Anaplastic Oligoastrocytoma,1,2,Anaplastic Oligoastrocytoma,1.0000,Oligoastrocytoma,0.9771,Anaplastic Oligodendroglioma,0.9701,Anaplastic,0.9566,Anaplastic Astrocytoma,0.9550
ANAPLASTIC OLIGODENDROGLIOMA,Anaplastic Oligodendroglioma,1,2,Anaplastic Oligodendroglioma,1.0000,Anaplastic Astrocytoma,0.9714,Anaplastic Oligoastrocytoma,0.9701,Anaplastic,0.9689,Oligodendroglioma,0.9677
"ANAPLASTIC OLIGODENDROGLIOMA, IDH-MUTANT AND 1P/19Q CO-DELETED","Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1,2,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9908,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9852,"Astrocytoma, IDH-Mutant, Grade 2",0.9621,"Astrocytoma, IDH-Mutant, Grade 3",0.9614,"Astrocytoma, IDH-Mutant, Grade 4",0.9602
"ANAPLASTIC OLIGODENDROGLIOMA, IDH-MUTANT AND 1P/19Q-CODELETED","Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1,2,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1.0000,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9949,"Astrocytoma, IDH-Mutant, Grade 3",0.9634,"Astrocytoma, IDH-Mutant, Grade 2",0.9624,"Astrocytoma, IDH-Mutant, Grade 4",0.9621
ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA,Anaplastic Pleomorphic Xanthoastrocytoma,1,2,Anaplastic Pleomorphic Xanthoastrocytoma,1.0000,Pleomorphic Xanthoastrocytoma,0.9822,Anaplastic,0.9494,Anaplastic Ependymoma,0.9483,Anaplastic Astrocytoma,0.9429
ANAPLASTIC THYROID CANCER,Thyroid Gland Anaplastic Carcinoma,1,2,Thyroid Gland Anaplastic Carcinoma,0.9878,Anaplastic Carcinoma,0.9692,Anaplastic,0.9573,Thyroid Gland Papillary Carcinoma,0.9561,Thyroid Gland Papillary and Follicular Carcinoma,0.9553
ANAPLASTIC THYROID CARCINOMA,Thyroid Gland Anaplastic Carcinoma,1,2,Thyroid Gland Anaplastic Carcinoma,0.9957,Anaplastic Carcinoma,0.9805,Thyroid Gland Carcinoma,0.9636,Thyroid Gland Papillary Carcinoma,0.9629,Anaplastic,0.9607
ANAPLASTIC_CARCINOMA,Anaplastic Carcinoma,1,2,Anaplastic Carcinoma,0.9927,Anaplastic,0.9732,Thyroid Gland Anaplastic Carcinoma,0.9726,Anaplastic Astrocytoma,0.9622,Anaplastic (Malignant) Meningioma,0.9604
ANAPLASTIC_LARGE_CELL_LYMPHOMA,Anaplastic Large Cell Lymphoma,1,2,Anaplastic Large Cell Lymphoma,0.9928,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.9698,Large Cell/Anaplastic Medulloblastoma,0.9650,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.9628,Anaplastic,0.9558
ANGIOCENTRIC GLIOMA,Angiocentric Glioma,1,2,Angiocentric Glioma,1.0000,Angiosarcoma,0.9265,Breast Angiosarcoma,0.9223,Adamantinomatous Craniopharyngioma,0.9211,Angioimmunoblastic T-Cell Lymphoma,0.9207
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,Angioimmunoblastic T-Cell Lymphoma,1,2,Angioimmunoblastic T-Cell Lymphoma,1.0000,Adult T-Cell Leukemia/Lymphoma,0.9483,T Lymphoblastic Leukemia/Lymphoma,0.9461,T-Cell Non-Hodgkin Lymphoma,0.9438,Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma,0.9412
ANGIOSARCOMA,Angiosarcoma,1,2,Angiosarcoma,1.0000,Breast Angiosarcoma,0.9839,Adenosarcoma,0.9564,Chondrosarcoma,0.9544,Uterine Corpus Adenosarcoma,0.9368
ANORECTAL MUCOSAL MELANOMA,Mucosal Melanoma<;>Anorectal,1,2,Mucosal Melanoma<;>Anorectal,0.9888,Mucosal Melanoma,0.9494,Mucosal Melanoma of the Head and Neck,0.9413,Rectal Mucinous Adenocarcinoma,0.9355,Colon Carcinoma<;>Melanoma,0.9325
ANSC,Anal Squamous Cell Carcinoma,99,2,Neurofibroma,0.8943,Not Otherwise Specified,0.8914,Neuroblastoma,0.8890,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.8859,Cecum,0.8859
APAD,Appendix Adenocarcinoma,99,2,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9018,Periosteal Osteosarcoma,0.9011,"Posterior Fossa Ependymoma, Group A (PFA)",0.9009,Astrocytoma,0.9009,Pancreatic Adenocarcinoma<;>Poorly Differentiated Adenocarcinoma Cell,0.8998
APL WITH PML-RARA,Acute Promyelocytic Leukemia with PML-RARA,1,2,Acute Promyelocytic Leukemia with PML-RARA,0.9733,PML-RARA Fusion Protein Expression,0.9471,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.9371,Acute Myeloid Leukemia with MLL Rearrangement,0.9291,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9290
APPENDICEAL ADENOCARCINOMA,Appendix Adenocarcinoma,1,2,Appendix Adenocarcinoma,0.9655,Appendix Mucinous Adenocarcinoma,0.9619,Appendix Goblet Cell Adenocarcinoma,0.9471,Adenocarcinoma,0.9463,Cecum Adenocarcinoma,0.9442
APPENDICEAL CANCER,Appendix Carcinoma,1,2,Appendix Carcinoma,0.9368,Appendix Adenocarcinoma,0.9344,Appendix Mucinous Adenocarcinoma,0.9330,Appendix Neuroendocrine Tumor,0.9205,Appendix Goblet Cell Adenocarcinoma,0.9201
ARM,Arm,1,2,Arm,1.0000,Thigh,0.8773,Rhabdomyosarcoma,0.8733,Monoclonal B-Cell Lymphocytosis,0.8720,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.8711
ASCENDING COLON,Ascending Colon,1,2,Ascending Colon,1.0000,Colon,0.9552,Sigmoid Colon,0.9547,Descending Colon,0.9538,Transverse Colon,0.9378
ASPS,Alveolar Soft Part Sarcoma,99,2,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.9045,Pancreatic Adenocarcinoma<;>Poorly Differentiated Adenocarcinoma Cell,0.9007,Pancreatic Serous Cystadenoma,0.8987,"Astrocytoma, IDH-Mutant, Grade 2",0.8985,"Astrocytoma, IDH-Mutant, Grade 3",0.8982
ASTOMOSIS RECURRENCE,Anastomosis<;>Recurrence,1,2,Anastomosis<;>Recurrence,0.9276,Recurrence,0.9255,Recurrent,0.9245,Recurrent Acute Myeloid Leukemia,0.9194,Metastatic Lesion<;>Recurrent,0.9143
ASTROBLASTOMA,"Astroblastoma, MN1-Altered",1,2,"Astroblastoma, MN1-Altered",0.9535,Hepatoblastoma,0.9472,Pineoblastoma,0.9379,Hemangioblastoma,0.9327,Medulloblastoma,0.9262
ASTROCYTOMA,Astrocytoma,1,2,Astrocytoma,1.0000,Anaplastic Astrocytoma,0.9654,"Astrocytoma, IDH-Mutant, Grade 2",0.9505,"Anaplastic Astrocytoma, IDH-Wildtype",0.9503,Pilocytic Astrocytoma,0.9484
"ASTROCYTOMA, ANAPLASTIC",Anaplastic Astrocytoma,1,2,Anaplastic Astrocytoma,0.9856,Malignant Glioma<;>Anaplastic Astrocytoma,0.9726,Anaplastic (Malignant) Meningioma,0.9711,Anaplastic,0.9706,"Anaplastic Astrocytoma, IDH-Wildtype",0.9694
"ASTROCYTOMA, SUBTYPE INDETERMINATE",Astrocytoma,1,2,Astrocytoma,0.9463,"Astrocytoma, IDH-Mutant, Grade 3",0.9444,"Astrocytoma, IDH-Mutant, Grade 4",0.9444,"Astrocytoma, IDH-Mutant, Grade 2",0.9434,"Anaplastic Astrocytoma, IDH-Wildtype",0.9393
ASTROCYTOMA_GRADE_III,Astrocytoma,2,2,"Astrocytoma, IDH-Mutant, Grade 3",0.9627,Astrocytoma,0.9605,"Astrocytoma, IDH-Mutant, Grade 4",0.9568,"Astrocytoma, IDH-Mutant, Grade 2",0.9541,Malignant Glioma<;>Anaplastic Astrocytoma,0.9536
ASTROCYTOMA_GRADE_III-IV,High Grade Astrocytic Tumor,5,2,"Astrocytoma, IDH-Mutant, Grade 4",0.9654,"Astrocytoma, IDH-Mutant, Grade 3",0.9651,Astrocytoma,0.9589,"Astrocytoma, IDH-Mutant, Grade 2",0.9586,High Grade Astrocytic Tumor,0.9533
ASTROCYTOMA_GRADE_IV,Astrocytoma,3,2,"Astrocytoma, IDH-Mutant, Grade 4",0.9648,"Astrocytoma, IDH-Mutant, Grade 3",0.9582,Astrocytoma,0.9552,"Astrocytoma, IDH-Mutant, Grade 2",0.9548,High Grade Astrocytic Tumor,0.9501
ATL,Adult T-Cell Leukemia/Lymphoma,3,2,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9236,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9236,Adult T-Cell Leukemia/Lymphoma,0.9198,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9195,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9143
ATRT,Atypical Teratoid/Rhabdoid Tumor,99,2,Adult T-Cell Leukemia/Lymphoma,0.9054,Rectum,0.9025,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9023,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9023,Angioimmunoblastic T-Cell Lymphoma,0.9011
ATYPICAL CHOROID PLEXUS PAPILLOMA,Atypical Choroid Plexus Papilloma,1,2,Atypical Choroid Plexus Papilloma,1.0000,Choroid Plexus Papilloma,0.9722,Choroid Plexus Neoplasm,0.9467,Atypical Meningioma,0.9448,Papilloma,0.9383
"ATYPICAL CHRONIC MYELOID LEUKAEMIA, BCR-ABL1 NEGATIVE","Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",1,2,"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",0.9981,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9732,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9659,Atypical Chronic Myeloid Leukemia,0.9633,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.9628
"ATYPICAL CHRONIC MYELOID LEUKEMIA, BCR-ABL1-","Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",1,2,"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",0.9857,Atypical Chronic Myeloid Leukemia,0.9764,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9662,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9616,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.9616
ATYPICAL GRANULAR CELL TUMOR,Granular Cell Tumor<;>Atypical,1,2,Granular Cell Tumor<;>Atypical,0.9921,Granular Cell Tumor,0.9674,Atypical Teratoid/Rhabdoid Tumor,0.9534,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.9474,Lung Atypical Carcinoid Tumor,0.9436
ATYPICAL LUNG CARCINOID,Lung Atypical Carcinoid Tumor,1,2,Lung Atypical Carcinoid Tumor,0.9882,Lung Carcinoid Tumor,0.9487,Atypical Meningioma,0.9442,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.9392,Atypical Teratoid/Rhabdoid Tumor,0.9381
ATYPICAL MENINGIOMA,Atypical Meningioma,1,2,Atypical Meningioma,1.0000,Atypical Choroid Plexus Papilloma,0.9448,Anaplastic (Malignant) Meningioma,0.9447,Atypical Teratoid/Rhabdoid Tumor,0.9409,Meningioma,0.9391
ATYPICAL NEVUS,Dysplastic Nevus,99,2,Atypical Meningioma,0.9457,Atypical Spindle Melanocyte<;>Epithelioid Melanocyte,0.9383,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.9348,Atypical Choroid Plexus Papilloma,0.9326,Atypical Teratoid/Rhabdoid Tumor,0.9285
ATYPICAL SPINDLED AND EPITHELIOID MELANOCYTIC PROLIFERATION,Atypical Spindle Melanocyte<;>Epithelioid Melanocyte,1,2,Atypical Spindle Melanocyte<;>Epithelioid Melanocyte,0.9839,Epithelioid Cell<;>Spindle Cell Neoplasm,0.9608,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.9418,Epithelioid Hemangioendothelioma,0.9380,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.9375
ATYPICAL TERATOID RHABDOID TUMOR ATRT,Atypical Teratoid/Rhabdoid Tumor,1,2,Atypical Teratoid/Rhabdoid Tumor,0.9836,Rhabdoid Tumor,0.9459,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.9352,Extrarenal Rhabdoid Tumor,0.9339,Granular Cell Tumor<;>Atypical,0.9314
ATYPICAL TERATOID/RHABDOID TUMOR,Atypical Teratoid/Rhabdoid Tumor,1,2,Atypical Teratoid/Rhabdoid Tumor,1.0000,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.9572,Granular Cell Tumor<;>Atypical,0.9506,Rhabdoid Tumor,0.9491,Lung Atypical Carcinoid Tumor,0.9464
B-CELL,B-Lymphocyte,1,2,B-Lymphocyte,0.9864,B-Cell Neoplasm,0.9617,B-Cell Non-Hodgkin Lymphoma,0.9539,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9494,Monoclonal B-Cell Lymphocytosis,0.9470
B-CELL ACUTE LYMPHOID LEUKEMIA,B Acute Lymphoblastic Leukemia,1,2,B Acute Lymphoblastic Leukemia,0.9801,B Lymphoblastic Leukemia/Lymphoma,0.9749,T Acute Lymphoblastic Leukemia,0.9717,Acute Lymphoblastic Leukemia,0.9682,B Acute Lymphoblastic Leukemia with t(9<;>22)(q34.1<;>q11.2)<;> BCR-ABL1,0.9637
B-CELL NON-HODGKIN LYMPHOMA,B-Cell Non-Hodgkin Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma,1.0000,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9838,Non-Hodgkin Lymphoma,0.9827,T-Cell Non-Hodgkin Lymphoma,0.9777,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.9767
"B-CELL, HODGKINS",Hodgkin Lymphoma,4,2,B-Cell Non-Hodgkin Lymphoma,0.9730,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9640,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.9589,Hodgkin Lymphoma,0.9585,T-Cell Non-Hodgkin Lymphoma,0.9557
"B-CELL, NON-HODGKINS",B-Cell Non-Hodgkin Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma,0.9918,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9769,Non-Hodgkin Lymphoma,0.9732,Mature B-Cell Non-Hodgkin Lymphoma,0.9732,T-Cell Non-Hodgkin Lymphoma,0.9709
"B-CELL, NON-HODGKINS, BURKITTS",B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9892,B-Cell Non-Hodgkin Lymphoma,0.9787,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.9664,Mature B-Cell Non-Hodgkin Lymphoma,0.9640,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9624
"B-CELL, NON-HODGKINS, FOLLICULAR",B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9849,B-Cell Non-Hodgkin Lymphoma,0.9667,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9599,Mature B-Cell Non-Hodgkin Lymphoma,0.9594,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.9588
"B-CELL, NON-HODGKINS, MANTLE CELL",B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.9869,B-Cell Non-Hodgkin Lymphoma,0.9724,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9687,Mature B-Cell Non-Hodgkin Lymphoma,0.9677,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9616
"B-CELL, NON-HODGKINS, MEDIASTINAL LARGE",B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,2,2,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9710,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9703,B-Cell Non-Hodgkin Lymphoma,0.9640,Mature B-Cell Non-Hodgkin Lymphoma,0.9603,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9582
"B-CELL, NON-HODGKINS, PRIMARY EFFUSION",B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.9915,Primary Effusion Lymphoma,0.9709,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9687,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9617,B-Cell Non-Hodgkin Lymphoma,0.9611
B-CELL_ALL,B Acute Lymphoblastic Leukemia,99,2,B-Lymphocyte,0.9563,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9458,B-Cell Non-Hodgkin Lymphoma,0.9451,B-Cell Neoplasm,0.9407,Mature B-Cell Non-Hodgkin Lymphoma,0.9382
B-CELL_LYMPHOMA_OTHER,B-Cell Neoplasm,5,2,B-Cell Non-Hodgkin Lymphoma,0.9739,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9676,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.9627,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9611,B-Cell Neoplasm,0.9609
B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,B Lymphoblastic Leukemia/Lymphoma,1,2,B Lymphoblastic Leukemia/Lymphoma,0.9981,T Lymphoblastic Leukemia/Lymphoma,0.9822,B Acute Lymphoblastic Leukemia,0.9762,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.9756,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9755
B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T9;22Q34.1;Q11.2,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,1,2,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.9934,B Acute Lymphoblastic Leukemia with t(9<;>22)(q34.1<;>q11.2)<;> BCR-ABL1,0.9796,B Lymphoblastic Leukemia/Lymphoma,0.9754,T Lymphoblastic Leukemia/Lymphoma,0.9737,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9671
B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T9;22Q34.1;Q11.2;BCR-ABL1,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,1,2,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.9903,B Acute Lymphoblastic Leukemia with t(9<;>22)(q34.1<;>q11.2)<;> BCR-ABL1,0.9759,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9748,B Lymphoblastic Leukemia/Lymphoma,0.9730,T Lymphoblastic Leukemia/Lymphoma,0.9654
"B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA, BCR-ABL1 LIKE","B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",1,2,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9980,B Lymphoblastic Leukemia/Lymphoma,0.9698,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.9626,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9580,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9575
B-PROLYMPHOCYTIC_LEUKEMIA,B-Cell Prolymphocytic Leukemia,1,2,B-Cell Prolymphocytic Leukemia,0.9908,B Lymphoblastic Leukemia/Lymphoma,0.9532,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9501,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.9451,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.9415
B1,Thymoma Type B1,1,2,Thymoma Type B1,0.9279,Thymoma Type B1<;>Thymoma Type B2,0.9071,B-Lymphocyte,0.9059,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9011,B-Cell Neoplasm,0.8940
B2,Thymoma Type B2,1,2,Thymoma Type B2,0.9305,Thymoma Type B2<;>Thymoma Type B3,0.9136,Thymoma Type B1<;>Thymoma Type B2,0.9077,B-Lymphocyte,0.8994,HER2-Positive Breast Carcinoma,0.8956
B3,Thymoma Type B3,1,2,Thymoma Type B3,0.9314,Thymoma Type B2<;>Thymoma Type B3,0.9130,Thymoma Type B2,0.8916,Basal,0.8907,Head and Neck Basaloid Carcinoma,0.8845
BARRETT_ASSOCIATED_ADENOCARCINOMA,Barrett Adenocarcinoma,1,2,Barrett Adenocarcinoma,0.9797,Adenocarcinoma,0.9490,Esophageal Adenocarcinoma,0.9447,Bladder Adenocarcinoma,0.9424,Breast Adenocarcinoma,0.9405
BASAL,Basal,1,2,Basal,1.0000,Basaloid Cell,0.9498,Basal Cell Carcinoma,0.9280,Basal-Like Breast Carcinoma,0.9254,Head and Neck Basaloid Carcinoma,0.9195
BASAL CELL ADENOCARCINOMA,Salivary Gland Basal Cell Adenocarcinoma,2,2,Basal Cell Carcinoma,0.9864,Salivary Gland Basal Cell Adenocarcinoma,0.9820,Squamous Cell Carcinoma<;>Basaloid Cell,0.9699,Basaloid Cell,0.9666,Lung Basaloid Large Cell Carcinoma,0.9656
BASAL CELL CARCINOMA,Basal Cell Carcinoma,1,2,Basal Cell Carcinoma,1.0000,Squamous Cell Carcinoma<;>Basaloid Cell,0.9771,Head and Neck Basaloid Carcinoma,0.9727,Salivary Gland Basal Cell Adenocarcinoma,0.9722,Basal-Like Breast Carcinoma,0.9717
BASAL-LIKE,Basal-Like Breast Carcinoma,2,2,Basal,0.9665,Basal-Like Breast Carcinoma,0.9549,Basaloid Cell,0.9534,Basal Cell Carcinoma,0.9398,Squamous Cell Carcinoma<;>Basaloid Cell,0.9297
BASALOID,Basaloid Cell,2,2,Basal,0.9766,Basaloid Cell,0.9675,Basal Cell Carcinoma,0.9413,Head and Neck Basaloid Carcinoma,0.9387,Basal-Like Breast Carcinoma,0.9351
BASALOID LARGE CELL CARCINOMA OF THE LUNG,Lung Basaloid Large Cell Carcinoma,1,2,Lung Basaloid Large Cell Carcinoma,0.9968,Basal Cell Carcinoma,0.9752,Squamous Cell Carcinoma<;>Basaloid Cell,0.9679,Salivary Gland Basal Cell Adenocarcinoma,0.9648,Basaloid Squamous Cell Carcinoma of the Penis,0.9642
BASALOID PENILE SQUAMOUS CELL CARCINOMA,Basaloid Squamous Cell Carcinoma of the Penis,1,2,Basaloid Squamous Cell Carcinoma of the Penis,0.9943,Basal Cell Carcinoma,0.9703,Squamous Cell Carcinoma of the Penis,0.9672,Squamous Cell Carcinoma<;>Basaloid Cell,0.9669,Head and Neck Basaloid Carcinoma,0.9640
BCP-ALL,B Acute Lymphoblastic Leukemia,99,2,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9085,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9047,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.9027,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.8992,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.8987
BCR-ABL1,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",2,2,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9623,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9586,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9569,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.9516,"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",0.9425
BENIGN INSULINOMA,Pancreatic Insulinoma<;>Benign,1,2,Pancreatic Insulinoma<;>Benign,0.9846,Benign Neoplasm,0.9416,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.9278,Benign Prostatic Hyperplasia,0.9265,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9243
BENIGN PHYLLODES TUMOR OF THE BREAST,Benign Breast Phyllodes Tumor,1,2,Benign Breast Phyllodes Tumor,0.9977,Malignant Breast Phyllodes Tumor,0.9837,Borderline Breast Phyllodes Tumor,0.9792,Phyllodes Tumor,0.9769,Benign Neoplasm,0.9424
BENIGN PT,Benign Breast Phyllodes Tumor,4,2,Benign Neoplasm,0.9424,Benign Prostatic Hyperplasia,0.9355,Pancreatic Insulinoma<;>Benign,0.9348,Benign Breast Phyllodes Tumor,0.9328,Pancreatic Intraductal Tubulopapillary Neoplasm,0.9103
BENIGN_NEOPLASIA,Benign Neoplasm,1,2,Benign Neoplasm,0.9782,Benign Prostatic Hyperplasia,0.9501,Malignant Neoplasm,0.9429,Breast Neoplasm,0.9364,Malignant Intestinal Neoplasm,0.9353
BILATERAL,Bilateral,1,2,Bilateral,1.0000,Unilateral,0.9241,Breast Mixed Ductal and Lobular Carcinoma,0.8971,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.8950,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.8948
BILE_DUCT,Bile Duct,1,2,Bile Duct,0.9862,Duct,0.9616,Biliary Tract,0.9527,Liver and Intrahepatic Bile Duct Carcinoma,0.9397,Liver and Intrahepatic Bile Duct Neoplasm,0.9387
BILIARY TRACT,Biliary Tract,1,2,Biliary Tract,1.0000,Bile Duct,0.9585,Proximal Bile Duct,0.9300,Liver and Intrahepatic Bile Duct Carcinoma,0.9272,Cholangiocarcinoma<;>Extrahepatic,0.9268
BILIARY TRACT CANCER,Liver and Intrahepatic Bile Duct Carcinoma,2,2,Biliary Tract,0.9595,Liver and Intrahepatic Bile Duct Carcinoma,0.9508,Liver and Intrahepatic Bile Duct Neoplasm,0.9477,Extrahepatic Bile Duct Adenocarcinoma,0.9451,Distal Bile Duct Adenocarcinoma,0.9444
"BILIARY TRACT CANCER, NOS",Liver and Intrahepatic Bile Duct Carcinoma,2,2,Liver and Intrahepatic Bile Duct Neoplasm,0.9502,Liver and Intrahepatic Bile Duct Carcinoma,0.9493,Gallbladder Carcinoma,0.9455,Biliary Tract,0.9407,Gallbladder Squamous Cell Carcinoma,0.9392
BIOPSY,Biopsy Specimen,1,2,Biopsy Specimen,0.9706,Paracentesis<;>Biopsy,0.9287,B-Lymphocyte,0.9129,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9117,B-Cell Neoplasm,0.9106
BIOPSY/PARACENTESIS,Paracentesis<;>Biopsy,1,2,Paracentesis<;>Biopsy,0.9890,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.9215,Biopsy Specimen,0.9203,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9184,Breast Ductal Carcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9184
BIPHASIC MESOTHELIOMA,Biphasic Mesothelioma,1,2,Biphasic Mesothelioma,1.0000,Pleural Biphasic Mesothelioma,0.9876,Biphasic Synovial Sarcoma,0.9509,Mesothelioma,0.9393,Sarcomatoid Mesothelioma,0.9268
BLADDER,Bladder,1,2,Bladder,1.0000,Bladder Urothelial Cell,0.9503,Bladder Urothelial Carcinoma,0.9295,Bladder Carcinoma,0.9275,Bladder Adenocarcinoma,0.9226
BLADDER ADENOCARCINOMA,Bladder Adenocarcinoma,1,2,Bladder Adenocarcinoma,1.0000,Bladder Carcinoma,0.9706,Breast Adenocarcinoma,0.9634,Bladder Urothelial Carcinoma,0.9593,Urethral Adenocarcinoma,0.9576
BLADDER CANCER,Bladder Carcinoma,1,2,Bladder Carcinoma,0.9805,Bladder Urothelial Carcinoma,0.9708,Bladder Adenocarcinoma,0.9629,Bladder Squamous Cell Carcinoma,0.9547,Bladder,0.9457
BLADDER SQUAMOUS CELL CARCINOMA,Bladder Squamous Cell Carcinoma,1,2,Bladder Squamous Cell Carcinoma,1.0000,Squamous Cell Carcinoma,0.9790,Lung Squamous Cell Carcinoma,0.9725,Urethral Squamous Cell Carcinoma,0.9723,Laryngeal Squamous Cell Carcinoma,0.9713
BLADDER UROTHELIAL,Bladder Urothelial Carcinoma,3,2,Bladder Urothelial Cell,0.9763,Bladder,0.9720,Bladder Urothelial Carcinoma,0.9583,Urothelial Papilloma,0.9463,Urothelial Carcinoma,0.9435
BLADDER UROTHELIAL CARCINOMA,Bladder Urothelial Carcinoma,1,2,Bladder Urothelial Carcinoma,1.0000,Urothelial Carcinoma,0.9900,Bladder Carcinoma,0.9853,Urethral Urothelial Carcinoma,0.9761,upper tract urothelial carcinoma,0.9648
BLADDER/URINARY TRACT,Urinary System,3,2,Bladder,0.9720,Bladder Urothelial Cell,0.9405,Urinary System,0.9389,Fibroblast<;>Urinary System,0.9379,Bladder Urothelial Carcinoma,0.9283
BLADDER/URINARY TRACT CANCER,Bladder Carcinoma,2,2,Bladder Urothelial Carcinoma,0.9636,Bladder Carcinoma,0.9621,Bladder Adenocarcinoma,0.9524,upper tract urothelial carcinoma,0.9501,Bladder Urachal Carcinoma,0.9496
"BLADDER/URINARY TRACT CANCER, NOS",Malignant Urinary System Neoplasm,99,2,Bladder Urothelial Carcinoma,0.9594,Bladder Carcinoma,0.9548,Bladder Squamous Cell Carcinoma,0.9491,infiltrating bladder urothelial carcinoma sarcomatoid variant,0.9462,Transurethral Resection of Bladder Tumor,0.9457
BLADDER_CANCER,Bladder Carcinoma,1,2,Bladder Carcinoma,0.9767,Bladder Urothelial Carcinoma,0.9680,Bladder Adenocarcinoma,0.9626,Bladder Squamous Cell Carcinoma,0.9528,Urothelial Carcinoma,0.9431
BLADDER_CARCINOMA,Bladder Carcinoma,1,2,Bladder Carcinoma,0.9941,Bladder Urothelial Carcinoma,0.9812,Bladder Adenocarcinoma,0.9699,Bladder Squamous Cell Carcinoma,0.9632,Urothelial Carcinoma,0.9626
BLADDER_SQUAMOUS,Bladder Squamous Cell Carcinoma,1,2,Bladder Squamous Cell Carcinoma,0.9699,Bladder Urothelial Cell,0.9414,Gallbladder Squamous Cell Carcinoma,0.9397,Urethral Squamous Cell Carcinoma,0.9393,Squamous Cell Carcinoma,0.9393
BLADDER_TRANSITIONAL_CELL,Bladder Urothelial Cell,2,2,Transitional Cells,0.9726,Bladder Urothelial Cell,0.9696,Transitional Cell Carcinoma,0.9581,"Kidney Carcinoma, Transitional Cells",0.9537,Papillary Transitional Cell Carcinoma,0.9441
BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM,Blastic Plasmacytoid Dendritic Cell Neoplasm,1,2,Blastic Plasmacytoid Dendritic Cell Neoplasm,1.0000,Histiocytic and Dendritic Cell Neoplasm,0.9497,Plasma Cell Leukemia,0.9473,B-Cell Neoplasm,0.9448,Plasmacytoma,0.9421
BLAST_CRISIS,Blastic Phase,1,2,Blastic Phase,0.9406,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9227,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.9160,Blastic Plasmacytoid Dendritic Cell Neoplasm,0.9143,Myelodysplastic Syndrome with Excess Blasts-2,0.9080
BLAST_PHASE_CHRONIC_MYELOID_LEUKAEMIA,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",2,2,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.9724,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9692,Blastic Phase,0.9567,Chronic Myelogenous Leukemia,0.9513,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9499
BLCA,Bladder Urothelial Carcinoma,99,2,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9055,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.8994,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.8994,B Lymphoblastic Leukemia/Lymphoma,0.8990,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.8988
BLL,B Lymphoblastic Leukemia/Lymphoma,3,2,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9042,Monoclonal B-Cell Lymphocytosis,0.8998,B Lymphoblastic Leukemia/Lymphoma,0.8979,Lymphoid,0.8978,Lobular,0.8973
BLOOD CANCER,Liquid Tumor,99,2,B-Cell Neoplasm,0.9163,Brain Neoplasm,0.9097,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9077,B-Cell Non-Hodgkin Lymphoma,0.9069,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9067
"BLOOD CANCER, NOS",Liquid Tumor,99,2,B-Cell Non-Hodgkin Lymphoma,0.9238,Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,0.9234,B-Cell Neoplasm,0.9233,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9221,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9220
BLUE NEVUS,Blue Nevus,1,2,Blue Nevus,1.0000,Hemangioma,0.9128,Dysplastic Nevus,0.9113,Extraventricular Neurocytoma,0.8988,Hemangioblastoma,0.8987
BONE,Bone,1,2,Bone,1.0000,Bone Sarcoma,0.9247,Bone Marrow-Derived Fibroblasts,0.9211,Brain,0.9134,Bone<;>Site of Metastasis,0.9124
BONE CANCER,Malignant Bone Neoplasm,2,2,Bone Sarcoma,0.9490,Malignant Bone Neoplasm,0.9446,Bone<;>Site of Metastasis<;>Prostate Adenocarcinoma,0.9427,Bone,0.9374,Bone<;>Site of Metastasis,0.9368
BONE SARCOMA,Bone Sarcoma,1,2,Bone Sarcoma,1.0000,Sarcoma,0.9725,Breast Sarcoma,0.9641,Synovial Sarcoma,0.9622,Ewing Sarcoma,0.9538
BONE SARCOMA OTHER,Bone Sarcoma,1,2,Bone Sarcoma,0.9631,Sarcoma,0.9423,Synovial Sarcoma,0.9352,Breast Sarcoma,0.9314,Synovial Sarcoma<;>Poorly Differentiated,0.9304
BONE_CANCER,Malignant Bone Neoplasm,2,2,Bone Sarcoma,0.9493,Malignant Bone Neoplasm,0.9475,Bone<;>Site of Metastasis<;>Prostate Adenocarcinoma,0.9439,Bone<;>Site of Metastasis,0.9378,Bone,0.9336
BORDERLINE PHYLLODES TUMOR OF THE BREAST,Borderline Breast Phyllodes Tumor,1,2,Borderline Breast Phyllodes Tumor,0.9974,Benign Breast Phyllodes Tumor,0.9833,Malignant Breast Phyllodes Tumor,0.9810,Phyllodes Tumor,0.9743,Borderline Ovarian Serous Tumor,0.9561
BORDERLINE PT,Borderline Breast Phyllodes Tumor,1,2,Borderline Breast Phyllodes Tumor,0.9349,Borderline Ovarian Serous Tumor,0.9260,Borderline Ovarian Clear Cell Tumor,0.9196,Borderline Ovarian Serous Tumor-Micropapillary Variant,0.9176,Benign Breast Phyllodes Tumor,0.9068
BOTRYOID,Botryoid-Type Embryonal Rhabdomyosarcoma,1,2,Botryoid-Type Embryonal Rhabdomyosarcoma,0.9406,Pharynx,0.9100,Chondroblastoma,0.8943,Retinoblastoma,0.8853,Rhabdomyosarcoma,0.8847
BOWEL,Intestine,1,2,Intestine,0.9576,Intestinal,0.9462,Colon,0.9294,Rectum,0.9286,Jejunum,0.9195
"BOWEL CANCER, NOS",Malignant Intestinal Neoplasm,1,2,Malignant Intestinal Neoplasm,0.9378,Small Intestinal Carcinoma,0.9353,Small Intestinal Adenocarcinoma,0.9291,Colon Carcinoma,0.9276,Colon Carcinoma<;>Melanoma,0.9275
BRAIN,Brain,1,2,Brain,1.0000,Central Nervous System<;>Brain,0.9559,Cerebral Cortex,0.9295,Glioblastoma,0.9266,Brain Neoplasm,0.9241
BRAIN CANCER,Malignant Brain Neoplasm,2,2,Brain Neoplasm,0.9673,Malignant Brain Neoplasm,0.9533,Brain,0.9441,Glioblastoma,0.9406,Childhood Brain Germ Cell Tumor,0.9348
BRAIN_CANCER,Malignant Brain Neoplasm,2,2,Brain Neoplasm,0.9661,Malignant Brain Neoplasm,0.9533,Glioblastoma,0.9395,Brain,0.9392,Childhood Brain Germ Cell Tumor,0.9338
BRCA,Breast Carcinoma,5,2,Breast,0.9276,HER2-Positive Breast Carcinoma,0.9216,Basal-Like Breast Carcinoma,0.9204,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.9185,Breast Carcinoma,0.9163
BRCA_BASAL,Basal,1,2,Basal,0.9582,Basal-Like Breast Carcinoma,0.9538,Basal Cell Carcinoma,0.9405,Basaloid Cell,0.9342,Head and Neck Basaloid Carcinoma,0.9322
BRCA_HER2,HER2-Positive Breast Carcinoma,1,2,HER2-Positive Breast Carcinoma,0.9606,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.9469,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.9457,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9457,HER2/Neu Positive,0.9446
BRCA_LUMA,Luminal A Breast Carcinoma,99,2,Basal-Like Breast Carcinoma,0.9194,Benign Breast Phyllodes Tumor,0.9162,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9152,Luminal B Breast Carcinoma,0.9135,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9135
BRCA_LUMB,Luminal B Breast Carcinoma,3,2,Basal-Like Breast Carcinoma,0.9209,Benign Breast Phyllodes Tumor,0.9167,Luminal B Breast Carcinoma,0.9140,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9125,Breast Lobular Carcinoma,0.9107
BRCA_NORMAL,Breast Carcinoma,99,2,Normal Breast-Like Subtype of Breast Carcinoma,0.9304,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9218,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9197,HER2-Positive Breast Carcinoma,0.9187,Basal-Like Breast Carcinoma,0.9186
BREAST,Breast,1,2,Breast,1.0000,fibroblast of breast,0.9477,Breast Sarcoma,0.9458,Breast Carcinoma,0.9407,Breast Ductal Carcinoma,0.9370
BREAST ANGIOSARCOMA,Breast Angiosarcoma,1,2,Breast Angiosarcoma,1.0000,Angiosarcoma,0.9839,Adenosarcoma,0.9507,Uterine Corpus Adenosarcoma,0.9476,Breast Sarcoma,0.9407
BREAST CANCER,Breast Carcinoma,1,2,Breast Carcinoma,0.9718,Breast Adenocarcinoma,0.9561,Breast Ductal Carcinoma,0.9549,Breast Neoplasm,0.9544,Breast,0.9512
"BREAST CANCER, NOS",Breast Carcinoma,1,2,Breast Carcinoma,0.9428,Breast Ductal Carcinoma,0.9405,Breast Neoplasm,0.9383,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9351,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9349
BREAST CARCINOMA,Breast Carcinoma,1,2,Breast Carcinoma,1.0000,Breast Ductal Carcinoma,0.9741,Carcinoma,0.9716,Invasive Breast Carcinoma,0.9689,Breast Lobular Carcinoma,0.9682
BREAST CARCINOMA OTHER,Breast Carcinoma,1,2,Breast Carcinoma,0.9598,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9478,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9477,Invasive Breast Carcinoma of No Special Type,0.9475,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.9471
BREAST DUCTAL CARCINOMA,Breast Ductal Carcinoma,1,2,Breast Ductal Carcinoma,1.0000,Breast Ductal Carcinoma In Situ,0.9765,Breast Carcinoma,0.9741,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9704,Breast Lobular Carcinoma,0.9661
BREAST DUCTAL CARCINOMA IN SITU,Breast Ductal Carcinoma In Situ,1,2,Breast Ductal Carcinoma In Situ,1.0000,Breast Ductal Carcinoma,0.9765,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9643,Cervical Adenocarcinoma In Situ,0.9614,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9614
BREAST DUCTAL HR+HER2+,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,1,2,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.9631,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9604,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9603,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9588,HER2-Positive Breast Carcinoma,0.9562
BREAST DUCTAL HR+HER2-,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,1,2,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9621,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9610,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.9600,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9585,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9553
BREAST DUCTAL HR-HER2+,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,3,2,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.9656,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9637,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9633,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9615,HER2-Positive Breast Carcinoma,0.9593
BREAST DUCTAL TRIPLE NEGATIVE,Breast Ductal Carcinoma<;>Triple-Negative Breast Cancer Finding,1,2,Breast Ductal Carcinoma<;>Triple-Negative Breast Cancer Finding,0.9767,Triple-Negative Breast Cancer Finding,0.9694,Invasive Breast Carcinoma of No Special Type<;>Triple-Negative Breast Cancer Finding,0.9633,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9527,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9467
"BREAST INVASIVE CANCER, NOS",Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,0.9650,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9581,Invasive Breast Carcinoma of No Special Type,0.9564,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9561,Invasive Breast Lobular Carcinoma,0.9547
BREAST INVASIVE CARCINOMA,Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,0.9984,Invasive Breast Lobular Carcinoma,0.9825,Breast Carcinoma,0.9751,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9739,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9698
BREAST INVASIVE CARCINOMA BRCA,Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,0.9789,Breast Carcinoma,0.9707,Invasive Breast Lobular Carcinoma,0.9688,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9653,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9615
BREAST INVASIVE CARCINOMA NOS,Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,0.9758,Invasive Breast Lobular Carcinoma,0.9661,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9636,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9609,Invasive Breast Carcinoma of No Special Type,0.9595
"BREAST INVASIVE CARCINOMA, NOS",Invasive Breast Carcinoma of No Special Type,5,2,Invasive Breast Carcinoma,0.9736,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9661,Invasive Breast Lobular Carcinoma,0.9650,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9638,Invasive Breast Carcinoma of No Special Type,0.9619
"BREAST INVASIVE CARCINOSARCOMA, NOS",Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,99,2,Invasive Breast Carcinoma,0.9572,Invasive Breast Carcinoma of No Special Type,0.9558,Uterine Carcinosarcoma,0.9549,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.9535,Carcinosarcoma,0.9518
BREAST INVASIVE DUCTAL CARCINOMA,Invasive Breast Carcinoma of No Special Type,99,2,Breast Ductal Carcinoma,0.9890,Invasive Breast Carcinoma,0.9847,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9826,Breast Ductal Carcinoma In Situ,0.9805,Invasive Breast Lobular Carcinoma,0.9804
BREAST INVASIVE LOBULAR CARCINOMA,Invasive Breast Lobular Carcinoma,1,2,Invasive Breast Lobular Carcinoma,0.9991,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9868,Breast Lobular Carcinoma,0.9859,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9819,Invasive Breast Carcinoma,0.9796
BREAST INVASIVE MIXED MUCINOUS CARCINOMA,Breast Mucinous Carcinoma,1,2,Breast Mucinous Carcinoma,0.9727,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.9672,Breast Mixed Ductal and Lobular Carcinoma,0.9659,Mixed Carcinoma,0.9620,Invasive Lung Mucinous Adenocarcinoma,0.9592
BREAST LOBULAR HR+,Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma,1,2,Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma,0.9542,Breast Lobular Carcinoma,0.9504,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9494,Lobular,0.9485,Invasive Breast Lobular Carcinoma,0.9438
BREAST MICROINVASIVE CARCINOMA,Microinvasive Breast Carcinoma,1,2,Microinvasive Breast Carcinoma,0.9988,Breast Carcinoma,0.9511,Breast Medullary Carcinoma,0.9500,Breast Metaplastic Carcinoma,0.9499,Invasive Breast Carcinoma,0.9485
BREAST MIXED DUCTAL AND LOBULAR CARCINOMA,Breast Mixed Ductal and Lobular Carcinoma,1,2,Breast Mixed Ductal and Lobular Carcinoma,1.0000,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9733,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9709,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9692,Breast Ductal Carcinoma,0.9641
"BREAST NEOPLASM, NOS",Breast Neoplasm,1,2,Breast Neoplasm,0.9679,Neoplasm,0.9539,Uterine Neoplasm,0.9490,Brain Neoplasm,0.9458,Benign Neoplasm,0.9452
BREAST SARCOMA,Breast Sarcoma,1,2,Breast Sarcoma,1.0000,Sarcoma,0.9663,Bone Sarcoma,0.9641,Breast Neoplasm,0.9528,Breast,0.9458
BREAST_ADENOCARCINOMA,Breast Adenocarcinoma,1,2,Breast Adenocarcinoma,0.9931,Adenocarcinoma,0.9735,Lung Adenocarcinoma,0.9624,Breast Carcinoma,0.9622,Prostate Adenocarcinoma,0.9594
BREAST_CANCER,Breast Carcinoma,1,2,Breast Carcinoma,0.9689,Breast Neoplasm,0.9572,Breast Adenocarcinoma,0.9562,Breast Ductal Carcinoma,0.9512,Breast,0.9488
BREAST_CARCINOMA,Breast Carcinoma,1,2,Breast Carcinoma,0.9924,Carcinoma,0.9697,Breast Ductal Carcinoma,0.9677,Breast Adenocarcinoma,0.9644,Invasive Breast Carcinoma,0.9633
BREAST_DUCTAL_CARCINOMA,Breast Ductal Carcinoma,1,2,Breast Ductal Carcinoma,0.9937,Breast Ductal Carcinoma In Situ,0.9724,Breast Carcinoma,0.9715,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9706,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9661
BRENNER TUMOR,Brenner Tumor,1,2,Brenner Tumor,1.0000,Breast Neoplasm,0.9198,Endometrioid Tumor,0.9176,Breast Adenocarcinoma,0.9163,Breast Carcinoma,0.9146
BRENNER_TUMOR,Brenner Tumor,1,2,Brenner Tumor,0.9927,Breast Neoplasm,0.9213,Breast Adenocarcinoma,0.9177,Brain Neoplasm,0.9171,Uterine Neoplasm,0.9149
BRENNER_TUMOUR,Brenner Tumor,1,2,Brenner Tumor,0.9863,Breast Neoplasm,0.9217,Breast Adenocarcinoma,0.9190,Breast Carcinoma,0.9159,Brain Neoplasm,0.9141
BRONCHIOALVEOLAR_CARCINOMA,Lung Adenocarcinoma In Situ,99,2,Lung Carcinoma,0.9576,Lung Adenosquamous Carcinoma,0.9522,Breast Carcinoma,0.9467,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9435,Lung Adenocarcinoma,0.9432
BRONCHIOALVEOLAR_CARCINOMA; NON-SMALL_CELL LUNG_CANCER,Lung Adenocarcinoma In Situ<;>Lung Non-Small Cell Carcinoma,99,2,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9773,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9756,Lung Non-Small Cell Carcinoma,0.9723,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9723,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9674
BRONCHIOLOALVEOLAR_ADENOCARCINOMA,Minimally Invasive Lung Adenocarcinoma,99,2,Lung Adenocarcinoma,0.9564,Breast Adenocarcinoma,0.9551,Adenocarcinoma,0.9501,Lung Acinar Adenocarcinoma,0.9492,Bronchiolar Adenoma/Ciliated Muconodular Papillary Tumor,0.9477
BUCCAL_MUCOSA,Buccal Mucosa,1,2,Buccal Mucosa,0.9904,Mucosa,0.9531,Buccal Mucosa Squamous Cell Carcinoma,0.9468,Mucosal Melanoma of the Head and Neck,0.9324,Mucosal Melanoma<;>Anorectal,0.9270
BURKITT LYMPHOMA,Burkitt Lymphoma,1,2,Burkitt Lymphoma,1.0000,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9691,B Lymphoblastic Leukemia/Lymphoma,0.9435,B-Cell Non-Hodgkin Lymphoma,0.9387,B-Cell Neoplasm,0.9367
BURKITTS LYMPHOMA,Burkitt Lymphoma,1,2,Burkitt Lymphoma,0.9990,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9685,B Lymphoblastic Leukemia/Lymphoma,0.9432,B-Cell Non-Hodgkin Lymphoma,0.9373,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9362
BURKITT_LYMPHOMA,Burkitt Lymphoma,1,2,Burkitt Lymphoma,0.9949,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9734,B Lymphoblastic Leukemia/Lymphoma,0.9501,B-Cell Non-Hodgkin Lymphoma,0.9442,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9433
B_CELL,B-Lymphocyte,1,2,B-Lymphocyte,0.9776,B-Cell Neoplasm,0.9582,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9477,B-Cell Non-Hodgkin Lymphoma,0.9476,Activated B-Cell Positive,0.9411
B_CELL_BURKITT,Burkitt Lymphoma,2,2,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9707,Burkitt Lymphoma,0.9636,B-Lymphocyte,0.9530,B-Cell Neoplasm,0.9524,B-Cell Non-Hodgkin Lymphoma,0.9477
B_CELL_FOLLICULAR,Follicular Lymphoma,3,2,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9663,Follicular Helper T-Cell Lymphoma,0.9523,Follicular Lymphoma,0.9452,B-Lymphocyte,0.9425,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9325
B_CELL_LYMPHOMA_UNSPECIFIED,B-Cell Non-Hodgkin Lymphoma,2,2,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.9629,B-Cell Non-Hodgkin Lymphoma,0.9579,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.9575,B-Cell Neoplasm,0.9484,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9481
B_CELL_MANTLE_CELL,Mantle Cell Lymphoma,2,2,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.9660,Mantle Cell Lymphoma,0.9604,B-Lymphocyte,0.9454,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9405,B-Cell Neoplasm,0.9373
B_CELL_MEDIASTINAL_LARGE,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,1,2,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9654,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9540,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9468,B-Lymphocyte,0.9367,Diffuse Large B-Cell Lymphoma,0.9362
B_CELL_NON_HODGKIN_LYMPHOMA,B-Cell Non-Hodgkin Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma,0.9959,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9839,Non-Hodgkin Lymphoma,0.9791,T-Cell Non-Hodgkin Lymphoma,0.9755,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.9752
B_CELL_PRIMARY_EFFUSION,Primary Effusion Lymphoma,2,2,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.9791,Primary Effusion Lymphoma,0.9654,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9521,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9503,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9415
CAECUM ADENOCARCINOMA,Cecum Adenocarcinoma,4,2,Colon Adenocarcinoma,0.9555,Cervical Adenocarcinoma,0.9491,Colorectal Adenocarcinoma,0.9458,Cecum Adenocarcinoma,0.9447,Rectal Adenocarcinoma,0.9447
CAECUM_ADENOCARCINOMA,Cecum Adenocarcinoma,5,2,Colon Adenocarcinoma,0.9539,Adenocarcinoma,0.9474,Cervical Adenocarcinoma,0.9467,Colorectal Adenocarcinoma,0.9463,Cecum Adenocarcinoma,0.9450
CANCER IDENTIFICATION IDC,Invasive Breast Carcinoma of No Special Type,99,2,Invasive Breast Carcinoma,0.9346,Adenocarcinoma<;>Invasive,0.9315,Breast Adenocarcinoma,0.9291,Breast Ductal Carcinoma In Situ,0.9280,Breast Carcinoma,0.9275
CANCER IDENTIFICATION ILC,Invasive Breast Lobular Carcinoma,1,2,Invasive Breast Lobular Carcinoma,0.9172,Well Differentiated Lesion<;>Invasive,0.9149,Invasive Breast Carcinoma,0.9149,Liver and Intrahepatic Bile Duct Neoplasm,0.9136,Adenocarcinoma<;>Invasive,0.9121
CANCER IDENTIFICATION MIDLC,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,99,2,Microinvasive Breast Carcinoma,0.9122,Mucinous Adenocarcinoma<;>Lymph Node,0.9113,Invasive Lung Mucinous Adenocarcinoma,0.9109,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9108,Adenocarcinoma<;>Invasive,0.9099
CANCER OF UNKNOWN PRIMARY,Malignant Neoplasm,99,2,Melanoma of Unknown Primary,0.9693,Primary Neoplasm,0.9446,Primary Neoplasm<;>Unpaired,0.9427,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9346,Primary Neoplasm<;>Paired,0.9337
"CANCER OF UNKNOWN PRIMARY, NOS",Carcinoma,99,2,Melanoma of Unknown Primary,0.9560,Unclassified Renal Cell Carcinoma,0.9418,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9399,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9392,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9388
CARCINOID,Carcinoid Tumor,1,2,Carcinoid Tumor,0.9754,Carcinosarcoma,0.9741,Lung Carcinoid Tumor,0.9593,Uterine Carcinosarcoma,0.9553,Ovarian Carcinosarcoma,0.9521
CARCINOID TUMOR,Carcinoid Tumor,1,2,Carcinoid Tumor,1.0000,Lung Carcinoid Tumor,0.9780,Carcinosarcoma,0.9699,Uterine Carcinosarcoma,0.9555,Lung Atypical Carcinoid Tumor,0.9529
CARCINOID-ENDOCRINE TUMOUR,Carcinoid Tumor,1,2,Carcinoid Tumor,0.9644,Lung Carcinoid Tumor,0.9555,Carcinosarcoma,0.9552,Ovarian Carcinosarcoma,0.9498,Uterine Carcinosarcoma,0.9437
CARCINOMA,Carcinoma,1,2,Carcinoma,1.0000,Breast Carcinoma,0.9716,Colon Carcinoma,0.9661,Lung Carcinoma,0.9653,Cervical Carcinoma,0.9649
CARCINOMA OF UTERINE CERVIX,Cervical Carcinoma,2,2,uterine corpus endometrial carcinoma,0.9787,Cervical Carcinoma,0.9775,Endometrial Carcinoma<;>Uterine Corpus Cancer,0.9759,Endometrial Carcinoma,0.9740,Carcinoma,0.9711
CARCINOMA PATIENT WITH METASTATIC CARCINOMA OF THE PROSTATE AND A 3 YEAR HISTORY OF LYMPHOCYTIC LEUKEMIA.,Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,1,2,Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,0.9633,Brain<;>Site of Metastasis<;>Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,0.9502,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.9405,Chronic Lymphocytic Leukemia,0.9399,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.9313
CARCINOMA SMALL CELL,Small Cell Neuroendocrine Carcinoma,3,2,Lung Small Cell Carcinoma,0.9795,Small Cell Adenocarcinoma,0.9777,Small Cell Neuroendocrine Carcinoma,0.9707,Ovarian Small Cell Carcinoma,0.9683,Non-Small Cell Carcinoma,0.9659
CARCINOMA WITH CHONDROID METAPLASIA,Breast Carcinoma with Chondroid Metaplasia,1,2,Breast Carcinoma with Chondroid Metaplasia,0.9845,Carcinoma,0.9522,Breast Carcinoma with Osseous Metaplasia,0.9517,Metaplastic Carcinoma,0.9453,Carcinoma<;>Poorly Differentiated,0.9434
CARCINOMA WITH OSSEOUS METAPLASIA,Breast Carcinoma with Osseous Metaplasia,1,2,Breast Carcinoma with Osseous Metaplasia,0.9895,Breast Carcinoma with Chondroid Metaplasia,0.9612,Breast Metaplastic Carcinoma<;>Epithelial,0.9489,Metaplastic Carcinoma,0.9477,Odontogenic Carcinoma,0.9450
CARCINOMA WITH SQUAMOUS DIFFERENTIATION,Gallbladder Squamous Cell Carcinoma,99,2,Squamous Cell Carcinoma<;>Poorly Differentiated,0.9727,Squamous Cell Carcinoma,0.9717,Lung Squamous Cell Carcinoma,0.9677,Salivary Gland Squamous Cell Carcinoma,0.9632,Cervical Squamous Cell Carcinoma,0.9630
"CARCINOMA, ANAPLASTIC",Anaplastic Carcinoma,1,2,Anaplastic Carcinoma,0.9866,Thyroid Gland Anaplastic Carcinoma,0.9706,Anaplastic,0.9698,Anaplastic (Malignant) Meningioma,0.9662,Anaplastic Astrocytoma,0.9599
"CARCINOMA, BRENNER",Brenner Tumor,1,2,Brenner Tumor,0.9700,Carcinoma,0.9515,Breast Carcinoma,0.9458,Lung Carcinoma,0.9379,Endometrial Carcinoma,0.9352
"CARCINOMA, FOLLICULAR",Thyroid Gland Follicular Carcinoma,1,2,Thyroid Gland Follicular Carcinoma,0.9752,Thyroid Gland Papillary and Follicular Carcinoma,0.9645,Follicular Variant Thyroid Gland Papillary Carcinoma,0.9611,Thyroid Gland Follicular Carcinoma<;>Metastasis,0.9606,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.9602
"CARCINOMA, GIANT CELL",Giant Cell Carcinoma,1,2,Giant Cell Carcinoma,0.9855,Giant Cell Tumor,0.9677,Giant Cell Tumor of Bone,0.9593,Giant Cell,0.9575,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.9492
"CARCINOMA, GINGIVAL",Gingival Carcinoma,1,2,Gingival Carcinoma,0.9896,Salivary Gland Carcinoma,0.9633,Carcinoma,0.9612,Gastric Carcinoma,0.9527,Breast Carcinoma,0.9478
"CARCINOMA, MUCOEPIDERMOID",Mucoepidermoid Carcinoma,1,2,Mucoepidermoid Carcinoma,0.9843,Lung Mucoepidermoid Carcinoma,0.9767,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.9597,Epithelial-Myoepithelial Carcinoma,0.9494,Carcinoma,0.9465
"CARCINOMA, PAPILLARY",Papillary Carcinoma,1,2,Papillary Carcinoma,0.9876,Papillary Renal Cell Carcinoma,0.9745,Thyroid Gland Papillary Carcinoma,0.9733,Acinar Cell Carcinoma<;>Papillary,0.9713,Papillary Adenocarcinoma,0.9711
"CARCINOMA, VULVAR",Vulvar Carcinoma,1,2,Vulvar Carcinoma,0.9873,Vulvar Carcinoma<;>Vaginal Carcinoma,0.9775,Vulvar Squamous Cell Carcinoma,0.9752,Vaginal Carcinoma,0.9624,Vaginal Squamous Cell Carcinoma,0.9554
CARCINOMA-UD,Carcinoma<;>Undifferentiated,2,2,Carcinoma,0.9563,Carcinoma<;>Undifferentiated,0.9539,Urethral Carcinoma,0.9513,Urothelial Carcinoma,0.9511,Adenocarcinoma<;>Undifferentiated Carcinoma,0.9480
CARCINOMA-VPD,Carcinoma<;>Poorly Differentiated,5,2,Vulvar Carcinoma,0.9502,Carcinoma,0.9489,Prostate Carcinoma,0.9486,Vulvar Carcinoma<;>Vaginal Carcinoma,0.9448,Carcinoma<;>Poorly Differentiated,0.9415
CARCINOSARCOMA-MALIGNANT_MESODERMAL_MIXED_TUMOUR,Carcinosarcoma,99,2,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9809,Malignant Mixed Mesodermal (Mullerian) Tumor<;>Carcinosarcoma<;>Yolk Sac Tumor,0.9775,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9770,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9766,Malignant Mixed Mesodermal (Mullerian) Tumor,0.9621
CARCINOSARCOMA-MAMMARY GLAND,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,99,2,Carcinosarcoma,0.9677,Uterine Carcinosarcoma,0.9595,Ovarian Carcinosarcoma,0.9572,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9502,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.9499
CARCINOSARCOMA-MAMMARY GLAND; BREAST,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,99,2,Carcinosarcoma,0.9614,Uterine Carcinosarcoma,0.9545,Ovarian Carcinosarcoma,0.9521,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.9498,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9473
CASTLEMAN'S DISEASE,Castleman Disease,1,2,Castleman Disease,0.9972,Erdheim-Chester Disease,0.9095,Rosai-Dorfman Disease,0.9065,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.9060,Monoclonal B-Cell Lymphocytosis,0.9058
CASTRATION-RESISTANT PROSTATE CANCER,Castration-Resistant Prostate Carcinoma,1,2,Castration-Resistant Prostate Carcinoma,0.9943,Castration-Resistant Prostate Carcinoma<;>Prostate Adenocarcinoma,0.9869,Castration-Resistant Prostate Carcinoma<;>Metastatic Prostate Carcinoma,0.9826,Castration-Resistant Prostate Carcinoma<;>Non-Metastatic Prostate Carcinoma,0.9776,Castration-Resistant Prostate Carcinoma<;>Prostate Neuroendocrine Neoplasm,0.9711
CBFB-MYH11,CBFB-MYH11 Fusion Protein Expression,1,2,CBFB-MYH11 Fusion Protein Expression,0.9685,PAX3/FOXO1 Fusion Gene,0.8993,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.8991,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.8987,Hemangioma,0.8972
CCOV,Malignant Ovarian Clear Cell Tumor,99,2,Hepatitis C Virus,0.9086,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.9042,Ovarian Clear Cell Cystadenocarcinoma,0.9019,Colon,0.9010,Cervical Carcinoma,0.8996
CCRCC,Clear Cell Renal Cell Carcinoma,2,2,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9359,Clear Cell Renal Cell Carcinoma,0.9343,Renal Cell Carcinoma,0.9308,Clear Cell Papillary Renal Neoplasm,0.9289,Renal Cell Carcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9261
CD30+_ANAPLASTIC_LARGE_CELL_LYMPHOMA,Anaplastic Large Cell Lymphoma,3,2,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.9566,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.9523,Anaplastic Large Cell Lymphoma,0.9516,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9485,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.9484
CECUM,Cecum,1,2,Cecum,1.0000,Cecum Adenocarcinoma,0.9546,Intestine,0.9267,Colon,0.9191,Rectum,0.9184
CELL LINE,Cell Line,1,2,Cell Line,1.0000,immortal fibroblast cell line cell,0.9434,immortal embryo-derived fibroblast cell line cell,0.9401,immortal epithelial cell line cell,0.9397,"Malignant Tumor, Small Cell Type",0.9274
CELLULAR SCHWANNOMA,Cellular Schwannoma,1,2,Cellular Schwannoma,1.0000,Schwannoma,0.9409,Melanotic Schwannoma,0.9199,Plexiform Schwannoma,0.9175,Neoplastic Fibroblast-Like Cell,0.9170
CENTRAL NEUROCYTOMA,Central Neurocytoma,1,2,Central Neurocytoma,1.0000,Central Nervous System Melanoma,0.9411,Central Nervous System Neoplasm,0.9354,Extraventricular Neurocytoma,0.9327,Central Nervous System<;>Brain,0.9308
CENTROBLASTIC,Centroblastic Lymphoma,1,2,Centroblastic Lymphoma,0.9757,Chondroblastoma,0.9111,Pancreatoblastoma,0.9081,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9064,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9056
CERVICAL ADENOCARCINOMA,Cervical Adenocarcinoma,1,2,Cervical Adenocarcinoma,1.0000,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9743,Cervical Carcinoma,0.9735,Cervical Endometrioid Adenocarcinoma,0.9670,Adenocarcinoma,0.9647
CERVICAL ADENOCARCINOMA IN SITU,Cervical Adenocarcinoma In Situ,1,2,Cervical Adenocarcinoma In Situ,1.0000,Lung Adenocarcinoma In Situ,0.9707,Lung Adenocarcinoma In Situ<;>Lung Non-Small Cell Carcinoma,0.9621,Breast Ductal Carcinoma In Situ,0.9614,Cervical Adenocarcinoma,0.9593
CERVICAL ADENOID CYSTIC CARCINOMA,Cervical Adenoid Cystic Carcinoma,1,2,Cervical Adenoid Cystic Carcinoma,1.0000,Adenoid Cystic Carcinoma,0.9857,Breast Adenoid Cystic Carcinoma,0.9801,Lung Adenoid Cystic Carcinoma,0.9716,Cervical Adenosquamous Carcinoma,0.9655
CERVICAL ADENOSQUAMOUS CARCINOMA,Cervical Adenosquamous Carcinoma,1,2,Cervical Adenosquamous Carcinoma,1.0000,Adenosquamous Carcinoma,0.9850,Endometrial Adenosquamous Carcinoma,0.9827,Esophageal Adenosquamous Carcinoma,0.9772,Gastric Adenosquamous Carcinoma,0.9758
CERVICAL CANCER,Cervical Carcinoma,1,2,Cervical Carcinoma,0.9801,Cervical Adenocarcinoma,0.9692,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9649,Cervical Squamous Cell Carcinoma,0.9636,Cervical Squamous Neoplasm,0.9552
"CERVICAL CANCER, NOS",Cervical Carcinoma,2,2,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9556,Cervical Carcinoma,0.9551,Cervical Squamous Cell Carcinoma,0.9523,Cervical Squamous Neoplasm,0.9479,Cervical Adenosquamous Carcinoma,0.9468
CERVICAL CLEAR CELL CARCINOMA,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",5,2,Endometrial Clear Cell Adenocarcinoma,0.9687,Clear Cell Adenocarcinoma,0.9685,Clear Cell Renal Cell Carcinoma,0.9670,Adenocarcinoma Clear Cell,0.9646,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.9644
CERVICAL ENDOMETRIOID CARCINOMA,Cervical Endometrioid Adenocarcinoma,1,2,Cervical Endometrioid Adenocarcinoma,0.9898,Endometrial Endometrioid Adenocarcinoma,0.9758,Endometrioid Adenocarcinoma,0.9736,Ovarian Endometrioid Adenocarcinoma,0.9722,Endometrial Carcinoma,0.9710
CERVICAL NEUROENDOCRINE TUMOR,Cervical Neuroendocrine Tumor,1,2,Cervical Neuroendocrine Tumor,1.0000,Cervical Small Cell Neuroendocrine Carcinoma,0.9719,Neuroendocrine Carcinoma,0.9633,Neuroendocrine Tumor,0.9632,Esophageal Neuroendocrine Tumor,0.9630
CERVICAL SQUAMOUS CELL,Cervical Squamous Cell Carcinoma,1,2,Cervical Squamous Cell Carcinoma,0.9870,Squamous Cell Carcinoma,0.9682,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9664,Cervical Squamous Neoplasm,0.9628,Endometrial Squamous Cell Carcinoma,0.9615
CERVICAL SQUAMOUS CELL CARCINOMA,Cervical Squamous Cell Carcinoma,1,2,Cervical Squamous Cell Carcinoma,1.0000,Squamous Cell Carcinoma,0.9809,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9804,Cervical Squamous Neoplasm,0.9775,Endometrial Squamous Cell Carcinoma,0.9766
CERVICAL_ADENOCARCINOMA,Cervical Adenocarcinoma,1,2,Cervical Adenocarcinoma,0.9948,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9783,Cervical Carcinoma,0.9703,Adenocarcinoma,0.9641,Cervical Endometrioid Adenocarcinoma,0.9640
CERVICAL_CARCINOMA,Cervical Carcinoma,1,2,Cervical Carcinoma,0.9944,Cervical Adenocarcinoma,0.9723,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9722,Cervical Squamous Cell Carcinoma,0.9717,Carcinoma,0.9665
CERVICAL_SMALL_CELL,Cervical Small Cell Neuroendocrine Carcinoma,2,2,Small Cell,0.9594,Cervical Small Cell Neuroendocrine Carcinoma,0.9590,Small Cell Adenocarcinoma,0.9501,Ovarian Small Cell Carcinoma,0.9478,Cervical Squamous Cell Carcinoma,0.9474
CERVICAL_SQUAMOUS,Cervical Squamous Neoplasm,2,2,Cervical Squamous Cell Carcinoma,0.9711,Cervical Squamous Neoplasm,0.9642,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9637,Human Papillomavirus Positive<;>Squamous Cell Carcinoma,0.9546,Squamous Cell Carcinoma,0.9521
CERVICOMEDULLARY HEMANGIOBLASTOMA,Hemangioblastoma<;>Cervicomedullary Junction,1,2,Hemangioblastoma<;>Cervicomedullary Junction,0.9805,Hemangioblastoma,0.9421,Hemangioma,0.9364,Epithelioid Hemangioendothelioma,0.9193,Breast Carcinoma with Osseous Metaplasia,0.9152
CERVIX,Cervix Uteri,1,2,Cervix Uteri,0.9836,Cervical Carcinoma,0.9431,Cervical Adenocarcinoma,0.9386,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9374,Cervical Adenocarcinoma In Situ,0.9358
CESC,Cervical Squamous Cell Carcinoma,99,2,Chondrosarcoma,0.8907,Esophagus,0.8858,Central Nervous System Ewing Sarcoma<;>CIC Gene Rearrangement,0.8844,Acute Myeloid Leukemia with Mutated CEBPA,0.8819,Central Nervous System Disorder,0.8818
CESC_ADENOCARCINOMA,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,2,2,Cervical Adenocarcinoma,0.9370,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9361,Carcinoma,0.9338,Adenocarcinoma,0.9315,Endometrial Adenocarcinoma,0.9311
CESC_SQUAMOUSCARCINOMA,Cervical Squamous Cell Carcinoma,1,2,Cervical Squamous Cell Carcinoma,0.9266,Esophageal Squamous Cell Carcinoma,0.9256,Endometrial Squamous Cell Carcinoma,0.9244,Skin Squamous Cell Carcinoma,0.9234,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9234
CHOL,Cholangiocarcinoma,1,2,Cholangiocarcinoma,0.9327,Cholangiocarcinoma<;>Extrahepatic,0.9212,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.9145,Intrahepatic Cholangiocarcinoma,0.9141,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9095
CHOL EXTRA,Extrahepatic Bile Duct Adenocarcinoma,99,2,Extra-Adrenal Pheochromocytoma,0.9207,Extraskeletal Myxoid Chondrosarcoma,0.9070,Cholangiocarcinoma<;>Extrahepatic,0.9070,Extraskeletal Osteosarcoma,0.9055,Extrarenal Rhabdoid Tumor,0.9048
CHOL INTRA,Intrahepatic Cholangiocarcinoma,1,2,Intrahepatic Cholangiocarcinoma,0.9180,Intrahepatic,0.9166,Cholangiocarcinoma<;>Extrahepatic,0.9099,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9092,Liver and Intrahepatic Bile Duct Carcinoma,0.9071
CHOLANGIO EXTRAHEPATIC,Extrahepatic Bile Duct Adenocarcinoma,3,2,Cholangiocarcinoma<;>Extrahepatic,0.9611,Extrahepatic,0.9559,Extrahepatic Bile Duct Adenocarcinoma,0.9474,Intrahepatic Cholangiocarcinoma,0.9430,Cholangiocarcinoma,0.9419
CHOLANGIO INTRAHEPATIC,Intrahepatic Cholangiocarcinoma,1,2,Intrahepatic Cholangiocarcinoma,0.9628,Intrahepatic,0.9567,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9491,Cholangiocarcinoma,0.9466,Liver and Intrahepatic Bile Duct Carcinoma,0.9447
CHOLANGIOCARCINOMA,Cholangiocarcinoma,1,2,Cholangiocarcinoma,1.0000,Intrahepatic Cholangiocarcinoma,0.9709,Cholangiocarcinoma<;>Extrahepatic,0.9634,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9566,Hilar Cholangiocarcinoma,0.9532
"CHOLANGIOCARCINOMA, EXTRAHEPATIC",Cholangiocarcinoma<;>Extrahepatic,1,2,Cholangiocarcinoma<;>Extrahepatic,0.9891,Cholangiocarcinoma,0.9695,Intrahepatic Cholangiocarcinoma,0.9684,Extrahepatic,0.9637,Extrahepatic Bile Duct Adenocarcinoma,0.9612
"CHOLANGIOCARCINOMA, INTRAHEPATIC",Intrahepatic Cholangiocarcinoma,1,2,Intrahepatic Cholangiocarcinoma,0.9899,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9756,Cholangiocarcinoma,0.9733,Cholangiocarcinoma<;>Extrahepatic,0.9690,Intrahepatic,0.9656
CHOLANGIOCARCINOMA; DISTAL,Distal Bile Duct Adenocarcinoma,2,2,Cholangiocarcinoma<;>Extrahepatic,0.9603,Distal Bile Duct Adenocarcinoma,0.9588,Cholangiocarcinoma,0.9486,Distal,0.9428,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9426
CHOLANGIOCARCINOMA; HILAR/PERIHILAR,Hilar Cholangiocarcinoma,1,2,Hilar Cholangiocarcinoma,0.9635,Cholangiocarcinoma<;>Extrahepatic,0.9503,Intrahepatic Cholangiocarcinoma,0.9479,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9475,Cholangiocarcinoma,0.9468
CHOLANGIOCARCINOMA; INTRAHEPATIC,Intrahepatic Cholangiocarcinoma,1,2,Intrahepatic Cholangiocarcinoma,0.9865,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9765,Cholangiocarcinoma<;>Extrahepatic,0.9703,Cholangiocarcinoma,0.9697,Intrahepatic,0.9658
CHONDROBLASTIC OSTEOSARCOMA,Chondroblastic Osteosarcoma,1,2,Chondroblastic Osteosarcoma,1.0000,Chondroblastoma,0.9679,Osteosarcoma,0.9640,Osteoblastic Osteosarcoma,0.9625,Chondrosarcoma,0.9611
CHONDROBLASTOMA,Chondroblastoma,1,2,Chondroblastoma,1.0000,Chondroblastic Osteosarcoma,0.9679,Chondrosarcoma,0.9573,Breast Carcinoma with Chondroid Metaplasia,0.9482,Mesenchymal Chondrosarcoma,0.9481
CHONDROSARCOMA,Chondrosarcoma,1,2,Chondrosarcoma,1.0000,Mesenchymal Chondrosarcoma,0.9708,Chondroblastic Osteosarcoma,0.9611,Adenosarcoma,0.9581,Chondroblastoma,0.9573
CHORDOMA,Chordoma,1,2,Chordoma,1.0000,Sacral Chordoma,0.9626,Ependymoma,0.9292,Papilloma,0.9270,Myxoma,0.9218
"CHORDOMA, SACRAL",Sacral Chordoma,1,2,Sacral Chordoma,0.9849,Chordoma,0.9655,Sacrococcygeal Teratoma,0.9276,Ependymoma,0.9161,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.9156
CHORDOMA_SACRAL,Sacral Chordoma,1,2,Sacral Chordoma,0.9848,Chordoma,0.9678,Sacrococcygeal Teratoma,0.9284,Ependymoma,0.9128,Schwannoma,0.9127
CHORIOCARCINOMA,Choriocarcinoma,1,2,Choriocarcinoma,1.0000,Choriocarcinoma<;>Nonseminomatous,0.9542,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,0.9515,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9503,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,0.9439
CHORIOCARCINOMANON-SEMINOMA,Choriocarcinoma<;>Nonseminomatous,99,2,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,0.9778,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9740,Choriocarcinoma,0.9648,Testicular Seminoma,0.9592,Yolk Sac Tumor<;>Seminoma,0.9576
CHOROID PLEXUS PAPILLOMA,Choroid Plexus Papilloma,1,2,Choroid Plexus Papilloma,1.0000,Atypical Choroid Plexus Papilloma,0.9722,Choroid Plexus Neoplasm,0.9692,Papilloma,0.9540,Ependymoma,0.9338
CHOROID PLEXUS TUMOR,Choroid Plexus Neoplasm,1,2,Choroid Plexus Neoplasm,0.9885,Choroid Plexus Papilloma,0.9725,Atypical Choroid Plexus Papilloma,0.9479,Ependymal Tumor,0.9441,Central Nervous System Neoplasm,0.9365
CHROMOPHOBE,Chromophobe Renal Cell Carcinoma,1,2,Chromophobe Renal Cell Carcinoma,0.9560,Classic Variant of Chromophobe Renal Cell Carcinoma,0.9429,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.9392,Chromothripsis,0.9310,Choriocarcinoma,0.9028
CHROMOPHOBE KIDNEY RENAL CELL CARCINOMA,Chromophobe Renal Cell Carcinoma,1,2,Chromophobe Renal Cell Carcinoma,0.9975,Classic Variant of Chromophobe Renal Cell Carcinoma,0.9796,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.9658,Renal Cell Carcinoma,0.9644,Clear Cell Renal Cell Carcinoma,0.9606
CHROMOPHOBE RENAL CELL CARCINOMA,Chromophobe Renal Cell Carcinoma,1,2,Chromophobe Renal Cell Carcinoma,1.0000,Classic Variant of Chromophobe Renal Cell Carcinoma,0.9809,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.9684,Renal Cell Carcinoma,0.9591,Clear Cell Renal Cell Carcinoma,0.9560
CHROMOPHOBE RENAL CELL CARCINOMA,Chromophobe Renal Cell Carcinoma,1,2,Chromophobe Renal Cell Carcinoma,0.9953,Classic Variant of Chromophobe Renal Cell Carcinoma,0.9782,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.9663,Renal Cell Carcinoma,0.9599,Clear Cell Renal Cell Carcinoma,0.9545
"CHROMOPHOBE, CLASSIC",Classic Variant of Chromophobe Renal Cell Carcinoma,1,2,Classic Variant of Chromophobe Renal Cell Carcinoma,0.9647,Chromophobe Renal Cell Carcinoma,0.9489,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.9417,Classic Hodgkin Lymphoma,0.9106,Classic Thyroid Gland Papillary Carcinoma,0.9091
"CHROMOPHOBE, EOSINOPHILIC",Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,1,2,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.9694,Chromophobe Renal Cell Carcinoma,0.9431,Classic Variant of Chromophobe Renal Cell Carcinoma,0.9428,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9185,Chromothripsis,0.9171
CHROMOTHRIPSIS,Chromothripsis,1,2,Chromothripsis,1.0000,Pleomorphic Xanthoastrocytoma,0.9155,Chromophobe Renal Cell Carcinoma,0.9036,Classic Variant of Chromophobe Renal Cell Carcinoma,0.9019,Chondrosarcoma,0.9012
"CHRONIC LYMPHOBLASTIC LEUKEMIA CLL, B-CELL",Chronic Lymphoblastic Lymphoma,1,2,Chronic Lymphoblastic Lymphoma,0.9706,Chronic Lymphocytic Leukemia,0.9695,B Lymphoblastic Leukemia/Lymphoma,0.9666,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.9641,T Lymphoblastic Leukemia/Lymphoma,0.9584
CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1,2,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1.0000,Chronic Lymphocytic Leukemia,0.9768,Chronic Lymphoblastic Lymphoma,0.9615,B Lymphoblastic Leukemia/Lymphoma,0.9518,T Lymphoblastic Leukemia/Lymphoma,0.9497
CHRONIC MYELOGENOUS LEUKEMIA,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",99,2,Chronic Myelogenous Leukemia,1.0000,Chronic Myelomonocytic Leukemia,0.9859,Chronic Myelomonocytic Leukemia-1,0.9733,Chronic Myelomonocytic Leukemia-2,0.9719,Chronic Lymphocytic Leukemia,0.9658
CHRONIC MYELOGENOUS LEUKEMIA CML,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",99,2,Chronic Myelogenous Leukemia,0.9915,Chronic Myelomonocytic Leukemia,0.9767,Chronic Myelomonocytic Leukemia-1,0.9657,Chronic Myelomonocytic Leukemia-2,0.9654,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.9595
"CHRONIC MYELOGENOUS LEUKEMIA CML, BLAST CRISIS","Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",2,2,Chronic Myelogenous Leukemia,0.9722,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.9697,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9666,Chronic Myelomonocytic Leukemia,0.9602,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9566
"CHRONIC MYELOID LEUKEMIA, BCR-ABL1+","Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1,2,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9833,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.9800,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9784,"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",0.9665,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9622
CHRONIC MYELOMONOCYTIC LEUKAEMIA,Chronic Myelomonocytic Leukemia,1,2,Chronic Myelomonocytic Leukemia,0.9933,Chronic Myelomonocytic Leukemia-1,0.9780,Chronic Myelogenous Leukemia,0.9774,Chronic Myelomonocytic Leukemia-2,0.9760,Acute Myelomonocytic Leukemia,0.9698
CHRONIC MYELOMONOCYTIC LEUKEMIA,Chronic Myelomonocytic Leukemia,1,2,Chronic Myelomonocytic Leukemia,1.0000,Chronic Myelogenous Leukemia,0.9859,Chronic Myelomonocytic Leukemia-1,0.9856,Chronic Myelomonocytic Leukemia-2,0.9828,Acute Myelomonocytic Leukemia,0.9765
CHRONIC MYELOMONOCYTIC LEUKEMIA 1,Chronic Myelomonocytic Leukemia-1,1,2,Chronic Myelomonocytic Leukemia-1,0.9966,Chronic Myelomonocytic Leukemia-2,0.9886,Chronic Myelomonocytic Leukemia,0.9864,Chronic Myelogenous Leukemia,0.9729,Acute Myelomonocytic Leukemia,0.9702
CHRONIC MYELOMONOCYTIC LEUKEMIA 2,Chronic Myelomonocytic Leukemia-2,1,2,Chronic Myelomonocytic Leukemia-2,0.9968,Chronic Myelomonocytic Leukemia-1,0.9856,Chronic Myelomonocytic Leukemia,0.9782,Chronic Myelogenous Leukemia,0.9669,Acute Myelomonocytic Leukemia,0.9605
CHRONIC_LYMPHOCYTIC_LEUKAEMIA-SMALL_LYMPHOCYTIC_LYMPHOMA,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1,2,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.9834,Chronic Lymphocytic Leukemia,0.9581,Chronic Lymphoblastic Lymphoma,0.9528,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9514,B Lymphoblastic Leukemia/Lymphoma,0.9448
CHRONIC_MYELOID_LEUKAEMIA,Chronic Myelogenous Leukemia,1,2,Chronic Myelogenous Leukemia,0.9753,Chronic Myelomonocytic Leukemia,0.9665,Chronic Myelomonocytic Leukemia-2,0.9582,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9579,Chronic Myelomonocytic Leukemia-1,0.9577
CILIATED MUCONODULAR PAPILLARY TUMOR OF THE LUNG,Bronchiolar Adenoma/Ciliated Muconodular Papillary Tumor,1,2,Bronchiolar Adenoma/Ciliated Muconodular Papillary Tumor,0.9805,Lung Mucoepidermoid Carcinoma,0.9508,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.9479,Lung Papillary Adenocarcinoma,0.9451,Lung Mucinous Adenocarcinoma,0.9423
CIN,Chromosomal Instability,99,2,Cervical Carcinoma,0.9025,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,0.9004,Human Papillomavirus Positive<;>Squamous Cell Carcinoma,0.8990,Cervical Squamous Cell Carcinoma,0.8968,uterine corpus endometrial carcinoma<;>Copy Number<;>Low,0.8961
CLASSIC,Classic Histology,1,2,Classic Histology,0.9487,Classic Hodgkin Lymphoma,0.9240,Classic Variant of Chromophobe Renal Cell Carcinoma,0.9067,Classic Thyroid Gland Papillary Carcinoma,0.9053,Chronic Myelomonocytic Leukemia,0.8898
CLASSICAL,Classic Histology,1,2,Classic Histology,0.9213,Classic Hodgkin Lymphoma,0.9018,Classic Variant of Chromophobe Renal Cell Carcinoma,0.8938,Atypical Chronic Myeloid Leukemia,0.8910,Classic Thyroid Gland Papillary Carcinoma,0.8886
CLASSICAL HCA,Hepatocellular Adenoma,99,2,Classic Histology,0.9169,Classic Variant of Chromophobe Renal Cell Carcinoma,0.9067,Classic Hodgkin Lymphoma,0.8995,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.8949,Classic Thyroid Gland Papillary Carcinoma,0.8948
CLASSICAL HODGKIN LYMPHOMA,Classic Hodgkin Lymphoma,1,2,Classic Hodgkin Lymphoma,0.9848,Hodgkin Lymphoma,0.9583,Non-Hodgkin Lymphoma,0.9536,B-Cell Non-Hodgkin Lymphoma,0.9420,"Malignant Lymphoma, Histiocytic, Diffuse",0.9407
CLAUDIN-LOW,Claudin-Low,1,2,Claudin-Low,1.0000,Low Grade Glioma<;>Low Grade Astrocytoma,0.9111,Cytogenetic Abnormality<;>Low Risk,0.9100,Low-CSD Melanoma,0.9095,Low Grade Glioma,0.9054
CLEAR CELL ADENOCARCINOMA,Clear Cell Adenocarcinoma,1,2,Clear Cell Adenocarcinoma,1.0000,Adenocarcinoma Clear Cell,0.9934,Endometrial Clear Cell Adenocarcinoma,0.9806,Clear Cell Renal Cell Carcinoma,0.9785,Clear Cell,0.9656
CLEAR CELL BORDERLINE OVARIAN TUMOR,Borderline Ovarian Clear Cell Tumor,1,2,Borderline Ovarian Clear Cell Tumor,0.9964,Ovarian Clear Cell Tumor,0.9791,Malignant Ovarian Clear Cell Tumor,0.9790,Ovarian Clear Cell Cystadenocarcinoma,0.9695,Borderline Ovarian Serous Tumor,0.9617
CLEAR CELL CARCINOMA,Clear Cell Adenocarcinoma,2,2,Clear Cell Renal Cell Carcinoma,0.9888,Clear Cell Adenocarcinoma,0.9879,Adenocarcinoma Clear Cell,0.9792,Clear Cell,0.9714,Endometrial Clear Cell Adenocarcinoma,0.9709
CLEAR CELL CARCINOMA OF THE LUNG,"Lung Large Cell Carcinoma, Clear Cell Variant",3,2,Clear Cell Adenocarcinoma,0.9851,Clear Cell Renal Cell Carcinoma,0.9827,"Lung Large Cell Carcinoma, Clear Cell Variant",0.9800,Adenocarcinoma Clear Cell,0.9796,Endometrial Clear Cell Adenocarcinoma,0.9693
CLEAR CELL ODONTOGENIC CARCINOMA,Clear Cell Odontogenic Carcinoma,1,2,Clear Cell Odontogenic Carcinoma,1.0000,Odontogenic Carcinoma,0.9630,Clear Cell Renal Cell Carcinoma,0.9624,Clear Cell Adenocarcinoma,0.9616,Adenocarcinoma Clear Cell,0.9604
CLEAR CELL OVARIAN CANCER,Ovarian Clear Cell Tumor,1,2,Ovarian Clear Cell Tumor,0.9898,Malignant Ovarian Clear Cell Tumor,0.9799,Ovarian Clear Cell Cystadenocarcinoma,0.9745,Clear Cell Renal Cell Carcinoma,0.9713,Clear Cell Adenocarcinoma,0.9713
CLEAR CELL PAPILLARY RENAL CELL CARCINOMA,Clear Cell Papillary Renal Neoplasm,1,2,Clear Cell Papillary Renal Neoplasm,0.9930,Clear Cell Renal Cell Carcinoma,0.9882,Papillary Renal Cell Carcinoma,0.9824,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9711,Renal Cell Carcinoma,0.9708
CLEAR CELL RENAL CELL CARCINOMA,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,1.0000,Renal Cell Carcinoma,0.9807,Clear Cell Papillary Renal Neoplasm,0.9802,Clear Cell Adenocarcinoma,0.9785,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9762
CLEAR CELL SARCOMA,Clear Cell Sarcoma of Soft Tissue,1,2,Clear Cell Sarcoma of Soft Tissue,0.9838,Clear Cell Adenocarcinoma,0.9702,Clear Cell Renal Cell Carcinoma,0.9687,Adenocarcinoma Clear Cell,0.9639,Clear Cell,0.9598
CLEAR_CELL,Clear Cell,1,2,Clear Cell,0.9908,Clear Cell Adenocarcinoma,0.9593,Adenocarcinoma Clear Cell,0.9580,Clear Cell Renal Cell Carcinoma,0.9576,"Lung Large Cell Carcinoma, Clear Cell Variant",0.9518
CLEAR_CELL_CARCINOMA,Clear Cell Adenocarcinoma,2,2,Clear Cell Renal Cell Carcinoma,0.9834,Clear Cell Adenocarcinoma,0.9833,Adenocarcinoma Clear Cell,0.9765,Endometrial Clear Cell Adenocarcinoma,0.9689,"Lung Large Cell Carcinoma, Clear Cell Variant",0.9671
CLEAR_CELL_RENAL_CELL_CARCINOMA,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.9950,Renal Cell Carcinoma,0.9797,Clear Cell Papillary Renal Neoplasm,0.9784,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9771,Clear Cell Adenocarcinoma,0.9740
CLL,Chronic Lymphocytic Leukemia,1,2,Chronic Lymphocytic Leukemia,0.9379,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.9360,Leukemia,0.9308,Lymphoma,0.9277,B-Cell Prolymphocytic Leukemia,0.9251
CML,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1,2,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9501,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9438,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.9432,Chronic Myelogenous Leukemia,0.9402,"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",0.9346
CMML,Chronic Myelomonocytic Leukemia,3,2,Chronic Myelomonocytic Leukemia-2,0.9044,Chronic Myelomonocytic Leukemia-1,0.9012,Chronic Myelomonocytic Leukemia,0.8967,Monoclonal B-Cell Lymphocytosis,0.8950,Melanoma,0.8947
CNS,Malignant Central Nervous System Neoplasm,99,2,Central Nervous System<;>Brain,0.9609,Central Nervous System Disorder,0.9428,Central Nervous System Melanoma,0.9343,Brain,0.9321,Central Nervous System Medulloepithelioma,0.9293
CNS CANCER,Malignant Central Nervous System Neoplasm,2,2,Central Nervous System Neoplasm,0.9514,Malignant Central Nervous System Neoplasm,0.9481,Brain Neoplasm,0.9346,Central Nervous System Disorder,0.9329,Malignant Brain Neoplasm,0.9307
CNS DISEASE,Central Nervous System Disorder,1,2,Central Nervous System Disorder,0.9611,Central Nervous System<;>Brain,0.9314,Central Nervous System Neoplasm,0.9291,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9253,Malignant Central Nervous System Neoplasm,0.9251
CNS EFT-CIC,Central Nervous System Ewing Sarcoma<;>CIC Gene Rearrangement,1,2,Central Nervous System Ewing Sarcoma<;>CIC Gene Rearrangement,0.9308,Central Nervous System<;>Brain,0.9198,Supratentorial Ependymoma<;>Subependymoma,0.9087,Central Nervous System Disorder,0.9084,Central Nervous System Medulloepithelioma,0.9076
CNS EMBRYONAL NOS,Central Nervous System Embryonal Tumor,1,2,Central Nervous System Embryonal Tumor,0.9510,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.9504,Embryonal Neoplasm,0.9318,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9316,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9298
"CNS EMBRYONAL TUMOR, NOS","Central Nervous System Embryonal Tumor, Not Otherwise Specified",2,2,Central Nervous System Embryonal Tumor,0.9764,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.9754,Germ Cell Tumor<;>Embryonal Carcinoma,0.9549,Embryonal Neoplasm,0.9548,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9532
CNS GERMINOMA,Central Nervous System Germinoma,1,2,Central Nervous System Germinoma,0.9795,Germinoma,0.9668,Germ Cell Tumor,0.9388,Childhood Brain Germ Cell Tumor,0.9370,Central Nervous System Neoplasm,0.9330
CNS/BRAIN,Central Nervous System<;>Brain,1,2,Central Nervous System<;>Brain,0.9736,Brain,0.9598,Central Nervous System Disorder,0.9450,Central Nervous System Melanoma,0.9340,Central Nervous System Medulloepithelioma,0.9309
COAD,Colon Adenocarcinoma,3,2,Colon,0.9092,Hypermutated Colorectal Carcinoma,0.9060,Colon Adenocarcinoma,0.9037,Colorectal,0.9015,Colon Carcinoma,0.9005
COAD_CIN,Colon Adenocarcinoma<;>Chromosomal Instability,1,2,Colon Adenocarcinoma<;>Chromosomal Instability,0.9173,Colon Carcinoma,0.9108,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9106,Colon Carcinoma<;>Melanoma,0.9092,Cervical Carcinoma,0.9088
COAD_GS,Colon Adenocarcinoma,99,2,Glioblastoma<;>IDH Gene Family Mutation,0.9119,Gastric Adenocarcinoma<;>Chromosomal Instability,0.9080,Low Grade Glioma<;>IDH Gene Family Mutation,0.9070,Gastric Adenocarcinoma<;>Microsatellite Instability,0.9066,"Astrocytoma, IDH-Mutant, Grade 2",0.9061
COAD_MSI,Colon Adenocarcinoma<;>Microsatellite Instability,1,2,Colon Adenocarcinoma<;>Microsatellite Instability,0.9420,Gastric Adenocarcinoma<;>Microsatellite Instability,0.9338,Rectal Adenocarcinoma<;>Microsatellite Instability,0.9317,Hypermutated Colorectal Carcinoma,0.9312,Colon Adenocarcinoma<;>Chromosomal Instability,0.9284
COAD_POLE,Colon Adenocarcinoma<;>POLE Gene Mutation,1,2,Colon Adenocarcinoma<;>POLE Gene Mutation,0.9336,Endometrial Carcinoma<;>POLE Gene Mutation,0.9307,Gastric Adenocarcinoma<;>POLE Gene Mutation,0.9241,Rectal Adenocarcinoma<;>POLE Gene Mutation,0.9225,Esophageal Adenocarcinoma<;>POLE Gene Mutation,0.9221
COLLECTING DUCT RENAL CELL CARCINOMA,Collecting Duct Carcinoma,1,2,Collecting Duct Carcinoma,0.9819,Renal Cell Carcinoma,0.9686,Clear Cell Renal Cell Carcinoma,0.9574,Kidney Carcinoma,0.9542,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9491
COLON,Colon,1,2,Colon,1.0000,Colorectal,0.9599,Sigmoid Colon,0.9567,Colon Adenocarcinoma,0.9563,Ascending Colon,0.9552
COLON ADENOCARCINOMA,Colon Adenocarcinoma,1,2,Colon Adenocarcinoma,1.0000,Colorectal Adenocarcinoma,0.9809,Colon Carcinoma,0.9773,Colon Mucinous Adenocarcinoma,0.9750,Adenocarcinoma,0.9637
COLON ADENOCARCINOMA IN SITU,Colon Adenocarcinoma,4,2,Cervical Adenocarcinoma In Situ,0.9759,Lung Adenocarcinoma In Situ,0.9752,Lung Adenocarcinoma In Situ<;>Lung Non-Small Cell Carcinoma,0.9650,Colon Adenocarcinoma,0.9585,Breast Ductal Carcinoma In Situ,0.9550
COLON CANCER,Colon Carcinoma,1,2,Colon Carcinoma,0.9816,Colon Adenocarcinoma,0.9735,Colon Carcinoma<;>Melanoma,0.9649,Colon,0.9616,Colorectal Carcinoma,0.9602
COLON CARCINOMA,Colon Carcinoma,1,2,Colon Carcinoma,1.0000,Colorectal Carcinoma,0.9801,Colon Adenocarcinoma,0.9773,Colon Carcinoma<;>Melanoma,0.9702,Carcinoma,0.9661
COLON MUCINOUS ADENOCARCINOMA,Colon Mucinous Adenocarcinoma,1,2,Colon Mucinous Adenocarcinoma,1.0000,Mucinous Adenocarcinoma,0.9807,Appendix Mucinous Adenocarcinoma,0.9753,Rectal Mucinous Adenocarcinoma<;>Colon Mucinous Adenocarcinoma,0.9751,Colon Adenocarcinoma,0.9750
COLONIC TYPE ADENOCARCINOMA OF THE APPENDIX,Appendix Adenocarcinoma,3,2,Gastric Intestinal-Type Adenocarcinoma,0.9637,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.9615,Appendix Adenocarcinoma,0.9614,Appendix Goblet Cell Adenocarcinoma,0.9607,Appendix Mucinous Adenocarcinoma,0.9579
COLON_CANCER,Colon Carcinoma,1,2,Colon Carcinoma,0.9784,Colon Adenocarcinoma,0.9717,Colon Carcinoma<;>Melanoma,0.9688,Colorectal Carcinoma,0.9592,Colon,0.9570
COLON_CARCINOMA,Colon Carcinoma,1,2,Colon Carcinoma,0.9925,Colorectal Carcinoma,0.9750,Colon Adenocarcinoma,0.9734,Colon Carcinoma<;>Melanoma,0.9732,Carcinoma,0.9676
COLON_CARCINOMA AND MELANOMA,Colon Carcinoma<;>Melanoma,1,2,Colon Carcinoma<;>Melanoma,0.9878,Colon Carcinoma,0.9619,Colon Adenocarcinoma,0.9537,Colon Mucinous Adenocarcinoma,0.9476,Colorectal Carcinoma,0.9472
COLORECTAL,Colorectal,1,2,Colorectal,1.0000,Colorectal Carcinoma,0.9631,Colorectal Adenocarcinoma,0.9610,Colon,0.9599,Fibroblast<;>Colorectal,0.9513
COLORECTAL ADENOCARCINOMA,Colorectal Adenocarcinoma,1,2,Colorectal Adenocarcinoma,1.0000,Colon Adenocarcinoma,0.9809,Colorectal Carcinoma,0.9742,Rectal Adenocarcinoma,0.9669,Adenocarcinoma,0.9656
COLORECTAL CANCER,Colorectal Carcinoma,1,2,Colorectal Carcinoma,0.9803,Colorectal Adenocarcinoma,0.9701,Colorectal,0.9686,Colon Carcinoma,0.9589,Metastatic Colorectal Carcinoma,0.9544
COLORECTAL CARCINOMA,Colorectal Carcinoma,1,2,Colorectal Carcinoma,1.0000,Colon Carcinoma,0.9801,Colorectal Adenocarcinoma,0.9742,Colorectal Neuroendocrine Carcinoma,0.9682,Metastatic Colorectal Carcinoma,0.9673
COLORECTAL CARCINOMA OTHER,Colorectal Carcinoma,1,2,Colorectal Carcinoma,0.9641,Colorectal Adenocarcinoma,0.9557,Metastatic Colorectal Carcinoma,0.9487,Colon Carcinoma,0.9471,Colorectal,0.9469
COLORECTAL HYPERMUTATED,Microsatellite Stable Colorectal Carcinoma,99,2,Hypermutated Colorectal Carcinoma,0.9850,Colorectal,0.9429,Colon Adenocarcinoma<;>Microsatellite Instability,0.9310,Colorectal Adenocarcinoma,0.9301,Mucosal Melanoma<;>Anorectal,0.9274
COLORECTAL MSS,Microsatellite Stable Colorectal Carcinoma,3,2,Colorectal,0.9594,Hypermutated Colorectal Carcinoma,0.9459,Microsatellite Stable Colorectal Carcinoma,0.9427,Colorectal Adenocarcinoma,0.9371,Colon Adenocarcinoma<;>Microsatellite Instability,0.9348
COLORECTAL NEUROENDOCRINE TUMOR,Colorectal Neuroendocrine Tumor,1,2,Colorectal Neuroendocrine Tumor,1.0000,Colorectal Neuroendocrine Carcinoma,0.9868,Neuroendocrine Tumor,0.9715,Pancreatic Neuroendocrine Tumor,0.9651,Esophageal Neuroendocrine Tumor,0.9609
COLORECTAL_ADENOCARCINOMA,Colorectal Adenocarcinoma,1,2,Colorectal Adenocarcinoma,0.9934,Colon Adenocarcinoma,0.9744,Colorectal Carcinoma,0.9695,Adenocarcinoma,0.9636,Rectal Adenocarcinoma,0.9634
COLORECTAL_CANCER,Colorectal Carcinoma,1,2,Colorectal Carcinoma,0.9766,Colorectal Adenocarcinoma,0.9685,Colorectal,0.9652,Colon Carcinoma,0.9546,Metastatic Colorectal Carcinoma,0.9542
COLUMNAR,Columnar Cell,1,2,Columnar Cell,0.9703,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.9347,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9007,Colon,0.8993,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.8964
COLUMNAR CELL VARIANT,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,2,2,Columnar Cell,0.9778,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.9630,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.9272,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9187,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.9165
COMBINED ADENOCARCINOMA - HIGH GRADE NEUROENDOCRINE CARCINOMA OF SMALL CELL TYPE,High Grade<;>Small Cell Neuroendocrine Carcinoma<;>Small Cell Adenocarcinoma,1,2,High Grade<;>Small Cell Neuroendocrine Carcinoma<;>Small Cell Adenocarcinoma,0.9799,Combined Lung Small Cell Carcinoma,0.9688,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9610,Cervical Small Cell Neuroendocrine Carcinoma,0.9608,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.9600
COMBINED HGNEC/AC,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,99,2,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.9113,Combined Lung Small Cell Carcinoma,0.9061,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.9016,Endometrial Carcinoma<;>Mixed,0.8979,Digestive System Mixed Adenoneuroendocrine Carcinoma,0.8976
COMBINED SMALL CELL LUNG CARCINOMA,Combined Lung Small Cell Carcinoma,1,2,Combined Lung Small Cell Carcinoma,0.9992,Lung Small Cell Carcinoma,0.9611,Lung Non-Small Cell Carcinoma,0.9561,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9548,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9521
COMPLEX CYTOGENETICS,Complex Karyotype,1,2,Complex Karyotype,0.9856,Cytogenetic Abnormality<;>Low Risk,0.9134,Cytogenetic Abnormality<;>Intermediate Risk,0.9115,Normal Karyotype,0.9075,Central Nervous System Ewing Sarcoma<;>CIC Gene Rearrangement,0.9070
CONGENITAL FIBROSARCOMA,Congenital Peribronchial Myofibroblastic Tumor,3,2,Infantile Fibrosarcoma,0.9599,Fibrosarcoma,0.9448,Congenital Peribronchial Myofibroblastic Tumor,0.9362,Sclerosing Epithelioid Fibrosarcoma,0.9258,Myxoinflammatory Fibroblastic Sarcoma,0.9182
CONVENTIONAL LEIOMYOSARCOMA,Conventional Leiomyosarcoma,1,2,Conventional Leiomyosarcoma,1.0000,Leiomyosarcoma,0.9503,Well Differentiated Leiomyosarcoma,0.9371,Uterine Corpus Leiomyosarcoma,0.9348,Uterine Corpus Myxoid Leiomyosarcoma,0.9334
COPY-NUMBER HIGH SEROUS-LIKE,Endometrial Serous Adenocarcinoma,99,2,Serous Adenocarcinoma<;>High Grade,0.9572,Cystadenocarcinoma<;>High Grade<;>Serous,0.9489,Ovarian High Grade Serous Adenocarcinoma,0.9485,Ovarian Low Grade Serous Adenocarcinoma,0.9472,Fallopian Tube High Grade Serous Adenocarcinoma,0.9458
COPY-NUMBER LOW ENDOMETRIOD,Endometrial Endometrioid Adenocarcinoma,99,2,uterine corpus endometrial carcinoma<;>Copy Number<;>Low,0.9552,uterine corpus endometrial carcinoma<;>Copy Number<;>High,0.9448,Low Grade Endometrioid Stromal Sarcoma,0.9323,Cytogenetic Abnormality<;>Low Risk,0.9244,Endometrial Carcinoma<;>POLE Gene Mutation,0.9239
CORTICAL,Cerebral Cortex,1,2,Cerebral Cortex,0.9570,Adrenal Cortical Adenoma,0.9164,Adrenal Cortical Carcinoma,0.9149,Central Nervous System<;>Brain,0.9127,Brain,0.9080
CRANIOPHARYNGIOMA,Craniopharyngioma,1,2,Craniopharyngioma,1.0000,Adamantinomatous Craniopharyngioma,0.9606,Glioma,0.9347,Brain Neoplasm,0.9337,Meningioma,0.9335
"CRANIOPHARYNGIOMA, ADAMANTINOMATOUS TYPE",Adamantinomatous Craniopharyngioma,1,2,Adamantinomatous Craniopharyngioma,0.9791,Craniopharyngioma,0.9589,Adamantinoma,0.9384,"Posterior Fossa Ependymoma, Group A (PFA)",0.9382,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.9382
CRC HM,Microsatellite Stable Colorectal Carcinoma,99,2,Colorectal,0.9409,Colon,0.9295,Metastatic Colorectal Carcinoma<;>Primary,0.9291,Metastatic Colorectal Carcinoma,0.9279,Hypermutated Colorectal Carcinoma,0.9279
CRC MSS,Microsatellite Stable Colorectal Carcinoma,2,2,Hypermutated Colorectal Carcinoma,0.9376,Microsatellite Stable Colorectal Carcinoma,0.9316,Colorectal,0.9311,Colon Mucinous Adenocarcinoma,0.9289,Colon Adenocarcinoma<;>Microsatellite Instability,0.9272
CRIBIFORM MORULAR,Thyroid Gland Cribriform Morular Carcinoma,2,2,Cribriform,0.9416,Thyroid Gland Cribriform Morular Carcinoma,0.9355,Breast Tubular Carcinoma<;>Cribriform Pattern,0.9109,Breast Tubular Carcinoma<;>Cribriform,0.9068,Cribriform<;>Solid,0.9052
CRIBRIFORM,Cribriform,1,2,Cribriform,1.0000,Cribriform<;>Solid,0.9564,Cribriform<;>Solid<;>Tubular,0.9469,Breast Tubular Carcinoma<;>Cribriform,0.9397,Thyroid Gland Cribriform Morular Carcinoma,0.9381
CRIBRIFORM/SOLID,Cribriform<;>Solid,1,2,Cribriform<;>Solid,0.9905,Cribriform<;>Solid<;>Tubular,0.9748,Cribriform,0.9635,Breast Tubular Carcinoma<;>Cribriform,0.9427,Solid,0.9377
CRIBRIFORM/SOLID/TUBULAR,Cribriform<;>Solid<;>Tubular,1,2,Cribriform<;>Solid<;>Tubular,0.9879,Cribriform<;>Solid,0.9763,Breast Tubular Carcinoma<;>Cribriform,0.9583,Cribriform,0.9567,Breast Tubular Carcinoma<;>Cribriform Pattern,0.9520
CRIBRIFORM/TUBULAR,Breast Tubular Carcinoma<;>Cribriform,3,2,Cribriform<;>Solid<;>Tubular,0.9800,Cribriform,0.9678,Breast Tubular Carcinoma<;>Cribriform,0.9630,Breast Tubular Carcinoma<;>Cribriform Pattern,0.9562,Cribriform<;>Solid,0.9547
CRPC-ADENO,Castration-Resistant Prostate Carcinoma<;>Prostate Adenocarcinoma,2,2,Adenosarcoma,0.9387,Castration-Resistant Prostate Carcinoma<;>Prostate Adenocarcinoma,0.9331,Castration-Resistant Prostate Carcinoma<;>Non-Metastatic Prostate Carcinoma,0.9253,Castration-Resistant Prostate Carcinoma<;>Prostate Neuroendocrine Neoplasm,0.9252,Prostate Adenocarcinoma,0.9245
CRPC-NE,Castration-Resistant Prostate Carcinoma<;>Prostate Neuroendocrine Neoplasm,1,2,Castration-Resistant Prostate Carcinoma<;>Prostate Neuroendocrine Neoplasm,0.9420,Castration-Resistant Prostate Carcinoma<;>Non-Metastatic Prostate Carcinoma,0.9312,Prostate Neuroendocrine Carcinoma,0.9307,Castration-Resistant Prostate Carcinoma<;>Metastatic Prostate Carcinoma,0.9270,Castration-Resistant Prostate Carcinoma<;>Prostate Adenocarcinoma,0.9270
CSCC,Skin Squamous Cell Carcinoma,99,2,Cholangiocarcinoma,0.9095,Colorectal,0.9059,Colon,0.9049,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9043,Carcinoma,0.9036
CUTANEOUS MALIGNANCY OF HAIR MATRIX CELLS,Pilomatrical Carcinoma,99,2,Malignant Skin Neoplasm,0.9511,Cutaneous Melanoma,0.9432,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9393,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9388,Skin Carcinoma,0.9382
CUTANEOUS MELANOMA,Cutaneous Melanoma,1,2,Cutaneous Melanoma,1.0000,Melanoma,0.9596,Cutaneous Nodular Melanoma,0.9545,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9512,Melanoma Involvement of Regional Cutaneous or Subcutaneous Tissue,0.9443
CUTANEOUS SQUAMOUS CELL,Skin Squamous Cell Carcinoma,1,2,Skin Squamous Cell Carcinoma,0.9766,Squamous Cell Carcinoma,0.9609,Skin Acantholytic Squamous Cell Carcinoma,0.9553,Lung Squamous Cell Carcinoma,0.9550,Cervical Squamous Cell Carcinoma,0.9541
CUTANEOUS SQUAMOUS CELL CARCINOMA,Skin Squamous Cell Carcinoma,1,2,Skin Squamous Cell Carcinoma,0.9882,Squamous Cell Carcinoma,0.9743,Skin Carcinoma,0.9733,Lung Squamous Cell Carcinoma,0.9695,Cervical Squamous Cell Carcinoma,0.9691
CUTANEOUS T CELL LYMPHOMA,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,2,2,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9855,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9717,Cutaneous Melanoma,0.9540,Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma,0.9515,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.9490
CYSTADENOCARCINOMA,Cystadenocarcinoma,1,2,Cystadenocarcinoma,1.0000,Mucinous Cystadenocarcinoma,0.9762,Serous Cystadenocarcinoma,0.9742,Ovarian Clear Cell Cystadenocarcinoma,0.9645,Cystadenocarcinoma<;>Poorly Differentiated,0.9643
"CYSTADENOCARCINOMA, CLEAR CELL",Ovarian Clear Cell Cystadenocarcinoma,1,2,Ovarian Clear Cell Cystadenocarcinoma,0.9833,Adenocarcinoma Clear Cell,0.9627,Cystadenocarcinoma,0.9625,Clear Cell Adenocarcinoma,0.9606,Ovarian Clear Cell Tumor,0.9595
"CYSTADENOCARCINOMA, ENDOMETRIOID",Cystadenocarcinoma<;>Endometrioid Adenocarcinoma,1,2,Cystadenocarcinoma<;>Endometrioid Adenocarcinoma,0.9847,Cystadenocarcinoma,0.9619,Ovarian Endometrioid Adenocarcinoma,0.9604,Endometrial Endometrioid Adenocarcinoma,0.9554,Ovarian Clear Cell Cystadenocarcinoma,0.9554
"CYSTADENOCARCINOMA, HIGH GRADE SEROUS",Cystadenocarcinoma<;>High Grade<;>Serous,1,2,Cystadenocarcinoma<;>High Grade<;>Serous,0.9934,Serous Cystadenocarcinoma,0.9715,Serous Adenocarcinoma<;>High Grade,0.9691,Ovarian High Grade Serous Adenocarcinoma,0.9681,Cystadenocarcinoma<;>Poorly Differentiated,0.9656
"CYSTADENOCARCINOMA, MUCINOUS",Mucinous Cystadenocarcinoma,1,2,Mucinous Cystadenocarcinoma,0.9846,Cystadenocarcinoma,0.9737,Cystadenocarcinoma<;>High Grade<;>Serous,0.9661,Pancreatic Mucinous-Cystic Neoplasm,0.9633,Serous Cystadenocarcinoma,0.9626
CYSTECTOMY,Cystectomy,1,2,Cystectomy,1.0000,Transurethral Resection of Bladder Tumor,0.9242,Cystadenocarcinoma,0.9109,Bladder Urothelial Carcinoma,0.9102,Urothelial Carcinoma,0.9081
CYSTOADENOCARCINOMA-PD,Cystadenocarcinoma<;>Poorly Differentiated,3,2,Pancreatic Serous Cystadenoma,0.9380,Cystadenocarcinoma,0.9378,Cystadenocarcinoma<;>Poorly Differentiated,0.9316,Ovarian Small Cell Carcinoma<;>Dermoid Cyst,0.9307,Adenocarcinoma<;>Dermoid Cyst,0.9291
CYTOLOGY,Cytology Specimen Type,1,2,Cytology Specimen Type,0.9425,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9111,Cervical Squamous Cell Carcinoma,0.9087,Human Papillomavirus Positive<;>Squamous Cell Carcinoma,0.9075,Cervical Squamous Neoplasm,0.9064
DEDIFFERENTIATED,Dedifferentiated Chondrosarcoma,1,2,Dedifferentiated Chondrosarcoma,0.9686,Dedifferentiated Liposarcoma,0.9659,Endometrial Dedifferentiated Carcinoma,0.9521,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,0.9296,Poorly Differentiated,0.9132
DEDIFFERENTIATED CHONDROSARCOMA,Dedifferentiated Chondrosarcoma,1,2,Dedifferentiated Chondrosarcoma,1.0000,Dedifferentiated Liposarcoma,0.9621,Endometrial Dedifferentiated Carcinoma,0.9539,Chondrosarcoma,0.9495,Mesenchymal Chondrosarcoma,0.9462
DEDIFFERENTIATED LIPOSARCOMA,Dedifferentiated Liposarcoma,1,2,Dedifferentiated Liposarcoma,1.0000,Dedifferentiated Chondrosarcoma,0.9621,Liposarcoma,0.9496,Endometrial Dedifferentiated Carcinoma,0.9495,Well Differentiated Liposarcoma,0.9434
DENSE/DIFFUSE ANAPLASIA,Anaplastic Lesion<;>Diffuse,2,2,Diffuse Astrocytoma,0.9378,Anaplastic Lesion<;>Diffuse,0.9354,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9321,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9319,"Malignant Lymphoma, Histiocytic, Diffuse",0.9293
DERMATOFIBROMA,Skin Fibrous Histiocytoma,3,2,Dermatofibrosarcoma Protuberans,0.9521,Fibromatosis,0.9316,Skin Fibrous Histiocytoma,0.9312,Skin Fibroblastic Neoplasm,0.9297,Follicular Dendritic Cell Sarcoma,0.9293
DERMATOFIBROSARCOMA PROTUBERANS,Dermatofibrosarcoma Protuberans,1,2,Dermatofibrosarcoma Protuberans,1.0000,Myxofibrosarcoma,0.9316,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.9216,Desmoid Fibromatosis,0.9210,Myelodysplastic/Myeloproliferative Neoplasm,0.9205
DESCENDING COLON,Descending Colon,1,2,Descending Colon,1.0000,Ascending Colon,0.9538,Colon,0.9464,Sigmoid Colon,0.9376,Transverse Colon,0.9351
DESMOID FIBROMATOSIS,Desmoid Fibromatosis,1,2,Desmoid Fibromatosis,1.0000,Fibromatosis,0.9574,Desmoplastic,0.9490,Desmoplastic Melanoma,0.9408,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.9279
DESMOID TUMOR,Desmoid Fibromatosis,2,2,Desmoplastic,0.9593,Desmoid Fibromatosis,0.9568,Desmoplastic Small Round Cell Tumor,0.9514,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.9466,Desmoplastic Melanoma,0.9447
DESMOID/AGGRESSIVE FIBROMATOSIS,Desmoid Fibromatosis,1,2,Desmoid Fibromatosis,0.9625,Fibromatosis,0.9443,Desmoplastic,0.9421,Desmoplastic/Nodular Medulloblastoma,0.9336,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.9326
DESMOPLASTIC,Desmoplastic,1,2,Desmoplastic,1.0000,Desmoplastic Melanoma,0.9787,Desmoplastic Neurotropic Melanoma,0.9567,Desmoid Fibromatosis,0.9490,Desmoplastic Small Round Cell Tumor,0.9453
DESMOPLASTIC MELANOMA,Desmoplastic Melanoma,1,2,Desmoplastic Melanoma,1.0000,Desmoplastic,0.9787,Desmoplastic Neurotropic Melanoma,0.9713,Desmoplastic/Nodular Medulloblastoma,0.9420,Desmoid Fibromatosis,0.9408
DESMOPLASTIC SMALL ROUND CELL TUMOR,Desmoplastic Small Round Cell Tumor,1,2,Desmoplastic Small Round Cell Tumor,1.0000,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.9798,"Malignant Tumor, Small Cell Type",0.9470,Desmoplastic,0.9453,Round Cell Sarcoma,0.9434
DESMOPLASTIC SMALL-ROUND-CELL TUMOR,Desmoplastic Small Round Cell Tumor,1,2,Desmoplastic Small Round Cell Tumor,0.9978,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.9810,"Malignant Tumor, Small Cell Type",0.9512,Desmoplastic,0.9512,Round Cell Sarcoma,0.9397
DESMOPLASTIC/NODULAR MEDULLOBLASTOMA,Desmoplastic/Nodular Medulloblastoma,1,2,Desmoplastic/Nodular Medulloblastoma,1.0000,Desmoplastic,0.9424,Desmoplastic Neurotropic Melanoma,0.9424,Desmoplastic Melanoma,0.9420,Medulloblastoma,0.9416
DIABETES DIAGNOSIS INDICATOR,Diabetes Mellitus,1,2,Diabetes Mellitus,0.9314,"Astrocytoma, IDH-Mutant, Grade 2",0.9047,"Astrocytoma, IDH-Mutant, Grade 4",0.9042,Well Differentiated Lesion<;>Invasive,0.9038,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9014
DIAPHRAGM,Diaphragm,1,2,Diaphragm,1.0000,Lung,0.9259,Abdomen,0.9148,Peritoneum,0.9103,Peritoneal Mesothelioma,0.9059
DIFFSE LARGE B-CELL LYMPHOMA,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.9671,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9503,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9497,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9495,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9474
DIFFUSE,Diffuse,1,2,Diffuse,1.0000,Diffuse Astrocytoma,0.9585,Diffuse Glioma,0.9491,Diffuse Large B-Cell Lymphoma,0.9429,Diffuse Malignant Mesothelioma,0.9416
DIFFUSE (LINITUS-PLASTICUS),Linitis Plastica,3,2,"Malignant Lymphoma, Histiocytic, Diffuse",0.9359,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9342,Linitis Plastica,0.9338,Diffuse,0.9327,Diffuse Large B-Cell Lymphoma,0.9326
DIFFUSE ANAPLASIA,Anaplastic Lesion<;>Diffuse,3,2,Diffuse Astrocytoma,0.9629,Diffuse,0.9477,Anaplastic Lesion<;>Diffuse,0.9447,Diffuse Malignant Mesothelioma,0.9430,"Malignant Lymphoma, Histiocytic, Diffuse",0.9426
DIFFUSE ASTROCYTOMA,Diffuse Astrocytoma,1,2,Diffuse Astrocytoma,1.0000,Diffuse Glioma,0.9737,Diffuse Midline Glioma,0.9593,Diffuse,0.9585,Anaplastic Lesion<;>Diffuse,0.9557
"DIFFUSE ASTROCYTOMA, IDH-MUTANT","Astrocytoma, IDH-Mutant, Grade 2",1,2,"Astrocytoma, IDH-Mutant, Grade 2",0.9710,"Astrocytoma, IDH-Mutant, Grade 3",0.9695,"Astrocytoma, IDH-Mutant, Grade 4",0.9695,"Anaplastic Astrocytoma, IDH-Wildtype",0.9624,"Diffuse Midline Glioma, H3 K27M-Mutant",0.9600
DIFFUSE GLIOMA,Diffuse Glioma,1,2,Diffuse Glioma,1.0000,Diffuse Midline Glioma,0.9801,Diffuse Astrocytoma,0.9737,Diffuse Leptomeningeal Glioneuronal Tumor,0.9600,Diffuse Intrinsic Pontine Glioma,0.9504
DIFFUSE INTRINSIC PONTINE GLIOMA,Diffuse Intrinsic Pontine Glioma,1,2,Diffuse Intrinsic Pontine Glioma,1.0000,Diffuse Midline Glioma,0.9555,Diffuse Glioma,0.9504,Diffuse Leptomeningeal Glioneuronal Tumor,0.9481,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9373
DIFFUSE LARGE B-CELL LYMPHOMA,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,1.0000,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9788,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9769,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9743,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9640
DIFFUSE LARGE B-CELL LYMPHOMA DLBCL,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.9946,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9766,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9753,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9711,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9602
DIFFUSE LARGE B-CELL LYMPHOMA DLBCL NOS ANY ANATOMIC SITE NODAL OR EXTRANODAL,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.9707,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9703,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9692,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9677,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9661
"DIFFUSE LARGE B-CELL LYMPHOMA, NOS",Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.9868,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9740,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9721,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9717,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9666
DIFFUSE LARGE CELL LYMPHOMA NON-CLEAVED TYPE,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",1,2,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9771,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9696,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9696,Diffuse Large B-Cell Lymphoma,0.9669,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9559
DIFFUSE LEPTOMENINGEAL  GLIONEURONAL TUMOR,Diffuse Leptomeningeal Glioneuronal Tumor,1,2,Diffuse Leptomeningeal Glioneuronal Tumor,1.0000,Diffuse Midline Glioma,0.9638,Diffuse Glioma,0.9600,Diffuse Astrocytoma,0.9536,Diffuse Intrinsic Pontine Glioma,0.9481
DIFFUSE LINITUS-PLASTICUS,Linitis Plastica,1,2,Linitis Plastica,0.9468,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,0.9224,Diffuse Large B-Cell Lymphoma,0.9217,"Malignant Lymphoma, Histiocytic, Diffuse",0.9202,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9193
DIFFUSE MALIGNANT MESOTHELIOMA - NOS,Diffuse Malignant Mesothelioma,1,2,Diffuse Malignant Mesothelioma,0.9843,"Malignant Lymphoma, Histiocytic, Diffuse",0.9556,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9500,Diffuse Large B-Cell Lymphoma,0.9449,Diffuse Astrocytoma,0.9414
DIFFUSE MIDLINE GLIOMA,Diffuse Midline Glioma,1,2,Diffuse Midline Glioma,1.0000,Diffuse Glioma,0.9801,Diffuse Leptomeningeal Glioneuronal Tumor,0.9638,Diffuse Astrocytoma,0.9593,Diffuse Intrinsic Pontine Glioma,0.9555
"DIFFUSE MIDLINE GLIOMA, H3K27M MUTANT","Diffuse Midline Glioma, H3 K27M-Mutant",1,2,"Diffuse Midline Glioma, H3 K27M-Mutant",0.9844,Diffuse Midline Glioma,0.9549,"Astrocytoma, IDH-Mutant, Grade 3",0.9451,"Astrocytoma, IDH-Mutant, Grade 4",0.9444,Low Grade Glioma<;>IDH Gene Family Mutation,0.9439
DIFFUSE SCLEROSING VARIANT,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,1,2,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,0.9686,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.9489,Diffuse,0.9434,Diffuse Large B-Cell Lymphoma,0.9422,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9405
DIFFUSE TYPE STOMACH ADENOCARCINOMA,Gastric Diffuse Adenocarcinoma,1,2,Gastric Diffuse Adenocarcinoma,0.9818,Gastric Intestinal-Type Adenocarcinoma,0.9589,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9476,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,0.9467,Gastric Adenocarcinoma,0.9467
DIFFUSE_ADENOCARCINOMA,Gastric Diffuse Adenocarcinoma,1,2,Gastric Diffuse Adenocarcinoma,0.9734,Diffuse Malignant Mesothelioma,0.9558,Diffuse Astrocytoma,0.9556,Diffuse,0.9513,Adenocarcinoma,0.9502
DIFFUSE_GASTRIC,Gastric Diffuse Adenocarcinoma,1,2,Gastric Diffuse Adenocarcinoma,0.9684,Diffuse,0.9554,Diffuse Glioma,0.9381,Gastric,0.9380,Diffuse Large B-Cell Lymphoma,0.9355
DIFFUSE_HISTIOCYTIC_LYMPHOMA,"Malignant Lymphoma, Histiocytic, Diffuse",1,2,"Malignant Lymphoma, Histiocytic, Diffuse",0.9829,Diffuse Large B-Cell Lymphoma,0.9691,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9562,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9536,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9488
DIFFUSE_LARGE_B_CELL_LYMPHOMA,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.9932,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9775,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9736,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9691,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9678
DIPG,Diffuse Intrinsic Pontine Glioma,99,2,Descending Colon,0.8852,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.8819,Low Grade Glioma<;>IDH Gene Family Mutation,0.8816,Myelodysplastic Syndrome with Isolated del(5q),0.8811,Distal,0.8805
DIPLOID,Diploidy,1,2,Diploidy,0.9909,Hypodiploidy,0.9252,Hyperdiploidy,0.9238,Normal Karyotype,0.9175,Near-Haploidy,0.9109
DISSEMINATED JUVENILE XANTHOGRANULOMA,Disseminated Juvenile Xanthogranuloma,1,2,Disseminated Juvenile Xanthogranuloma,1.0000,Diffuse Leptomeningeal Glioneuronal Tumor,0.9259,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,0.9241,"Malignant Lymphoma, Histiocytic, Diffuse",0.9234,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9221
DISTAL,Distal,1,2,Distal,1.0000,Distal Bile Duct Adenocarcinoma,0.9312,Distant,0.9270,Proximal Bile Duct,0.9161,Descending Colon,0.9160
DISTANT,Distant,1,2,Distant,1.0000,Distant Metastasis,0.9426,Distant Metastasis<;>Lung,0.9389,Distal,0.9270,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9081
DISTANT METASTASIS,Distant Metastasis,1,2,Distant Metastasis,1.0000,Distant Metastasis<;>Lung,0.9824,Metastasis,0.9471,Metastatic,0.9445,Distant,0.9426
DISTANT METASTASIS: LUNG,Distant Metastasis<;>Lung,1,2,Distant Metastasis<;>Lung,0.9935,Distant Metastasis,0.9796,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9487,Brain<;>Site of Metastasis,0.9482,Breast Ductal Carcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9472
DISTANT METASTASIS: S.C.,Distant Metastasis,2,2,Distant Metastasis<;>Lung,0.9531,Distant Metastasis,0.9455,Metastatic Colorectal Carcinoma<;>Primary,0.9414,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9362,Metastatic Colorectal Carcinoma,0.9347
DISTANT METS,Distant Metastasis,2,2,Distant,0.9610,Distant Metastasis,0.9315,Distant Metastasis<;>Lung,0.9273,Distal,0.9075,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.8955
DLBC,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.9168,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9165,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9136,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9114,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9107
DLBCL,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.9431,Lymphoma,0.9412,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9367,B-Cell Non-Hodgkin Lymphoma,0.9365,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9358
DOWN SYNDROME,Down Syndrome,1,2,Down Syndrome,1.0000,Acute Megakaryoblastic Leukemia<;>Down Syndrome,0.9435,Myeloid Leukemia Associated with Down Syndrome,0.9418,Myelodysplastic Syndrome,0.9246,Myelodysplastic Syndrome with del(5q),0.9140
DOWN SYNDROME; ACUTE MEGAKARYOBLASTIC LEUKAEMIA,Myeloid Leukemia Associated with Down Syndrome,2,2,Acute Megakaryoblastic Leukemia<;>Down Syndrome,0.9888,Myeloid Leukemia Associated with Down Syndrome,0.9617,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9575,Acute Megakaryoblastic Leukemia,0.9552,Myelodysplastic Syndrome,0.9465
DUCT,Duct,1,2,Duct,1.0000,Bile Duct,0.9683,Ductal,0.9499,Salivary Duct Carcinoma,0.9268,Biliary Tract,0.9244
DUCTAL,Ductal,1,2,Ductal,1.0000,Breast Ductal Carcinoma,0.9544,Duct,0.9499,Pancreatic Ductal Adenocarcinoma,0.9478,Prostate Ductal Adenocarcinoma,0.9451
DUCTAL ADENOCARCINOMA,Pancreatic Ductal Adenocarcinoma,2,2,Prostate Ductal Adenocarcinoma,0.9878,Pancreatic Ductal Adenocarcinoma,0.9848,Breast Ductal Carcinoma,0.9729,Breast Adenocarcinoma,0.9700,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.9633
"DUCTAL ADENOCARCINOMA, EXOCRINE",Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,1,2,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.9841,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland<;>Ductal,0.9721,Pancreatic Ductal Adenocarcinoma,0.9719,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland,0.9660,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.9637
DUCTAL ADENOSQUAMOUS CARCINOMA,Pancreatic Adenosquamous Carcinoma<;>Ductal,1,2,Pancreatic Adenosquamous Carcinoma<;>Ductal,0.9833,Adenosquamous Carcinoma,0.9807,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.9797,Pancreatic Adenosquamous Carcinoma,0.9768,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland<;>Ductal,0.9749
"DUCTAL ADENOSQUAMOUS CARCINOMA, EXOCRINE",Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland<;>Ductal,1,2,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland<;>Ductal,0.9891,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland,0.9844,Pancreatic Adenosquamous Carcinoma<;>Ductal,0.9812,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.9746,Pancreatic Adenosquamous Carcinoma,0.9697
DUCTAL AND LOBULAR,Breast Mixed Ductal and Lobular Carcinoma,5,2,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9650,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9648,Ductal,0.9633,Lobular,0.9627,Breast Mixed Ductal and Lobular Carcinoma,0.9557
DUCTAL AND LOBULAR FEATURES,Breast Mixed Ductal and Lobular Carcinoma,5,2,Ductal,0.9459,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9441,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9436,Lobular,0.9401,Breast Mixed Ductal and Lobular Carcinoma,0.9360
DUCTAL AND MICROPAPILLARY,Ductal<;>Micropapillary Growth Pattern,1,2,Ductal<;>Micropapillary Growth Pattern,0.9636,Ductal,0.9474,Micropapillary Growth Pattern<;>Solid,0.9395,Lung Micropapillary Adenocarcinoma,0.9387,Micropapillary Growth Pattern,0.9371
DUCTAL CARCINOMA,Breast Ductal Carcinoma,1,2,Breast Ductal Carcinoma,0.9945,Breast Ductal Carcinoma In Situ,0.9692,Prostate Ductal Adenocarcinoma,0.9662,Breast Carcinoma,0.9641,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9632
DUCTAL CARCINOMA IN SITU DCIS,Breast Ductal Carcinoma In Situ,1,2,Breast Ductal Carcinoma In Situ,0.9915,Breast Ductal Carcinoma,0.9636,Cervical Adenocarcinoma In Situ,0.9601,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9543,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9521
DUCTAL CARCINOMA- MAMMARY GLAND,Breast Ductal Carcinoma,1,2,Breast Ductal Carcinoma,0.9872,Breast Ductal Carcinoma In Situ,0.9707,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9671,Breast Carcinoma,0.9667,Prostate Ductal Adenocarcinoma,0.9644
DUCTAL CARCINOMA- MAMMARY GLAND; BREAST; DUCT; METASTATIC SITE: PLEURAL EFFUSION;,Breast Ductal Carcinoma<;>Pleural Effusion<;>Site of Metastasis,1,2,Breast Ductal Carcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9875,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9788,Pleural Effusion<;>Site of Metastasis,0.9651,Breast Ductal Carcinoma,0.9437,Pancreatic Adenosquamous Carcinoma<;>Ductal,0.9424
DUCTAL/LOBULAR,Breast Mixed Ductal and Lobular Carcinoma,5,2,Ductal,0.9697,Lobular,0.9669,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9572,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9559,Breast Mixed Ductal and Lobular Carcinoma,0.9557
DUCTAL/NST,Breast Ductal Carcinoma,99,2,Ductal,0.9471,Pancreatic Adenosquamous Carcinoma<;>Ductal,0.9274,Breast Ductal Carcinoma<;>Triple-Negative Breast Cancer Finding,0.9273,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9272,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland<;>Ductal,0.9264
DUCTAL_CARCINOMA,Breast Ductal Carcinoma,1,2,Breast Ductal Carcinoma,0.9889,Breast Ductal Carcinoma In Situ,0.9675,Prostate Ductal Adenocarcinoma,0.9666,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9642,Pancreatic Ductal Adenocarcinoma,0.9623
DUODENAL ADENOCARCINOMA,Duodenal Adenocarcinoma,1,2,Duodenal Adenocarcinoma,1.0000,Pancreatic Ductal Adenocarcinoma,0.9583,Pancreatic Adenocarcinoma,0.9529,Gastric Adenocarcinoma,0.9520,Colorectal Adenocarcinoma,0.9517
DUODENAL_ADENOCARCINOMA,Duodenal Adenocarcinoma,1,2,Duodenal Adenocarcinoma,0.9951,Pancreatic Ductal Adenocarcinoma,0.9565,Adenocarcinoma,0.9513,Pancreatic Adenocarcinoma,0.9497,Colorectal Adenocarcinoma,0.9489
DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR,Dysembryoplastic Neuroepithelial Tumor,1,2,Dysembryoplastic Neuroepithelial Tumor,1.0000,Neuroepithelial Neoplasm,0.9540,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9436,Neuroepithelial Neoplasm<;>High Grade,0.9420,Primitive Neuroectodermal Tumor,0.9399
DYSGERMINOMA,Ovarian Dysgerminoma,1,2,Ovarian Dysgerminoma,0.9729,Ovarian Dysgerminoma<;>Yolk Sac Tumor,0.9434,Myelodysplastic Syndrome with Multilineage Dysplasia,0.9144,Acute Myeloid Leukemia with Multilineage Dysplasia,0.9097,"Myelodysplastic Syndrome, Unclassifiable",0.9066
EARLY STAGE PRIMARY,Limited Stage<;>Primary,1,2,Limited Stage<;>Primary,0.9579,Primary,0.9328,Early T Acute Lymphoblastic Leukemia,0.9205,Occult Stage,0.9153,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.9142
EARLY T-CELL PRECURSOR LYMPHOBLASTIC LEUKEMIA,Early T Acute Lymphoblastic Leukemia,1,2,Early T Acute Lymphoblastic Leukemia,0.9806,T Lymphoblastic Leukemia/Lymphoma,0.9633,T Acute Lymphoblastic Leukemia,0.9594,B Lymphoblastic Leukemia/Lymphoma,0.9541,B Acute Lymphoblastic Leukemia with t(9<;>22)(q34.1<;>q11.2)<;> BCR-ABL1,0.9537
EBER+ - LIKELY II,Epstein-Barr Virus Early RNA Positive,1,2,Epstein-Barr Virus Early RNA Positive,0.9025,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.8977,"Posterior Fossa Ependymoma, Group B (PFB)",0.8949,Estrogen Receptor Positive<;>HER2/Neu Negative,0.8945,Esophageal Well Differentiated Squamous Cell Carcinoma<;>Invasive,0.8934
EBER+ II,Epstein-Barr Virus Early RNA Positive,1,2,Epstein-Barr Virus Early RNA Positive,0.9080,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.9033,"Posterior Fossa Ependymoma, Group B (PFB)",0.9006,Estrogen Receptor Positive<;>HER2/Neu Negative,0.8997,B-Lymphocyte,0.8994
EBER+ III,Epstein-Barr Virus Early RNA Positive,3,2,Extraventricular Neurocytoma,0.9016,"Posterior Fossa Ependymoma, Group B (PFB)",0.9008,Epstein-Barr Virus Early RNA Positive,0.8981,Invasive Breast Carcinoma of No Special Type<;>Triple-Negative Breast Cancer Finding,0.8939,Anaplastic Ependymoma,0.8916
EBV,Epstein-Barr Virus,2,2,EBV-Related Lymphoma,0.9633,Epstein-Barr Virus,0.9545,Gastric Adenocarcinoma<;>Epstein-Barr Virus,0.9410,Epstein-Barr Virus Early RNA Positive,0.9333,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.9174
EBV-ASSOCIATED,EBV-Related Lymphoma,1,2,EBV-Related Lymphoma,0.9614,Epstein-Barr Virus,0.9296,Gastric Adenocarcinoma<;>Epstein-Barr Virus,0.9289,Epstein-Barr Virus Early RNA Positive,0.9203,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.9151
EMBRYONAL,Embryonal Carcinoma,1,2,Embryonal Carcinoma,0.9620,Embryonal Neoplasm,0.9594,Embryonal Rhabdomyosarcoma,0.9550,Embryonal Carcinoma<;>Seminoma,0.9434,Central Nervous System Embryonal Tumor,0.9400
EMBRYONAL CARCINOMA,Embryonal Carcinoma,1,2,Embryonal Carcinoma,1.0000,Embryonal Neoplasm,0.9824,Embryonal Carcinoma<;>Seminoma,0.9718,Germ Cell Tumor<;>Embryonal Carcinoma,0.9688,Embryonal Rhabdomyosarcoma,0.9613
EMBRYONAL CARCINOMANON-SEMINOMA,Embryonal Carcinoma<;>Nonseminomatous,99,2,Embryonal Carcinoma<;>Seminoma,0.9894,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.9778,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9746,Embryonal Carcinoma,0.9716,Germ Cell Tumor<;>Embryonal Carcinoma,0.9713
EMBRYONAL CARCINOMASEMINOMA,Embryonal Carcinoma<;>Seminoma,3,2,Embryonal Carcinoma,0.9855,Embryonal Neoplasm,0.9763,Embryonal Carcinoma<;>Seminoma,0.9696,Germ Cell Tumor<;>Embryonal Carcinoma,0.9690,Embryonal Carcinoma<;>Nonseminomatous,0.9682
EMBRYONAL CARCINOMA[NOT AVAILABLE],Embryonal Carcinoma,1,2,Embryonal Carcinoma,0.9696,Embryonal Carcinoma<;>Nonseminomatous,0.9663,Embryonal Neoplasm,0.9620,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.9609,Embryonal Carcinoma<;>Seminoma,0.9594
EMBRYONAL CARCINOMA[NOT AVAILABLE][NOT AVAILABLE][NOT AVAILABLE],Embryonal Carcinoma,3,2,Embryonal Carcinoma<;>Nonseminomatous,0.9696,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.9657,Embryonal Carcinoma,0.9651,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9641,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9624
EMBRYONAL RHABDOMYOSARCOMA,Embryonal Rhabdomyosarcoma,1,2,Embryonal Rhabdomyosarcoma,1.0000,Embryonal Neoplasm,0.9623,Embryonal Carcinoma,0.9613,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.9589,Botryoid-Type Embryonal Rhabdomyosarcoma,0.9563
EMBRYONAL TUMOR,Embryonal Neoplasm,1,2,Embryonal Neoplasm,0.9855,Embryonal Carcinoma,0.9834,Central Nervous System Embryonal Tumor,0.9695,Germ Cell Tumor<;>Embryonal Carcinoma,0.9675,Embryonal Rhabdomyosarcoma,0.9620
EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",99,2,Embryonal Tumor with Multilayered Rosettes,0.9621,Central Nervous System Embryonal Tumor,0.9538,Embryonal Neoplasm,0.9495,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.9473,Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle,0.9460
EMBRYO_CARCINOMA,Embryonal Carcinoma,1,2,Embryonal Carcinoma,0.9791,Embryonal Neoplasm,0.9650,Embryonal Carcinoma<;>Seminoma,0.9606,Germ Cell Tumor<;>Embryonal Carcinoma,0.9570,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,0.9511
EMBT,Embryonal Neoplasm,99,2,Ewing Sarcoma<;>ERG Gene Rearrangement,0.8884,Esophagus,0.8867,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.8865,AML1-ETO Fusion Protein Expression,0.8863,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.8858
EMT,Epithelial-to-Mesenchymal Transition,1,2,Epithelial-to-Mesenchymal Transition,0.9500,Epithelial,0.9205,Omentum,0.9139,Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma,0.9101,Epithelial-Myoepithelial Carcinoma,0.9035
ENCAPSULATED GLIOMA,Glioma,1,2,Glioma,0.9394,Optic Nerve Glioma,0.9211,Glioblastoma,0.9186,Low Grade Glioma,0.9155,Glioblastoma<;>Undifferentiated,0.9146
ENDOCERVICAL ADENOCARCINOMA,Cervical Adenocarcinoma,2,2,"Mucinous Adenocarcinoma, Endocervical Type",0.9637,Cervical Adenocarcinoma,0.9566,Cervical Endometrioid Adenocarcinoma,0.9511,Endometrial Adenocarcinoma,0.9491,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9441
ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE,Cervical Adenocarcinoma,99,2,"Mucinous Adenocarcinoma, Endocervical Type",0.9733,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.9504,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.9491,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9418,Cervical Endometrioid Adenocarcinoma,0.9376
ENDOCERVICAL TYPE OF ADENOCARCINOMA,Cervical Adenocarcinoma,99,2,"Mucinous Adenocarcinoma, Endocervical Type",0.9810,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.9575,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.9511,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9474,Cervical Endometrioid Adenocarcinoma,0.9422
ENDOCRINE,Endocrine,1,2,Endocrine,1.0000,Pituitary Neuroendocrine Tumor,0.9141,Thyroid Gland,0.9098,Adrenal Gland Pheochromocytoma<;>Paraganglioma,0.9091,Adrenal Gland Pheochromocytoma,0.9077
ENDOMETRIAL ADENOCARCINOMA,Endometrial Adenocarcinoma,1,2,Endometrial Adenocarcinoma,1.0000,Endometrial Endometrioid Adenocarcinoma,0.9829,Endometrial Carcinoma,0.9742,Endometrial Serous Adenocarcinoma,0.9739,Endometrioid Adenocarcinoma,0.9736
ENDOMETRIAL ADENOSQUAMOUS CARCINOMA,Endometrial Adenosquamous Carcinoma,1,2,Endometrial Adenosquamous Carcinoma,1.0000,Adenosquamous Carcinoma,0.9862,Cervical Adenosquamous Carcinoma,0.9827,Esophageal Adenosquamous Carcinoma,0.9816,Gastric Adenosquamous Carcinoma,0.9803
ENDOMETRIAL CANCER,Endometrial Carcinoma,1,2,Endometrial Carcinoma,0.9804,Endometrial Carcinoma<;>Uterine Corpus Cancer,0.9702,Endometrial Adenocarcinoma,0.9695,Endometrial Endometrioid Adenocarcinoma,0.9608,Endometrial Squamous Cell Carcinoma,0.9588
ENDOMETRIAL CARCINOMA,Endometrial Carcinoma,1,2,Endometrial Carcinoma,1.0000,uterine corpus endometrial carcinoma,0.9797,Endometrial Carcinoma<;>Uterine Corpus Cancer,0.9785,Endometrial Adenocarcinoma,0.9742,Endometrial Squamous Cell Carcinoma,0.9690
ENDOMETRIAL SQUAMOUS CELL CARCINOMA,Endometrial Squamous Cell Carcinoma,1,2,Endometrial Squamous Cell Carcinoma,1.0000,Esophageal Squamous Cell Carcinoma,0.9771,Cervical Squamous Cell Carcinoma,0.9766,Squamous Cell Carcinoma,0.9763,Lung Squamous Cell Carcinoma,0.9714
ENDOMETRIAL STROMAL SARCOMA,Endometrioid Stromal Sarcoma,1,2,Endometrioid Stromal Sarcoma,0.9804,Low Grade Endometrioid Stromal Sarcoma,0.9599,Endometrioid Stromal Sarcoma<;>High Grade,0.9581,Uterine Corpus Sarcoma,0.9468,Uterine Corpus Sarcoma<;>Mesenchymal,0.9432
ENDOMETRIAL_ADENOCARCINOMA,Endometrial Adenocarcinoma,1,2,Endometrial Adenocarcinoma,0.9934,Endometrial Endometrioid Adenocarcinoma,0.9780,Endometrial Serous Adenocarcinoma,0.9698,Endometrial Carcinoma,0.9697,Endometrioid Adenocarcinoma,0.9683
ENDOMETRIAL_ADENOSQUAMOUS,Endometrial Adenosquamous Carcinoma,1,2,Endometrial Adenosquamous Carcinoma,0.9814,Adenosquamous Carcinoma,0.9668,Esophageal Adenosquamous Carcinoma,0.9646,Gastric Adenosquamous Carcinoma,0.9633,Cervical Adenosquamous Carcinoma,0.9617
ENDOMETRIAL_SQUAMOUS,Endometrial Squamous Cell Carcinoma,1,2,Endometrial Squamous Cell Carcinoma,0.9729,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9467,Endometrial Adenosquamous Carcinoma,0.9455,Esophageal Squamous Cell Carcinoma,0.9448,Cervical Squamous Cell Carcinoma,0.9444
ENDOMETRIAL_STROMAL_SARCOMA,Endometrioid Stromal Sarcoma,1,2,Endometrioid Stromal Sarcoma,0.9766,Endometrioid Stromal Sarcoma<;>High Grade,0.9603,Low Grade Endometrioid Stromal Sarcoma,0.9565,Uterine Corpus Sarcoma<;>Mesenchymal,0.9497,Sarcoma,0.9464
ENDOMETRIOID,Endometrioid Tumor,3,2,Endometrioid Adenocarcinoma,0.9729,Endometrial Endometrioid Adenocarcinoma,0.9723,Endometrioid Tumor,0.9681,Ovarian Endometrioid Adenocarcinoma,0.9678,Cervical Endometrioid Adenocarcinoma,0.9641
ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX,Cervical Endometrioid Adenocarcinoma,3,2,Endometrioid Adenocarcinoma,0.9804,Endometrial Endometrioid Adenocarcinoma,0.9796,Cervical Endometrioid Adenocarcinoma,0.9792,Ovarian Endometrioid Adenocarcinoma,0.9739,Endometrioid Tumor,0.9629
ENDOMETRIOID CARCINOMA,Endometrioid Adenocarcinoma,1,2,Endometrioid Adenocarcinoma,0.9858,Endometrioid Tumor,0.9846,Endometrial Endometrioid Adenocarcinoma,0.9820,Ovarian Endometrioid Adenocarcinoma,0.9773,Cervical Endometrioid Adenocarcinoma,0.9765
ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA,Endometrial Endometrioid Adenocarcinoma,1,2,Endometrial Endometrioid Adenocarcinoma,0.9909,Endometrioid Adenocarcinoma,0.9899,Ovarian Endometrioid Adenocarcinoma,0.9845,Cervical Endometrioid Adenocarcinoma,0.9822,Endometrial Adenocarcinoma,0.9761
ENDOMETRIOID OVARIAN CANCER,Ovarian Endometrioid Adenocarcinoma,2,2,Endometrioid Tumor,0.9835,Ovarian Endometrioid Adenocarcinoma,0.9823,Endometrioid Adenocarcinoma,0.9809,Endometrial Endometrioid Adenocarcinoma,0.9759,Cervical Endometrioid Adenocarcinoma,0.9714
ENDOMETRIOID_CARCINOMA,Endometrioid Adenocarcinoma,1,2,Endometrioid Adenocarcinoma,0.9827,Endometrial Endometrioid Adenocarcinoma,0.9802,Endometrioid Tumor,0.9799,Ovarian Endometrioid Adenocarcinoma,0.9759,Cervical Endometrioid Adenocarcinoma,0.9754
ENDOMETRIUM,Endometrium,1,2,Endometrium,1.0000,Endometrial Adenocarcinoma,0.9345,Endometrial Endometrioid Adenocarcinoma,0.9327,Endometrial Carcinoma,0.9293,Cervix Uteri,0.9262
EPENDYMOBLASTOMA,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",99,2,Ependymoma,0.9786,Ependymal Tumor,0.9710,Anaplastic Ependymoma,0.9552,Myxopapillary Ependymoma,0.9475,"Posterior Fossa Ependymoma, Group A (PFA)",0.9441
EPENDYMOMA,Ependymoma,1,2,Ependymoma,1.0000,Ependymal Tumor,0.9797,Anaplastic Ependymoma,0.9609,Myxopapillary Ependymoma,0.9589,"Posterior Fossa Ependymoma, Group A (PFA)",0.9452
EPENDYMOMAL TUMOR,Ependymal Tumor,1,2,Ependymal Tumor,0.9828,Ependymoma,0.9693,Anaplastic Ependymoma,0.9450,Myxopapillary Ependymoma,0.9414,Central Nervous System Embryonal Tumor,0.9395
EPITHELIAL,Epithelial,1,2,Epithelial,1.0000,Epithelial-to-Mesenchymal Transition,0.9487,Epithelial-Myoepithelial Carcinoma,0.9382,Oral Epithelial Dysplasia,0.9376,immortal epithelial cell line cell,0.9375
EPITHELIAL TYPE METAPLASTIC BREAST CANCER,Breast Metaplastic Carcinoma<;>Epithelial,1,2,Breast Metaplastic Carcinoma<;>Epithelial,0.9808,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.9702,Breast Metaplastic Carcinoma,0.9664,Metaplastic Carcinoma,0.9631,Normal Breast-Like Subtype of Breast Carcinoma,0.9509
EPITHELIAL-MYOEPITHELIAL CARCINOMA,Epithelial-Myoepithelial Carcinoma,1,2,Epithelial-Myoepithelial Carcinoma,1.0000,Breast Metaplastic Carcinoma<;>Epithelial,0.9522,Malignant Myoepithelioma,0.9504,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.9463,Mucoepidermoid Carcinoma,0.9421
EPITHELIOID,Epithelioid Cell,1,2,Epithelioid Cell,0.9788,Epithelioid Mesothelioma,0.9678,Epithelioid Sarcoma,0.9615,Epithelioid Hemangioendothelioma,0.9603,Pleural Epithelioid Mesothelioma,0.9518
EPITHELIOID CELL,Epithelioid Cell,1,2,Epithelioid Cell,1.0000,Epithelioid Cell<;>Spindle Cell Neoplasm,0.9577,Epithelioid Mesothelioma,0.9574,Epithelioid Sarcoma,0.9550,Epithelioid Hemangioendothelioma,0.9487
EPITHELIOID CELL TUMOR,Malignant PEComa,99,2,Epithelioid Cell,0.9799,Epithelioid Trophoblastic Tumor,0.9706,Epithelioid Sarcoma,0.9697,Epithelioid Cell<;>Spindle Cell Neoplasm,0.9684,Epithelioid Mesothelioma,0.9585
EPITHELIOID CELLSPINDLE CELL,Epithelioid Cell<;>Spindle Cell Neoplasm,2,2,Epithelioid Cell,0.9734,Epithelioid Cell<;>Spindle Cell Neoplasm,0.9528,Epithelioid Mesothelioma,0.9417,Epithelioid Sarcoma,0.9405,Pleural Epithelioid Mesothelioma,0.9340
EPITHELIOID FIBROSARCOMA,Sclerosing Epithelioid Fibrosarcoma,2,2,Epithelioid Sarcoma,0.9710,Sclerosing Epithelioid Fibrosarcoma,0.9703,Epithelioid Mesothelioma,0.9639,Epithelioid Hemangioendothelioma,0.9618,Epithelioid Cell,0.9539
EPITHELIOID HEMANGIOENDOTHELIOMA,Epithelioid Hemangioendothelioma,1,2,Epithelioid Hemangioendothelioma,1.0000,Epithelioid Sarcoma,0.9604,Epithelioid Mesothelioma,0.9569,Epithelioid Trophoblastic Tumor,0.9530,Epithelioid Cell,0.9487
EPITHELIOID MESOTHELIOMA,Epithelioid Mesothelioma,1,2,Epithelioid Mesothelioma,1.0000,Pleural Epithelioid Mesothelioma,0.9884,Epithelioid Sarcoma,0.9659,Epithelioid Cell,0.9574,Epithelioid Hemangioendothelioma,0.9569
EPITHELIOID SARCOMA,Epithelioid Sarcoma,1,2,Epithelioid Sarcoma,1.0000,Epithelioid Mesothelioma,0.9659,Epithelioid Hemangioendothelioma,0.9604,Epithelioid Trophoblastic Tumor,0.9557,Epithelioid Cell,0.9550
EPITHELIOID TROPHOBLASTIC TUMOR,Epithelioid Trophoblastic Tumor,1,2,Epithelioid Trophoblastic Tumor,1.0000,Epithelioid Sarcoma,0.9557,Epithelioid Hemangioendothelioma,0.9530,Epithelioid Cell<;>Spindle Cell Neoplasm,0.9490,Epithelioid Mesothelioma,0.9483
EPITHELIOID_SARCOMA,Epithelioid Sarcoma,1,2,Epithelioid Sarcoma,0.9906,Epithelioid Mesothelioma,0.9608,Epithelioid Cell<;>Spindle Cell Neoplasm,0.9602,Epithelioid Hemangioendothelioma,0.9539,Epithelioid Cell,0.9514
EPM,Ependymoma,99,2,"Posterior Fossa Ependymoma, Group A (PFA)",0.9149,"Posterior Fossa Ependymoma, Group B (PFB)",0.9136,Epithelioid Cell,0.9129,Pleural Epithelioid Mesothelioma,0.9103,Epithelioid Hemangioendothelioma,0.9081
ER+,Estrogen Receptor Positive,3,2,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.9222,Estrogen Receptor Positive<;>HER2/Neu Positive,0.9170,Estrogen Receptor Positive,0.9170,Estrogen Receptor Positive<;>HER2/Neu Negative,0.9148,Estrogen Receptor Negative<;>HER2/Neu Positive,0.9142
ER+HER2+,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,2,2,Estrogen Receptor Positive<;>HER2/Neu Positive,0.9620,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.9603,Estrogen Receptor Negative<;>HER2/Neu Positive,0.9585,Estrogen Receptor Positive<;>HER2/Neu Negative,0.9584,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.9535
ERDHEIM-CHESTER DISEASE,Erdheim-Chester Disease,1,2,Erdheim-Chester Disease,1.0000,Rosai-Dorfman Disease,0.9167,Extranodal Disease,0.9096,Castleman Disease,0.9095,Extramammary Paget Disease,0.9074
ERNEG_HER2NEG,Estrogen Receptor Negative<;>HER2/Neu Negative,1,2,Estrogen Receptor Negative<;>HER2/Neu Negative,0.9514,Estrogen Receptor Negative<;>HER2/Neu Positive,0.9507,Estrogen Receptor Positive<;>HER2/Neu Negative,0.9503,Estrogen Receptor Positive<;>HER2/Neu Positive,0.9455,HER2/Neu Positive,0.9411
ERNEG_HER2POS,Estrogen Receptor Negative<;>HER2/Neu Positive,1,2,Estrogen Receptor Negative<;>HER2/Neu Positive,0.9413,Estrogen Receptor Positive<;>HER2/Neu Negative,0.9411,Estrogen Receptor Positive<;>HER2/Neu Positive,0.9407,Estrogen Receptor Negative<;>HER2/Neu Negative,0.9385,HER2/Neu Positive,0.9385
ERPOS_HER2NEG,Estrogen Receptor Positive<;>HER2/Neu Negative,2,2,Estrogen Receptor Negative<;>HER2/Neu Negative,0.9412,Estrogen Receptor Positive<;>HER2/Neu Negative,0.9403,Estrogen Receptor Negative<;>HER2/Neu Positive,0.9401,Estrogen Receptor Positive<;>HER2/Neu Positive,0.9371,HER2/Neu Positive,0.9319
ERPOS_HER2POS,Estrogen Receptor Positive<;>HER2/Neu Positive,1,2,Estrogen Receptor Positive<;>HER2/Neu Positive,0.9308,Estrogen Receptor Positive<;>HER2/Neu Negative,0.9301,Estrogen Receptor Negative<;>HER2/Neu Positive,0.9297,Estrogen Receptor Negative<;>HER2/Neu Negative,0.9277,HER2-Positive Breast Carcinoma,0.9263
ERYTHROLEUKEMIA,Erythroleukemia,1,2,Erythroleukemia,1.0000,Acute Erythroid Leukemia,0.9419,Pure Erythroid Leukemia,0.9375,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,0.9225,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9214
ES,Ewing Sarcoma,99,2,Ewing Sarcoma<;>ERG Gene Rearrangement,0.9054,Esophagus,0.8999,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.8964,Supratentorial Ependymoma<;>Subependymoma,0.8953,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.8952
ESCA,Esophageal Carcinoma,99,2,Endometrium,0.9022,Epithelial,0.8963,Endometrial Squamous Cell Carcinoma,0.8950,Embryonal Carcinoma<;>Seminoma,0.8943,Ependymoma,0.8941
ESCA_CIN,Esophageal Adenocarcinoma<;>Chromosomal Instability,99,2,Endometrial Squamous Cell Carcinoma,0.9007,Embryonal Carcinoma<;>Seminoma,0.9005,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9003,Cervical Squamous Cell Carcinoma,0.8998,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.8975
ESCA_ESCC,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,1,2,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9208,Esophageal Carcinoma,0.9134,Esophageal Squamous Cell Carcinoma,0.9133,Esophageal Adenocarcinoma,0.9132,Esophageal Melanoma,0.9122
ESCA_GS,Esophageal Adenocarcinoma,99,2,Embryonal Carcinoma<;>Seminoma,0.9007,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.8996,Testicular Seminoma,0.8945,Ewing Sarcoma<;>ERG Gene Rearrangement,0.8905,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8905
ESCA_MSI,Esophageal Adenocarcinoma<;>Microsatellite Instability,2,2,Endometrial Carcinoma<;>Microsatellite Instability,0.9156,Esophageal Adenocarcinoma<;>Microsatellite Instability,0.9062,Low-CSD Melanoma,0.9037,Embryonal Carcinoma<;>Seminoma,0.9028,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.9019
ESCA_POLE,Esophageal Adenocarcinoma<;>POLE Gene Mutation,3,2,POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma,0.9153,Endometrial Carcinoma<;>POLE Gene Mutation,0.9132,Esophageal Adenocarcinoma<;>POLE Gene Mutation,0.9001,Endometrium,0.8978,Embryonal Carcinoma<;>Seminoma,0.8935
ESOPHAGEAL ADENOCARCINOMA,Esophageal Adenocarcinoma,1,2,Esophageal Adenocarcinoma,1.0000,Esophageal Carcinoma,0.9731,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9714,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.9631,Adenocarcinoma,0.9602
ESOPHAGEAL ADENOCARINOMA,Esophageal Adenocarcinoma,99,2,Esophageal Adenosquamous Carcinoma,0.9569,Adenosarcoma,0.9396,Gastric Adenosquamous Carcinoma,0.9364,Cervical Adenosquamous Carcinoma,0.9342,Adenoid Cystic Carcinoma,0.9335
ESOPHAGEAL ADENOSQUAMOUS CARCINOMA,Esophageal Adenosquamous Carcinoma,1,2,Esophageal Adenosquamous Carcinoma,1.0000,Adenosquamous Carcinoma,0.9836,Endometrial Adenosquamous Carcinoma,0.9816,Gastric Adenosquamous Carcinoma,0.9790,Lung Adenosquamous Carcinoma,0.9778
ESOPHAGEAL CANCER,Esophageal Carcinoma,1,2,Esophageal Carcinoma,0.9799,Esophageal Adenocarcinoma,0.9694,Esophageal Squamous Cell Carcinoma,0.9669,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9644,Esophageal Melanoma,0.9547
ESOPHAGEAL CARCINOMA,Esophageal Carcinoma,1,2,Esophageal Carcinoma,1.0000,Esophageal Squamous Cell Carcinoma,0.9773,Esophageal Adenocarcinoma,0.9731,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9698,Esophageal Adenosquamous Carcinoma,0.9634
ESOPHAGEAL CARCINOMA OTHER,Esophageal Carcinoma,1,2,Esophageal Carcinoma,0.9647,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9582,Esophageal Adenocarcinoma,0.9556,Esophageal Squamous Cell Carcinoma,0.9510,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.9495
ESOPHAGEAL LN,Esophageal Lymph Node,1,2,Esophageal Lymph Node,0.9752,Esophagus,0.9455,Esophageal Melanoma,0.9358,Esophageal Neuroendocrine Tumor,0.9272,Esophageal Adenocarcinoma,0.9239
ESOPHAGEAL NEUROENDOCRINE TUMOR,Esophageal Neuroendocrine Tumor,1,2,Esophageal Neuroendocrine Tumor,1.0000,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.9777,Neuroendocrine Tumor,0.9742,Gastric Neuroendocrine Tumor,0.9649,Pancreatic Neuroendocrine Tumor,0.9637
ESOPHAGEAL POORLY DIFFERENTIATED CARCINOMA,Esophageal Carcinoma,4,2,Carcinoma<;>Poorly Differentiated,0.9688,Esophageal Well Differentiated Squamous Cell Carcinoma<;>Invasive,0.9687,Squamous Cell Carcinoma<;>Poorly Differentiated,0.9668,Esophageal Carcinoma,0.9663,Gastric Carcinoma<;>Poorly Differentiated,0.9641
ESOPHAGEAL SQUAMOUS CELL CARCINOMA,Esophageal Squamous Cell Carcinoma,1,2,Esophageal Squamous Cell Carcinoma,1.0000,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9863,Squamous Cell Carcinoma,0.9816,Esophageal Carcinoma,0.9773,Endometrial Squamous Cell Carcinoma,0.9771
"ESOPHAGEAL/STOMACH CANCER, NOS",Esophageal Carcinoma,4,2,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9638,Esophageal Squamous Cell Carcinoma,0.9559,Esophageal Well Differentiated Squamous Cell Carcinoma<;>Invasive,0.9526,Esophageal Carcinoma,0.9512,Esophageal Adenosquamous Carcinoma,0.9510
ESOPHAGOGASTRIC ADENOCARCINOMA,Gastroesophageal Junction Adenocarcinoma,2,2,Esophageal Adenocarcinoma,0.9767,Gastroesophageal Junction Adenocarcinoma,0.9677,Gastric Adenocarcinoma,0.9591,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9512,Esophageal Carcinoma,0.9511
ESOPHAGOGASTRIC CANCER,Gastroesophageal Cancer,1,2,Gastroesophageal Cancer,0.9726,Esophageal Carcinoma,0.9554,Esophageal Adenocarcinoma,0.9514,Gastroesophageal Cancer<;>Primary Neoplasm,0.9509,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9478
ESOPHAGOGASTRIC CARCINOMA,Gastroesophageal Cancer,2,2,Esophageal Carcinoma,0.9730,Gastroesophageal Cancer,0.9593,Esophageal Adenocarcinoma,0.9566,Esophageal Squamous Cell Carcinoma,0.9545,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9530
ESOPHAGUS,Esophagus,1,2,Esophagus,1.0000,Esophageal Melanoma,0.9404,Esophageal Adenocarcinoma,0.9365,Esophageal Lymph Node,0.9356,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9308
"ESOPHAGUS ADENOCARCINOMA, NOS",Esophageal Adenocarcinoma,1,2,Esophageal Adenocarcinoma,0.9661,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9636,Esophageal Adenosquamous Carcinoma,0.9563,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.9537,Esophageal Well Differentiated Squamous Cell Carcinoma<;>Invasive,0.9522
ESOPHAGUS SQUAMOUS CELL CARCINOMA,Esophageal Squamous Cell Carcinoma,1,2,Esophageal Squamous Cell Carcinoma,0.9967,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9838,Squamous Cell Carcinoma,0.9826,Lung Squamous Cell Carcinoma,0.9767,Endometrial Squamous Cell Carcinoma,0.9759
ESOPHAGUS/STOMACH,Esophageal Carcinoma,99,2,Esophagus,0.9709,Stomach,0.9493,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9310,Esophageal Melanoma,0.9265,Esophageal Adenocarcinoma,0.9251
ESOPHAGUS_ADENOCARCINOMA,Esophageal Adenocarcinoma,1,2,Esophageal Adenocarcinoma,0.9863,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9703,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.9611,Adenocarcinoma,0.9582,Esophageal Carcinoma,0.9581
ESOPHAGUS_SQUAMOUS,Esophageal Squamous Cell Carcinoma,1,2,Esophageal Squamous Cell Carcinoma,0.9629,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9624,Esophagus,0.9526,Esophageal Well Differentiated Squamous Cell Carcinoma<;>Invasive,0.9485,Squamous Cell Carcinoma,0.9461
ESSENTIAL THROMBOCYTHAEMIA,Essential Thrombocythemia,1,2,Essential Thrombocythemia,0.9912,Essential Thrombocythemia<;>Myelofibrosis,0.9722,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.9150,Polycythemia Vera<;>Myelofibrosis,0.9116,Acute Myeloid Leukemia with Mutated CEBPA,0.9044
ESSENTIAL THROMBOCYTHEMIA,Essential Thrombocythemia,1,2,Essential Thrombocythemia,1.0000,Essential Thrombocythemia<;>Myelofibrosis,0.9758,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.9159,Polycythemia Vera<;>Myelofibrosis,0.9131,Acute Erythroid Leukemia,0.9070
ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS,Essential Thrombocythemia<;>Myelofibrosis,1,2,Essential Thrombocythemia<;>Myelofibrosis,0.9912,Essential Thrombocythemia,0.9811,Polycythemia Vera<;>Myelofibrosis,0.9418,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.9375,Primary Myelofibrosis,0.9313
ESSENTIAL_THROMBOCYTHAEMIA,Essential Thrombocythemia,1,2,Essential Thrombocythemia,0.9828,Essential Thrombocythemia<;>Myelofibrosis,0.9721,Polycythemia Vera<;>Myelofibrosis,0.9187,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.9172,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.9060
ETMR,Embryonal Tumor with Multilayered Rosettes,99,2,ETV4 Gene,0.9397,ETV1 Gene,0.9377,AML1-ETO Fusion Protein Expression,0.9154,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9032,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9019
ETP-ALL,Early T Acute Lymphoblastic Leukemia,99,2,ETV4 Gene,0.9311,ETV1 Gene,0.9280,AML1-ETO Fusion Protein Expression,0.9112,Adult T-Cell Leukemia/Lymphoma,0.8998,"Posterior Fossa Ependymoma, Group A (PFA)",0.8956
EWING FAMILY TUMOR,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,5,2,Ewing Sarcoma,0.9615,Ewing Sarcoma<;>ERG Gene Rearrangement,0.9529,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9448,Central Nervous System Ewing Sarcoma<;>CIC Gene Rearrangement,0.9383,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.9369
EWING SARCOMA,Ewing Sarcoma,1,2,Ewing Sarcoma,1.0000,Ewing Sarcoma<;>ERG Gene Rearrangement,0.9554,Bone Sarcoma,0.9538,Synovial Sarcoma,0.9486,Sarcoma,0.9479
EWING'S SARCOMA,Ewing Sarcoma,1,2,Ewing Sarcoma,0.9962,Ewing Sarcoma<;>ERG Gene Rearrangement,0.9568,Bone Sarcoma,0.9519,Sarcoma,0.9480,Synovial Sarcoma,0.9447
EWING-LIKE SARCOMA,Round Cell Sarcoma with EWSR1-non-ETS Fusion,3,2,Ewing Sarcoma,0.9757,Ewing Sarcoma<;>ERG Gene Rearrangement,0.9518,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.9438,Sarcoma,0.9422,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.9412
EWINGS SARCOMA,Ewing Sarcoma,1,2,Ewing Sarcoma,0.9980,Ewing Sarcoma<;>ERG Gene Rearrangement,0.9545,Bone Sarcoma,0.9466,Synovial Sarcoma,0.9419,Epithelioid Sarcoma,0.9404
EWINGS SARCOMA-PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOUR,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1,2,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.9948,Peripheral Primitive Neuroectodermal Tumor,0.9669,Primitive Neuroectodermal Tumor,0.9663,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9612,Ewing Sarcoma,0.9487
EWINGS_SARCOMA,Ewing Sarcoma,1,2,Ewing Sarcoma,0.9912,Ewing Sarcoma<;>ERG Gene Rearrangement,0.9603,Bone Sarcoma,0.9495,Sarcoma,0.9474,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9471
EWING_SARCOMA,Ewing Sarcoma,1,2,Ewing Sarcoma,0.9909,Ewing Sarcoma<;>ERG Gene Rearrangement,0.9613,Bone Sarcoma,0.9510,Sarcoma,0.9499,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.9483
EWS-ERG,Ewing Sarcoma<;>ERG Gene Rearrangement,1,2,Ewing Sarcoma<;>ERG Gene Rearrangement,0.9542,ERG Gene,0.9426,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9391,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.9261,Central Nervous System Ewing Sarcoma<;>CIC Gene Rearrangement,0.9156
EWS-FLI1,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,1,2,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9637,FLI1 Gene,0.9592,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.9253,Ewing Sarcoma<;>ERG Gene Rearrangement,0.9237,PAX3/FOXO1 Fusion Gene,0.9199
EXOCRINE,Exocrine Gland,1,2,Exocrine Gland,0.9843,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.9529,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland,0.9426,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland<;>Ductal,0.9376,Acinar Cell,0.9226
EXOCRINE_ADENOCARCINOMA,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,1,2,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.9777,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland,0.9695,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland<;>Ductal,0.9680,Pancreatic Ductal Adenocarcinoma,0.9584,Pancreatic Adenocarcinoma,0.9575
EXOCRINE_ADENOSQUAMOUS,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland,1,2,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland,0.9791,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland<;>Ductal,0.9755,Pancreatic Adenosquamous Carcinoma<;>Ductal,0.9625,Pancreatic Adenosquamous Carcinoma,0.9583,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.9561
EXTRA GONADAL GERM CELL TUMOR,Extragonadal Germ Cell Tumor,1,2,Extragonadal Germ Cell Tumor,0.9836,Ovarian Germ Cell Tumor,0.9599,Germ Cell Tumor,0.9591,Testicular Non-Seminomatous Germ Cell Tumor,0.9554,Nongerminomatous Germ Cell Tumor,0.9524
EXTRA-ADRENAL PHEOCHROMOCYTOMA,Extra-Adrenal Sympathetic Paraganglioma,2,2,Extra-Adrenal Pheochromocytoma,1.0000,Extra-Adrenal Sympathetic Paraganglioma,0.9771,Adrenal Gland Pheochromocytoma,0.9617,Adrenal Gland Pheochromocytoma<;>Paraganglioma,0.9540,Extrarenal Rhabdoid Tumor,0.9475
EXTRACRANIAL RHABDOID,Rhabdoid Tumor<;>Extracranial,1,2,Rhabdoid Tumor<;>Extracranial,0.9767,Extrarenal Rhabdoid Tumor,0.9397,Rhabdoid Tumor,0.9240,Extraventricular Neurocytoma,0.9064,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.9053
EXTRAGONADAL GERM CELL TUMOR,Extragonadal Germ Cell Tumor,1,2,Extragonadal Germ Cell Tumor,1.0000,Nongerminomatous Germ Cell Tumor<;>Yolk Sac Tumor,0.9584,Nongerminomatous Germ Cell Tumor,0.9581,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.9560,Testicular Non-Seminomatous Germ Cell Tumor,0.9496
EXTRAHEPATIC,Extrahepatic,1,2,Extrahepatic,1.0000,Cholangiocarcinoma<;>Extrahepatic,0.9624,Extrahepatic Bile Duct Adenocarcinoma,0.9437,Intrahepatic,0.9358,Intrahepatic Cholangiocarcinoma,0.9250
EXTRAHEPATIC CHOLANGIOCARCINOMA,Extrahepatic Bile Duct Adenocarcinoma,5,2,Cholangiocarcinoma<;>Extrahepatic,0.9869,Intrahepatic Cholangiocarcinoma,0.9721,Cholangiocarcinoma,0.9678,Extrahepatic,0.9674,Extrahepatic Bile Duct Adenocarcinoma,0.9660
EXTRAMAMMARY PAGET DISEASE,Extramammary Paget Disease,1,2,Extramammary Paget Disease,1.0000,Extranodal Disease,0.9468,Nipple Paget Disease,0.9322,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.9310,Extragonadal Germ Cell Tumor,0.9299
EXTRANODAL DISEASE,Extranodal Disease,1,2,Extranodal Disease,1.0000,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.9566,Extragonadal Germ Cell Tumor,0.9468,Extramammary Paget Disease,0.9468,Non-Hodgkin Lymphoma,0.9302
EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE MALT LYMPHOMA,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1,2,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.9963,Marginal Zone Lymphoma,0.9553,Nodal Marginal Zone Lymphoma,0.9541,Extranodal Disease,0.9497,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.9481
EXTRANODAL_DISEASE,Extranodal Disease,1,2,Extranodal Disease,0.9952,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.9555,Extramammary Paget Disease,0.9471,Extragonadal Germ Cell Tumor,0.9437,Non-Hodgkin Lymphoma,0.9288
EXTRARENAL RHABDOID TUMOR,Extrarenal Rhabdoid Tumor,1,2,Extrarenal Rhabdoid Tumor,1.0000,Rhabdoid Tumor<;>Extracranial,0.9592,Extra-Adrenal Pheochromocytoma,0.9475,Rhabdoid Tumor,0.9465,Extragonadal Germ Cell Tumor,0.9463
EXTRASKELETAL MYXOID CHONDROSARCOMA,Extraskeletal Myxoid Chondrosarcoma,1,2,Extraskeletal Myxoid Chondrosarcoma,1.0000,Extraskeletal Osteosarcoma,0.9654,Chondrosarcoma,0.9420,Dedifferentiated Chondrosarcoma,0.9374,Extrarenal Rhabdoid Tumor,0.9362
EXTRASKELETAL OSTEOSARCOMA,Extraskeletal Osteosarcoma,1,2,Extraskeletal Osteosarcoma,1.0000,Extraskeletal Myxoid Chondrosarcoma,0.9654,Osteosarcoma,0.9481,Osteoblastic Osteosarcoma,0.9400,Chondroblastic Osteosarcoma,0.9365
EXTRAVENTRICULAR NEUROCYTOMA,Extraventricular Neurocytoma,1,2,Extraventricular Neurocytoma,1.0000,Central Neurocytoma,0.9327,Central Nervous System<;>Brain,0.9109,Supratentorial Ependymoma<;>Subependymoma,0.9101,Hemangioma,0.9096
FATTY LIVER DISEASE,fatty liver disease,1,2,fatty liver disease,1.0000,Liver,0.9232,Hepatitis B Virus,0.9184,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9150,Hepatitis C Virus,0.9108
FH-DEFICIENT RENAL CELL CARCINOMA,Fumarate Hydratase-Deficient Renal Cell Carcinoma,1,2,Fumarate Hydratase-Deficient Renal Cell Carcinoma,0.9763,Renal Cell Carcinoma<;>Poorly Differentiated,0.9565,Renal Cell Carcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9529,Renal Cell Carcinoma,0.9517,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9491
FIBROBLASTIC MYOFIBROBLASTIC TUMOR,Inflammatory Myofibroblastic Tumor,4,2,Skin Fibroblastic Neoplasm,0.9634,Neoplastic Fibroblast-Like Cell,0.9509,Myxoinflammatory Fibroblastic Sarcoma,0.9494,Inflammatory Myofibroblastic Tumor,0.9480,Fibroblastic Osteosarcoma,0.9454
FIBROBLASTIC OSTEOSARCOMA,Fibroblastic Osteosarcoma,1,2,Fibroblastic Osteosarcoma,1.0000,Chondroblastic Osteosarcoma,0.9545,Osteosarcoma,0.9519,Osteoblastic Osteosarcoma,0.9450,Skin Fibroblastic Neoplasm,0.9436
FIBROBLAST_BONE,Bone Marrow-Derived Fibroblasts,1,2,Bone Marrow-Derived Fibroblasts,0.9595,Fibroblast<;>Soft Tissue,0.9477,fibroblast of breast,0.9465,fibroblast of lung,0.9463,Fibroblastic Osteosarcoma,0.9455
FIBROBLAST_BREAST,fibroblast of breast,1,2,fibroblast of breast,0.9892,fibroblast of lung,0.9472,Breast,0.9372,Fibroblast<;>Lymphocyte,0.9363,Skin Fibroblastic Neoplasm,0.9351
FIBROBLAST_COLORECTAL,Fibroblast<;>Colorectal,1,2,Fibroblast<;>Colorectal,0.9887,Colorectal,0.9392,fibroblast of breast,0.9357,fibroblast of lung,0.9335,Skin Fibroblastic Neoplasm,0.9298
FIBROBLAST_LIKE,Neoplastic Fibroblast-Like Cell,2,2,fibroblast of lung,0.9481,Neoplastic Fibroblast-Like Cell,0.9457,Fibroblast<;>Lymphocyte,0.9399,fibroblast of breast,0.9396,Skin Fibroblastic Neoplasm,0.9386
FIBROBLAST_LUNG,fibroblast of lung,1,2,fibroblast of lung,0.9885,fibroblast of breast,0.9490,Fibroblast<;>Lymphocyte,0.9468,Bone Marrow-Derived Fibroblasts,0.9388,Skin Fibroblastic Neoplasm,0.9367
FIBROBLAST_LYMPHOCYTE,Fibroblast<;>Lymphocyte,1,2,Fibroblast<;>Lymphocyte,0.9845,fibroblast of lung,0.9492,fibroblast of breast,0.9437,Fibroblast<;>Soft Tissue,0.9346,Skin Fibroblastic Neoplasm,0.9307
FIBROBLAST_SKIN,Skin Fibroblastic Neoplasm,2,2,fibroblast of lung,0.9572,Skin Fibroblastic Neoplasm,0.9524,fibroblast of breast,0.9513,Fibroblast<;>Lymphocyte,0.9504,Fibroblast<;>Soft Tissue,0.9488
FIBROBLAST_SOFT_TISSUE,Fibroblast<;>Soft Tissue,1,2,Fibroblast<;>Soft Tissue,0.9878,Soft Tissue,0.9549,fibroblast of lung,0.9416,Skin Fibroblastic Neoplasm,0.9412,Soft Tissue Sarcoma,0.9401
FIBROBLAST_UPPER_AERODIGESTIVE,Fibroblast<;>upper aerodigestive tract,1,2,Fibroblast<;>upper aerodigestive tract,0.9898,upper aerodigestive tract neoplasm,0.9491,upper aerodigestive tract neoplasm<;>Oral Cavity Squamous Cell Carcinoma,0.9438,fibroblast of lung,0.9307,Fibroblast<;>Lymphocyte,0.9214
FIBROBLAST_URINARY_TRACT,Fibroblast<;>Urinary System,1,2,Fibroblast<;>Urinary System,0.9700,Fibroblast<;>upper aerodigestive tract,0.9509,fibroblast of lung,0.9450,fibroblast of breast,0.9371,Skin Fibroblastic Neoplasm,0.9282
FIBROLAMELLAR CARCINOMA,Fibrolamellar Carcinoma,1,2,Fibrolamellar Carcinoma,1.0000,Hepatocellular Carcinoma,0.9429,Plexiform Fibrohistiocytic Tumor,0.9327,Thyroid Gland Follicular Carcinoma,0.9311,Nasopharyngeal Carcinoma,0.9308
FIBROLAMELLAR HEPATOCELLUAR CARCINOMA,Fibrolamellar Carcinoma,1,2,Fibrolamellar Carcinoma,0.9755,Hepatocellular Carcinoma,0.9608,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9501,Pleomorphic Hepatocellular Carcinoma,0.9387,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9372
FIBROMATOSIS,Fibromatosis,1,2,Fibromatosis,1.0000,Desmoid Fibromatosis,0.9574,Fibrothecoma,0.9324,Myxoinflammatory Fibroblastic Sarcoma,0.9305,Ovarian Fibrothecoma,0.9300
FIBROSARCOMA,Fibrosarcoma,1,2,Fibrosarcoma,1.0000,Infantile Fibrosarcoma,0.9560,Sclerosing Epithelioid Fibrosarcoma,0.9466,Myxoinflammatory Fibroblastic Sarcoma,0.9414,Neoplastic Fibroblast-Like Cell,0.9347
FIBROSARCOMA_CANCER,Fibrosarcoma,1,2,Fibrosarcoma,0.9742,Infantile Fibrosarcoma,0.9409,Skin Fibroblastic Neoplasm,0.9336,Neoplastic Fibroblast-Like Cell,0.9319,Myxoinflammatory Fibroblastic Sarcoma,0.9311
FIBROTHECOMA,Fibrothecoma,1,2,Fibrothecoma,1.0000,Ovarian Fibrothecoma,0.9729,Fibromatosis,0.9324,Desmoid Fibromatosis,0.9189,Fibrosarcoma,0.9091
FIRST RECURRENCE,First Relapse,1,2,First Relapse,0.9621,Recurrence,0.9532,Recurrent,0.9366,Regional<;>Recurrence,0.9256,Locally Recurrent Malignant Neoplasm,0.9198
FL,Follicular Lymphoma,3,2,FLI1 Gene,0.9441,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9238,Follicular Lymphoma,0.9182,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9177,Fibromatosis,0.9163
FOCAL ANAPLASIA,Anaplastic Lesion<;>Focal,1,2,Anaplastic Lesion<;>Focal,0.9540,Anaplastic Lesion<;>Diffuse,0.9283,"Neoplasm Recurrence, Local",0.9151,Diffuse Astrocytoma,0.9130,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.9101
FOCAL MUCINOUS FEATURES,Mucinous,2,2,Anaplastic Lesion<;>Focal,0.9316,Mucinous,0.9230,Breast Mucinous Carcinoma,0.9177,Colon Mucinous Adenocarcinoma,0.9165,Pancreatic Mucinous-Cystic Neoplasm,0.9160
FOCAL NEUROENDOCRINE COMPONENT,Neuroendocrine Neoplasm,99,2,Anaplastic Lesion<;>Focal,0.9292,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9223,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.9196,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9176,Digestive System Neuroendocrine Tumor,0.9125
FOCAL SIGNET RING,Signet Ring Cell,1,2,Signet Ring Cell,0.9225,Signet Ring Cell Carcinoma,0.9180,Pancreatic Signet Ring Cell Carcinoma,0.9168,Signet Ring Cell<;>Mucinous,0.9152,Signet Ring Adenocarcinoma Cell,0.9133
FOLLICULAR,Follicle,2,2,Follicular Lymphoma,0.9556,Follicle,0.9549,Thyroid Gland Follicular Carcinoma,0.9366,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9308,Follicular Helper T-Cell Lymphoma,0.9289
FOLLICULAR CARCINOMA,Thyroid Gland Follicular Carcinoma,1,2,Thyroid Gland Follicular Carcinoma,0.9785,Follicular Lymphoma,0.9577,Thyroid Gland Follicular Carcinoma<;>Metastasis,0.9571,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.9544,Follicular Variant Thyroid Gland Papillary Carcinoma,0.9544
FOLLICULAR DENDRITIC CELL SARCOMA,Follicular Dendritic Cell Sarcoma,1,2,Follicular Dendritic Cell Sarcoma,1.0000,Histiocytic and Dendritic Cell Neoplasm,0.9541,Follicular Lymphoma,0.9440,Thyroid Gland Follicular Carcinoma,0.9384,Follicular Helper T-Cell Lymphoma,0.9360
FOLLICULAR IN MET,Thyroid Gland Follicular Carcinoma<;>Metastasis,1,2,Thyroid Gland Follicular Carcinoma<;>Metastasis,0.9181,Follicle,0.9176,Thyroid Gland Follicular Carcinoma,0.9115,Follicular Lymphoma,0.9111,Follicular Variant Thyroid Gland Papillary Carcinoma,0.9087
FOLLICULAR LYMPHOMA,Follicular Lymphoma,1,2,Follicular Lymphoma,1.0000,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9637,Follicular Helper T-Cell Lymphoma,0.9637,Thyroid Gland Follicular Carcinoma,0.9501,Follicular Dendritic Cell Sarcoma,0.9440
FOLLICULAR THYROID CANCER,Thyroid Gland Follicular Carcinoma,1,2,Thyroid Gland Follicular Carcinoma,0.9853,Thyroid Gland Follicular Carcinoma<;>Metastasis,0.9687,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.9651,Thyroid Gland Papillary and Follicular Carcinoma,0.9640,Follicular Variant Thyroid Gland Papillary Carcinoma,0.9639
FOLLICULAR THYROID CARCINOMA,Thyroid Gland Follicular Carcinoma,1,2,Thyroid Gland Follicular Carcinoma,0.9951,Follicular Variant Thyroid Gland Papillary Carcinoma,0.9739,Thyroid Gland Papillary and Follicular Carcinoma,0.9738,Thyroid Gland Follicular Carcinoma<;>Metastasis,0.9730,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.9714
"FOLLICULAR, HURTHLE",Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,99,2,Follicular Lymphoma,0.9269,Follicular Helper T-Cell Lymphoma,0.9257,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9244,Thyroid Gland Follicular Carcinoma,0.9216,Follicular Variant Thyroid Gland Papillary Carcinoma,0.9210
"FOLLICULAR, PAPILLARY",Thyroid Gland Papillary and Follicular Carcinoma,2,2,Papillary,0.9607,Thyroid Gland Papillary and Follicular Carcinoma,0.9575,Follicular Variant Thyroid Gland Papillary Carcinoma,0.9532,Acinar Cell Carcinoma<;>Papillary,0.9359,Papillary Carcinoma,0.9332
FOLLICULAR_CARCINOMA,Thyroid Gland Follicular Carcinoma,1,2,Thyroid Gland Follicular Carcinoma,0.9767,Thyroid Gland Follicular Carcinoma<;>Metastasis,0.9607,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.9594,Thyroid Gland Papillary and Follicular Carcinoma,0.9571,Follicular Lymphoma,0.9561
FOURTH RECURRENCE,Recurrence,1,2,Recurrence,0.9314,Recurrent,0.9168,Regional<;>Recurrence,0.9111,Anastomosis<;>Recurrence,0.9078,"Neoplasm Recurrence, Local",0.9042
FUSION+ RMS,Fusion-Positive Rhabdomyosarcoma,1,2,Fusion-Positive Rhabdomyosarcoma,0.9358,Fusion-Negative Rhabdomyosarcoma,0.9216,PML-RARA Fusion Protein Expression,0.9115,Rhabdomyosarcoma,0.9086,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9086
FUSION- RMS,Fusion-Negative Rhabdomyosarcoma,2,2,Fusion-Positive Rhabdomyosarcoma,0.9364,Fusion-Negative Rhabdomyosarcoma,0.9297,PML-RARA Fusion Protein Expression,0.9212,Rhabdomyosarcoma,0.9185,PAX3/FOXO1 Fusion Gene,0.9123
GALLBLADDER ADENOCARCINOMA,Gallbladder Adenocarcinoma,1,2,Gallbladder Adenocarcinoma,1.0000,Gallbladder Carcinoma,0.9780,Gastric Adenocarcinoma,0.9652,Gallbladder Adenosquamous Carcinoma,0.9619,Bladder Adenocarcinoma,0.9558
"GALLBLADDER ADENOCARCINOMA, NOS",Gallbladder Adenocarcinoma,1,2,Gallbladder Adenocarcinoma,0.9774,Gallbladder Adenosquamous Carcinoma,0.9673,Gallbladder Carcinoma,0.9668,Gallbladder Squamous Cell Carcinoma,0.9559,Gallbladder Large Cell Neuroendocrine Carcinoma,0.9534
GALLBLADDER ADENOSQUAMOUS CARCINOMA,Gallbladder Adenosquamous Carcinoma,1,2,Gallbladder Adenosquamous Carcinoma,1.0000,Gastric Adenosquamous Carcinoma,0.9812,Adenosquamous Carcinoma,0.9744,Pancreatic Adenosquamous Carcinoma,0.9728,Lung Adenosquamous Carcinoma,0.9695
GALLBLADDER CANCER,Gallbladder Carcinoma,1,2,Gallbladder Carcinoma,0.9850,Gallbladder Adenocarcinoma,0.9730,Gallbladder Squamous Cell Carcinoma,0.9561,Gallbladder Adenosquamous Carcinoma,0.9510,Gallbladder Neuroendocrine Tumor,0.9505
GALLBLADDER CARCINOMA,Gallbladder Carcinoma,1,2,Gallbladder Carcinoma,1.0000,Gallbladder Adenocarcinoma,0.9780,Gallbladder Squamous Cell Carcinoma,0.9652,Gallbladder Adenosquamous Carcinoma,0.9643,Gastric Carcinoma,0.9607
GALLBLADDER CARCINOMA OTHER,Gallbladder Carcinoma,1,2,Gallbladder Carcinoma,0.9675,Gallbladder Adenocarcinoma,0.9593,Gallbladder Squamous Cell Carcinoma,0.9457,Gallbladder Adenosquamous Carcinoma,0.9456,Gallbladder Large Cell Neuroendocrine Carcinoma,0.9455
GALLBLADDER NEUROENDOCRINE TUMOR,Gallbladder Neuroendocrine Tumor,1,2,Gallbladder Neuroendocrine Tumor,1.0000,Gallbladder Large Cell Neuroendocrine Carcinoma,0.9761,Gallbladder Small Cell Neuroendocrine Carcinoma,0.9735,Gastric Neuroendocrine Tumor,0.9725,Pancreatic Neuroendocrine Tumor,0.9643
GALLBLADDER_ADENOCARCINOMA,Gallbladder Adenocarcinoma,1,2,Gallbladder Adenocarcinoma,0.9934,Gallbladder Carcinoma,0.9711,Gallbladder Adenosquamous Carcinoma,0.9605,Gastric Adenocarcinoma,0.9587,Adenocarcinoma,0.9530
GANGLIOGLIOMA,Ganglioglioma,1,2,Ganglioglioma,1.0000,Anaplastic Ganglioglioma,0.9670,Glioma,0.9344,Gliosarcoma,0.9304,Oligodendroglioma,0.9292
GANGLIONEUROBLASTOMA,Ganglioneuroblastoma,1,2,Ganglioneuroblastoma,1.0000,"Ganglioneuroblastoma, Nodular",0.9697,Ganglioneuroma,0.9666,"Ganglioneuroblastoma, Intermixed",0.9611,Maturing Ganglioneuroma<;>Ganglioneuroblastoma<;>Well Differentiated,0.9367
"GANGLIONEUROBLASTOMA, INTERMIXED","Ganglioneuroblastoma, Intermixed",1,2,"Ganglioneuroblastoma, Intermixed",1.0000,Ganglioneuroblastoma,0.9611,"Ganglioneuroblastoma, Nodular",0.9520,Ganglioneuroma,0.9437,Maturing Ganglioneuroma<;>Ganglioneuroblastoma<;>Well Differentiated,0.9339
"GANGLIONEUROBLASTOMA, NODULAR","Ganglioneuroblastoma, Nodular",1,2,"Ganglioneuroblastoma, Nodular",1.0000,Ganglioneuroblastoma,0.9697,"Ganglioneuroblastoma, Intermixed",0.9520,Ganglioneuroma,0.9463,Maturing Ganglioneuroma<;>Ganglioneuroblastoma<;>Well Differentiated,0.9352
GANGLIONEUROMA,Ganglioneuroma,1,2,Ganglioneuroma,1.0000,Ganglioneuroblastoma,0.9666,"Ganglioneuroblastoma, Nodular",0.9463,"Ganglioneuroblastoma, Intermixed",0.9437,Maturing Ganglioneuroma<;>Ganglioneuroblastoma<;>Well Differentiated,0.9406
"GANGLIONEUROMA, MATURING SUBTYPE OR GANGLIONEUROBLASTOMA, WELL DIFFERENTIATED",Maturing Ganglioneuroma<;>Ganglioneuroblastoma<;>Well Differentiated,1,2,Maturing Ganglioneuroma<;>Ganglioneuroblastoma<;>Well Differentiated,0.9902,"Ganglioneuroblastoma, Nodular",0.9492,Ganglioneuroma,0.9471,"Ganglioneuroblastoma, Intermixed",0.9453,Ganglioneuroblastoma,0.9430
GASTRIC,Gastric,1,2,Gastric,1.0000,Stomach,0.9564,Gastric Adenocarcinoma,0.9371,Gastric Carcinoma,0.9319,Gastric Tubular Adenocarcinoma,0.9250
GASTRIC ADENOCARCINOMA,Gastric Adenocarcinoma,1,2,Gastric Adenocarcinoma,1.0000,Gastric Carcinoma,0.9725,Gastric Mucinous Adenocarcinoma,0.9694,Gastric Tubular Adenocarcinoma,0.9694,Gastric Diffuse Adenocarcinoma,0.9659
GASTRIC CANCER,Gastric Carcinoma,1,2,Gastric Carcinoma,0.9786,Gastric Adenocarcinoma,0.9683,Gastric Carcinoma<;>Poorly Differentiated,0.9453,Gastroesophageal Cancer,0.9437,Gastric Mucinous Adenocarcinoma,0.9431
GASTRIC CARCINOMA OTHER,Gastric Carcinoma,1,2,Gastric Carcinoma,0.9624,Gastric Adenocarcinoma,0.9531,Gastric Carcinoma<;>Poorly Differentiated,0.9526,Gastric Undifferentiated Carcinoma,0.9368,Gastric Adenosquamous Carcinoma,0.9356
GASTRIC NEUROENDOCRINE TUMOR,Gastric Neuroendocrine Tumor,1,2,Gastric Neuroendocrine Tumor,1.0000,Gallbladder Neuroendocrine Tumor,0.9725,Gastric Small Cell Neuroendocrine Carcinoma,0.9687,Neuroendocrine Tumor,0.9679,Pancreatic Neuroendocrine Tumor,0.9657
GASTRIC TYPE MUCINOUS CARCINOMA,Mucinous gastric carcinoma,1,2,Mucinous gastric carcinoma,0.9816,Gastric Mucinous Adenocarcinoma,0.9732,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.9609,Gastric Intestinal-Type Adenocarcinoma,0.9598,"Mucinous Adenocarcinoma, Endocervical Type",0.9592
GASTRIC_ADENOCARCINOMA,Gastric Adenocarcinoma,1,2,Gastric Adenocarcinoma,0.9915,Gastric Carcinoma,0.9663,Gastric Mucinous Adenocarcinoma,0.9648,Gastric Tubular Adenocarcinoma,0.9630,Gastric Intestinal-Type Adenocarcinoma,0.9621
GASTRIC_CANCER,Gastric Carcinoma,1,2,Gastric Carcinoma,0.9733,Gastric Adenocarcinoma,0.9662,Gastric Carcinoma<;>Poorly Differentiated,0.9445,Gastric Mucinous Adenocarcinoma,0.9429,Gastric Intestinal-Type Adenocarcinoma,0.9418
GASTRIC_SMALL_CELL,Gastric Small Cell Neuroendocrine Carcinoma,1,2,Gastric Small Cell Neuroendocrine Carcinoma,0.9611,Small Cell,0.9594,Small Cell Adenocarcinoma,0.9456,Gallbladder Small Cell Neuroendocrine Carcinoma,0.9455,"Malignant Tumor, Small Cell Type",0.9383
GASTROINTESTINAL NEUROENDOCRINE,Digestive System Neuroendocrine Tumor,1,2,Digestive System Neuroendocrine Tumor,0.9496,Gastric Neuroendocrine Tumor,0.9488,Colorectal Neuroendocrine Tumor,0.9371,Small Intestinal Neuroendocrine Neoplasm,0.9369,Small Intestinal Neuroendocrine Neoplasm<;>Well Differentiated,0.9357
GASTROINTESTINAL NEUROENDOCRINE TUMOR,Digestive System Neuroendocrine Tumor,3,2,Gastric Neuroendocrine Tumor,0.9796,Colorectal Neuroendocrine Tumor,0.9734,Digestive System Neuroendocrine Tumor,0.9692,Neuroendocrine Tumor,0.9684,Pancreatic Neuroendocrine Tumor,0.9657
GASTROINTESTINAL NEUROENDOCRINE TUMORS,Digestive System Neuroendocrine Tumor,3,2,Gastric Neuroendocrine Tumor,0.9776,Colorectal Neuroendocrine Tumor,0.9720,Digestive System Neuroendocrine Tumor,0.9683,Neuroendocrine Tumor,0.9661,Pancreatic Neuroendocrine Tumor,0.9644
GASTROINTESTINAL STROMAL,Gastrointestinal Stromal Tumor,1,2,Gastrointestinal Stromal Tumor,0.9678,Intestinal,0.9184,Fibroblast<;>Colorectal,0.9150,Gastric Intestinal-Type Adenocarcinoma,0.9138,Intestine,0.9137
GASTROINTESTINAL STROMAL TUMOR,Gastrointestinal Stromal Tumor,1,2,Gastrointestinal Stromal Tumor,1.0000,Malignant Intestinal Neoplasm,0.9295,Gastric Neuroendocrine Tumor,0.9290,Small Intestinal Carcinoma,0.9289,Digestive System Neuroendocrine Tumor,0.9274
GB,Glioblastoma,1,2,Glioblastoma,0.9061,Gastric,0.9044,Brain,0.9044,Glioma,0.9027,Glioblastoma<;>IDH Gene Family Mutation,0.8920
GBC,Gallbladder Carcinoma,99,2,Glioblastoma,0.9056,Glioma,0.9044,Gastric,0.9042,Brain,0.8977,Giant Cell,0.8959
GBM,Glioblastoma,1,2,Glioblastoma,0.9591,Glioma,0.9498,Glioblastoma<;>IDH Gene Family Mutation,0.9335,"Glioblastoma, IDH-Wildtype",0.9326,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.9320
GBM_IDHMUT-NON-CODEL,Glioblastoma<;>IDH Gene Family Mutation,99,2,"Glioblastoma, IDH-Wildtype",0.9509,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.9479,Glioblastoma<;>IDH Family Wildtype,0.9472,"Astrocytoma, IDH-Mutant, Grade 2",0.9451,"Astrocytoma, IDH-Mutant, Grade 4",0.9448
GBM_IDHWT,Glioblastoma<;>IDH Family Wildtype,2,2,"Glioblastoma, IDH-Wildtype",0.9583,Glioblastoma<;>IDH Family Wildtype,0.9572,Glioblastoma<;>IDH Gene Family Mutation,0.9569,Gliosarcoma<;>IDH Family Wildtype,0.9500,"Astrocytoma, IDH-Mutant, Grade 2",0.9497
GCB,germinal center B cell,1,2,germinal center B cell,0.9099,Giant Cell,0.9053,Giant Cell Tumor,0.9044,Gastric,0.9023,Giant Cell Carcinoma,0.9007
GERM CELL,Germ Cell,1,2,Germ Cell,1.0000,Germ Cell Tumor,0.9518,Childhood Brain Germ Cell Tumor,0.9389,Ovarian Germ Cell Tumor,0.9358,Germ Cell Tumor<;>Embryonal Carcinoma,0.9317
GERM CELL TUMOR,Germ Cell Tumor,1,2,Germ Cell Tumor,1.0000,Testicular Germ Cell Tumor,0.9784,Ovarian Germ Cell Tumor,0.9765,Childhood Brain Germ Cell Tumor,0.9696,Germ Cell Tumor<;>Embryonal Carcinoma,0.9659
GERM CELL TUMOR (EMBRYONAL CARCINOMA),Embryonal Carcinoma,3,2,Germ Cell Tumor<;>Embryonal Carcinoma,0.9928,Embryonal Carcinoma<;>Seminoma,0.9745,Embryonal Carcinoma,0.9702,Germ Cell Tumor,0.9694,Embryonal Neoplasm,0.9667
GERM CELL TUMOR EMBRYONAL CARCINOMA,Germ Cell Tumor<;>Embryonal Carcinoma,1,2,Germ Cell Tumor<;>Embryonal Carcinoma,0.9923,Embryonal Carcinoma,0.9757,Embryonal Carcinoma<;>Seminoma,0.9749,Germ Cell Tumor,0.9675,Embryonal Neoplasm,0.9674
GERM CELL TUMOR WITH SOMATIC-TYPE MALIGNANCY,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,1,2,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,0.9802,Teratoma with Somatic-Type Malignancy,0.9743,Germ Cell Tumor,0.9700,Testicular Germ Cell Tumor,0.9584,Germ Cell Tumor<;>Embryonal Carcinoma,0.9577
"GERM CELL TUMOR, BRAIN",Childhood Brain Germ Cell Tumor,1,2,Childhood Brain Germ Cell Tumor,0.9818,Germ Cell Tumor,0.9809,Testicular Germ Cell Tumor,0.9635,Ovarian Germ Cell Tumor,0.9617,Germ Cell Tumor<;>Embryonal Carcinoma,0.9577
GERMINAL CENTER B-CELL TYPE,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,2,2,germinal center B cell,0.9844,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9690,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9380,Mature B-Cell Non-Hodgkin Lymphoma,0.9355,B-Cell Non-Hodgkin Lymphoma,0.9337
GERMINAL CENTER B-CELL-LIKE GCB DLBCL,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,2,2,germinal center B cell,0.9704,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9653,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.9401,Mature B-Cell Non-Hodgkin Lymphoma,0.9391,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9387
GERMINOMA,Germinoma,1,2,Germinoma,1.0000,Central Nervous System Germinoma,0.9554,Germ Cell Tumor,0.9411,Germ Cell,0.9297,Nongerminomatous Germ Cell Tumor,0.9274
GESTATIONAL TROPHOBLASTIC DISEASE,Gestational Trophoblastic Disorder,1,2,Gestational Trophoblastic Disorder,0.9884,Epithelioid Trophoblastic Tumor,0.9189,Ovarian Dysgerminoma<;>Yolk Sac Tumor,0.9158,Germ Cell Tumor<;>Embryonal Carcinoma,0.9143,Choriocarcinoma,0.9129
GIANT CELL 'MFH' / UNDIFFERENTIATED PLEOMORPHIC SARCOMA WITH GIANT CELLS,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,1,2,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.9555,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells<;>Sarcomatoid Carcinoma,0.9464,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.9451,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.9450,Giant Cell Tumor of Bone,0.9418
GIANT CELL TUMOR OF BONE,Giant Cell Tumor of Bone,1,2,Giant Cell Tumor of Bone,1.0000,Giant Cell Tumor,0.9814,Giant Cell Carcinoma,0.9624,Giant Cell,0.9514,Granulosa Cell Tumor,0.9473
GIANT CELL TUMOUR,Giant Cell Tumor,1,2,Giant Cell Tumor,0.9919,Giant Cell Carcinoma,0.9808,Giant Cell Tumor of Bone,0.9761,Giant Cell,0.9753,Granulosa Cell Tumor,0.9454
GIANT_CELL,Giant Cell,1,2,Giant Cell,0.9885,Giant Cell Tumor,0.9611,Giant Cell Carcinoma,0.9537,Giant Cell Tumor of Bone,0.9407,Germ Cell,0.9221
GIANT_CELL_TUMOUR,Giant Cell Tumor,1,2,Giant Cell Tumor,0.9811,Giant Cell Carcinoma,0.9761,Giant Cell Tumor of Bone,0.9665,Giant Cell,0.9664,Granulosa Cell Tumor,0.9455
GINET,Digestive System Neuroendocrine Tumor,99,2,Gastrointestinal Stromal Tumor,0.8990,Gastric Neuroendocrine Tumor,0.8981,Granular Cell Tumor,0.8980,Gastric,0.8959,Gastric Adenocarcinoma<;>Microsatellite Instability,0.8928
GINGIVAL,Gingiva,1,2,Gingiva,0.9586,Gingival Carcinoma,0.9321,Salivary Gland,0.9090,Gastric,0.8987,Buccal Mucosa,0.8908
GIST,Gastrointestinal Stromal Tumor,3,2,Stomach,0.9278,Leiomyosarcoma,0.9173,Gastrointestinal Stromal Tumor,0.9109,Hemangioma,0.9107,Rhabdomyosarcoma,0.9094
GLIAL CELL NEOPLASM,Neoplastic Glial Cell,1,2,Neoplastic Glial Cell,0.9751,Brain Neoplasm,0.9507,Glioma,0.9499,Glioneuronal Tumor,0.9496,High Grade Astrocytic Tumor,0.9394
GLIOBLASTOMA,Glioblastoma,1,2,Glioblastoma,1.0000,Glioma,0.9650,"Glioblastoma, IDH-Wildtype",0.9483,Glioblastoma<;>IDH Gene Family Mutation,0.9463,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.9450
GLIOBLASTOMA MULTIFORME,Glioblastoma,1,2,Glioblastoma,0.9583,Malignant Glioma,0.9460,Recurrent Malignant Glioma,0.9388,Malignant Glioma<;>Anaplastic Astrocytoma,0.9375,Glioblastoma<;>IDH Gene Family Mutation,0.9361
GLIOBLASTOMA MULTIFORME GBM,Glioblastoma,1,2,Glioblastoma,0.9587,Malignant Glioma,0.9486,Recurrent Malignant Glioma,0.9404,Glioblastoma<;>IDH Gene Family Mutation,0.9387,Malignant Glioma<;>Anaplastic Astrocytoma,0.9382
"GLIOBLASTOMA WITH PRIMITIVE NEURONAL COMPONENT, IDH-WILDTYPE","Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",1,2,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.9928,"Glioblastoma, IDH-Wildtype",0.9788,Glioblastoma<;>IDH Family Wildtype,0.9692,"Anaplastic Astrocytoma, IDH-Wildtype",0.9644,"Astrocytoma, IDH-Mutant, Grade 2",0.9615
"GLIOBLASTOMA, IDH-MUTANT","Astrocytoma, IDH-Mutant, Grade 4",4,2,"Glioblastoma, IDH-Wildtype",0.9795,"Astrocytoma, IDH-Mutant, Grade 2",0.9748,Glioblastoma<;>IDH Gene Family Mutation,0.9737,"Astrocytoma, IDH-Mutant, Grade 4",0.9728,"Astrocytoma, IDH-Mutant, Grade 3",0.9726
"GLIOBLASTOMA, IDH-WILDTPYE","Glioblastoma, IDH-Wildtype",1,2,"Glioblastoma, IDH-Wildtype",0.9817,Glioblastoma<;>IDH Family Wildtype,0.9692,"Astrocytoma, IDH-Mutant, Grade 2",0.9659,"Astrocytoma, IDH-Mutant, Grade 3",0.9648,Glioblastoma<;>IDH Gene Family Mutation,0.9635
"GLIOBLASTOMA, IDH-WILDTYPE","Glioblastoma, IDH-Wildtype",1,2,"Glioblastoma, IDH-Wildtype",1.0000,Glioblastoma<;>IDH Family Wildtype,0.9823,"Anaplastic Astrocytoma, IDH-Wildtype",0.9756,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.9723,Gliosarcoma<;>IDH Family Wildtype,0.9692
"GLIOBLASTOMA, UD",Glioblastoma<;>Undifferentiated,2,2,Glioblastoma,0.9544,Glioblastoma<;>Undifferentiated,0.9466,"Glioblastoma, IDH-Wildtype",0.9362,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.9356,Glioblastoma<;>IDH Gene Family Mutation,0.9338
"GLIOBLASTOMA,UD",Glioblastoma<;>Undifferentiated,2,2,Glioblastoma,0.9544,Glioblastoma<;>Undifferentiated,0.9466,"Glioblastoma, IDH-Wildtype",0.9362,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.9356,Glioblastoma<;>IDH Gene Family Mutation,0.9338
GLIOBLASTOMA_MULTIFORME,Glioblastoma,1,2,Glioblastoma,0.9623,Malignant Glioma,0.9483,Malignant Glioma<;>Anaplastic Astrocytoma,0.9443,Glioblastoma<;>IDH Gene Family Mutation,0.9395,Malignant Glioma<;>Secondary Malignant Neoplasm,0.9388
GLIOMA,Glioma,1,2,Glioma,1.0000,Glioblastoma,0.9650,Low Grade Glioma,0.9539,Malignant Glioma,0.9479,Optic Nerve Glioma,0.9470
GLIONEURONAL TUMOR,Glioneuronal Tumor,1,2,Glioneuronal Tumor,1.0000,Diffuse Leptomeningeal Glioneuronal Tumor,0.9470,Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle,0.9452,Brain Neoplasm,0.9415,Gliosarcoma,0.9366
GLIOSARCOMA,Gliosarcoma,1,2,Gliosarcoma,1.0000,Gliosarcoma<;>IDH Family Wildtype,0.9454,Glioma,0.9425,Glioneuronal Tumor,0.9366,Ganglioglioma,0.9304
"GLIOSARCOMA, IDH-WILDTYPE",Gliosarcoma<;>IDH Family Wildtype,1,2,Gliosarcoma<;>IDH Family Wildtype,0.9843,"Glioblastoma, IDH-Wildtype",0.9788,Glioblastoma<;>IDH Family Wildtype,0.9636,"Anaplastic Astrocytoma, IDH-Wildtype",0.9634,"Astrocytoma, IDH-Mutant, Grade 2",0.9590
GLOMANGIOSARCOMA,Malignant Glomus Tumor,2,2,Gliosarcoma,0.9319,Malignant Glomus Tumor,0.9244,Germ Cell Tumor,0.9129,Glioma,0.9127,Granular Cell Tumor,0.9106
GOBLET CELL ADENOCARCINOMA OF THE APPENDIX,Appendix Goblet Cell Adenocarcinoma,1,2,Appendix Goblet Cell Adenocarcinoma,0.9954,Appendix Adenocarcinoma,0.9685,Appendix Mucinous Adenocarcinoma,0.9665,Appendix Carcinoma,0.9496,Gastric Intestinal-Type Adenocarcinoma,0.9486
GOBLET CELL CARCINOID OF THE APPENDIX,Appendix Goblet Cell Adenocarcinoma,1,2,Appendix Goblet Cell Adenocarcinoma,0.9697,Appendix Mucinous Adenocarcinoma,0.9413,Gallbladder Large Cell Neuroendocrine Carcinoma,0.9388,Gallbladder Small Cell Neuroendocrine Carcinoma,0.9381,Appendix Neuroendocrine Tumor,0.9379
GRANULAR CELL TUMOR,Granular Cell Tumor,1,2,Granular Cell Tumor,1.0000,Granular Cell Tumor<;>Atypical,0.9718,Giant Cell Tumor,0.9529,Granulosa Cell Tumor,0.9473,Giant Cell Tumor of Bone,0.9472
GRANULOSA CELL TUMOR,Granulosa Cell Tumor,1,2,Granulosa Cell Tumor,1.0000,Ovarian Granulosa Cell Tumor,0.9879,Juvenile Granulosa Cell Tumor,0.9613,Germ Cell Tumor,0.9549,Ovarian Germ Cell Tumor,0.9549
GRANULOSA_CELL_TUMOR,Granulosa Cell Tumor,1,2,Granulosa Cell Tumor,0.9941,Ovarian Granulosa Cell Tumor,0.9817,Juvenile Granulosa Cell Tumor,0.9570,Germ Cell Tumor,0.9520,Testicular Germ Cell Tumor,0.9508
GRANULOSA_CELL_TUMOUR,Granulosa Cell Tumor,1,2,Granulosa Cell Tumor,0.9856,Ovarian Granulosa Cell Tumor,0.9742,Juvenile Granulosa Cell Tumor,0.9538,Germ Cell Tumor,0.9458,Testicular Germ Cell Tumor,0.9449
GS,Genomic Stability,99,2,Ganglioglioma,0.8985,Germ Cell,0.8982,Stomach,0.8969,Gliosarcoma,0.8947,Salivary Gland,0.8939
HAEMATOPOIETIC NEOPLASM,Hematopoietic and Lymphoid Cell Neoplasm,1,2,Hematopoietic and Lymphoid Cell Neoplasm,0.9557,Neoplasm,0.9453,Myeloid Neoplasm,0.9443,Histiocytic and Dendritic Cell Neoplasm,0.9390,Myeloproliferative Neoplasm,0.9363
HAIRY CELL,Hairy Cell,1,2,Hairy Cell,1.0000,Hairy Cell Leukemia,0.9570,Cell Line,0.9043,Cellular Schwannoma,0.9034,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9031
HAIRY CELL LEUKEMIA,Hairy Cell Leukemia,1,2,Hairy Cell Leukemia,1.0000,Hairy Cell,0.9570,Hematopoietic and Lymphoid Cell Neoplasm,0.9313,Adult T-Cell Leukemia/Lymphoma,0.9259,Plasma Cell Leukemia,0.9227
HAIRY_CELL_LEUKEMIA,Hairy Cell Leukemia,1,2,Hairy Cell Leukemia,0.9950,Hairy Cell,0.9510,Hematopoietic and Lymphoid Cell Neoplasm,0.9384,Adult T-Cell Leukemia/Lymphoma,0.9314,T Lymphoblastic Leukemia/Lymphoma,0.9275
HBS_ANTIGEN_CARRIER,Hepatitis B Virus Surface Antigen Positive,1,2,Hepatitis B Virus Surface Antigen Positive,0.9449,Hepatitis B Virus,0.9204,Hemangioblastoma,0.9043,Activated B-Cell Positive,0.9031,Hepatoblastoma,0.9021
HBV,Hepatitis B Virus,1,2,Hepatitis B Virus,0.9556,Hepatitis B Virus Surface Antigen Positive,0.9329,Hepatitis C Virus,0.9307,"Non-B, Non-C Hepatitis",0.9237,Hepatoblastoma,0.9189
HCA/HCC,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,1,2,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9405,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.9347,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9340,Hepatocellular Carcinoma,0.9330,Hepatocellular Adenoma,0.9282
HCC,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,0.9540,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9479,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9447,Hepatocellular Adenoma,0.9431,Hepatoblastoma,0.9429
HCC ON HCA,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,1,2,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9286,Hepatocellular Adenoma,0.9233,Hepatocellular Carcinoma,0.9225,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.9186,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9184
HCV,Hepatitis C Virus,1,2,Hepatitis C Virus,0.9545,Hepatitis B Virus,0.9399,"Non-B, Non-C Hepatitis",0.9263,Hepatitis B Virus Surface Antigen Positive,0.9212,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9151
HEAD & NECK SQUAMOUS CELL CARCINOMA,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,0.9985,Head and Neck Carcinoma,0.9844,Hypopharyngeal Squamous Cell Carcinoma,0.9780,Salivary Gland Squamous Cell Carcinoma,0.9746,Head and Neck Squamous Cell Carcinoma<;>Spindle Cell Squamous Cell Carcinoma,0.9743
HEAD & NECK SQUAMOUS CELL CARCINOMA BASALOID TYPE,Head and Neck Basaloid Carcinoma,1,2,Head and Neck Basaloid Carcinoma,0.9832,Squamous Cell Carcinoma<;>Basaloid Cell,0.9750,Basal Cell Carcinoma,0.9675,Head and Neck Squamous Cell Carcinoma,0.9652,Salivary Gland Basal Cell Adenocarcinoma,0.9651
"HEAD & NECK SQUAMOUS CELL CARCINOMA, SPINDLE CELL VARIANT",Head and Neck Squamous Cell Carcinoma<;>Spindle Cell Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma<;>Spindle Cell Squamous Cell Carcinoma,0.9875,Head and Neck Squamous Cell Carcinoma,0.9688,Lung Spindle Cell Carcinoma,0.9615,Spindle Cell Neoplasm,0.9582,Hypopharyngeal Squamous Cell Carcinoma,0.9539
HEAD AND NECK,Head and Neck,1,2,Head and Neck,1.0000,Head and Neck Carcinoma,0.9649,Head and Neck Squamous Cell Carcinoma,0.9521,Head and Neck Neuroendocrine Carcinoma,0.9470,Malignant Head and Neck Neoplasm,0.9414
HEAD AND NECK CANCER,Malignant Head and Neck Neoplasm,3,2,Head and Neck Carcinoma,0.9888,Head and Neck Squamous Cell Carcinoma,0.9755,Malignant Head and Neck Neoplasm,0.9689,Head and Neck,0.9686,Head and Neck Neuroendocrine Carcinoma,0.9651
"HEAD AND NECK CANCER, NOS",Malignant Head and Neck Neoplasm,3,2,Head and Neck Carcinoma,0.9633,Head and Neck Squamous Cell Carcinoma,0.9578,Malignant Head and Neck Neoplasm,0.9555,Head and Neck Neuroendocrine Carcinoma,0.9487,Head and Neck,0.9433
HEAD AND NECK CARCINOMA,Head and Neck Carcinoma,1,2,Head and Neck Carcinoma,1.0000,Head and Neck Squamous Cell Carcinoma,0.9837,Malignant Head and Neck Neoplasm,0.9742,Head and Neck Neuroendocrine Carcinoma,0.9724,Head and Neck,0.9649
HEAD AND NECK CARCINOMA OTHER,Malignant Head and Neck Neoplasm,3,2,Head and Neck Carcinoma,0.9701,Head and Neck Squamous Cell Carcinoma,0.9575,Malignant Head and Neck Neoplasm,0.9573,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Negative,0.9494,Head and Neck Neuroendocrine Carcinoma,0.9493
"HEAD AND NECK CARCINOMA, OTHER",Malignant Head and Neck Neoplasm,3,2,Head and Neck Carcinoma,0.9796,Head and Neck Squamous Cell Carcinoma,0.9668,Malignant Head and Neck Neoplasm,0.9645,Head and Neck Neuroendocrine Carcinoma,0.9563,Head and Neck,0.9559
HEAD AND NECK MUCOSAL MELANOMA,Mucosal Melanoma of the Head and Neck,1,2,Mucosal Melanoma of the Head and Neck,0.9955,Mucosal Melanoma,0.9609,Head and Neck Carcinoma,0.9546,Head and Neck Squamous Cell Carcinoma,0.9496,Head and Neck,0.9496
HEAD AND NECK NEUROENDOCRINE CARCINOMA,Head and Neck Neuroendocrine Carcinoma,1,2,Head and Neck Neuroendocrine Carcinoma,1.0000,Head and Neck Carcinoma,0.9724,Neuroendocrine Carcinoma,0.9701,Head and Neck Squamous Cell Carcinoma,0.9606,Malignant Head and Neck Neoplasm,0.9605
HEAD AND NECK SQUAMOUS,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,0.9846,Head and Neck Squamous Cell Carcinoma<;>Spindle Cell Squamous Cell Carcinoma,0.9643,Salivary Gland Squamous Cell Carcinoma,0.9615,Head and Neck Carcinoma,0.9612,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,0.9598
HEAD AND NECK SQUAMOUS CELL CARCINOMA,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,1.0000,Head and Neck Carcinoma,0.9837,Hypopharyngeal Squamous Cell Carcinoma,0.9801,Salivary Gland Squamous Cell Carcinoma,0.9770,Laryngeal Squamous Cell Carcinoma,0.9762
HEAD AND NECK SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,0.9687,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Negative,0.9602,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,0.9583,Head and Neck Carcinoma,0.9580,Hypopharyngeal Squamous Cell Carcinoma,0.9573
HEAD AND NECK SQUAMOUS CELL CARCINOMA,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,0.9947,Head and Neck Carcinoma,0.9819,Hypopharyngeal Squamous Cell Carcinoma,0.9755,Head and Neck Squamous Cell Carcinoma<;>Spindle Cell Squamous Cell Carcinoma,0.9747,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,0.9721
HEAD_NECK_CANCER,Head and Neck Carcinoma,1,2,Head and Neck Carcinoma,0.9834,Malignant Head and Neck Neoplasm,0.9705,Head and Neck Squamous Cell Carcinoma,0.9697,Head and Neck Neuroendocrine Carcinoma,0.9637,Head and Neck,0.9566
HEMANGIOBLASTOMA,Hemangioblastoma,1,2,Hemangioblastoma,1.0000,Hemangioma,0.9773,Hepatoblastoma,0.9631,Hemangioblastoma<;>Cervicomedullary Junction,0.9397,Pineoblastoma,0.9353
HEMANGIOMA,Hemangioma,1,2,Hemangioma,1.0000,Hemangioblastoma,0.9773,Hemangioblastoma<;>Cervicomedullary Junction,0.9376,Chondroblastoma,0.9342,Epithelioid Hemangioendothelioma,0.9332
HEMANGIOPERICYTOMA OF THE CENTRAL NERVOUS SYSTEM,Meningeal Solitary Fibrous Tumor,99,2,Central Nervous System Neoplasm,0.9523,Hemangioma,0.9485,Central Nervous System Embryonal Tumor,0.9461,Hemangioblastoma,0.9448,Central Nervous System Medulloepithelioma,0.9444
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,Hemophagocytic Lymphohistiocytosis,1,2,Hemophagocytic Lymphohistiocytosis,1.0000,Hematopoietic and Lymphoid Cell Neoplasm,0.9339,Histiocytosis,0.9305,Histiocytic and Dendritic Cell Neoplasm,0.9279,True Histiocytic Lymphoma,0.9272
HEPATIC FLEXURE,Hepatic Flexure,1,2,Hepatic Flexure,1.0000,Splenic Flexure,0.9631,Intrahepatic,0.9139,Hilar Cholangiocarcinoma,0.9107,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9093
HEPATOBILIARY CANCER,Liver and Intrahepatic Bile Duct Carcinoma,1,2,Liver and Intrahepatic Bile Duct Carcinoma,0.9549,Hepatoblastoma,0.9547,Liver and Intrahepatic Bile Duct Neoplasm,0.9519,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9506,Hepatocellular Carcinoma,0.9483
HEPATOBLASTOMA,Hepatoblastoma,1,2,Hepatoblastoma,1.0000,Hemangioblastoma,0.9631,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9434,Hepatocellular Adenoma,0.9430,Hepatocellular Carcinoma,0.9423
HEPATOCELLULAR ADENOMA,Hepatocellular Adenoma,1,2,Hepatocellular Adenoma,1.0000,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9825,Hepatocellular Carcinoma,0.9598,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9439,Hepatoblastoma,0.9430
HEPATOCELLULAR CARCINOMA,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,1.0000,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9751,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9630,Hepatocellular Adenoma,0.9598,Pleomorphic Hepatocellular Carcinoma,0.9515
HEPATOCELLULAR CARCINOMA PLUS INTRAHEPATIC CHOLANGIOCARCINOMA,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,1,2,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9843,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.9751,Liver and Intrahepatic Bile Duct Carcinoma,0.9746,Intrahepatic Cholangiocarcinoma,0.9710,Liver and Intrahepatic Bile Duct Neoplasm,0.9665
"HEPATOCELLULAR CARCINOMA, HBS-ANTIGEN CARRIER",Hepatitis B Virus Surface Antigen Positive,1,2,Hepatitis B Virus Surface Antigen Positive,0.9528,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9524,Hepatocellular Carcinoma,0.9486,Hepatoblastoma,0.9406,Hepatitis B Virus,0.9402
HEPATOCELLULAR_CANCER,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,0.9798,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9626,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9585,Hepatocellular Adenoma,0.9454,Liver and Intrahepatic Bile Duct Carcinoma,0.9440
HEPATOCELLULAR_CARCINOMA,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,0.9938,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9773,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9660,Hepatocellular Adenoma,0.9590,Liver and Intrahepatic Bile Duct Carcinoma,0.9520
HEPATOCHOLANGIOCARCINOMA MIXED,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1,2,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.9383,Cervical Carcinoma<;>Mixed,0.9257,Mixed<;>Serous<;>Clear Cells,0.9231,Liver and Intrahepatic Bile Duct Carcinoma,0.9229,Breast Mixed Ductal and Lobular Carcinoma,0.9226
HEPTOCELLULAR CARCINOMA,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,0.9452,Carcinoma,0.9378,Breast Carcinoma,0.9363,Nasopharyngeal Carcinoma,0.9324,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9313
HER2,HER2-Positive Breast Carcinoma,1,2,HER2-Positive Breast Carcinoma,0.9666,HER2/Neu Positive,0.9630,Estrogen Receptor Positive<;>HER2/Neu Positive,0.9475,Estrogen Receptor Positive<;>HER2/Neu Negative,0.9475,Estrogen Receptor Negative<;>HER2/Neu Positive,0.9473
HER2+,HER2/Neu Positive,2,2,HER2-Positive Breast Carcinoma,0.9694,HER2/Neu Positive,0.9622,Estrogen Receptor Positive<;>HER2/Neu Positive,0.9478,Estrogen Receptor Positive<;>HER2/Neu Negative,0.9477,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.9476
HER2-ENRICHED,HER2-Positive Breast Carcinoma,1,2,HER2-Positive Breast Carcinoma,0.9585,HER2/Neu Positive,0.9543,Estrogen Receptor Positive<;>HER2/Neu Positive,0.9482,Estrogen Receptor Negative<;>HER2/Neu Positive,0.9466,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.9466
HEREDITARY SPHEROCYTOSIS,Hereditary Spherocytosis,1,2,Hereditary Spherocytosis,1.0000,Histiocytosis,0.9184,Langerhans Cell Histiocytosis,0.9133,"Malignant Lymphoma, Histiocytic, Diffuse",0.9097,Hemophagocytic Lymphohistiocytosis,0.9092
HGGNOS,Malignant Glioma,99,2,Nongerminomatous Germ Cell Tumor,0.9077,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.9055,Glioma,0.9033,Low Grade Glioma<;>IDH Gene Family Mutation,0.9033,Low Grade Glioma<;>IDH Family Wildtype,0.8970
HGS,Ovarian High Grade Serous Adenocarcinoma,1,2,Ovarian High Grade Serous Adenocarcinoma,0.9092,Low Grade Glioma<;>IDH Gene Family Mutation,0.9072,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.9040,Glioblastoma<;>IDH Gene Family Mutation,0.9037,Fallopian Tube High Grade Serous Adenocarcinoma,0.9032
HGSOC,Ovarian High Grade Serous Adenocarcinoma,1,2,Ovarian High Grade Serous Adenocarcinoma,0.9086,Ovarian Seromucinous Carcinoma,0.9063,Ovarian Low Grade Serous Adenocarcinoma,0.9046,Low Grade Glioma<;>IDH Gene Family Mutation,0.9024,Fallopian Tube High Grade Serous Adenocarcinoma,0.9022
"HIGH-GRADE B-CELL LYMPHOMA, NOS","High Grade B-Cell Lymphoma, Not Otherwise Specified",1,2,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.9822,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.9730,B-Cell Non-Hodgkin Lymphoma,0.9643,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9637,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9580
"HIGH-GRADE B-CELL LYMPHOMA, WITH MYC AND BCL2 AND/OR BCL6 REARRANGEMENTS",High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1,2,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.9986,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.9662,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9549,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9539,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.9523
HIGH-GRADE ENDOMETRIAL STROMAL SARCOMA,Endometrioid Stromal Sarcoma<;>High Grade,1,2,Endometrioid Stromal Sarcoma<;>High Grade,0.9841,Low Grade Endometrioid Stromal Sarcoma,0.9758,Endometrioid Stromal Sarcoma,0.9631,Low Grade Fibromyxoid Sarcoma,0.9412,Ovarian High Grade Serous Adenocarcinoma,0.9412
"HIGH-GRADE GLIOMA, NOS",Malignant Glioma,99,2,High Grade Astrocytic Tumor,0.9600,Glioma,0.9579,Low Grade Glioma<;>Low Grade Astrocytoma,0.9555,Low Grade Glioma,0.9552,Low Grade Glioma<;>IDH Gene Family Mutation,0.9528
HIGH-GRADE GLIOMA/ASTROCYTOMA,Malignant Glioma<;>Anaplastic Astrocytoma,99,2,High Grade Astrocytic Tumor,0.9804,Low Grade Glioma<;>Low Grade Astrocytoma,0.9730,Glioma,0.9648,Low Grade Glioma,0.9647,"Astrocytoma, IDH-Mutant, Grade 3",0.9627
HIGH-GRADE NEUROENDOCRINE CARCINOMA OF THE COLON AND RECTUM,Colorectal Neuroendocrine Carcinoma,3,2,High Grade<;>Small Cell Neuroendocrine Carcinoma<;>Small Cell Adenocarcinoma,0.9751,Ovarian Neuroendocrine Carcinoma<;>High Grade,0.9696,Colorectal Neuroendocrine Carcinoma,0.9664,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.9642,Rectal Neuroendocrine Tumor<;>Well Differentiated,0.9638
HIGH-GRADE NEUROENDOCRINE CARCINOMA OF THE OVARY,Ovarian Neuroendocrine Carcinoma<;>High Grade,1,2,Ovarian Neuroendocrine Carcinoma<;>High Grade,0.9924,High Grade<;>Small Cell Neuroendocrine Carcinoma<;>Small Cell Adenocarcinoma,0.9691,Ovarian High Grade Serous Adenocarcinoma,0.9635,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.9633,Neuroendocrine Carcinoma,0.9569
HIGH-GRADE NEUROEPITHELIAL TUMOR,Neuroepithelial Neoplasm<;>High Grade,1,2,Neuroepithelial Neoplasm<;>High Grade,0.9885,Neuroepithelial Neoplasm,0.9604,High Grade Astrocytic Tumor,0.9528,High Grade<;>Small Cell Neuroendocrine Carcinoma<;>Small Cell Adenocarcinoma,0.9521,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.9513
HIGH-GRADE SEROUS FALLOPIAN TUBE CANCER,Fallopian Tube High Grade Serous Adenocarcinoma,1,2,Fallopian Tube High Grade Serous Adenocarcinoma,0.9929,Ovarian High Grade Serous Adenocarcinoma,0.9714,Serous Adenocarcinoma<;>High Grade,0.9704,Fallopian Tube Carcinoma<;>Ovarian Carcinoma,0.9663,Ovarian Low Grade Serous Adenocarcinoma,0.9663
HIGH-GRADE SEROUS OVARIAN CANCER,Ovarian High Grade Serous Adenocarcinoma,1,2,Ovarian High Grade Serous Adenocarcinoma,0.9910,Ovarian Low Grade Serous Adenocarcinoma,0.9822,Serous Adenocarcinoma<;>High Grade,0.9810,Fallopian Tube High Grade Serous Adenocarcinoma,0.9737,Cystadenocarcinoma<;>High Grade<;>Serous,0.9659
HIGH_GRADE_SEROUS,Ovarian High Grade Serous Adenocarcinoma,2,2,Serous Adenocarcinoma<;>High Grade,0.9733,Ovarian High Grade Serous Adenocarcinoma,0.9656,Cystadenocarcinoma<;>High Grade<;>Serous,0.9651,Ovarian Low Grade Serous Adenocarcinoma,0.9573,Fallopian Tube High Grade Serous Adenocarcinoma,0.9555
HILAR/PERIHILAR,Proximal Bile Duct,99,2,Hilar Cholangiocarcinoma,0.9287,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9156,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.9130,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9112,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9110
HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS,Histiocytic and Dendritic Cell Neoplasm,1,2,Histiocytic and Dendritic Cell Neoplasm,0.9988,"Malignant Lymphoma, Histiocytic, Diffuse",0.9598,Hematopoietic and Lymphoid Cell Neoplasm,0.9560,Follicular Dendritic Cell Sarcoma,0.9543,Langerhans Cell Histiocytosis,0.9539
HISTIOCYTIC DENDRITIC CELL SARCOMA,Histiocytic and Dendritic Cell Neoplasm,1,2,Histiocytic and Dendritic Cell Neoplasm,0.9827,Histiocytic Sarcoma,0.9689,Follicular Dendritic Cell Sarcoma,0.9655,"Malignant Lymphoma, Histiocytic, Diffuse",0.9460,Histiocytosis,0.9449
HISTIOCYTIC SARCOMA,Histiocytic Sarcoma,1,2,Histiocytic Sarcoma,1.0000,Histiocytosis,0.9597,Histiocytic and Dendritic Cell Neoplasm,0.9505,Bone Sarcoma,0.9432,Synovial Sarcoma,0.9432
HISTIOCYTIC_LYMPHOMA,True Histiocytic Lymphoma,4,2,Histiocytosis,0.9649,"Malignant Lymphoma, Histiocytic, Diffuse",0.9648,Histiocytic Sarcoma,0.9617,True Histiocytic Lymphoma,0.9600,Histiocytic and Dendritic Cell Neoplasm,0.9558
HISTIOCYTOSIS,Histiocytosis,1,2,Histiocytosis,1.0000,Langerhans Cell Histiocytosis,0.9670,Histiocytic Sarcoma,0.9597,Histiocytic and Dendritic Cell Neoplasm,0.9532,"Malignant Lymphoma, Histiocytic, Diffuse",0.9446
HNSC,Head and Neck Squamous Cell Carcinoma,2,2,Head and Neck,0.9175,Head and Neck Squamous Cell Carcinoma,0.9160,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Negative,0.9132,Head and Neck Neuroendocrine Carcinoma,0.9128,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,0.9122
HNSC_HPV+,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,1,2,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,0.9492,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Negative,0.9458,Human Papillomavirus Positive<;>Squamous Cell Carcinoma,0.9403,Head and Neck Squamous Cell Carcinoma,0.9309,Hypopharyngeal Squamous Cell Carcinoma,0.9283
HNSC_HPV-,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Negative,2,2,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,0.9503,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Negative,0.9474,Human Papillomavirus Positive<;>Squamous Cell Carcinoma,0.9407,Head and Neck Squamous Cell Carcinoma,0.9306,Hypopharyngeal Squamous Cell Carcinoma,0.9267
HODGKIN LYMPHOMA,Hodgkin Lymphoma,1,2,Hodgkin Lymphoma,1.0000,Classic Hodgkin Lymphoma,0.9593,Non-Hodgkin Lymphoma,0.9582,Lymphoma,0.9511,B-Cell Non-Hodgkin Lymphoma,0.9442
HODGKIN LYMPHOMA-LIKE PTLD,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,1,2,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.9613,Hodgkin Lymphoma,0.9402,Non-Hodgkin Lymphoma,0.9330,T-Cell Non-Hodgkin Lymphoma,0.9325,Classic Hodgkin Lymphoma,0.9324
HODGKINS,Hodgkin Lymphoma,1,2,Hodgkin Lymphoma,0.9796,Classic Hodgkin Lymphoma,0.9463,Non-Hodgkin Lymphoma,0.9445,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.9366,B-Cell Non-Hodgkin Lymphoma,0.9343
HODGKIN_LYMPHOMA,Hodgkin Lymphoma,1,2,Hodgkin Lymphoma,0.9921,Non-Hodgkin Lymphoma,0.9602,Classic Hodgkin Lymphoma,0.9576,Lymphoma,0.9508,B-Cell Non-Hodgkin Lymphoma,0.9472
HPV+ SCC I OR II,Human Papillomavirus Positive<;>Squamous Cell Carcinoma,1,2,Human Papillomavirus Positive<;>Squamous Cell Carcinoma,0.9533,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,0.9507,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Negative,0.9467,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.9431,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9427
HR+/HER2-,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,1,2,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9616,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9615,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.9612,Estrogen Receptor Negative<;>HER2/Neu Positive,0.9575,Estrogen Receptor Positive<;>HER2/Neu Positive,0.9571
HURTHLE,Thyroid Gland Oncocytic Carcinoma,99,2,Hemangioma,0.8882,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.8880,Hematopoietic and Lymphoid Cell Neoplasm,0.8863,Hemophagocytic Lymphohistiocytosis,0.8834,Cribriform,0.8833
HURTHLE CELL THYROID CANCER,Thyroid Gland Oncocytic Carcinoma,99,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.9408,Thyroid Gland Carcinoma,0.9340,thyroid gland squamous cell carcinoma,0.9335,Thyroid Gland Papillary Carcinoma,0.9272,Thyroid Gland Papillary and Follicular Carcinoma,0.9271
HYPERDIPLOID,Hyperdiploidy,1,2,Hyperdiploidy,0.9979,Hypodiploidy,0.9628,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.9399,Diploidy,0.9243,Normal Karyotype,0.9154
HYPERMUTATED,Hypermutated Colorectal Carcinoma,1,2,Hypermutated Colorectal Carcinoma,0.9608,High-Frequency Microsatellite Instability,0.9057,Mucosal Melanoma<;>Anorectal,0.9033,Metaplastic,0.9032,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0.9021
HYPERNEPHROMA-PD,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,99,2,Hyperdiploidy,0.9355,Myelodysplastic/Myeloproliferative Neoplasm,0.9112,Dermatofibrosarcoma Protuberans,0.9096,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9081,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9067
HYPERTENSION DIAGNOSIS,Hypertension,1,2,Hypertension,0.9676,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9138,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.9102,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.9102,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9097
HYPODIPLOID,Hypodiploidy,1,2,Hypodiploidy,0.9974,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.9629,Hyperdiploidy,0.9611,Diploidy,0.9226,Acute Megakaryoblastic Leukemia<;>Down Syndrome,0.9151
HYPOPHARYNGEAL,Hypopharyngeal Squamous Cell Carcinoma,1,2,Hypopharyngeal Squamous Cell Carcinoma,0.9436,Pharynx,0.9268,Head and Neck,0.9224,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Negative,0.9183,Head and Neck Carcinoma,0.9152
HYPOPHARYNX SQUAMOUS CELL CARCINOMA,Hypopharyngeal Squamous Cell Carcinoma,1,2,Hypopharyngeal Squamous Cell Carcinoma,0.9987,Head and Neck Squamous Cell Carcinoma,0.9776,Pharyngeal Squamous Cell Carcinoma,0.9723,Salivary Gland Squamous Cell Carcinoma,0.9691,Oral Cavity Squamous Cell Carcinoma,0.9685
IDC,Invasive Breast Carcinoma of No Special Type,99,2,Breast Ductal Carcinoma In Situ,0.9186,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9160,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9156,Breast Ductal Carcinoma,0.9148,Invasive Breast Carcinoma,0.9125
IDC HR+HER2+,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,99,2,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.9505,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9493,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9486,HER2-Positive Breast Carcinoma,0.9476,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9453
IDC HR+HER2-,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,5,2,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9497,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9496,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.9480,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9456,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9456
IDC HR-HER2+,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,99,2,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9524,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9521,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.9519,HER2-Positive Breast Carcinoma,0.9497,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9489
IDC TN,Invasive Breast Carcinoma of No Special Type<;>Triple-Negative Breast Cancer Finding,1,2,Invasive Breast Carcinoma of No Special Type<;>Triple-Negative Breast Cancer Finding,0.9125,Breast Ductal Carcinoma In Situ,0.9123,Breast Ductal Carcinoma<;>Triple-Negative Breast Cancer Finding,0.9121,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9093,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9083
ILC HR+HER2-,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,1,2,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9411,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9338,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9338,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9336,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9334
IMMATURE TERATOMA,Immature Teratoma,1,2,Immature Teratoma,1.0000,Teratoma,0.9589,Mature Teratoma,0.9532,Seminoma<;>Mature Teratoma,0.9433,Nonseminomatous<;>Immature Teratoma,0.9416
IMMORTALIZED_EMBRYONIC_FIBROBLAST,immortal embryo-derived fibroblast cell line cell,1,2,immortal embryo-derived fibroblast cell line cell,0.9691,immortal fibroblast cell line cell,0.9449,fibroblast of lung,0.9272,immortal epithelial cell line cell,0.9259,Bone Marrow-Derived Fibroblasts,0.9233
IMMORTALIZED_EPITHELIAL,immortal epithelial cell line cell,1,2,immortal epithelial cell line cell,0.9585,immortal embryo-derived fibroblast cell line cell,0.9375,immortal fibroblast cell line cell,0.9355,Epithelial,0.9353,Breast Metaplastic Carcinoma<;>Epithelial,0.9264
IMMORTALIZED_FIBROBLAST,immortal fibroblast cell line cell,1,2,immortal fibroblast cell line cell,0.9582,immortal embryo-derived fibroblast cell line cell,0.9548,immortal epithelial cell line cell,0.9303,Skin Fibroblastic Neoplasm,0.9271,fibroblast of lung,0.9256
IMMUNOBLASTIC,Immunoblastic Lymphoma,1,2,Immunoblastic Lymphoma,0.9798,Metaplastic,0.9253,Angioimmunoblastic T-Cell Lymphoma,0.9143,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9128,"Malignant Lymphoma, Histiocytic, Diffuse",0.9128
INCIDENTAL PROSTATE CANCER,Prostate Carcinoma<;>Incidental Finding,1,2,Prostate Carcinoma<;>Incidental Finding,0.9765,Prostate Adenocarcinoma,0.9250,Prostate Carcinoma,0.9227,Prostate Neuroendocrine Carcinoma,0.9219,Solid Pseudopapillary Neoplasm of the Pancreas,0.9182
INFANTILE FIBROSARCOMA,Infantile Fibrosarcoma,1,2,Infantile Fibrosarcoma,1.0000,Fibrosarcoma,0.9560,Infantile Sarcoma,0.9557,Infantile Myofibroma,0.9554,Sclerosing Epithelioid Fibrosarcoma,0.9330
INFANTILE MYOFIBROMA,Infantile Myofibroma,1,2,Infantile Myofibroma,1.0000,Infantile Fibrosarcoma,0.9554,Myofibroma,0.9479,Congenital Peribronchial Myofibroblastic Tumor,0.9413,Infantile Sarcoma,0.9389
INFANTILE SARCOMA,Infantile Sarcoma,1,2,Infantile Sarcoma,1.0000,Infantile Fibrosarcoma,0.9557,Intimal Sarcoma,0.9402,Infantile Myofibroma,0.9389,Sarcoma,0.9368
INFILTRATING CARCINOMA NOS,Invasive Breast Carcinoma,2,2,Infiltrating Urothelial Carcinoma,0.9596,Invasive Breast Carcinoma,0.9474,infiltrating bladder urothelial carcinoma sarcomatoid variant,0.9436,Carcinoma,0.9424,Invasive Breast Lobular Carcinoma,0.9412
INFILTRATING DUCTAL & LOBULAR,Breast Mixed Ductal and Lobular Carcinoma,4,2,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9692,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9682,Invasive Breast Lobular Carcinoma,0.9556,Breast Mixed Ductal and Lobular Carcinoma,0.9511,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9480
INFILTRATING DUCTAL AND LOBULAR CARCINOMA,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,1,2,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9830,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9789,Invasive Breast Lobular Carcinoma,0.9785,Breast Lobular Carcinoma,0.9693,Breast Mixed Ductal and Lobular Carcinoma,0.9637
INFILTRATING DUCTAL CARCINOMA,Invasive Breast Carcinoma of No Special Type,99,2,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9684,Invasive Breast Lobular Carcinoma,0.9680,Invasive Breast Carcinoma,0.9676,Breast Ductal Carcinoma,0.9671,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9638
INFILTRATING LOBULAR CARCINOMA,Invasive Breast Lobular Carcinoma,1,2,Invasive Breast Lobular Carcinoma,0.9796,Breast Lobular Carcinoma,0.9720,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9663,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9605,Invasive Breast Carcinoma,0.9541
INFILTRATING TUBULAR CARCINOMA,Breast Tubular Carcinoma,1,2,Breast Tubular Carcinoma,0.9638,Infiltrating Urothelial Carcinoma,0.9593,Tubular Adenocarcinoma,0.9579,Tubular Adenocarcinoma<;>Moderately Differentiated,0.9483,Tubulolobular Breast Carcinoma,0.9480
INFILTRATING TUBULO-LOBULAR CARCINOMA,Tubulolobular Breast Carcinoma,1,2,Tubulolobular Breast Carcinoma,0.9620,Invasive Breast Lobular Carcinoma,0.9607,Breast Tubular Carcinoma,0.9549,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9541,Breast Lobular Carcinoma,0.9501
INFLAMMATORY BREAST CANCER,Breast Inflammatory Carcinoma,1,2,Breast Inflammatory Carcinoma,0.9858,Inflammatory Myofibroblastic Tumor,0.9477,Lung Inflammatory Myofibroblastic Tumor,0.9379,Invasive Breast Carcinoma,0.9204,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9184
INFLAMMATORY MYOFIBROBLASTIC LUNG TUMOR,Lung Inflammatory Myofibroblastic Tumor,1,2,Lung Inflammatory Myofibroblastic Tumor,0.9975,Inflammatory Myofibroblastic Tumor,0.9881,Congenital Peribronchial Myofibroblastic Tumor,0.9487,Breast Inflammatory Carcinoma,0.9439,Myofibroma,0.9401
INFLAMMATORY MYOFIBROBLASTIC TUMOR,Inflammatory Myofibroblastic Tumor,1,2,Inflammatory Myofibroblastic Tumor,1.0000,Lung Inflammatory Myofibroblastic Tumor,0.9842,Breast Inflammatory Carcinoma,0.9466,Congenital Peribronchial Myofibroblastic Tumor,0.9450,Myofibroma,0.9419
INITIAL CNS TUMOR,Central Nervous System Neoplasm,1,2,Central Nervous System Neoplasm,0.9347,Malignant Central Nervous System Neoplasm,0.9330,Brain Neoplasm,0.9290,Central Nervous System Solitary Fibrous Tumor,0.9265,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9248
INITIAL CNS TUMOR FIRST HGG RECORD,Central Nervous System Neoplasm,99,2,Low Grade Glioma<;>IDH Gene Family Mutation,0.9247,Glioma,0.9239,Malignant Glioma<;>Secondary Malignant Neoplasm,0.9229,Glioblastoma<;>IDH Gene Family Mutation,0.9211,Malignant Glioma<;>Pediatric,0.9196
INITIAL CNS TUMOR LAST INITIAL,Central Nervous System Neoplasm,2,2,Malignant Central Nervous System Neoplasm,0.9281,Central Nervous System Neoplasm,0.9266,Central Nervous System Solitary Fibrous Tumor,0.9240,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9232,Malignant Glioma<;>Secondary Malignant Neoplasm,0.9210
INITIAL CNS TUMOR NEW LOCATION,Central Nervous System Neoplasm,2,2,Brain<;>Site of Metastasis,0.9328,Central Nervous System Neoplasm,0.9320,Brain Neoplasm,0.9292,Malignant Glioma<;>Secondary Malignant Neoplasm,0.9290,Central Nervous System Solitary Fibrous Tumor,0.9285
INTERMEDIATE RISK CYTOGENETIC ABNORMALITY,Cytogenetic Abnormality<;>Intermediate Risk,1,2,Cytogenetic Abnormality<;>Intermediate Risk,0.9941,Cytogenetic Abnormality<;>Low Risk,0.9624,MLL Gene Translocation<;>Low Risk,0.9245,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.9229,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.9214
INTERMEDIATELY DIFFERENTIATED ADENOCARCINOMA,Moderately Differentiated Adenocarcinoma Cell,4,2,Adenocarcinoma<;>Moderately Differentiated,0.9642,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9556,Adenocarcinoma<;>Poorly Differentiated,0.9546,Moderately Differentiated Adenocarcinoma Cell,0.9545,Poorly Differentiated Adenocarcinoma,0.9532
INTESTINAL,Intestinal,1,2,Intestinal,1.0000,Intestine,0.9800,Jejunum,0.9307,Small Intestinal Adenocarcinoma,0.9218,Malignant Intestinal Neoplasm,0.9200
INTESTINAL TYPE MUCINOUS CARCINOMA,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",1,2,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.9804,Gastric Intestinal-Type Adenocarcinoma,0.9655,"Mucinous Adenocarcinoma, Endocervical Type",0.9616,Mucinous gastric carcinoma,0.9602,Colon Mucinous Adenocarcinoma,0.9590
INTESTINAL TYPE STOMACH ADENOCARCINOMA,Gastric Intestinal-Type Adenocarcinoma,1,2,Gastric Intestinal-Type Adenocarcinoma,0.9941,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.9643,Small Intestinal Adenocarcinoma,0.9544,Gastric Adenocarcinoma,0.9513,Gastric Tubular Adenocarcinoma,0.9454
INTESTINAL_ADENOCARCINOMA,Gastric Intestinal-Type Adenocarcinoma,2,2,Small Intestinal Adenocarcinoma,0.9727,Gastric Intestinal-Type Adenocarcinoma,0.9667,Malignant Intestinal Neoplasm,0.9574,Colon Adenocarcinoma,0.9560,Colorectal Adenocarcinoma,0.9557
INTIMAL SARCOMA,Intimal Sarcoma,1,2,Intimal Sarcoma,1.0000,Infantile Sarcoma,0.9402,Synovial Sarcoma,0.9372,Breast Sarcoma,0.9279,Bone Sarcoma,0.9271
INTRACHOLECYSTIC PAPILLARY NEOPLASM,Gallbladder Intracholecystic Papillary Neoplasm,1,2,Gallbladder Intracholecystic Papillary Neoplasm,0.9864,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9436,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.9418,Breast Papillary Ductal Carcinoma with Invasion,0.9382,Pancreatic Intraductal Tubulopapillary Neoplasm,0.9361
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM,Pancreatic Intraductal Papillary-Mucinous Neoplasm,1,2,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.9944,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9815,Pancreatic Intraductal Tubulopapillary Neoplasm,0.9714,Pancreatic Mucinous-Cystic Neoplasm,0.9537,Breast Papillary Ductal Carcinoma with Invasion,0.9501
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM WITH AN ASSOCIATED INVASIVE CARCINOMA,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,1,2,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9958,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.9794,Breast Papillary Ductal Carcinoma with Invasion,0.9643,Pancreatic Intraductal Tubulopapillary Neoplasm,0.9623,Invasive Lung Mucinous Adenocarcinoma,0.9527
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM WITH INVASION,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,1,2,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9864,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.9820,Breast Papillary Ductal Carcinoma with Invasion,0.9671,Pancreatic Intraductal Tubulopapillary Neoplasm,0.9624,Invasive Lung Mucinous Adenocarcinoma,0.9490
INTRADUCTAL TUBULOPAPILLARY NEOPLASM,Pancreatic Intraductal Tubulopapillary Neoplasm,1,2,Pancreatic Intraductal Tubulopapillary Neoplasm,0.9946,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.9679,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9622,Gallbladder Intracholecystic Papillary Neoplasm,0.9358,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.9341
INTRAHEPATIC,Intrahepatic,1,2,Intrahepatic,1.0000,Intrahepatic Cholangiocarcinoma,0.9701,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9480,Liver and Intrahepatic Bile Duct Carcinoma,0.9419,Liver and Intrahepatic Bile Duct Neoplasm,0.9412
INTRAHEPATIC CHOLANGIOCARCINOMA,Intrahepatic Cholangiocarcinoma,1,2,Intrahepatic Cholangiocarcinoma,1.0000,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9786,Cholangiocarcinoma,0.9709,Intrahepatic,0.9701,Liver and Intrahepatic Bile Duct Carcinoma,0.9629
INVASIVE,Invasive,1,2,Invasive,1.0000,Adenocarcinoma<;>Invasive,0.9400,Well Differentiated Lesion<;>Invasive,0.9397,Invasive Breast Carcinoma,0.9363,Invasive Lung Mucinous Adenocarcinoma,0.9327
INVASIVE ADENOCARCINOMA,Adenocarcinoma<;>Invasive,1,2,Adenocarcinoma<;>Invasive,0.9878,Invasive Breast Carcinoma,0.9697,Invasive Lung Mucinous Adenocarcinoma,0.9662,Adenocarcinoma,0.9561,Well Differentiated Lesion<;>Invasive,0.9529
INVASIVE BREAST CANCER,Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,0.9896,Invasive Breast Lobular Carcinoma,0.9699,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9648,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9620,Invasive Breast Carcinoma of No Special Type,0.9602
INVASIVE BREAST CARCINOMA,Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,1.0000,Invasive Breast Lobular Carcinoma,0.9826,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9738,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9701,Breast Carcinoma,0.9689
INVASIVE DUCTAL AND LOBULAR CARCINOMA,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,1,2,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9962,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9936,Invasive Breast Lobular Carcinoma,0.9889,Invasive Breast Carcinoma,0.9764,Breast Lobular Carcinoma,0.9690
INVASIVE MIXED DUCTAL AND LOBULAR CARCINOMA,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,3,2,Breast Mixed Ductal and Lobular Carcinoma,0.9864,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9841,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9829,Invasive Breast Lobular Carcinoma,0.9742,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9679
INVASIVE MUCINOUS ADCA,Invasive Lung Mucinous Adenocarcinoma,1,2,Invasive Lung Mucinous Adenocarcinoma,0.9667,Adenocarcinoma<;>Invasive,0.9535,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9492,Mucinous Adenocarcinoma,0.9448,Minimally Invasive Lung Non-Mucinous Adenocarcinoma,0.9427
INVASIVE MUCINOUS ADENOCARCINOMA 82533,Invasive Lung Mucinous Adenocarcinoma,1,2,Invasive Lung Mucinous Adenocarcinoma,0.9681,Adenocarcinoma<;>Invasive,0.9560,Mucinous Adenocarcinoma,0.9528,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9516,Lung Mucinous Adenocarcinoma,0.9454
"INVASIVE, WELL-DIFFERENTIATED",Well Differentiated Lesion<;>Invasive,1,2,Well Differentiated Lesion<;>Invasive,0.9848,Esophageal Well Differentiated Squamous Cell Carcinoma<;>Invasive,0.9572,Invasive,0.9527,Adenocarcinoma<;>Well Differentiated,0.9509,Adenocarcinoma<;>Invasive,0.9503
INVASIVE-MUCINOUS,Invasive Lung Mucinous Adenocarcinoma,1,2,Invasive Lung Mucinous Adenocarcinoma,0.9726,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9573,Adenocarcinoma<;>Invasive,0.9545,Invasive,0.9527,Minimally Invasive Lung Non-Mucinous Adenocarcinoma,0.9522
INVASIVE_DUCTAL_CARCINOMA,Invasive Breast Carcinoma of No Special Type,99,2,Invasive Breast Carcinoma,0.9824,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9781,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9753,Invasive Breast Lobular Carcinoma,0.9749,Breast Ductal Carcinoma,0.9715
ISLET CELL TUMOR,Pancreatic Neuroendocrine Tumor,4,2,Pancreatic Acinar Cell Carcinoma,0.9382,Granulosa Cell Tumor,0.9377,Ovarian Granulosa Cell Tumor,0.9377,Pancreatic Neuroendocrine Tumor,0.9340,Ovarian Sertoli-Leydig Cell Tumor,0.9338
JEJUNUM,Jejunum,1,2,Jejunum,1.0000,Intestine,0.9443,Intestinal,0.9307,Cecum,0.9180,Colon,0.9081
JUVENILE GRANULOSA CELL TUMOR,Juvenile Granulosa Cell Tumor,1,2,Juvenile Granulosa Cell Tumor,1.0000,Granulosa Cell Tumor,0.9613,Ovarian Granulosa Cell Tumor,0.9558,Childhood Brain Germ Cell Tumor,0.9436,Testicular Germ Cell Tumor,0.9428
JUVENILE SECRETORY CARCINOMA OF THE BREAST,Breast Secretory Carcinoma,1,2,Breast Secretory Carcinoma,0.9693,Salivary Gland Secretory Carcinoma,0.9520,Juvenile Granulosa Cell Tumor,0.9489,Invasive Breast Lobular Carcinoma,0.9467,Luminal A Breast Carcinoma,0.9458
KATAEGIS,Kataegis,1,2,Kataegis,1.0000,"Posterior Fossa Ependymoma, Group A (PFA)",0.8951,Keratoacanthoma,0.8934,Gastric,0.8920,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.8893
KERATOACANTHOMA,Keratoacanthoma,1,2,Keratoacanthoma,1.0000,Chondroblastoma,0.9254,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9249,Skin Acantholytic Squamous Cell Carcinoma,0.9209,Oral Epithelial Dysplasia,0.9188
KICH,Chromophobe Renal Cell Carcinoma,99,2,Jejunum,0.8881,Bizarre Leiomyoma<;>Kidney Leiomyoma,0.8865,FLI1 Gene,0.8851,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.8833,Hemangioma,0.8811
KIDNEY,Kidney,1,2,Kidney,1.0000,Kidney Angiomyolipoma,0.9362,Kidney Oncocytoma,0.9360,Kidney Carcinoma,0.9348,"Kidney Carcinoma, Transitional Cells",0.9281
KIDNEY CANCER,Kidney Carcinoma,1,2,Kidney Carcinoma,0.9796,Renal Cell Carcinoma,0.9634,"Kidney Carcinoma, Transitional Cells",0.9537,Kidney Medullary Carcinoma,0.9535,Kidney,0.9474
"KIDNEY CANCER, NOS",Kidney Carcinoma,1,2,Kidney Carcinoma,0.9637,Renal Cell Carcinoma,0.9603,Clear Cell Renal Cell Carcinoma,0.9515,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9506,"Kidney Carcinoma, Transitional Cells",0.9488
KIDNEY CHROMOPHOBE,Chromophobe Renal Cell Carcinoma,1,2,Chromophobe Renal Cell Carcinoma,0.9629,Classic Variant of Chromophobe Renal Cell Carcinoma,0.9477,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.9400,Kidney,0.9271,Kidney Angiomyolipoma,0.9237
KIDNEY CLEAR CELL RENAL CARCINOMA,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.9927,Renal Cell Carcinoma,0.9849,Kidney Carcinoma,0.9810,Clear Cell Papillary Renal Neoplasm,0.9759,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9722
KIDNEY PAPILLARY RENAL CELL CARCINOMA,Papillary Renal Cell Carcinoma,1,2,Papillary Renal Cell Carcinoma,0.9943,Clear Cell Papillary Renal Neoplasm,0.9802,Renal Cell Carcinoma,0.9746,Kidney Carcinoma,0.9711,Papillary Carcinoma,0.9663
KIDNEY RENAL CELL CARCINOMA,Renal Cell Carcinoma,1,2,Renal Cell Carcinoma,0.9930,Kidney Carcinoma,0.9913,Clear Cell Renal Cell Carcinoma,0.9736,"Kidney Carcinoma, Transitional Cells",0.9705,Kidney Medullary Carcinoma,0.9699
KIDNEY RENAL CELL CARCINOMA OTHER,Renal Cell Carcinoma,1,2,Renal Cell Carcinoma,0.9666,Kidney Carcinoma,0.9618,Renal Cell Carcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9553,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9538,Renal Cell Carcinoma<;>Poorly Differentiated,0.9529
KIDNEY_CANCER,Kidney Carcinoma,1,2,Kidney Carcinoma,0.9766,Renal Cell Carcinoma,0.9622,"Kidney Carcinoma, Transitional Cells",0.9561,Kidney Medullary Carcinoma,0.9522,Kidney,0.9446
KIRC,Clear Cell Renal Cell Carcinoma,99,2,Kidney,0.8953,Mature T-Cell and NK-Cell Neoplasm,0.8935,Plasmacytoma,0.8932,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.8918,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.8907
KIRP,Papillary Renal Cell Carcinoma,99,2,Kidney,0.8940,Plasmacytoma,0.8864,Undifferentiated Round Cell Sarcoma,0.8854,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.8850,Mature T-Cell and NK-Cell Neoplasm,0.8848
LAML,Acute Myeloid Leukemia,99,2,Lung Lymphoepithelial Carcinoma,0.9032,Lung,0.8961,Myxoma,0.8907,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.8892,fibroblast of lung,0.8892
LANGERHANS CELL HISTIOCYTOSIS,Langerhans Cell Histiocytosis,1,2,Langerhans Cell Histiocytosis,1.0000,Histiocytosis,0.9670,Histiocytic and Dendritic Cell Neoplasm,0.9550,"Malignant Lymphoma, Histiocytic, Diffuse",0.9364,True Histiocytic Lymphoma,0.9336
LARGE CELL CARCINOMA-UD,Large Cell Carcinoma<;>Undifferentiated,1,2,Large Cell Carcinoma<;>Undifferentiated,0.9693,Large Cell Carcinoma,0.9687,Lung Large Cell Carcinoma,0.9592,Large Cell Neuroendocrine Carcinoma,0.9539,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9493
LARGE CELL LUNG CARCINOMA,Lung Large Cell Carcinoma,1,2,Lung Large Cell Carcinoma,0.9980,Large Cell Carcinoma,0.9910,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9746,"Lung Large Cell Carcinoma, Clear Cell Variant",0.9715,Large Cell Neuroendocrine Carcinoma,0.9697
LARGE CELL NEUROENDOCRINE CARCINOMA,Large Cell Neuroendocrine Carcinoma,1,2,Large Cell Neuroendocrine Carcinoma,1.0000,Gallbladder Large Cell Neuroendocrine Carcinoma,0.9757,Large Cell Carcinoma,0.9748,Small Cell Neuroendocrine Carcinoma,0.9713,Lung Large Cell Carcinoma,0.9679
LARGE CELL NEUROENDOCRINE CARCINOMA OF GALLBLADDER,Gallbladder Large Cell Neuroendocrine Carcinoma,1,2,Gallbladder Large Cell Neuroendocrine Carcinoma,0.9982,Gallbladder Small Cell Neuroendocrine Carcinoma,0.9853,Large Cell Neuroendocrine Carcinoma,0.9791,Gallbladder Neuroendocrine Tumor,0.9705,Gastric Small Cell Neuroendocrine Carcinoma,0.9678
LARGE CELL-UD,Large Cell Carcinoma<;>Undifferentiated,1,2,Large Cell Carcinoma<;>Undifferentiated,0.9357,Large Cell Carcinoma,0.9286,Small Cell,0.9256,Large Cell Neuroendocrine Carcinoma,0.9161,Lung Large Cell Carcinoma,0.9159
LARGE CELL/ANAPLASTIC MEDULLOBLASTOMA,Large Cell/Anaplastic Medulloblastoma,1,2,Large Cell/Anaplastic Medulloblastoma,1.0000,Anaplastic Large Cell Lymphoma,0.9624,Anaplastic Medulloblastoma,0.9608,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.9472,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9465
LARGE_CELL_CARCINOMA,Large Cell Carcinoma,1,2,Large Cell Carcinoma,0.9921,Lung Large Cell Carcinoma,0.9799,Large Cell Neuroendocrine Carcinoma,0.9722,Large Cell Carcinoma<;>Undifferentiated,0.9674,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9668
LARGE_CELL_LUNG_CANCER,Lung Large Cell Carcinoma,1,2,Lung Large Cell Carcinoma,0.9865,Large Cell Carcinoma,0.9766,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9737,"Lung Large Cell Carcinoma, Clear Cell Variant",0.9638,Lung Basaloid Large Cell Carcinoma,0.9580
LARYNGEAL,Laryngeal,1,2,Laryngeal,1.0000,Laryngeal Squamous Cell Carcinoma,0.9407,Head and Neck Squamous Cell Carcinoma,0.9118,upper aerodigestive tract neoplasm<;>Oral Cavity Squamous Cell Carcinoma,0.9112,Oropharyngeal Squamous Cell Carcinoma,0.9100
LARYNX SQUAMOUS CELL CARCINOMA,Laryngeal Squamous Cell Carcinoma,1,2,Laryngeal Squamous Cell Carcinoma,0.9947,Squamous Cell Carcinoma,0.9846,Lung Squamous Cell Carcinoma,0.9816,Head and Neck Squamous Cell Carcinoma,0.9804,Salivary Gland Squamous Cell Carcinoma,0.9784
LEIOMYOSARCOMA,Leiomyosarcoma,1,2,Leiomyosarcoma,1.0000,Uterine Corpus Leiomyosarcoma,0.9574,Well Differentiated Leiomyosarcoma,0.9544,Rhabdomyosarcoma,0.9533,Uterine Corpus Myxoid Leiomyosarcoma,0.9505
LEIOMYOSARCOMA LMS,Leiomyosarcoma,1,2,Leiomyosarcoma,0.9772,Well Differentiated Leiomyosarcoma,0.9450,Uterine Corpus Leiomyosarcoma,0.9424,Conventional Leiomyosarcoma,0.9416,Uterine Corpus Myxoid Leiomyosarcoma,0.9406
LENTIGO MALIGNA,Lentigo Maligna,1,2,Lentigo Maligna,1.0000,Lentigo Maligna Melanoma,0.9851,Malignant Skin Neoplasm,0.9278,Acral Lentiginous Melanoma,0.9252,"Malignant Lymphoma, Histiocytic, Diffuse",0.9180
LENTIGO MALIGNA MELANOMA,Lentigo Maligna Melanoma,1,2,Lentigo Maligna Melanoma,1.0000,Lentigo Maligna,0.9851,Acral Lentiginous Melanoma,0.9497,Melanoma,0.9396,Malignant Skin Neoplasm,0.9367
LEPIDIC,Lepidic Adenocarcinoma,1,2,Lepidic Adenocarcinoma,0.9561,Luminal A Breast Carcinoma,0.8988,Laryngeal,0.8965,Ovarian Low Grade Serous Adenocarcinoma,0.8950,Epithelial,0.8929
LEPIDIC ADENOCARCINOMA 82503,Lepidic Adenocarcinoma,1,2,Lepidic Adenocarcinoma,0.9712,Lung Mucinous Adenocarcinoma,0.9303,Lung Acinar Adenocarcinoma,0.9251,Lung Adenocarcinoma,0.9235,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.9232
LEUKAEMIA,Leukemia,1,2,Leukemia,0.9669,B Lymphoblastic Leukemia/Lymphoma,0.9391,Acute Myeloid Leukemia with MLL Rearrangement,0.9355,T Lymphoblastic Leukemia/Lymphoma,0.9353,Acute Myeloid Leukemia,0.9347
LEUKAPHERESIS,Leukapheresis,1,2,Leukapheresis,1.0000,Leukemia,0.9205,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.9086,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9078,Acute Megakaryoblastic Leukemia<;>Down Syndrome,0.9077
LEUKEMIA,Leukemia,1,2,Leukemia,1.0000,B Lymphoblastic Leukemia/Lymphoma,0.9527,T Lymphoblastic Leukemia/Lymphoma,0.9517,Acute Myeloid Leukemia,0.9495,Acute Lymphoblastic Leukemia,0.9472
LEUKEMIA_OTHER,Leukemia,1,2,Leukemia,0.9610,Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,0.9538,Acute Myeloid Leukemia Not Otherwise Specified,0.9509,B Lymphoblastic Leukemia/Lymphoma,0.9407,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9382
LGG,Low Grade Glioma,3,2,Ganglioglioma,0.8976,Glioma,0.8959,Low Grade Glioma,0.8957,Nongerminomatous Germ Cell Tumor,0.8907,Low Grade Glioma<;>Low Grade Astrocytoma,0.8903
LGG_IDHMUT-CODEL,Low Grade Glioma<;>IDH Gene Family Mutation,2,2,Low Grade Glioma<;>IDH Family Wildtype,0.9354,Low Grade Glioma<;>IDH Gene Family Mutation,0.9346,"Astrocytoma, IDH-Mutant, Grade 2",0.9317,"Astrocytoma, IDH-Mutant, Grade 4",0.9315,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9299
LGG_IDHMUT-NON-CODEL,Low Grade Glioma<;>IDH Gene Family Mutation,2,2,Low Grade Glioma<;>IDH Family Wildtype,0.9406,Low Grade Glioma<;>IDH Gene Family Mutation,0.9355,"Glioblastoma, IDH-Wildtype",0.9349,"Astrocytoma, IDH-Mutant, Grade 2",0.9332,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.9328
LGG_IDHWT,Low Grade Glioma<;>IDH Family Wildtype,1,2,Low Grade Glioma<;>IDH Family Wildtype,0.9326,Low Grade Glioma<;>IDH Gene Family Mutation,0.9290,"Glioblastoma, IDH-Wildtype",0.9272,Gliosarcoma<;>IDH Family Wildtype,0.9267,"Astrocytoma, IDH-Mutant, Grade 2",0.9250
LGSOC,Ovarian Low Grade Serous Adenocarcinoma,99,2,Oligoastrocytoma,0.8960,Low Grade Glioma<;>IDH Family Wildtype,0.8936,Low Grade Glioma<;>IDH Gene Family Mutation,0.8911,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.8909,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.8905
LIHB,Hepatoblastoma,99,2,Laryngeal,0.8929,Lobular,0.8856,Linitis Plastica,0.8850,fibroblast of lung,0.8840,Monoclonal B-Cell Lymphocytosis,0.8833
LIHC,Hepatocellular Carcinoma,99,2,Lung Lymphoepithelial Carcinoma,0.8905,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.8900,Liver and Intrahepatic Bile Duct Neoplasm,0.8899,Liver and Intrahepatic Bile Duct Carcinoma,0.8890,Linitis Plastica,0.8866
LIPOFIBROMATOSIS-LIKE NEURAL TUMOR,NTRK-Rearranged Spindle Cell Neoplasm,99,2,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.9369,Neoplastic Fibroblast-Like Cell,0.9332,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.9316,Skin Fibroblastic Neoplasm,0.9298,Dysembryoplastic Neuroepithelial Tumor,0.9297
LIPOSARCOMA,Liposarcoma,1,2,Liposarcoma,1.0000,Pleomorphic Liposarcoma,0.9587,Myxoid Liposarcoma,0.9581,Well Differentiated Liposarcoma,0.9519,Dedifferentiated Liposarcoma,0.9496
LIVER,Liver,1,2,Liver,1.0000,Liver and Intrahepatic Bile Duct Carcinoma,0.9293,Lung,0.9271,Liver and Intrahepatic Bile Duct Neoplasm,0.9259,fatty liver disease,0.9232
"LIVER CANCER, NOS",Liver and Intrahepatic Bile Duct Carcinoma,2,2,Hepatocellular Carcinoma,0.9470,Liver and Intrahepatic Bile Duct Carcinoma,0.9468,Liver and Intrahepatic Bile Duct Neoplasm,0.9462,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9395,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9387
LIVER HEPATOCELLULAR CARCINOMA,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,0.9904,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9700,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9650,Liver and Intrahepatic Bile Duct Carcinoma,0.9628,Hepatocellular Adenoma,0.9572
LIVER HEPATOCELLULAR CARCINOMA PLUS INTRAHEPATIC CHOLANGIOCARCINOMA,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,1,2,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9843,Liver and Intrahepatic Bile Duct Carcinoma,0.9802,Liver and Intrahepatic Bile Duct Neoplasm,0.9718,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.9717,Intrahepatic Cholangiocarcinoma,0.9711
LIVER TUMOR,Liver and Intrahepatic Bile Duct Neoplasm,1,2,Liver and Intrahepatic Bile Duct Neoplasm,0.9542,Liver and Intrahepatic Bile Duct Carcinoma,0.9508,Liver,0.9461,Hepatocellular Carcinoma,0.9436,Hepatoblastoma,0.9378
LIVER_CANCER,Liver and Intrahepatic Bile Duct Carcinoma,1,2,Liver and Intrahepatic Bile Duct Carcinoma,0.9549,Liver and Intrahepatic Bile Duct Neoplasm,0.9520,Liver,0.9500,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9479,Hepatocellular Carcinoma,0.9453
LNET,Lung Carcinoid Tumor,99,2,Lymph Node,0.9256,Esophageal Lymph Node,0.9037,MLL Gene Translocation<;>Low Risk,0.9000,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9000,MLL Gene Translocation,0.8987
LOBULAR,Lobular,1,2,Lobular,1.0000,Breast Lobular Carcinoma,0.9569,Invasive Breast Lobular Carcinoma,0.9416,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9371,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9334
LOBULAR CARCINOMA,Breast Lobular Carcinoma,1,2,Breast Lobular Carcinoma,0.9944,Invasive Breast Lobular Carcinoma,0.9777,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9636,Breast Carcinoma,0.9589,Lobular,0.9565
LOBULAR CARCINOMA WITH DUCTAL FEATURES,Breast Mixed Ductal and Lobular Carcinoma,5,2,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9726,Breast Lobular Carcinoma,0.9699,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9693,Breast Ductal Carcinoma,0.9664,Breast Mixed Ductal and Lobular Carcinoma,0.9634
LOBULAR/DUCTAL,Breast Mixed Ductal and Lobular Carcinoma,5,2,Lobular,0.9759,Ductal,0.9628,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9569,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9553,Breast Mixed Ductal and Lobular Carcinoma,0.9548
LOCAL RECURRENCE,"Neoplasm Recurrence, Local",1,2,"Neoplasm Recurrence, Local",0.9650,Locally Recurrent Malignant Neoplasm,0.9596,Recurrence,0.9528,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9520,Regional<;>Recurrence,0.9516
LOCALIZED,Localized,1,2,Localized,1.0000,Local-Regional,0.9330,Limited Stage<;>Primary,0.9009,Lobular,0.8997,Brain<;>Site of Metastasis<;>Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,0.8990
LOCALLY ADVANCED,Locally Advanced Malignant Neoplasm,1,2,Locally Advanced Malignant Neoplasm,0.9485,Local-Regional,0.9264,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9120,Localized,0.9101,Anaplastic Lesion<;>Diffuse,0.9049
LOCOREGIONAL,Local-Regional,4,2,"Neoplasm Recurrence, Local",0.9267,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9229,Metastatic Lesion<;>Recurrent,0.9189,Local-Regional,0.9173,Metastatic Malignant Neoplasm in the Lymph Nodes<;>Recurrent,0.9148
LOCOREGIONAL & DISTANT,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",1,2,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9434,Distant Metastasis<;>Lung,0.9380,Distant Metastasis,0.9260,Distant,0.9236,Metastatic Lesion<;>Recurrent,0.9216
LOCOREGIONAL AND DISTANT RECURRENCE,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",1,2,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9628,Metastatic Lesion<;>Recurrent,0.9513,"Neoplasm Recurrence, Local",0.9487,Metastatic Malignant Neoplasm in the Lymph Nodes<;>Recurrent,0.9456,Regional<;>Recurrence,0.9429
LOCOREGIONAL RECURRENCE,Locally Recurrent Malignant Neoplasm,4,2,Recurrence,0.9495,Regional<;>Recurrence,0.9472,"Neoplasm Recurrence, Local",0.9463,Locally Recurrent Malignant Neoplasm,0.9438,Metastatic Lesion<;>Recurrent,0.9412
LOW GRADE FIBROMYXOID SARCOMA,Low Grade Fibromyxoid Sarcoma,1,2,Low Grade Fibromyxoid Sarcoma,1.0000,Low Grade Endometrioid Stromal Sarcoma,0.9535,Endometrioid Stromal Sarcoma<;>High Grade,0.9430,Low Grade Glioma<;>Low Grade Astrocytoma,0.9394,Low Grade Glioma,0.9392
LOW HYPODIPLOID,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,2,2,Hypodiploidy,0.9771,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.9538,Hyperdiploidy,0.9396,Cytogenetic Abnormality<;>Low Risk,0.9256,Low-CSD Melanoma,0.9152
LOW-GRADE ENDOMETRIAL STROMAL SARCOMA,Low Grade Endometrioid Stromal Sarcoma,1,2,Low Grade Endometrioid Stromal Sarcoma,0.9874,Endometrioid Stromal Sarcoma<;>High Grade,0.9782,Endometrioid Stromal Sarcoma,0.9638,Low Grade Fibromyxoid Sarcoma,0.9557,Ovarian Low Grade Serous Adenocarcinoma,0.9424
LOW-GRADE FIBROMYXOID SARCOMA,Low Grade Fibromyxoid Sarcoma,1,2,Low Grade Fibromyxoid Sarcoma,0.9986,Low Grade Endometrioid Stromal Sarcoma,0.9536,Endometrioid Stromal Sarcoma<;>High Grade,0.9461,Low Grade Glioma<;>Low Grade Astrocytoma,0.9417,Low Grade Glioma,0.9390
LOW-GRADE GLIOMA NOS,Low Grade Glioma,1,2,Low Grade Glioma,0.9727,Low Grade Glioma<;>Low Grade Astrocytoma,0.9669,Low Grade Glioma<;>IDH Gene Family Mutation,0.9596,Low Grade Glioma<;>IDH Family Wildtype,0.9576,Glioma,0.9515
"LOW-GRADE GLIOMA, NOS",Low Grade Glioma,1,2,Low Grade Glioma,0.9737,Low Grade Glioma<;>Low Grade Astrocytoma,0.9706,Low Grade Glioma<;>IDH Gene Family Mutation,0.9603,Low Grade Glioma<;>IDH Family Wildtype,0.9587,Low Grade Glioma<;>Pediatric,0.9547
LOW-GRADE GLIOMA/ASTROCYTOMA,Low Grade Glioma<;>Low Grade Astrocytoma,1,2,Low Grade Glioma<;>Low Grade Astrocytoma,0.9894,Low Grade Glioma,0.9876,Low Grade Glioma<;>IDH Family Wildtype,0.9670,Low Grade Glioma<;>Pediatric,0.9652,Low Grade Glioma<;>IDH Gene Family Mutation,0.9651
LOW-GRADE NEUROEPITHELIAL TUMOR,Polymorphous Low Grade Neuroepithelial Tumor of the Young,2,2,Neuroepithelial Neoplasm<;>High Grade,0.9770,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.9626,Neuroepithelial Neoplasm,0.9579,Low Grade Glioma,0.9489,High Grade<;>Small Cell Neuroendocrine Carcinoma<;>Small Cell Adenocarcinoma,0.9466
LOW-GRADE SEROUS OVARIAN CANCER,Ovarian Low Grade Serous Adenocarcinoma,1,2,Ovarian Low Grade Serous Adenocarcinoma,0.9910,Ovarian High Grade Serous Adenocarcinoma,0.9804,Serous Adenocarcinoma<;>High Grade,0.9709,Fallopian Tube High Grade Serous Adenocarcinoma,0.9668,Ovarian Serous Adenocarcinoma,0.9609
LOW_GRADE_SEROUS,Ovarian Low Grade Serous Adenocarcinoma,1,2,Ovarian Low Grade Serous Adenocarcinoma,0.9664,Serous Adenocarcinoma<;>High Grade,0.9609,Cystadenocarcinoma<;>High Grade<;>Serous,0.9556,Serous,0.9528,Ovarian High Grade Serous Adenocarcinoma,0.9523
LUAD,Lung Adenocarcinoma,99,2,Lung Lymphoepithelial Carcinoma,0.8950,Lung,0.8910,Linitis Plastica,0.8897,Leukapheresis,0.8880,Lobular,0.8879
LUMA,Luminal A Breast Carcinoma,99,2,Leiomyosarcoma,0.9077,Lobular,0.9032,Liposarcoma,0.9007,Linitis Plastica,0.8959,Benign Breast Phyllodes Tumor,0.8958
LUMB,Luminal B Breast Carcinoma,99,2,Leiomyosarcoma,0.9038,Benign Breast Phyllodes Tumor,0.8992,Liposarcoma,0.8961,Lobular,0.8948,Basal-Like Breast Carcinoma,0.8908
LUMINAL A,Luminal A Breast Carcinoma,1,2,Luminal A Breast Carcinoma,0.9598,Luminal B Breast Carcinoma,0.9469,Lobular,0.9182,Ductal,0.9139,Epithelial,0.9045
LUMINAL B,Luminal B Breast Carcinoma,1,2,Luminal B Breast Carcinoma,0.9634,Luminal A Breast Carcinoma,0.9571,Lobular,0.9148,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9112,B-Lymphocyte,0.9104
LUMINALA,Luminal A Breast Carcinoma,1,2,Luminal A Breast Carcinoma,0.9525,Luminal B Breast Carcinoma,0.9364,Lobular,0.9252,Ductal,0.9193,Epithelial,0.9085
LUMINALB,Luminal B Breast Carcinoma,2,2,Luminal A Breast Carcinoma,0.9568,Luminal B Breast Carcinoma,0.9502,Lobular,0.9229,Ductal,0.9153,Benign Breast Phyllodes Tumor,0.9110
LUNG,Lung,1,2,Lung,1.0000,fibroblast of lung,0.9485,Lung Adenocarcinoma,0.9357,Lung Lymphoepithelial Carcinoma,0.9286,Liver,0.9271
LUNG ACINAR ADENOCARCINOMA,Lung Acinar Adenocarcinoma,1,2,Lung Acinar Adenocarcinoma,1.0000,Prostate Acinar Adenocarcinoma,0.9730,Lung Adenocarcinoma,0.9698,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.9618,Acinar Cell Carcinoma,0.9578
LUNG ADENOCARCINOMA,Lung Adenocarcinoma,1,2,Lung Adenocarcinoma,1.0000,Adenocarcinoma,0.9760,Lung Acinar Adenocarcinoma,0.9698,Lung Carcinoma,0.9676,Breast Adenocarcinoma,0.9672
LUNG ADENOCARCINOMA IN SITU,Lung Adenocarcinoma In Situ,1,2,Lung Adenocarcinoma In Situ,1.0000,Lung Adenocarcinoma In Situ<;>Lung Non-Small Cell Carcinoma,0.9873,Cervical Adenocarcinoma In Situ,0.9707,Breast Ductal Carcinoma In Situ,0.9562,Lung Adenocarcinoma,0.9498
LUNG ADENOCARCINOMA MIXED SUBTYPE,"Lung Adenocarcinoma, Mixed Subtype",1,2,"Lung Adenocarcinoma, Mixed Subtype",0.9975,Mixed Cell Adenocarcinoma,0.9714,Lung Non-Mucinous Adenocarcinoma,0.9552,Malignant Mixed Tumor of the Salivary Gland<;>Lung Neoplasm,0.9530,Lung Adenocarcinoma,0.9524
LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED NOS,Lung Adenocarcinoma,99,2,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9666,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9608,Lung Adenocarcinoma In Situ<;>Lung Non-Small Cell Carcinoma,0.9596,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9590,"Lung Adenocarcinoma, Mixed Subtype",0.9589
LUNG ADENOSQUAMOUS CARCINOMA,Lung Adenosquamous Carcinoma,1,2,Lung Adenosquamous Carcinoma,1.0000,Adenosquamous Carcinoma,0.9886,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9796,Esophageal Adenosquamous Carcinoma,0.9778,Gastric Adenosquamous Carcinoma,0.9775
LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS,Lung Mucinous Adenocarcinoma,1,2,Lung Mucinous Adenocarcinoma,0.9740,Breast Mucinous Carcinoma,0.9661,Invasive Lung Mucinous Adenocarcinoma,0.9615,Lung Non-Mucinous Adenocarcinoma,0.9587,Mucinous Adenocarcinoma,0.9573
LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS,Lung Non-Mucinous Adenocarcinoma,4,2,Lung Non-Small Cell Carcinoma,0.9557,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9525,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.9524,Lung Non-Mucinous Adenocarcinoma,0.9522,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9487
LUNG CANCER,Lung Carcinoma,1,2,Lung Carcinoma,0.9714,Lung Adenocarcinoma,0.9607,Lung Squamous Cell Carcinoma,0.9551,Lung Sarcomatoid Carcinoma,0.9472,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9470
"LUNG CANCER, NOS",Lung Carcinoma,1,2,Lung Carcinoma,0.9511,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9501,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9495,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9488,Lung Non-Small Cell Carcinoma,0.9464
LUNG CARCINOID,Lung Carcinoid Tumor,1,2,Lung Carcinoid Tumor,0.9861,Lung Atypical Carcinoid Tumor,0.9616,Carcinosarcoma,0.9578,Carcinoid Tumor,0.9571,Uterine Carcinosarcoma,0.9496
LUNG MICROPAPILLARY ADENOCARCINOMA,Lung Micropapillary Adenocarcinoma,1,2,Lung Micropapillary Adenocarcinoma,1.0000,Lung Papillary Adenocarcinoma,0.9662,Lung Adenocarcinoma,0.9564,Lung Mucinous Adenocarcinoma,0.9528,Papillary Adenocarcinoma,0.9518
LUNG MUCINOUS ADENOCARCINOMA,Lung Colloid Adenocarcinoma,99,2,Lung Mucinous Adenocarcinoma,1.0000,Mucinous Adenocarcinoma,0.9778,Invasive Lung Mucinous Adenocarcinoma,0.9776,Lung Non-Mucinous Adenocarcinoma,0.9757,Colon Mucinous Adenocarcinoma,0.9685
LUNG NEUROENDOCRINE,Lung Carcinoid Tumor,2,2,Lung,0.9512,Lung Carcinoid Tumor,0.9386,Adenocarcinoma with Neuroendocrine Differentiation,0.9357,Pancreatic Neuroendocrine Tumor,0.9312,Neuroendocrine Tumor,0.9311
LUNG NEUROENDOCRINE TUMOR,Lung Carcinoid Tumor,2,2,Neuroendocrine Tumor,0.9750,Lung Carcinoid Tumor,0.9668,Pancreatic Neuroendocrine Tumor,0.9667,Pituitary Neuroendocrine Tumor,0.9648,Neuroendocrine Neoplasm,0.9642
LUNG PAPILLARY ADENOCARCINOMA,Lung Papillary Adenocarcinoma,1,2,Lung Papillary Adenocarcinoma,1.0000,Papillary Adenocarcinoma,0.9866,Gastric Papillary Adenocarcinoma,0.9680,Lung Micropapillary Adenocarcinoma,0.9662,Papillary Carcinoma,0.9647
LUNG SQUAMOUS CELL CARCINOMA,Lung Squamous Cell Carcinoma,1,2,Lung Squamous Cell Carcinoma,1.0000,Squamous Cell Carcinoma,0.9902,Laryngeal Squamous Cell Carcinoma,0.9811,Skin Squamous Cell Carcinoma,0.9785,Prostate Squamous Cell Carcinoma,0.9764
LUNG_CANCER,Lung Carcinoma,1,2,Lung Carcinoma,0.9685,Lung Adenocarcinoma,0.9603,Lung Squamous Cell Carcinoma,0.9517,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9500,Lung Sarcomatoid Carcinoma,0.9476
LUNG_CARCINOID,Lung Carcinoid Tumor,1,2,Lung Carcinoid Tumor,0.9771,Lung Atypical Carcinoid Tumor,0.9552,Carcinosarcoma,0.9464,Carcinoid Tumor,0.9445,Lung Adenocarcinoma,0.9396
LUNG_CARCINOMA,Lung Carcinoma,1,2,Lung Carcinoma,0.9932,Lung Adenocarcinoma,0.9677,Lung Squamous Cell Carcinoma,0.9669,Lung Large Cell Carcinoma,0.9653,Lung Pleomorphic Carcinoma,0.9647
LUNG_NSC,Lung Non-Small Cell Carcinoma,4,2,Lung,0.9570,fibroblast of lung,0.9334,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9287,Lung Non-Small Cell Carcinoma,0.9266,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9254
LUNG_SMALL_CELL,Lung Small Cell Carcinoma,1,2,Lung Small Cell Carcinoma,0.9722,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9633,Lung Non-Small Cell Carcinoma,0.9629,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9622,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9580
LUSC,Lung Squamous Cell Carcinoma,99,2,Lung Lymphoepithelial Carcinoma,0.9009,Linitis Plastica,0.8969,Lung,0.8936,Low-CSD Melanoma,0.8910,PML-RARA Fusion Protein Expression,0.8898
LYMPH NODE,Lymph Node,1,2,Lymph Node,1.0000,Esophageal Lymph Node,0.9426,Lung Lymphoepithelial Carcinoma,0.9301,Lymphoid,0.9300,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,0.9295
"LYMPHATIC CANCER, NOS",Lymphoma,99,2,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9297,Lung Lymphoepithelial Carcinoma,0.9287,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9282,Lymphocytic Neoplasm,0.9271,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9245
LYMPHOBLASTIC LYMPHOMA,Lymphoblastic Lymphoma,1,2,Lymphoblastic Lymphoma,1.0000,B Lymphoblastic Leukemia/Lymphoma,0.9711,T Lymphoblastic Leukemia/Lymphoma,0.9635,Chronic Lymphoblastic Lymphoma,0.9598,Acute Lymphoblastic Leukemia,0.9598
LYMPHOBLASTIC_LYMPHOMA,Lymphoblastic Lymphoma,1,2,Lymphoblastic Lymphoma,0.9945,B Lymphoblastic Leukemia/Lymphoma,0.9736,T Lymphoblastic Leukemia/Lymphoma,0.9676,Acute Lymphoblastic Leukemia,0.9591,Chronic Lymphoblastic Lymphoma,0.9578
LYMPHOEPITHELIOMA-LIKE CARCINOMA OF THE LUNG,Lung Lymphoepithelial Carcinoma,1,2,Lung Lymphoepithelial Carcinoma,0.9824,Lung Mucoepidermoid Carcinoma,0.9551,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.9483,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9411,Lung Adenoid Cystic Carcinoma,0.9399
LYMPHOID,Lymphoid,1,2,Lymphoid,1.0000,Hematopoietic and Lymphoid Cell Neoplasm,0.9411,Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,0.9333,Lymph Node,0.9300,Brain<;>Site of Metastasis<;>Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,0.9271
LYMPHOID CANCER,Lymphoma,99,2,Lymphoid,0.9561,Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,0.9504,Hematopoietic and Lymphoid Cell Neoplasm,0.9436,Lymphocytic Neoplasm,0.9419,Brain<;>Site of Metastasis<;>Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,0.9371
LYMPHOID NEOPLASM,Lymphocytic Neoplasm,1,2,Lymphocytic Neoplasm,0.9692,Hematopoietic and Lymphoid Cell Neoplasm,0.9661,Lymphoid,0.9553,B-Cell Neoplasm,0.9510,Lymphoma,0.9469
LYMPHOMA,Lymphoma,1,2,Lymphoma,1.0000,Hodgkin Lymphoma,0.9511,Immunoblastic Lymphoma,0.9472,B Lymphoblastic Leukemia/Lymphoma,0.9466,Non-Hodgkin Lymphoma,0.9459
LYMPHOMA_BURKITT,Burkitt Lymphoma,1,2,Burkitt Lymphoma,0.9844,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9717,Lymphoma,0.9529,B Lymphoblastic Leukemia/Lymphoma,0.9522,B-Cell Non-Hodgkin Lymphoma,0.9470
LYMPHOMA_DLBCL,Diffuse Large B-Cell Lymphoma,2,2,Lymphoma,0.9676,Diffuse Large B-Cell Lymphoma,0.9472,B-Cell Non-Hodgkin Lymphoma,0.9453,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9445,Hodgkin Lymphoma,0.9445
LYMPHOMA_HODGKIN,Hodgkin Lymphoma,1,2,Hodgkin Lymphoma,0.9825,Lymphoma,0.9672,Non-Hodgkin Lymphoma,0.9634,Classic Hodgkin Lymphoma,0.9559,B-Cell Non-Hodgkin Lymphoma,0.9516
LYMPHOMA_UNSPECIFIED,Lymphoma,3,2,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.9543,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.9442,Lymphoma,0.9385,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.9379,B-Cell Non-Hodgkin Lymphoma,0.9366
M0,Acute Myeloid Leukemia with Minimal Differentiation,99,2,Acute Monoblastic and Monocytic Leukemia,0.8912,"Astroblastoma, MN1-Altered",0.8872,Metastatic,0.8824,Melanoma of Unknown Primary,0.8813,"Diffuse Midline Glioma, H3 K27M-Mutant",0.8809
M1AUER,Acute Myeloid Leukemia without Maturation<;>Auer Rods Present,99,2,Acute Monoblastic and Monocytic Leukemia,0.9007,"Astroblastoma, MN1-Altered",0.8924,Unilateral,0.8915,Melanoma of Unknown Primary,0.8874,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.8842
M2,Acute Myeloid Leukemia with Maturation,99,2,"Diffuse Midline Glioma, H3 K27M-Mutant",0.8853,HER2-Positive Breast Carcinoma,0.8842,Metastatic,0.8840,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,0.8829,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.8826
M2AUER,Acute Myeloid Leukemia with Maturation<;>Auer Rods Present,99,2,"Astroblastoma, MN1-Altered",0.8974,Acute Monoblastic and Monocytic Leukemia,0.8920,Estrogen Receptor Positive<;>HER2/Neu Negative,0.8912,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.8912,Estrogen Receptor Negative<;>HER2/Neu Positive,0.8908
M3,Acute Promyelocytic Leukemia with PML-RARA,99,2,"Diffuse Midline Glioma, H3 K27M-Mutant",0.8854,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.8806,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.8806,Moderately Differentiated,0.8774,Thymoma Type B2<;>Thymoma Type B3,0.8771
M4,Acute Myelomonocytic Leukemia,99,2,Thymoma Type B3,0.8958,Thymoma Type B2<;>Thymoma Type B3,0.8820,Monoclonal Gammopathy of Undetermined Significance,0.8737,"Astrocytoma, IDH-Mutant, Grade 4",0.8734,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.8729
M4AUER,Acute Myelomonocytic Leukemia<;>Auer Rods Present,99,2,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.8839,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.8839,Thymoma Type B3,0.8813,"Astroblastoma, MN1-Altered",0.8811,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.8806
M5,Acute Monoblastic and Monocytic Leukemia,99,2,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.8883,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.8883,Melanoma,0.8864,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.8857,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.8857
M5A,Acute Monoblastic and Monocytic Leukemia,5,2,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.8909,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.8909,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.8892,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.8892,Acute Monoblastic and Monocytic Leukemia,0.8889
M6,Acute Erythroid Leukemia,99,2,Acute Monoblastic and Monocytic Leukemia,0.8895,"Astroblastoma, MN1-Altered",0.8870,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.8821,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.8821,Metastatic,0.8818
M7,Acute Megakaryoblastic Leukemia,99,2,"Astroblastoma, MN1-Altered",0.9002,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.8997,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.8997,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.8967,"Diffuse Midline Glioma, H3 K27M-Mutant",0.8958
M7DOWN,Acute Megakaryoblastic Leukemia<;>Down Syndrome,99,2,"Diffuse Midline Glioma, H3 K27M-Mutant",0.9027,Myelodysplastic Syndrome with Isolated del(5q),0.8902,"Astroblastoma, MN1-Altered",0.8884,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.8883,Myelodysplastic Syndrome with del(5q),0.8870
MALIGNANT AMELANOTIC MELANOMA,Amelanotic Melanoma,1,2,Amelanotic Melanoma,0.9832,Malignant Skin Neoplasm,0.9435,Malignant Myoepithelioma,0.9406,Melanoma,0.9377,Malignant Neoplasm,0.9368
MALIGNANT FIBROUS HISTIOCYTOMA,Undifferentiated Pleomorphic Sarcoma,99,2,Skin Fibrous Histiocytoma,0.9590,Malignant Bone Neoplasm,0.9559,Malignant Neoplasm,0.9520,Malignant Skin Neoplasm,0.9515,"Malignant Lymphoma, Histiocytic, Diffuse",0.9487
MALIGNANT FIBROUS HISTIOCYTOMA-PLEOMORPHIC SARCOMA,Undifferentiated Pleomorphic Sarcoma,99,2,Pleomorphic Rhabdomyosarcoma,0.9554,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.9553,Skin Fibrous Histiocytoma,0.9512,"Malignant Lymphoma, Histiocytic, Diffuse",0.9500,Histiocytic Sarcoma,0.9497
MALIGNANT LYMPHOMA,Lymphoma,99,2,Malignant Neoplasm,0.9667,Malignant Bone Neoplasm,0.9591,Malignant Skin Neoplasm,0.9578,Malignant Brain Neoplasm,0.9577,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9540
MALIGNANT MELANOMA,Melanoma,3,2,Malignant Skin Neoplasm,0.9619,Malignant Neoplasm,0.9577,Melanoma,0.9563,Malignant Myoepithelioma,0.9549,Malignant Bone Neoplasm,0.9483
MALIGNANT MELANOTIC MELANOMA,Melanoma,1,2,Melanoma,0.9487,Malignant Skin Neoplasm,0.9479,Melanotic Schwannoma,0.9444,Mucosal Melanoma,0.9404,Malignant Myoepithelioma,0.9399
MALIGNANT MIXED MULLERIAN TUMOR MMMT,Malignant Mixed Mesodermal (Mullerian) Tumor,1,2,Malignant Mixed Mesodermal (Mullerian) Tumor,0.9750,Malignant Mixed Mesodermal (Mullerian) Tumor<;>Carcinosarcoma<;>Yolk Sac Tumor,0.9497,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.9436,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9432,Malignant Ovarian Mucinous Tumor,0.9404
MALIGNANT PERIPHERAL NERVE SHEATH TUMOR,Malignant Peripheral Nerve Sheath Tumor,1,2,Malignant Peripheral Nerve Sheath Tumor,1.0000,Malignant Central Nervous System Neoplasm,0.9573,Nerve Sheath Neoplasm,0.9560,Malignant Skin Neoplasm,0.9498,Malignant Soft Tissue Neoplasm,0.9490
MALIGNANT PERIPHERAL NERVE SHEATH TUMORS MPNST,Malignant Peripheral Nerve Sheath Tumor,1,2,Malignant Peripheral Nerve Sheath Tumor,0.9886,Nerve Sheath Neoplasm,0.9496,Malignant Central Nervous System Neoplasm,0.9475,Malignant Skin Neoplasm,0.9449,Malignant Neoplasm,0.9447
MALIGNANT PHYLLODES TUMOR OF THE BREAST,Malignant Breast Phyllodes Tumor,1,2,Malignant Breast Phyllodes Tumor,0.9975,Benign Breast Phyllodes Tumor,0.9821,Phyllodes Tumor,0.9808,Borderline Breast Phyllodes Tumor,0.9752,Malignant Peritoneal Neoplasm,0.9449
MALIGNANT PT,Malignant Breast Phyllodes Tumor,99,2,Malignant Pleural Neoplasm,0.9510,Malignant Neoplasm,0.9510,Malignant Peritoneal Neoplasm,0.9508,Malignant PEComa,0.9455,Malignant Bone Neoplasm,0.9436
MALIGNANT RHABDOID TUMOR,Rhabdoid Tumor,1,2,Rhabdoid Tumor,0.9739,Malignant Neoplasm,0.9591,Malignant Bone Neoplasm,0.9544,Malignant Brain Neoplasm,0.9539,Malignant Myoepithelioma,0.9467
MALIGNANT SACROCOCCYGEAL TERATOMA,Sacrococcygeal Teratoma,1,2,Sacrococcygeal Teratoma,0.9769,Malignant Seminal Vesicle Neoplasm,0.9421,Teratoma,0.9419,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9404,Teratoma with Somatic-Type Malignancy,0.9397
MALIGNANT SMALL CELL TUMOR,"Malignant Tumor, Small Cell Type",1,2,"Malignant Tumor, Small Cell Type",0.9873,Small Cell Adenocarcinoma,0.9638,Lung Small Cell Carcinoma,0.9607,Small Cell Neuroendocrine Carcinoma,0.9583,Ovarian Small Cell Carcinoma,0.9576
MALIGNANT TUMOR,Malignant Neoplasm,1,2,Malignant Neoplasm,0.9814,Malignant Brain Neoplasm,0.9714,Malignant Bone Neoplasm,0.9708,Malignant Skin Neoplasm,0.9670,Malignant Ovarian Mucinous Tumor,0.9639
MALIGNANT_FIBROUS_HISTIOCYTOMA,Undifferentiated Pleomorphic Sarcoma,99,2,Skin Fibrous Histiocytoma,0.9589,"Malignant Lymphoma, Histiocytic, Diffuse",0.9528,Malignant Bone Neoplasm,0.9505,Malignant Skin Neoplasm,0.9499,Malignant Neoplasm,0.9488
MALIGNANT_MELANOMA,Melanoma,4,2,Malignant Skin Neoplasm,0.9605,Malignant Neoplasm,0.9555,Malignant Myoepithelioma,0.9549,Melanoma,0.9516,Malignant Mixed Mesodermal (Mullerian) Tumor,0.9457
MALIGNANT_PAPILLARY_SEROUS_ADENOCARCINOMA,Papillary Serous Cystadenocarcinoma,2,2,Papillary Adenocarcinoma,0.9656,Papillary Serous Cystadenocarcinoma,0.9650,Serous Adenocarcinoma,0.9602,Acinar Cell Carcinoma<;>Papillary,0.9575,Ovarian Serous Adenocarcinoma,0.9555
MALIGNANT_RHABDOID_TUMOR,Rhabdoid Tumor,1,2,Rhabdoid Tumor,0.9727,Malignant Neoplasm,0.9578,Malignant Brain Neoplasm,0.9531,Malignant Bone Neoplasm,0.9518,Rhabdoid Tumor<;>Extracranial,0.9479
MAMMARY ANALOGUE SECRETORY CARCINOMA OF SALIVARY GLAND ORIGIN,Salivary Gland Secretory Carcinoma,1,2,Salivary Gland Secretory Carcinoma,0.9698,Salivary Gland Carcinoma,0.9623,Breast Secretory Carcinoma,0.9612,Salivary Gland Adenocarcinoma,0.9588,Salivary Duct Carcinoma,0.9543
MANTLE CELL LYMPHOMA,Mantle Cell Lymphoma,1,2,Mantle Cell Lymphoma,1.0000,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.9749,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9364,Mature B-Cell Non-Hodgkin Lymphoma,0.9351,B-Cell Non-Hodgkin Lymphoma,0.9339
MANTLE_CELL_LYMPHOMA,Mantle Cell Lymphoma,1,2,Mantle Cell Lymphoma,0.9943,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.9786,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9447,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9427,B-Cell Non-Hodgkin Lymphoma,0.9416
MANUBRIUM,Manubrium,1,2,Manubrium,1.0000,Cribriform,0.9285,Cribriform<;>Solid,0.9020,Thyroid Gland Cribriform Morular Carcinoma,0.8975,Prostate Acinar Adenocarcinoma<;>Cribriform,0.8918
MARGINAL ZONE LYMPHOMA,Marginal Zone Lymphoma,1,2,Marginal Zone Lymphoma,1.0000,Nodal Marginal Zone Lymphoma,0.9839,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.9594,Mantle Cell Lymphoma,0.9287,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.9191
MASKED LOW HYPODIPLOID,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,3,2,Hypodiploidy,0.9509,Masked Near-Haploidy,0.9448,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.9324,Hyperdiploidy,0.9247,Cytogenetic Abnormality<;>Low Risk,0.9100
MASKED NEAR HAPLOID,Masked Near-Haploidy,1,2,Masked Near-Haploidy,0.9913,Near-Haploidy,0.9540,Hypodiploidy,0.9062,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.8980,Nonseminomatous<;>Yolk Sac Tumor,0.8947
MASTOCYTOSIS,Mastocytosis,1,2,Mastocytosis,1.0000,Systemic Mastocytosis,0.9570,Histiocytosis,0.9240,Melanoma,0.9199,Langerhans Cell Histiocytosis,0.9155
MATURE,Mature,1,2,Mature,1.0000,Mature Teratoma,0.9498,Mature B-Cell Neoplasm,0.9251,Seminoma<;>Mature Teratoma,0.9196,Mature B-Cell Non-Hodgkin Lymphoma,0.9188
MATURE B-CELL LYMPHOMA,Mature B-Cell Non-Hodgkin Lymphoma,2,2,Mature B-Cell Neoplasm,0.9857,Mature B-Cell Non-Hodgkin Lymphoma,0.9845,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9523,Mature T-Cell and NK-Cell Neoplasm,0.9496,B-Cell Neoplasm,0.9487
MATURE B-CELL NEOPLASMS,Mature B-Cell Neoplasm,1,2,Mature B-Cell Neoplasm,0.9983,Mature B-Cell Non-Hodgkin Lymphoma,0.9745,B-Cell Neoplasm,0.9701,Mature T-Cell and NK-Cell Neoplasm,0.9638,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9467
MATURE T AND NK NEOPLASMS,Mature T-Cell and NK-Cell Neoplasm,1,2,Mature T-Cell and NK-Cell Neoplasm,0.9947,Mature B-Cell Neoplasm,0.9574,Mature B-Cell Non-Hodgkin Lymphoma,0.9421,Adult T-Cell Leukemia/Lymphoma,0.9383,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.9343
MATURE TERATOMA,Mature Teratoma,1,2,Mature Teratoma,1.0000,Seminoma<;>Mature Teratoma,0.9666,Teratoma,0.9581,Immature Teratoma,0.9532,Mature,0.9498
MBL,Medulloblastoma,99,2,Monoclonal B-Cell Lymphocytosis,0.9131,Meningioma,0.9123,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9106,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.9073,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9067
MCRC METASTASIS,Metastatic Colorectal Carcinoma,2,2,Metastasis,0.9505,Metastatic Colorectal Carcinoma,0.9497,Metastatic Colorectal Carcinoma<;>Primary,0.9407,Metastatic,0.9366,Metastatic Lesion,0.9326
MCRC PRIMARY,Metastatic Colorectal Carcinoma<;>Primary,1,2,Metastatic Colorectal Carcinoma<;>Primary,0.9426,Primary,0.9336,Primary Myelofibrosis,0.9201,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9171,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9122
MDS,Myelodysplastic Syndrome,2,2,Myelodysplastic Syndrome with Multilineage Dysplasia,0.9242,Myelodysplastic Syndrome,0.9223,Myelodysplastic Syndrome with del(5q),0.9197,Myelodysplastic Syndrome with Isolated del(5q),0.9195,Myelodysplastic/Myeloproliferative Neoplasm,0.9189
MDS WITH EXCESS BLASTS,Myelodysplastic Syndrome with Excess Blasts,1,2,Myelodysplastic Syndrome with Excess Blasts,0.9790,Myelodysplastic Syndrome with Excess Blasts-1,0.9719,Myelodysplastic Syndrome with Excess Blasts-2,0.9704,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.9283,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.9267
MDS WITH EXCESS BLASTS-1,Myelodysplastic Syndrome with Excess Blasts-1,1,2,Myelodysplastic Syndrome with Excess Blasts-1,0.9841,Myelodysplastic Syndrome with Excess Blasts-2,0.9809,Myelodysplastic Syndrome with Excess Blasts,0.9744,Myelodysplastic Syndrome with Isolated del(5q),0.9384,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.9358
MDS WITH EXCESS BLASTS-2,Myelodysplastic Syndrome with Excess Blasts-2,1,2,Myelodysplastic Syndrome with Excess Blasts-2,0.9857,Myelodysplastic Syndrome with Excess Blasts-1,0.9805,Myelodysplastic Syndrome with Excess Blasts,0.9741,Myelodysplastic Syndrome with Isolated del(5q),0.9424,Myelodysplastic Syndrome with del(5q),0.9402
MDS WITH ISOLATED DEL5Q,Myelodysplastic Syndrome with Isolated del(5q),1,2,Myelodysplastic Syndrome with Isolated del(5q),0.9748,Myelodysplastic Syndrome with del(5q),0.9679,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.9284,Myelodysplastic Syndrome with Excess Blasts-2,0.9277,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.9268
MDS WITH MULTILINEAGE DYSPLASIA,Myelodysplastic Syndrome with Multilineage Dysplasia,1,2,Myelodysplastic Syndrome with Multilineage Dysplasia,0.9796,Acute Myeloid Leukemia with Multilineage Dysplasia,0.9673,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.9558,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.9555,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.9472
MDS WITH RING SIDEROBLASTS,Myelodysplastic Syndrome with Ring Sideroblasts,1,2,Myelodysplastic Syndrome with Ring Sideroblasts,0.9802,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.9720,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.9701,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.9663,Myelodysplastic Syndrome with Multilineage Dysplasia,0.9226
MDS WITH RING SIDEROBLASTS AND MULTILINEAGE DYSPLASIA,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,1,2,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.9854,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.9801,Myelodysplastic Syndrome with Ring Sideroblasts,0.9740,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.9640,Myelodysplastic Syndrome with Multilineage Dysplasia,0.9561
MDS WITH RING SIDEROBLASTS AND SINGLE LINEAGE DYSPLASIA,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1,2,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.9884,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.9801,Myelodysplastic Syndrome with Ring Sideroblasts,0.9746,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.9646,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.9594
MDS WITH SINGLE LINEAGE DYSPLASIA,Myelodysplastic Syndrome with Single Lineage Dysplasia,1,2,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.9814,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.9534,Myelodysplastic Syndrome with Multilineage Dysplasia,0.9492,Acute Myeloid Leukemia with Multilineage Dysplasia,0.9472,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.9346
"MDS, UNCLASSIFIABLE","Myelodysplastic Syndrome, Unclassifiable",1,2,"Myelodysplastic Syndrome, Unclassifiable",0.9720,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",0.9674,Unclassified,0.9449,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.9295,Myelodysplastic/Myeloproliferative Neoplasm,0.9283
MDS-U,"Myelodysplastic Syndrome, Unclassifiable",1,2,"Myelodysplastic Syndrome, Unclassifiable",0.9139,Myelodysplastic Syndrome with Isolated del(5q),0.9135,Myelodysplastic Syndrome with del(5q),0.9123,"Astrocytoma, IDH-Mutant, Grade 4",0.9066,"Astrocytoma, IDH-Mutant, Grade 2",0.9064
MDS/MPN WITH RING SIDEROBLASTS AND THROMBOCYTOSIS,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,1,2,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.9885,Myelodysplastic Syndrome with Ring Sideroblasts,0.9759,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.9725,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.9717,Myelodysplastic Syndrome with Excess Blasts-2,0.9365
"MDS/MPN, UNCLASSIFIABLE","Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",1,2,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",0.9780,"Myelodysplastic Syndrome, Unclassifiable",0.9773,Myelodysplastic/Myeloproliferative Neoplasm,0.9447,Unclassified,0.9357,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.9282
MDSMPN,Myelodysplastic/Myeloproliferative Neoplasm,3,2,Myelodysplastic Syndrome with Multilineage Dysplasia,0.9079,Myxoma,0.9032,Myelodysplastic/Myeloproliferative Neoplasm,0.9014,Myelodysplastic Syndrome,0.8994,Myelodysplastic Syndrome with Isolated del(5q),0.8993
MDSMPN DIAGNOSIS AT ACQUISITION,Myelodysplastic/Myeloproliferative Neoplasm,99,2,Myelodysplastic Syndrome with Multilineage Dysplasia,0.9259,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.9212,Myelodysplastic Syndrome with Isolated del(5q),0.9195,Myelodysplastic Syndrome with del(5q),0.9178,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.9169
MEDULLARY,"Medullary Carcinoma, Not Otherwise Specified",3,2,Medullary Carcinoma,0.9540,Breast Medullary Carcinoma,0.9434,"Medullary Carcinoma, Not Otherwise Specified",0.9411,Thyroid Gland Medullary Carcinoma,0.9369,Kidney Medullary Carcinoma,0.9363
MEDULLARY BREAST CARCINOMA,Breast Medullary Carcinoma,1,2,Breast Medullary Carcinoma,0.9989,Medullary Carcinoma,0.9879,Thyroid Gland Medullary Carcinoma,0.9721,Colon Medullary Carcinoma,0.9670,"Medullary Carcinoma, Not Otherwise Specified",0.9643
MEDULLARY CARCINOMA,"Medullary Carcinoma, Not Otherwise Specified",99,2,Medullary Carcinoma,1.0000,Breast Medullary Carcinoma,0.9854,Thyroid Gland Medullary Carcinoma,0.9783,Colon Medullary Carcinoma,0.9755,Kidney Medullary Carcinoma,0.9732
MEDULLARY CARCINOMA OF THE COLON,Colon Medullary Carcinoma,1,2,Colon Medullary Carcinoma,0.9955,Medullary Carcinoma,0.9830,Breast Medullary Carcinoma,0.9718,Kidney Medullary Carcinoma,0.9681,Thyroid Gland Medullary Carcinoma,0.9661
MEDULLARY THYROID CANCER,Thyroid Gland Medullary Carcinoma,1,2,Thyroid Gland Medullary Carcinoma,0.9882,Medullary Carcinoma,0.9746,Breast Medullary Carcinoma,0.9652,"Medullary Carcinoma, Not Otherwise Specified",0.9557,Thyroid Gland Carcinoma,0.9546
MEDULLARY THYROID CARCINOMA,Thyroid Gland Medullary Carcinoma,1,2,Thyroid Gland Medullary Carcinoma,0.9963,Medullary Carcinoma,0.9831,Breast Medullary Carcinoma,0.9722,Thyroid Gland Carcinoma,0.9651,"Medullary Carcinoma, Not Otherwise Specified",0.9608
MEDULLARY_CARCINOMA,Medullary Carcinoma,1,2,Medullary Carcinoma,0.9954,Breast Medullary Carcinoma,0.9831,Thyroid Gland Medullary Carcinoma,0.9765,Colon Medullary Carcinoma,0.9738,"Medullary Carcinoma, Not Otherwise Specified",0.9730
MEDULLA_CARCINOMA,Thyroid Gland Medullary Carcinoma,4,2,Medullary Carcinoma,0.9772,Breast Medullary Carcinoma,0.9691,Kidney Medullary Carcinoma,0.9662,Thyroid Gland Medullary Carcinoma,0.9615,"Medullary Carcinoma, Not Otherwise Specified",0.9611
MEDULLOBLASTOMA,Medulloblastoma,1,2,Medulloblastoma,1.0000,Anaplastic Medulloblastoma,0.9506,"Medulloblastoma, Non-WNT/Non-SHH, Group 3",0.9490,Large Cell/Anaplastic Medulloblastoma,0.9461,Desmoplastic/Nodular Medulloblastoma,0.9416
MED_GROUP_3,"Medulloblastoma, Non-WNT/Non-SHH, Group 3",1,2,"Medulloblastoma, Non-WNT/Non-SHH, Group 3",0.9228,"Astrocytoma, IDH-Mutant, Grade 3",0.9000,Chronic Myelomonocytic Leukemia-2,0.8993,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.8986,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.8986
MELANOMA,Melanoma,1,2,Melanoma,1.0000,Cutaneous Melanoma,0.9596,Mucosal Melanoma,0.9524,Ocular Melanoma,0.9475,Colon Carcinoma<;>Melanoma,0.9469
MELANOMA CUTANEOUS,Cutaneous Melanoma,1,2,Cutaneous Melanoma,0.9968,Melanoma,0.9705,Cutaneous Nodular Melanoma,0.9533,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9514,Melanoma Involvement of Regional Cutaneous or Subcutaneous Tissue,0.9502
MELANOMA MUCOSAL,Mucosal Melanoma,1,2,Mucosal Melanoma,0.9953,Mucosal Melanoma of the Head and Neck,0.9702,Melanoma,0.9612,Mucosal Melanoma<;>Anorectal,0.9527,Cutaneous Melanoma,0.9455
MELANOMA OF UNKNOWN PRIMARY,Melanoma of Unknown Primary,1,2,Melanoma of Unknown Primary,1.0000,Melanoma,0.9380,Primary Neoplasm<;>Unpaired,0.9310,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9306,Uveal Melanoma,0.9306
MELANOMA OTHER,Melanoma,1,2,Melanoma,0.9629,Melanoma of Unknown Primary,0.9332,Cutaneous Melanoma,0.9300,Ocular Melanoma,0.9286,Melanoma Involvement of Regional Cutaneous or Subcutaneous Tissue,0.9263
MELANOMA UVEAL,Uveal Melanoma,1,2,Uveal Melanoma,0.9949,Melanoma,0.9551,Ocular Melanoma,0.9528,Uveal Tract,0.9483,Cutaneous Melanoma,0.9385
"MELANOMA, AMELANOTIC",Amelanotic Melanoma,1,2,Amelanotic Melanoma,0.9878,Melanoma,0.9500,Mucosal Melanoma<;>Anorectal,0.9337,Ocular Melanoma,0.9314,Mucosal Melanoma of the Head and Neck,0.9312
MELANOTIC MELANOMA,Melanoma,2,2,Melanotic Schwannoma,0.9675,Melanoma,0.9503,Neurocutaneous Melanosis,0.9284,Mucosal Melanoma,0.9264,Cutaneous Melanoma,0.9245
MELANOTIC SCHWANNOMA,Melanotic Schwannoma,1,2,Melanotic Schwannoma,1.0000,Schwannoma,0.9431,Plexiform Schwannoma,0.9400,Neurocutaneous Melanosis,0.9324,Atypical Spindle Melanocyte<;>Epithelioid Melanocyte,0.9276
MENINGIOMA,Meningioma,1,2,Meningioma,1.0000,Anaplastic (Malignant) Meningioma,0.9474,Atypical Meningioma,0.9391,Craniopharyngioma,0.9335,Glioblastoma,0.9299
MENINGOTHELIAL TUMOR,Meningioma,2,2,Meningeal Solitary Fibrous Tumor,0.9404,Meningioma,0.9342,Malignant Brain Neoplasm,0.9300,Brain Neoplasm,0.9270,Merkel Cell Carcinoma,0.9255
MERKEL CELL CARCINOMA,Merkel Cell Carcinoma,1,2,Merkel Cell Carcinoma,1.0000,Urethral Squamous Cell Carcinoma,0.9357,Buccal Mucosa Squamous Cell Carcinoma,0.9333,Squamous Cell Carcinoma,0.9327,Head and Neck Squamous Cell Carcinoma,0.9320
MERKEL_CELL_CARCINOMA,Merkel Cell Carcinoma,1,2,Merkel Cell Carcinoma,0.9961,Urethral Squamous Cell Carcinoma,0.9334,Buccal Mucosa Squamous Cell Carcinoma,0.9318,Head and Neck Squamous Cell Carcinoma,0.9318,Squamous Cell Carcinoma,0.9315
MESENCHYMAL CHONDROSARCOMA,Mesenchymal Chondrosarcoma,1,2,Mesenchymal Chondrosarcoma,1.0000,Chondrosarcoma,0.9708,Chondroblastic Osteosarcoma,0.9536,Chondroblastoma,0.9481,Dedifferentiated Chondrosarcoma,0.9462
MESENCHYMAL NEOPLASM,Mesenchymal Cell Neoplasm,1,2,Mesenchymal Cell Neoplasm,0.9905,Malignant Neoplasm,0.9432,Neoplasm,0.9427,Mesenchymal Chondrosarcoma,0.9399,Malignant Soft Tissue Neoplasm,0.9362
MESO,Mesothelioma,99,2,Mesonephric Adenocarcinoma,0.9095,Mucinous,0.9059,Mucosal Melanoma<;>Anorectal,0.9020,Malignant Mixed Mesodermal (Mullerian) Tumor,0.8995,Mucosa,0.8971
MESONEPHRIC CARCINOMA,Mesonephric Adenocarcinoma,1,2,Mesonephric Adenocarcinoma,0.9865,Mucoepidermoid Carcinoma,0.9391,Neuroendocrine Carcinoma,0.9350,Breast Mucinous Carcinoma,0.9337,Lung Mucoepidermoid Carcinoma,0.9314
MESOTHELIOMA,Mesothelioma,1,2,Mesothelioma,1.0000,Pleural Mesothelioma,0.9769,Peritoneal Mesothelioma,0.9657,Testicular mesothelioma,0.9520,Pleural Sarcomatoid Mesothelioma,0.9454
MET,Metastatic,1,2,Metastatic,0.8946,Metastasis,0.8910,Brain<;>Site of Metastasis,0.8841,AML1-ETO Fusion Protein Expression,0.8840,Melanoma,0.8829
METAPLASIA,Metaplasia,1,2,Metaplasia,1.0000,Metaplastic,0.9494,Metaplastic Carcinoma,0.9441,Breast Carcinoma with Osseous Metaplasia,0.9316,Breast Metaplastic Carcinoma<;>Epithelial,0.9311
METAPLASTIC,Metaplastic,1,2,Metaplastic,1.0000,Metaplastic Carcinoma,0.9716,Breast Metaplastic Carcinoma,0.9561,Breast Metaplastic Carcinoma<;>Epithelial,0.9560,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.9526
METAPLASTIC BREAST CANCER,Breast Metaplastic Carcinoma,2,2,Metaplastic Carcinoma,0.9859,Breast Metaplastic Carcinoma,0.9848,Breast Metaplastic Carcinoma<;>Epithelial,0.9755,Metaplastic,0.9703,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.9668
METAPLASTIC CARCINOMA,Metaplastic Carcinoma,1,2,Metaplastic Carcinoma,1.0000,Breast Metaplastic Carcinoma,0.9865,Breast Metaplastic Carcinoma<;>Epithelial,0.9751,Metaplastic,0.9716,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.9649
METAPLASTIC_BREAST_CARCINOMA,Breast Metaplastic Carcinoma,1,2,Breast Metaplastic Carcinoma,0.9915,Metaplastic Carcinoma,0.9874,Breast Metaplastic Carcinoma<;>Epithelial,0.9858,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.9715,Metaplastic,0.9647
METAPLASTIC_CARCINOMA,Metaplastic Carcinoma,1,2,Metaplastic Carcinoma,0.9951,Breast Metaplastic Carcinoma,0.9840,Breast Metaplastic Carcinoma<;>Epithelial,0.9786,Metaplastic,0.9683,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.9651
METASTASIS,Metastasis,1,2,Metastasis,1.0000,Metastatic,0.9753,Metastatic Lesion,0.9686,Bone<;>Site of Metastasis,0.9554,Brain<;>Site of Metastasis,0.9541
METASTATIC,Metastatic,1,2,Metastatic,1.0000,Metastatic Lesion,0.9788,Metastasis,0.9753,Metastatic Colorectal Carcinoma,0.9608,Metastatic Ovarian Carcinoma,0.9590
METASTATIC CARCINOMA,Carcinoma,99,2,Metastatic Colorectal Carcinoma,0.9798,Metastatic,0.9757,Metastatic Ovarian Carcinoma,0.9755,Metastatic Lesion,0.9672,Metastatic Colorectal Carcinoma<;>Primary,0.9605
METASTATIC CASTRATION-RESISTANT,Castration-Resistant Prostate Carcinoma<;>Metastatic Prostate Carcinoma,1,2,Castration-Resistant Prostate Carcinoma<;>Metastatic Prostate Carcinoma,0.9735,Castration-Resistant Prostate Carcinoma,0.9686,Castration-Resistant Prostate Carcinoma<;>Non-Metastatic Prostate Carcinoma,0.9659,Castration-Resistant Prostate Carcinoma<;>Prostate Adenocarcinoma,0.9635,Castration-Resistant Prostate Carcinoma<;>Prostate Neuroendocrine Neoplasm,0.9526
METASTATIC DISEASE,Metastatic Lesion,2,2,Metastatic,0.9845,Metastatic Lesion,0.9799,Metastasis,0.9751,Metastatic Ovarian Carcinoma,0.9578,Metastatic Colorectal Carcinoma,0.9572
METASTATIC DISEASE CONFIRMED,Metastatic Lesion,1,2,Metastatic Lesion,0.9627,Metastatic,0.9617,Metastasis,0.9579,Metastatic Colorectal Carcinoma,0.9445,Metastatic Ovarian Carcinoma,0.9444
METASTATIC HORMONE-SENSITIVE,Castration-Sensitive Prostate Carcinoma,1,2,Castration-Sensitive Prostate Carcinoma,0.9433,Castration-Resistant Prostate Carcinoma<;>Metastatic Prostate Carcinoma,0.9421,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.9411,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9410,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.9402
METASTATIC SITE: BONE,Bone<;>Site of Metastasis,1,2,Bone<;>Site of Metastasis,0.9906,Brain<;>Site of Metastasis,0.9765,Bone<;>Site of Metastasis<;>Prostate Adenocarcinoma,0.9756,Metastatic Lesion,0.9602,Pleural Effusion<;>Site of Metastasis,0.9551
METASTATIC SITE: BRAIN,Brain<;>Site of Metastasis,1,2,Brain<;>Site of Metastasis,0.9915,Bone<;>Site of Metastasis,0.9718,Brain<;>Site of Metastasis<;>Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,0.9607,Metastatic Lesion,0.9582,Bone<;>Site of Metastasis<;>Prostate Adenocarcinoma,0.9537
METASTATIC SITE: PLEURAL EFFUSION,Pleural Effusion<;>Site of Metastasis,1,2,Pleural Effusion<;>Site of Metastasis,0.9935,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9851,Breast Ductal Carcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9813,Brain<;>Site of Metastasis,0.9495,Bone<;>Site of Metastasis,0.9474
"METASTATIC, VARIANT HISTOLOGY",Aggressive Variant Prostate Carcinoma,3,2,Metastatic,0.9507,Metastatic Lesion,0.9475,Aggressive Variant Prostate Carcinoma,0.9432,Metastatic Ovarian Carcinoma,0.9430,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9378
METASTATIC_OVARIAN_CANCER,Metastatic Ovarian Carcinoma,1,2,Metastatic Ovarian Carcinoma,0.9886,Metastatic,0.9579,Ovarian Carcinoma,0.9518,Ovarian Adenocarcinoma,0.9477,Metastatic Colorectal Carcinoma,0.9477
METATYPICAL,Skin Metatypical Carcinoma,1,2,Skin Metatypical Carcinoma,0.9413,Myelodysplastic/Myeloproliferative Neoplasm,0.9006,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.8980,Overt Primary Myelofibrosis,0.8976,Malignant Mixed Mesodermal (Mullerian) Tumor,0.8972
MGUS,Monoclonal Gammopathy of Undetermined Significance,1,2,Monoclonal Gammopathy of Undetermined Significance,0.9091,Malignant Glomus Tumor,0.9010,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.8961,Low Grade Glioma<;>IDH Gene Family Mutation,0.8926,Glioblastoma,0.8913
MICROPAPILLARY,Micropapillary Growth Pattern,1,2,Micropapillary Growth Pattern,0.9503,Micropapillary Growth Pattern<;>Solid,0.9448,Lung Micropapillary Adenocarcinoma,0.9440,Ductal<;>Micropapillary Growth Pattern,0.9425,Borderline Ovarian Serous Tumor-Micropapillary Variant,0.9248
MICROPAPILLARY ADENOCARCINOMA 82653,Lung Micropapillary Adenocarcinoma,1,2,Lung Micropapillary Adenocarcinoma,0.9674,Breast Adenocarcinoma,0.9375,Ductal<;>Micropapillary Growth Pattern,0.9369,Papillary Adenocarcinoma,0.9361,Pancreatic Ductal Adenocarcinoma,0.9354
MICROPAPILLARY/ SOLID,Micropapillary Growth Pattern<;>Solid,1,2,Micropapillary Growth Pattern<;>Solid,0.9662,Solid,0.9396,Micropapillary Growth Pattern,0.9325,Breast Solid Papillary Carcinoma,0.9319,Ductal<;>Micropapillary Growth Pattern,0.9316
"MINIMALLY INVASIVE ADENOCARCINOMA, NON-MUCINOUS 82502",Minimally Invasive Lung Non-Mucinous Adenocarcinoma,1,2,Minimally Invasive Lung Non-Mucinous Adenocarcinoma,0.9744,Minimally Invasive Lung Adenocarcinoma,0.9535,Invasive Lung Mucinous Adenocarcinoma,0.9521,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9500,Lung Non-Mucinous Adenocarcinoma,0.9487
MISCELLANEOUS BRAIN TUMOR,Brain Neoplasm,99,2,Malignant Brain Neoplasm,0.9235,"Medullary Carcinoma, Not Otherwise Specified",0.9203,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.9182,Malignant Central Nervous System Neoplasm,0.9170,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9170
MISCELLANEOUS NEUROEPITHELIAL TUMOR,Neuroepithelial Neoplasm,1,2,Neuroepithelial Neoplasm,0.9476,Neuroepithelial Neoplasm<;>High Grade,0.9413,Dysembryoplastic Neuroepithelial Tumor,0.9367,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.9256,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.9240
MIT FAMILY TRANSLOCATION RENAL CELL CARCINOMA,MiT Family Translocation-Associated Renal Cell Carcinoma,1,2,MiT Family Translocation-Associated Renal Cell Carcinoma,0.9939,Renal Cell Carcinoma,0.9337,Kidney Carcinoma,0.9308,Kidney Medullary Carcinoma,0.9293,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,0.9282
MIXED,Mixed,1,2,Mixed,1.0000,Mixed Carcinoma,0.9436,Mixed Cell Adenocarcinoma,0.9414,Mixed Germ Cell Tumor,0.9251,Cervical Carcinoma<;>Mixed,0.9188
MIXED 80% ALVEOLAR,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,99,2,"Lung Adenocarcinoma, Mixed Subtype",0.9341,Mixed Cell Adenocarcinoma,0.9312,Alveolar,0.9305,Mixed,0.9281,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.9208
MIXED ACINAR & DUCTAL,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,99,2,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9690,Breast Mixed Ductal and Lobular Carcinoma,0.9556,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.9504,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9467,Mixed Cell Adenocarcinoma,0.9461
MIXED ACINAR-DUCTAL CARCINOMA,Pancreatic Mixed Acinar-Ductal Carcinoma,1,2,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9914,Breast Mixed Ductal and Lobular Carcinoma,0.9766,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.9736,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9702,Mixed Carcinoma,0.9697
MIXED ACINAR-NEUROENDOCRINE CARCINOMA,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,1,2,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.9923,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9807,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9754,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9725,Mixed Carcinoma,0.9591
MIXED ADENOCARCINOMA AND NEUROENDOCRINE CARCINOMA,Digestive System Mixed Adenoneuroendocrine Carcinoma,99,2,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.9797,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9781,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9728,Adenocarcinoma with Neuroendocrine Differentiation,0.9696,Mixed Cell Adenocarcinoma,0.9642
MIXED CANCER TYPES,Mixed Carcinoma,1,2,Mixed Carcinoma,0.9734,Mixed Cell Adenocarcinoma,0.9656,Cervical Carcinoma<;>Mixed,0.9566,Endometrial Carcinoma<;>Mixed,0.9541,Mixed Germ Cell Tumor,0.9510
MIXED CARCINOMA,Mixed Carcinoma,1,2,Mixed Carcinoma,1.0000,Cervical Carcinoma<;>Mixed,0.9710,Mixed Cell Adenocarcinoma,0.9702,Endometrial Carcinoma<;>Mixed,0.9663,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.9620
MIXED CERVICAL CARCINOMA,Cervical Carcinoma<;>Mixed,1,2,Cervical Carcinoma<;>Mixed,0.9922,Mixed Carcinoma,0.9809,Endometrial Carcinoma<;>Mixed,0.9694,Mixed Cell Adenocarcinoma,0.9550,Breast Mixed Ductal and Lobular Carcinoma,0.9543
MIXED DUCTAL 65% AND ACINAR,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,99,2,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9603,Breast Mixed Ductal and Lobular Carcinoma,0.9496,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.9425,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9424,Mixed Cell Adenocarcinoma,0.9396
MIXED DUCTAL AND ACINAR,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,99,2,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9683,Breast Mixed Ductal and Lobular Carcinoma,0.9566,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.9491,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9455,Mixed Cell Adenocarcinoma,0.9454
MIXED DUCTAL AND ACINAR TYPE,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,99,2,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9668,Breast Mixed Ductal and Lobular Carcinoma,0.9555,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.9498,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9498,Mixed Cell Adenocarcinoma,0.9474
MIXED GERM CELL TUMOR,Mixed Germ Cell Tumor,1,2,Mixed Germ Cell Tumor,1.0000,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.9659,Germ Cell Tumor,0.9616,Mixed Carcinoma,0.9477,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,0.9469
MIXED INFILTRATING LOBULAR AND GRADE 1 DUCTAL CARCINOMA,Breast Mixed Ductal and Lobular Carcinoma,1,2,Breast Mixed Ductal and Lobular Carcinoma,0.9764,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9641,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9626,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9622,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.9554
MIXED INVASIVE DUCTAL AND INVASIVE LOBULAR,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,2,2,Breast Mixed Ductal and Lobular Carcinoma,0.9775,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9680,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9669,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9600,Invasive Breast Lobular Carcinoma,0.9535
MIXED OVARIAN CARCINOMA,ovary mixed epithelial carcinoma,1,2,ovary mixed epithelial carcinoma,0.9853,Mixed Carcinoma,0.9746,Endometrial Carcinoma<;>Mixed,0.9669,Cervical Carcinoma<;>Mixed,0.9658,Mixed Cell Adenocarcinoma,0.9573
"MIXED PHENOTYPE ACUTE LEUKAEMIA, B/MYELOID, NOS","Mixed Phenotype Acute Leukemia, B/Myeloid",1,2,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.9906,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.9892,"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",0.9854,Acute Myeloid Leukemia with Maturation,0.9548,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9530
"MIXED PHENOTYPE ACUTE LEUKAEMIA, T/MYELOID, NOS","Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",1,2,"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",0.9885,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.9851,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.9844,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9554,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9554
"MIXED PHENOTYPE ACUTE LEUKEMIA, B/MYELOID, NOS","Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",2,2,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.9963,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.9942,"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",0.9904,Acute Myeloid Leukemia with Maturation,0.9617,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9560
"MIXED PHENOTYPE ACUTE LEUKEMIA, T/MYELOID, NOS","Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",1,2,"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",0.9939,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.9908,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.9894,Acute Myeloid Leukemia with Maturation,0.9607,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9582
MIXED SEROUS AND ENDOMETRIOID,Endometrial Serous Adenocarcinoma,99,2,Endometrial Carcinoma<;>Mixed,0.9546,Mixed<;>Serous<;>Clear Cells,0.9508,Endometrial Clear Cell Adenocarcinoma<;>Mixed,0.9411,ovary mixed epithelial carcinoma,0.9409,Cervical Carcinoma<;>Mixed,0.9409
MIXED_ADENOSQUAMOUS_CARCINOMA,Adenosquamous Carcinoma,1,2,Adenosquamous Carcinoma,0.9713,Mixed Carcinoma,0.9680,Endometrial Carcinoma<;>Mixed,0.9671,Mixed Cell Adenocarcinoma,0.9650,Lung Adenosquamous Carcinoma,0.9649
MIXED_CARCINOMA,Mixed Carcinoma,1,2,Mixed Carcinoma,0.9938,Cervical Carcinoma<;>Mixed,0.9721,Endometrial Carcinoma<;>Mixed,0.9692,Mixed Cell Adenocarcinoma,0.9676,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.9637
MIXED_ENDOMETRIOID_CLEAR_CELL,Endometrial Clear Cell Adenocarcinoma<;>Mixed,1,2,Endometrial Clear Cell Adenocarcinoma<;>Mixed,0.9760,Mixed<;>Serous<;>Clear Cells,0.9681,Endometrial Carcinoma<;>Mixed,0.9600,Endometrial Clear Cell Adenocarcinoma,0.9481,Mixed Cell Adenocarcinoma,0.9475
MIXED_GERM_CELL,Mixed Germ Cell Tumor,1,2,Mixed Germ Cell Tumor,0.9706,Germ Cell,0.9479,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.9476,Mixed,0.9389,Mixed Cell Adenocarcinoma,0.9383
MIXED_SEROUS_CLEAR_CELL,Mixed<;>Serous<;>Clear Cells,1,2,Mixed<;>Serous<;>Clear Cells,0.9889,Endometrial Clear Cell Adenocarcinoma<;>Mixed,0.9586,Mixed Cell Adenocarcinoma,0.9494,Endometrial Carcinoma<;>Mixed,0.9417,Cervical Carcinoma<;>Mixed,0.9409
"MLL TRANSLOCATION, POOR RISK",MLL Gene Translocation<;>Low Risk,1,2,MLL Gene Translocation<;>Low Risk,0.9810,Cytogenetic Abnormality<;>Low Risk,0.9478,MLL Gene Translocation,0.9478,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9462,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9462
"MLL TRANSLOCATION, T9:11",MLL Gene Translocation,3,2,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9660,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9660,MLL Gene Translocation,0.9503,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.9485,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9374
"MLL TRANSLOCATION, T9;11",Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,2,2,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9668,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9668,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.9502,MLL Gene Translocation,0.9500,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9382
MLL-ALL,Acute Myeloid Leukemia with MLL Rearrangement,4,2,MLL Gene Translocation,0.9475,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9450,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9450,Acute Myeloid Leukemia with MLL Rearrangement,0.9414,MLL Gene Translocation<;>Low Risk,0.9402
MMMT,Malignant Mixed Mesodermal (Mullerian) Tumor,2,2,Melanoma,0.9118,Malignant Mixed Mesodermal (Mullerian) Tumor,0.9116,Mesothelioma,0.9089,Metastasis,0.9052,Mucosal Melanoma,0.8982
MODERATELY DIFFERENTIATED,Moderately Differentiated,1,2,Moderately Differentiated,1.0000,Moderately Differentiated Adenocarcinoma Cell,0.9530,Adenocarcinoma<;>Moderately Differentiated,0.9509,Well Differentiated,0.9416,Poorly Differentiated,0.9393
MODERATELY DIFFERENTIATED DUCTAL ADENOCARCINOMA 60% + NEUROENDOCRINE 40%,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,1,2,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9771,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9624,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.9578,Adenocarcinoma with Neuroendocrine Differentiation,0.9575,Adenocarcinoma<;>Moderately Differentiated,0.9564
MODERATELY DIFFERENTIATED TUBULAR ADENOCARCINOMA,Tubular Adenocarcinoma<;>Moderately Differentiated,1,2,Tubular Adenocarcinoma<;>Moderately Differentiated,0.9948,Tubular Adenocarcinoma<;>Well Differentiated Adenocarcinoma Cell,0.9782,Tubular Adenocarcinoma,0.9731,Adenocarcinoma<;>Moderately Differentiated,0.9665,Moderately Differentiated Adenocarcinoma Cell,0.9640
MONOCLONAL B-CELL LYMPHOCYTOSIS,Monoclonal B-Cell Lymphocytosis,1,2,Monoclonal B-Cell Lymphocytosis,1.0000,B-Lymphocyte,0.9506,B-Cell Neoplasm,0.9488,B Lymphoblastic Leukemia/Lymphoma,0.9453,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9448
MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA,Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma,1,2,Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma,1.0000,Angioimmunoblastic T-Cell Lymphoma,0.9412,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.9395,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9383,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9375
MORPHEAN,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,99,2,Malignant Mixed Mesodermal (Mullerian) Tumor,0.9039,Metaplasia,0.9037,Metaplastic,0.9000,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.8979,Malignant Mixed Mesodermal (Mullerian) Tumor<;>Carcinosarcoma<;>Yolk Sac Tumor,0.8972
MSI,Microsatellite Instability,1,2,Microsatellite Instability,0.9295,High-Frequency Microsatellite Instability,0.9256,Colon Adenocarcinoma<;>Microsatellite Instability,0.9238,Gastric Adenocarcinoma<;>Microsatellite Instability,0.9217,Rectal Adenocarcinoma<;>Microsatellite Instability,0.9201
MSI HYPER-MUTATED,Microsatellite Instability,99,2,High-Frequency Microsatellite Instability,0.9442,Colon Adenocarcinoma<;>Microsatellite Instability,0.9225,Colon Adenocarcinoma<;>POLE Gene Mutation,0.9217,Hypermutated Colorectal Carcinoma,0.9206,Esophageal Adenocarcinoma<;>Microsatellite Instability,0.9169
MSI-H,High-Frequency Microsatellite Instability,1,2,High-Frequency Microsatellite Instability,0.9312,Colon Adenocarcinoma<;>Microsatellite Instability,0.9290,Gastric Adenocarcinoma<;>Microsatellite Instability,0.9267,Esophageal Adenocarcinoma<;>Microsatellite Instability,0.9244,Microsatellite Instability,0.9239
MSS,Microsatellite Stable,99,2,Hypermutated Colorectal Carcinoma,0.8988,Myxoma,0.8969,Mucinous,0.8951,Metaplastic,0.8951,"Myelodysplastic Syndrome, Unclassifiable",0.8929
MUCINOUS,Mucinous,1,2,Mucinous,1.0000,Mucinous Adenocarcinoma,0.9658,Mucinous Cystadenocarcinoma,0.9550,Mucinous gastric carcinoma,0.9519,Colon Mucinous Adenocarcinoma,0.9512
MUCINOUS ADENOCARCINOMA LYMPH NODE,Mucinous Adenocarcinoma<;>Lymph Node,1,2,Mucinous Adenocarcinoma<;>Lymph Node,0.9945,Mucinous Adenocarcinoma,0.9544,Appendix Mucinous Adenocarcinoma,0.9508,Colon Mucinous Adenocarcinoma,0.9493,Lung Mucinous Adenocarcinoma,0.9493
MUCINOUS ADENOCARCINOMA OF ENDOCERVICAL TYPE,"Mucinous Adenocarcinoma, Endocervical Type",1,2,"Mucinous Adenocarcinoma, Endocervical Type",0.9983,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.9727,Mucinous Adenocarcinoma,0.9626,Colon Mucinous Adenocarcinoma,0.9581,Appendix Mucinous Adenocarcinoma,0.9517
MUCINOUS ADENOCARCINOMA OF THE APPENDIX,Appendix Mucinous Adenocarcinoma,1,2,Appendix Mucinous Adenocarcinoma,0.9943,Mucinous Adenocarcinoma,0.9823,Colon Mucinous Adenocarcinoma,0.9786,Gastric Mucinous Adenocarcinoma,0.9708,Appendix Adenocarcinoma,0.9691
MUCINOUS ADENOCARCINOMA OF THE COLON AND RECTUM,Rectal Mucinous Adenocarcinoma<;>Colon Mucinous Adenocarcinoma,3,2,Colon Mucinous Adenocarcinoma,0.9859,Rectal Mucinous Adenocarcinoma,0.9829,Rectal Mucinous Adenocarcinoma<;>Colon Mucinous Adenocarcinoma,0.9815,Mucinous Adenocarcinoma,0.9799,Appendix Mucinous Adenocarcinoma,0.9738
MUCINOUS CARCINOMA,Mucinous Adenocarcinoma,3,2,Breast Mucinous Carcinoma,0.9868,Mucinous gastric carcinoma,0.9811,Mucinous Adenocarcinoma,0.9797,Mucinous Cystadenocarcinoma,0.9682,Colon Mucinous Adenocarcinoma,0.9661
MUCINOUS COLLOID ADENOCARCINOMA,Gastric Mucinous Adenocarcinoma,99,2,Lung Colloid Adenocarcinoma,0.9663,Mucinous Adenocarcinoma,0.9663,Pancreatic Colloid Carcinoma,0.9589,Colon Mucinous Adenocarcinoma,0.9580,Appendix Mucinous Adenocarcinoma,0.9568
MUCINOUS CYSTADENOCARCINOMA,Mucinous Cystadenocarcinoma,1,2,Mucinous Cystadenocarcinoma,1.0000,Cystadenocarcinoma,0.9762,Serous Cystadenocarcinoma,0.9701,Pancreatic Mucinous-Cystic Neoplasm,0.9692,Breast Mucinous Carcinoma,0.9627
MUCINOUS CYSTIC NEOPLASM,Pancreatic Mucinous-Cystic Neoplasm,1,2,Pancreatic Mucinous-Cystic Neoplasm,0.9897,Mucinous Cystadenocarcinoma,0.9781,Malignant Ovarian Mucinous Tumor,0.9568,Mucinous gastric carcinoma,0.9564,Mucinous Adenocarcinoma,0.9562
MUCINOUS FEATURES,Mucinous,1,2,Mucinous,0.9542,Mucinous Adenocarcinoma,0.9368,Breast Mucinous Carcinoma,0.9294,"Mucinous Adenocarcinoma, Endocervical Type",0.9284,Mucinous Cystadenocarcinoma,0.9263
"MUCINOUS FEATURES, SIGNET RING FEATURES",Signet Ring Cell<;>Mucinous,1,2,Signet Ring Cell<;>Mucinous,0.9649,Rectal Signet Ring Cell Adenocarcinoma<;>Colon Signet Ring Cell Adenocarcinoma,0.9469,Pancreatic Signet Ring Cell Carcinoma,0.9465,Signet Ring Adenocarcinoma Cell,0.9434,Signet Ring Cell Carcinoma,0.9433
MUCINOUS FEATURES; SIGNET RING FEATURES,Signet Ring Cell<;>Mucinous,1,2,Signet Ring Cell<;>Mucinous,0.9668,Rectal Signet Ring Cell Adenocarcinoma<;>Colon Signet Ring Cell Adenocarcinoma,0.9480,Pancreatic Signet Ring Cell Carcinoma,0.9476,Signet Ring Cell Carcinoma,0.9449,Appendix Signet Ring Cell Carcinoma,0.9444
MUCINOUS LIPOSARCOMA,Liposarcoma<;>Mucinous,1,2,Liposarcoma<;>Mucinous,0.9871,Myxoid Liposarcoma,0.9519,Lung Mucinous Adenocarcinoma,0.9503,Breast Mucinous Carcinoma,0.9491,Liposarcoma,0.9488
MUCINOUS OVARIAN CANCER,Malignant Ovarian Mucinous Tumor,1,2,Malignant Ovarian Mucinous Tumor,0.9767,Mucinous Adenocarcinoma,0.9718,Breast Mucinous Carcinoma,0.9716,Mucinous gastric carcinoma,0.9707,Mucinous Cystadenocarcinoma,0.9638
MUCINOUS STOMACH ADENOCARCINOMA,Gastric Mucinous Adenocarcinoma,1,2,Gastric Mucinous Adenocarcinoma,0.9898,Mucinous Adenocarcinoma,0.9783,Mucinous gastric carcinoma,0.9753,Colon Mucinous Adenocarcinoma,0.9737,Appendix Mucinous Adenocarcinoma,0.9681
MUCINOUS_CARCINOMA,Mucinous Adenocarcinoma,2,2,Breast Mucinous Carcinoma,0.9839,Mucinous Adenocarcinoma,0.9784,Mucinous gastric carcinoma,0.9768,Mucinous Cystadenocarcinoma,0.9681,Colon Mucinous Adenocarcinoma,0.9664
MUCM,Mucosal Melanoma,3,2,Mucinous,0.9236,Mucosal Melanoma of the Head and Neck,0.9227,Mucosal Melanoma,0.9226,Lung Mucoepidermoid Carcinoma,0.9224,Mucoepidermoid Carcinoma,0.9223
MUCOEPIDERMOID CARCINOMA,Mucoepidermoid Carcinoma,1,2,Mucoepidermoid Carcinoma,1.0000,Lung Mucoepidermoid Carcinoma,0.9844,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.9570,Breast Mucinous Carcinoma,0.9441,Epithelial-Myoepithelial Carcinoma,0.9421
MUCOEPIDERMOID CARCINOMA OF THE LUNG,Lung Mucoepidermoid Carcinoma,1,2,Lung Mucoepidermoid Carcinoma,0.9929,Mucoepidermoid Carcinoma,0.9847,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.9746,Lung Lymphoepithelial Carcinoma,0.9568,Lung Mucinous Adenocarcinoma,0.9508
MUCOEPIDERMOID_CARCINOMA,Mucoepidermoid Carcinoma,1,2,Mucoepidermoid Carcinoma,0.9934,Lung Mucoepidermoid Carcinoma,0.9810,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.9606,Epithelial-Myoepithelial Carcinoma,0.9473,Breast Mucinous Carcinoma,0.9445
MUCOSAL,Mucosa,1,2,Mucosa,0.9777,Mucosal Melanoma,0.9589,Mucosal Melanoma of the Head and Neck,0.9458,Buccal Mucosa,0.9376,Mucosal Melanoma<;>Anorectal,0.9314
MUCOSAL MELANOMA OF THE ESOPHAGUS,Esophageal Melanoma,3,2,Mucosal Melanoma of the Head and Neck,0.9739,Mucosal Melanoma,0.9730,Esophageal Melanoma,0.9687,Mucosal Melanoma<;>Anorectal,0.9493,Melanoma,0.9474
MUCOSAL MELANOMA OF THE URETHRA,Urethral Melanoma,1,2,Urethral Melanoma,0.9752,Mucosal Melanoma of the Head and Neck,0.9662,Mucosal Melanoma,0.9655,Mucosal Melanoma<;>Anorectal,0.9439,Mucosa,0.9385
MUCOSAL MELANOMA OF THE VULVA/VAGINA,Vaginal Melanoma,1,2,Vaginal Melanoma,0.9679,Mucosal Melanoma of the Head and Neck,0.9672,Mucosal Melanoma,0.9615,Mucosal Melanoma<;>Anorectal,0.9475,Vulvar Carcinoma<;>Vaginal Carcinoma,0.9465
MULLERIAN CARCINOMA,Malignant Mixed Mesodermal (Mullerian) Tumor,99,2,Breast Mucinous Carcinoma,0.9440,Endometrial Carcinoma,0.9371,Breast Metaplastic Carcinoma,0.9357,Carcinoma,0.9348,Salivary Gland Carcinoma,0.9343
MULLERIAN CARCINOSARCOMA AND YOLK SAC TUMOR,Malignant Mixed Mesodermal (Mullerian) Tumor<;>Carcinosarcoma<;>Yolk Sac Tumor,1,2,Malignant Mixed Mesodermal (Mullerian) Tumor<;>Carcinosarcoma<;>Yolk Sac Tumor,0.9800,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9749,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9727,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9700,Yolk Sac Tumor,0.9623
MULLERIAN_CARCINOMA,Malignant Mixed Mesodermal (Mullerian) Tumor,99,2,Breast Mucinous Carcinoma,0.9435,Carcinoma,0.9419,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9391,Endometrial Carcinoma,0.9390,Breast Metaplastic Carcinoma<;>Epithelial,0.9383
MULTIPLE MYELOMA,Plasma Cell Myeloma,1,2,Plasma Cell Myeloma,0.9262,Smoldering Plasma Cell Myeloma,0.9171,Plasma Cell Myeloma<;>Plasmacytoma,0.9157,Malignant Mixed Mesodermal (Mullerian) Tumor,0.9128,Metastasis,0.9077
"MULTIPLE MYELOMA, PLASMACYTOMA",Plasma Cell Myeloma<;>Plasmacytoma,1,2,Plasma Cell Myeloma<;>Plasmacytoma,0.9677,Plasma Cell Myeloma,0.9653,Plasmacytoma,0.9605,Smoldering Plasma Cell Myeloma,0.9408,Plasma Cell Leukemia,0.9388
MULTIPLE_MYELOMA,Plasma Cell Myeloma,1,2,Plasma Cell Myeloma,0.9321,Smoldering Plasma Cell Myeloma,0.9291,Plasma Cell Myeloma<;>Plasmacytoma,0.9274,Malignant Mixed Mesodermal (Mullerian) Tumor,0.9224,Monoclonal Gammopathy of Undetermined Significance,0.9197
MUSCLE,Muscle,1,2,Muscle,1.0000,Melanoma Involvement of Regional Cutaneous or Subcutaneous Tissue,0.9079,Lung,0.9033,Rhabdomyosarcoma,0.9027,Skin,0.9027
MUSCLE INVASIVE UROTHELIAL CARCINOMA PT2 OR ABOVE,Infiltrating Urothelial Carcinoma,1,2,Infiltrating Urothelial Carcinoma,0.9495,Urothelial Carcinoma,0.9474,Bladder Urothelial Carcinoma,0.9462,upper tract urothelial carcinoma,0.9454,infiltrating bladder urothelial carcinoma sarcomatoid variant,0.9444
MYCOSIS FUNGOIDES,Mycosis Fungoides,1,2,Mycosis Fungoides,1.0000,Mycosis Fungoides and Sezary Syndrome,0.9477,Skin Metatypical Carcinoma,0.9164,Malignant Skin Neoplasm,0.9152,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9143
MYCOSIS_FUNGOIDES,Mycosis Fungoides,1,2,Mycosis Fungoides,0.9918,Mycosis Fungoides and Sezary Syndrome,0.9440,Malignant Skin Neoplasm,0.9126,Skin Metatypical Carcinoma,0.9120,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9109
MYCOSIS_FUNGOIDES-SEZARY_SYNDROME,Mycosis Fungoides and Sezary Syndrome,1,2,Mycosis Fungoides and Sezary Syndrome,0.9937,Sezary Syndrome,0.9616,Mycosis Fungoides,0.9565,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9173,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9147
MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL(5Q),Myelodysplastic Syndrome with del(5q),2,2,Myelodysplastic Syndrome with Isolated del(5q),0.9964,Myelodysplastic Syndrome with del(5q),0.9922,Myelodysplastic Syndrome with Excess Blasts-2,0.9591,Myelodysplastic Syndrome,0.9588,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9584
MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL5Q,Myelodysplastic Syndrome with Isolated del(5q),1,2,Myelodysplastic Syndrome with Isolated del(5q),0.9887,Myelodysplastic Syndrome with del(5q),0.9841,Myelodysplastic Syndrome,0.9533,Myelodysplastic Syndrome with Excess Blasts-2,0.9517,Myeloid Leukemia Associated with Down Syndrome,0.9517
"MYELODYSPLASTIC SYNDROME, UNCLASSIFIABLE","Myelodysplastic Syndrome, Unclassifiable",1,2,"Myelodysplastic Syndrome, Unclassifiable",1.0000,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",0.9894,Myelodysplastic/Myeloproliferative Neoplasm,0.9603,Myelodysplastic Syndrome,0.9590,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9512
MYELODYSPLASTIC SYNDROMES,Myelodysplastic Syndrome,1,2,Myelodysplastic Syndrome,0.9955,Myelodysplastic/Myeloproliferative Neoplasm,0.9720,Myelodysplastic Syndrome with Multilineage Dysplasia,0.9714,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9677,Therapy-Related Myelodysplastic Syndrome,0.9644
"MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE","Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",1,2,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",1.0000,"Myelodysplastic Syndrome, Unclassifiable",0.9894,Myelodysplastic/Myeloproliferative Neoplasm,0.9738,Myeloproliferative Neoplasm,0.9563,Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,0.9493
MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS,Myelodysplastic/Myeloproliferative Neoplasm,1,2,Myelodysplastic/Myeloproliferative Neoplasm,0.9987,Myeloproliferative Neoplasm,0.9798,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",0.9724,Myelodysplastic Syndrome,0.9719,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9621
MYELOID ATYPICAL,Atypical Chronic Myeloid Leukemia,1,2,Atypical Chronic Myeloid Leukemia,0.9661,Myeloid Neoplasm,0.9449,Acute Myeloid Leukemia,0.9366,"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",0.9358,Atypical Meningioma,0.9342
MYELOID LEUKAEMIA ASSOCIATED WITH DOWN SYNDROME,Myeloid Leukemia Associated with Down Syndrome,1,2,Myeloid Leukemia Associated with Down Syndrome,0.9925,Acute Megakaryoblastic Leukemia<;>Down Syndrome,0.9584,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9498,Myelodysplastic Syndrome,0.9442,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.9441
MYELOID LEUKEMIA ASSOCIATED WITH DOWN SYNDROME,Myeloid Leukemia Associated with Down Syndrome,1,2,Myeloid Leukemia Associated with Down Syndrome,1.0000,Acute Megakaryoblastic Leukemia<;>Down Syndrome,0.9651,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9557,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.9504,Myelodysplastic Syndrome,0.9486
MYELOID NEOPLASM,Myeloid Neoplasm,1,2,Myeloid Neoplasm,1.0000,Myeloid Sarcoma,0.9720,Myeloproliferative Neoplasm,0.9619,Therapy-Related Myeloid Neoplasm,0.9562,Myelodysplastic/Myeloproliferative Neoplasm,0.9552
MYELOID SARCOMA,Myeloid Sarcoma,1,2,Myeloid Sarcoma,1.0000,Myeloid Neoplasm,0.9720,Sarcoma,0.9492,Acute Myeloid Leukemia,0.9458,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.9429
MYELOMA,Plasma Cell Myeloma,1,2,Plasma Cell Myeloma,0.9544,Plasma Cell Myeloma<;>Plasmacytoma,0.9465,Smoldering Plasma Cell Myeloma,0.9324,Plasmacytoma,0.9305,Monoclonal Gammopathy of Undetermined Significance,0.9243
MYELOPROLIFERATIVE NEOPLASMS,Myeloproliferative Neoplasm,1,2,Myeloproliferative Neoplasm,0.9984,Myelodysplastic/Myeloproliferative Neoplasm,0.9802,Myeloid Neoplasm,0.9613,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",0.9565,Chronic Myelomonocytic Leukemia,0.9453
MYOEPITHELIAL CARCINOMA,Malignant Myoepithelioma,2,2,Epithelial-Myoepithelial Carcinoma,0.9786,Malignant Myoepithelioma,0.9557,Mucoepidermoid Carcinoma,0.9408,Breast Metaplastic Carcinoma<;>Epithelial,0.9351,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.9332
MYOFIBROMA,Myofibroma,1,2,Myofibroma,1.0000,Infantile Myofibroma,0.9479,Inflammatory Myofibroblastic Tumor,0.9419,Lung Inflammatory Myofibroblastic Tumor,0.9416,Chondroblastoma,0.9262
MYXOFIBROSARCOMA,Myxofibrosarcoma,1,2,Myxofibrosarcoma,1.0000,Myxoid Liposarcoma,0.9614,Myxoma,0.9534,Myxoinflammatory Fibroblastic Sarcoma,0.9503,Leiomyosarcoma,0.9426
MYXOID CHONDROSARCOMA,Extraskeletal Myxoid Chondrosarcoma,1,2,Extraskeletal Myxoid Chondrosarcoma,0.9610,Chondrosarcoma,0.9610,Myxoid Liposarcoma,0.9587,Mesenchymal Chondrosarcoma,0.9514,Myxoma,0.9497
MYXOID FIBROSARCOMA,Myxofibrosarcoma,1,2,Myxofibrosarcoma,0.9653,Myxoinflammatory Fibroblastic Sarcoma,0.9635,Fibrosarcoma,0.9630,Myxoma,0.9568,Myxoid Liposarcoma,0.9546
MYXOID LIPOSARCOMA,Myxoid Liposarcoma,1,2,Myxoid Liposarcoma,1.0000,myxoid/round cell liposarcoma,0.9659,Myxofibrosarcoma,0.9614,Liposarcoma,0.9581,Myxoma,0.9556
MYXOID/ROUND-CELL LIPOSARCOMA,myxoid/round cell liposarcoma,1,2,myxoid/round cell liposarcoma,0.9992,Myxoid Liposarcoma,0.9661,Round Cell Sarcoma,0.9517,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.9453,Liposarcoma,0.9453
MYXOINFLAMMATORY FIBROBLASTIC SARCOMA,Myxoinflammatory Fibroblastic Sarcoma,1,2,Myxoinflammatory Fibroblastic Sarcoma,1.0000,Myxofibrosarcoma,0.9503,Skin Fibroblastic Neoplasm,0.9484,Myxoid Liposarcoma,0.9443,Fibroblastic Osteosarcoma,0.9434
MYXOMA,Myxoma,1,2,Myxoma,1.0000,Myxoid Liposarcoma,0.9556,Myxofibrosarcoma,0.9534,Myxopapillary Ependymoma,0.9481,myxoid/round cell liposarcoma,0.9378
MYXOPAPILLARY EPENDYMOMA,Myxopapillary Ependymoma,1,2,Myxopapillary Ependymoma,1.0000,Ependymoma,0.9589,Myxoma,0.9481,Ependymal Tumor,0.9469,Myxofibrosarcoma,0.9334
NASOPHARYNGEAL CARCINOMA,Nasopharyngeal Carcinoma,1,2,Nasopharyngeal Carcinoma,1.0000,Nasopharyngeal-Type Undifferentiated Carcinoma,0.9529,Head and Neck Carcinoma,0.9520,Neuroendocrine Carcinoma,0.9506,Pharyngeal Squamous Cell Carcinoma,0.9502
NATURAL KILLER CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,1,2,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,1.0000,B Lymphoblastic Leukemia/Lymphoma,0.9560,T Lymphoblastic Leukemia/Lymphoma,0.9539,Lymphoblastic Lymphoma,0.9470,Mature T-Cell and NK-Cell Neoplasm,0.9453
NATURAL KILLER NK CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,1,2,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.9964,Mature T-Cell and NK-Cell Neoplasm,0.9509,B Lymphoblastic Leukemia/Lymphoma,0.9498,T Lymphoblastic Leukemia/Lymphoma,0.9482,Hematopoietic and Lymphoid Cell Neoplasm,0.9409
NBL,Neuroblastoma,1,2,Neuroblastoma,0.9155,Blue Nevus,0.9060,Neurofibroma,0.9040,Olfactory Neuroblastoma,0.9023,Nephroblastomatosis,0.8983
NBNC,"Non-B, Non-C Hepatitis",99,2,Neuroblastoma,0.9169,Olfactory Neuroblastoma,0.9026,Neurofibroma,0.9022,Blue Nevus,0.8994,Central Nervous System<;>Brain,0.8921
NEAR HAPLOID,Near-Haploidy,1,2,Near-Haploidy,0.9924,Masked Near-Haploidy,0.9594,Hypodiploidy,0.9150,Diploidy,0.9107,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.9071
NEPHROBLASTOMATOSIS,Nephroblastomatosis,1,2,Nephroblastomatosis,1.0000,"Ganglioneuroblastoma, Nodular",0.9290,Ganglioneuroblastoma,0.9270,Kidney Angiomyolipoma,0.9216,Kidney Carcinoma,0.9173
NERVE SHEATH TUMOR,Nerve Sheath Neoplasm,1,2,Nerve Sheath Neoplasm,0.9858,Malignant Peripheral Nerve Sheath Tumor,0.9586,Schwannoma,0.9478,Neuroepithelial Neoplasm,0.9274,Plexiform Schwannoma,0.9270
NESTED STROMAL EPITHELIAL TUMOR OF THE LIVER,Calcifying Nested Stromal-Epithelial Tumor of the Liver,1,2,Calcifying Nested Stromal-Epithelial Tumor of the Liver,0.9799,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9298,Liver and Intrahepatic Bile Duct Neoplasm,0.9295,Lung Inflammatory Myofibroblastic Tumor,0.9293,ovary mixed epithelial carcinoma,0.9290
NEUROBLASTOMA,Neuroblastoma,1,2,Neuroblastoma,1.0000,Olfactory Neuroblastoma,0.9632,Neurofibroma,0.9313,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9203,"Ganglioneuroblastoma, Nodular",0.9180
NEUROBLASTOMA,Neuroblastoma,1,2,Neuroblastoma,0.9840,Olfactory Neuroblastoma,0.9508,Neurofibroma,0.9273,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9236,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.9235
NEUROCUTANEOUS MELANOCYTOSIS,Neurocutaneous Melanosis,1,2,Neurocutaneous Melanosis,0.9941,Cutaneous Nodular Melanoma,0.9334,Melanotic Schwannoma,0.9322,Central Nervous System Melanoma,0.9300,Cutaneous Melanoma,0.9281
NEUROENDOCRINE,Neuroendocrine Neoplasm,2,2,Neuroendocrine Tumor,0.9592,Neuroendocrine Neoplasm,0.9544,Pituitary Neuroendocrine Tumor,0.9493,Pancreatic Neuroendocrine Tumor,0.9486,Neuroendocrine Carcinoma,0.9481
NEUROENDOCRINE CARCINOMA,Neuroendocrine Carcinoma,1,2,Neuroendocrine Carcinoma,1.0000,Neuroendocrine Tumor,0.9780,Prostate Neuroendocrine Carcinoma,0.9770,Colorectal Neuroendocrine Carcinoma,0.9762,Neuroendocrine Neoplasm,0.9760
NEUROENDOCRINE CARCINOMA NOS,Neuroendocrine Carcinoma,1,2,Neuroendocrine Carcinoma,0.9817,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.9649,Endometrial Neuroendocrine Carcinoma,0.9622,Head and Neck Neuroendocrine Carcinoma,0.9622,Neuroendocrine Neoplasm,0.9616
"NEUROENDOCRINE CARCINOMA, NOS",Neuroendocrine Carcinoma,1,2,Neuroendocrine Carcinoma,0.9796,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.9671,Neuroendocrine Neoplasm,0.9633,Head and Neck Neuroendocrine Carcinoma,0.9629,Endometrial Neuroendocrine Carcinoma,0.9627
NEUROENDOCRINE TUMOR,Neuroendocrine Tumor,1,2,Neuroendocrine Tumor,1.0000,Neuroendocrine Neoplasm,0.9850,Pancreatic Neuroendocrine Tumor,0.9799,Neuroendocrine Carcinoma,0.9780,Pituitary Neuroendocrine Tumor,0.9763
"NEUROENDOCRINE TUMOR, NOS",Neuroendocrine Tumor,1,2,Neuroendocrine Tumor,0.9729,Neuroendocrine Neoplasm,0.9665,Neuroendocrine Carcinoma,0.9618,Appendix Neuroendocrine Tumor,0.9614,Pituitary Neuroendocrine Tumor,0.9574
NEUROEPITHELIAL TUMOR,Neuroepithelial Neoplasm,1,2,Neuroepithelial Neoplasm,0.9867,Neuroepithelial Neoplasm<;>High Grade,0.9645,Dysembryoplastic Neuroepithelial Tumor,0.9606,Primitive Neuroectodermal Tumor,0.9428,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.9377
NEUROEPITHELIOMA,Primitive Neuroectodermal Tumor,99,2,Neuroepithelial Neoplasm,0.9569,Neuroepithelial Neoplasm<;>High Grade,0.9389,Malignant Myoepithelioma,0.9286,Central Nervous System Medulloepithelioma,0.9275,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.9269
NEUROFIBROMA,Neurofibroma,1,2,Neurofibroma,1.0000,Plexiform Neurofibroma,0.9542,Neuroblastoma,0.9313,Schwannoma,0.9259,Plexiform Schwannoma,0.9246
NEUROTROPIC,Desmoplastic Neurotropic Melanoma,1,2,Desmoplastic Neurotropic Melanoma,0.9411,Extraventricular Neurocytoma,0.9133,Peripheral Nervous System,0.9021,Malignant Peripheral Nerve Sheath Tumor,0.9017,Central Nervous System<;>Brain,0.9016
NHL,Non-Hodgkin Lymphoma,1,2,Non-Hodgkin Lymphoma,0.9379,B-Cell Non-Hodgkin Lymphoma,0.9328,Lymphoma,0.9318,Hodgkin Lymphoma,0.9299,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9261
NKC,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,2,2,Mature T-Cell and NK-Cell Neoplasm,0.9271,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.9186,NTRK-Rearranged Spindle Cell Neoplasm,0.9020,Blue Nevus,0.8993,nan,0.8945
NODAL MARGINAL ZONE LYMPHOMA,Nodal Marginal Zone Lymphoma,1,2,Nodal Marginal Zone Lymphoma,1.0000,Marginal Zone Lymphoma,0.9839,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.9597,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9213,Mature B-Cell Non-Hodgkin Lymphoma,0.9207
NODAL PERIPHERAL T-CELL LYMPHOMA WITH TFH PHENOTYPE,Follicular Helper T-Cell Lymphoma,3,2,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.9533,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9504,Follicular Helper T-Cell Lymphoma,0.9492,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9473,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9471
NODULAR,Nodular Neoplasm,1,2,Nodular Neoplasm,0.9726,Cutaneous Nodular Melanoma,0.9586,"Ganglioneuroblastoma, Nodular",0.9358,Desmoplastic/Nodular Medulloblastoma,0.9348,Nodal Marginal Zone Lymphoma,0.9046
NON AML MDSMPN DIAGNOSIS AT ACQUISITION,Myelodysplastic/Myeloproliferative Neoplasm,99,2,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.9389,"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",0.9378,Acute Myeloid Leukemia with Multilineage Dysplasia,0.9354,Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,0.9329,Acute Myeloid Leukemia Not Otherwise Specified,0.9326
NON SMALL CELL LUNG CANCER,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.9898,Non-Small Cell Carcinoma,0.9856,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9791,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9764,Lung Small Cell Carcinoma,0.9719
NON SMALL CELL LUNG CANCER OTHER,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.9815,Non-Small Cell Carcinoma,0.9778,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9755,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9736,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9678
NON-GERMINOMATOUS GERM CELL TUMOR,Nongerminomatous Germ Cell Tumor,2,2,Testicular Non-Seminomatous Germ Cell Tumor,0.9778,Nongerminomatous Germ Cell Tumor,0.9727,Nongerminomatous Germ Cell Tumor<;>Yolk Sac Tumor,0.9685,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.9682,Extragonadal Germ Cell Tumor,0.9641
NON-GLABROUS SKIN,Non-Glabrous Skin,1,2,Non-Glabrous Skin,1.0000,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9169,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9151,B-Cell Non-Hodgkin Lymphoma,0.9117,Non-Hodgkin Lymphoma,0.9112
NON-HODGKIN LYMPHOMA,Non-Hodgkin Lymphoma,1,2,Non-Hodgkin Lymphoma,1.0000,B-Cell Non-Hodgkin Lymphoma,0.9827,T-Cell Non-Hodgkin Lymphoma,0.9724,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9637,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9620
NON-HODGKINS LYMPHOMA,Non-Hodgkin Lymphoma,1,2,Non-Hodgkin Lymphoma,0.9990,B-Cell Non-Hodgkin Lymphoma,0.9815,T-Cell Non-Hodgkin Lymphoma,0.9717,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9621,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9605
NON-METASTATIC CASTRATION-RESISTANT,Castration-Resistant Prostate Carcinoma<;>Non-Metastatic Prostate Carcinoma,1,2,Castration-Resistant Prostate Carcinoma<;>Non-Metastatic Prostate Carcinoma,0.9767,Castration-Resistant Prostate Carcinoma<;>Metastatic Prostate Carcinoma,0.9671,Castration-Resistant Prostate Carcinoma,0.9582,Castration-Resistant Prostate Carcinoma<;>Prostate Adenocarcinoma,0.9579,Castration-Resistant Prostate Carcinoma<;>Prostate Neuroendocrine Neoplasm,0.9523
NON-PAPILLARY,Non-Papillary Pattern,1,2,Non-Papillary Pattern,0.9782,Papillary,0.9612,Papillary Carcinoma,0.9303,Acinar Cell Carcinoma<;>Papillary,0.9277,Papillary Renal Cell Carcinoma,0.9276
NON-SEMINOMA,Nongerminomatous Germ Cell Tumor,99,2,Testicular Non-Seminomatous Germ Cell Tumor,0.9629,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9608,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,0.9530,Testicular Seminoma,0.9513,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.9488
NON-SEMINOMA; CHORIOCARCINOMANON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURE,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Choriocarcinoma<;>Mature Teratoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,0.9815,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9781,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9763,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.9758,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.9758
NON-SEMINOMA; EMBRYONAL CARCINOMA,Embryonal Carcinoma<;>Nonseminomatous,4,2,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.9859,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9818,Embryonal Carcinoma<;>Seminoma,0.9780,Embryonal Carcinoma<;>Nonseminomatous,0.9764,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9755
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA MATURE,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,2,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9812,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9783,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9721,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9717,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.9710
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; CHORIOCARCINOMANON-SEMINOMA; YOLK SAC TUMORSEMINOMA; NOS,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,1,2,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9809,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9782,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9758,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,0.9739,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,0.9728
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9829,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9800,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.9753,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9751,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.9735
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMOR,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,1,2,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9824,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,0.9806,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.9767,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.9767,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9752
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; CHORIOCARCINOMA,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,1,2,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,0.9811,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9770,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9759,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,0.9744,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.9743
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; TERATOMA IMMATURE,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9781,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9778,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9778,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.9774,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.9774
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; TERATOMA MATURE,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,2,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9781,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9778,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9778,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.9774,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.9774
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURESEMINOMA; NOS,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9781,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9778,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9778,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.9774,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.9774
NON-SEMINOMA; EMBRYONAL CARCINOMASEMINOMA; NOS,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,1,2,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.9840,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9827,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9779,Embryonal Carcinoma<;>Nonseminomatous,0.9758,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9736
NON-SEMINOMA; EMBRYONAL CARCINOMA[NOT AVAILABLE],Embryonal Carcinoma<;>Nonseminomatous,3,2,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.9823,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9779,Embryonal Carcinoma<;>Nonseminomatous,0.9740,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9723,Embryonal Carcinoma<;>Seminoma,0.9707
NON-SEMINOMA; EMBRYONAL CARCINOMA[NOT AVAILABLE][NOT AVAILABLE][NOT AVAILABLE],Embryonal Carcinoma<;>Nonseminomatous,4,2,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.9813,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9782,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9732,Embryonal Carcinoma<;>Nonseminomatous,0.9732,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9689
NON-SEMINOMA; TERATOMA IMMATURE,Nonseminomatous<;>Immature Teratoma,2,2,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9700,Nonseminomatous<;>Immature Teratoma,0.9677,Seminoma<;>Mature Teratoma,0.9665,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9646,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.9639
NON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma,2,2,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.9742,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma,0.9742,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma<;>Seminoma,0.9742,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9730,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9730
NON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor,1,2,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor,0.9777,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor,0.9773,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9766,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Choriocarcinoma<;>Mature Teratoma,0.9766,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.9766
NON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMA,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,1,2,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9783,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Choriocarcinoma<;>Mature Teratoma,0.9783,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.9783,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.9783,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9783
NON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA MATURE,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,1,2,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9783,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Choriocarcinoma<;>Mature Teratoma,0.9783,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.9783,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.9783,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9783
NON-SEMINOMA; TERATOMA MATURE,Nonseminomatous<;>Mature Teratoma,4,2,Seminoma<;>Mature Teratoma,0.9741,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9719,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9638,Nonseminomatous<;>Mature Teratoma,0.9631,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9617
NON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9799,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9772,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9749,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9745,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.9737
NON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; EMBRYONAL CARCINOMA,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,3,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9747,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9725,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.9706,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9706,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9706
NON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9747,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9725,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.9706,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9706,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9706
NON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; CHORIOCARCINOMA,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Choriocarcinoma<;>Mature Teratoma,99,2,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma,0.9739,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma<;>Seminoma,0.9739,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.9738,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9729,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9729
NON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMASEMINOMA; NOS,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,99,2,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma,0.9739,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma<;>Seminoma,0.9739,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.9738,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9729,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9729
NON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor,1,2,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor,0.9773,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9758,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9758,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.9747,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma,0.9745
NON-SEMINOMA; TERATOMA MATURESEMINOMA; NOSNON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9798,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9773,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.9738,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9736,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9733
NON-SEMINOMA; TERATOMA MATURE[NOT AVAILABLE]NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9768,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9755,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9710,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.9701,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9701
NON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Yolk Sac Tumor,4,2,Yolk Sac Tumor<;>Seminoma,0.9785,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor,0.9735,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9727,Nonseminomatous<;>Yolk Sac Tumor,0.9725,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor,0.9719
NON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMA,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,1,2,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9823,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,0.9812,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9769,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.9768,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.9768
NON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURE,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,99,2,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9782,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9782,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.9772,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.9772,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9763
NON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA MATURESEMINOMA; NOS,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,4,2,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9782,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9782,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.9772,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.9772,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9763
NON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; TERATOMA MATURE,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor,1,2,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor,0.9740,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9728,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9728,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.9725,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma,0.9722
NON-SEMINOMATOUS GERM CELL TUMO,Nongerminomatous Germ Cell Tumor,99,2,Testicular Non-Seminomatous Germ Cell Tumor,0.9763,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9510,Testicular Seminoma,0.9468,Testicular Germ Cell Tumor,0.9436,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9403
NON-SEMINOMATOUS GERM CELL TUMOR,Nongerminomatous Germ Cell Tumor,2,2,Testicular Non-Seminomatous Germ Cell Tumor,0.9941,Nongerminomatous Germ Cell Tumor,0.9623,Testicular Germ Cell Tumor,0.9616,Germ Cell Tumor,0.9603,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9603
"NON-SEMINOMATOUS GERM CELL TUMOR, PREDOMINANTLY YOLK SAC TYPE",Nongerminomatous Germ Cell Tumor<;>Yolk Sac Tumor,5,2,Yolk Sac Tumor<;>Seminoma,0.9739,Testicular Non-Seminomatous Germ Cell Tumor,0.9735,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9730,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor,0.9726,Nongerminomatous Germ Cell Tumor<;>Yolk Sac Tumor,0.9724
NON-SEMINOMATOUS MIXED GERM CELL TUMOR,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,3,2,Testicular Non-Seminomatous Germ Cell Tumor,0.9822,Mixed Germ Cell Tumor,0.9751,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.9708,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9622,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9587
NON-SMALL CELL LUNG,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.9826,Non-Small Cell Carcinoma,0.9768,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9727,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9701,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9685
NON-SMALL CELL LUNG CANCER,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.9919,Non-Small Cell Carcinoma,0.9853,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9834,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9807,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9757
"NON-SMALL CELL LUNG CANCER NSCLC, ADENOCARCINOMA",Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,1,2,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9871,Lung Non-Small Cell Carcinoma,0.9825,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9799,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9769,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9746
"NON-SMALL CELL LUNG CANCER NSCLC, ADENOSQUAMOUS CARCINOMA",Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,1,2,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9917,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9799,Lung Non-Small Cell Carcinoma,0.9753,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9733,Lung Adenosquamous Carcinoma,0.9731
"NON-SMALL CELL LUNG CANCER NSCLC, LARGE CELL CARCINOMA",Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9888,Lung Non-Small Cell Carcinoma,0.9814,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9805,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9758,Lung Large Cell Carcinoma,0.9728
"NON-SMALL CELL LUNG CANCER NSCLC, MUCOEPIDERMOID CARCINOMA",Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,1,2,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.9909,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9740,Lung Mucoepidermoid Carcinoma,0.9719,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9715,Lung Non-Small Cell Carcinoma,0.9705
"NON-SMALL CELL LUNG CANCER NSCLC, SQUAMOUS CELL CARCINOMA",Lung Squamous Cell Carcinoma,99,2,Lung Non-Small Cell Carcinoma,0.9839,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9820,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9806,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9794,Non-Small Cell Carcinoma,0.9746
"NON-SMALL CELL LUNG CANCER NSCLC, UNSPECIFIED",Lung Non-Small Cell Carcinoma,2,2,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9684,Lung Non-Small Cell Carcinoma,0.9674,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9652,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9647,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9631
NON-SMALL_CELL LUNG_CANCER,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.9888,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9836,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9817,Non-Small Cell Carcinoma,0.9811,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9750
NON_HODGKIN_LYMPHOMA,Non-Hodgkin Lymphoma,1,2,Non-Hodgkin Lymphoma,0.9964,B-Cell Non-Hodgkin Lymphoma,0.9799,T-Cell Non-Hodgkin Lymphoma,0.9704,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9634,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9620
NON_SMALL_CELL_CARCINOMA,Non-Small Cell Carcinoma,1,2,Non-Small Cell Carcinoma,0.9948,Lung Non-Small Cell Carcinoma,0.9836,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9766,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9735,Lung Small Cell Carcinoma,0.9700
NON_SMALL_CELL_LUNG_CANCER,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.9873,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9820,Non-Small Cell Carcinoma,0.9814,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9797,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9733
NORMAL KARYOTYPE,Normal Karyotype,1,2,Normal Karyotype,1.0000,NUP98 Gene<;>Chromosomal Translocation,0.9271,Cytogenetic Abnormality<;>Low Risk,0.9232,Complex Karyotype,0.9232,Hyperdiploidy,0.9180
NORMAL-LIKE,Normal Breast-Like Subtype of Breast Carcinoma,1,2,Normal Breast-Like Subtype of Breast Carcinoma,0.9448,Normal Karyotype,0.9197,Nonseminomatous<;>Immature Teratoma,0.9160,Nonseminomatous<;>Mature Teratoma,0.9154,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9150
NOS,Not Otherwise Specified,3,2,Olfactory Neuroblastoma,0.8861,Central Nervous System<;>Brain,0.8848,Not Otherwise Specified,0.8846,Cecum,0.8843,nan,0.8843
NOSNON-SEMINOMA,Nonseminomatous,99,2,Testicular Seminoma,0.9516,Seminoma,0.9474,Testicular Non-Seminomatous Germ Cell Tumor,0.9360,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9318,Seminoma<;>Mature Teratoma,0.9264
NOT SPECIFIED,Not Otherwise Specified,1,2,Not Otherwise Specified,0.9812,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.9371,Acute Myeloid Leukemia Not Otherwise Specified,0.9252,"Medullary Carcinoma, Not Otherwise Specified",0.9227,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.9192
NO_FUSION,Ewing Sarcoma,99,2,Fusion-Negative Rhabdomyosarcoma,0.9215,Fusion-Positive Rhabdomyosarcoma,0.9055,Not Otherwise Specified,0.9028,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.9027,PAX3/FOXO1 Fusion Gene,0.9025
NSCLC,Lung Non-Small Cell Carcinoma,99,2,Lung Adenocarcinoma,0.9483,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9415,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9409,Lung Carcinoma,0.9393,Lung Adenosquamous Carcinoma,0.9384
"NSCLC, ADENOCARCINOMA",Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,3,2,Lung Adenocarcinoma,0.9750,Adenocarcinoma,0.9621,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9592,"Lung Adenocarcinoma, Mixed Subtype",0.9538,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9532
NSCLC_ADENOCARCINOMA,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,3,2,Lung Adenocarcinoma,0.9754,Adenocarcinoma,0.9581,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9572,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9498,Lung Adenosquamous Carcinoma,0.9496
NSCLC_ADENOSQUAMOUS,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,2,2,Lung Adenosquamous Carcinoma,0.9758,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9658,Adenosquamous Carcinoma,0.9638,Esophageal Adenosquamous Carcinoma,0.9553,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.9543
NSCLC_LARGE_CELL,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,2,2,Lung Large Cell Carcinoma,0.9707,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9654,"Lung Large Cell Carcinoma, Clear Cell Variant",0.9604,Large Cell Carcinoma,0.9587,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9508
NSCLC_MUCOEPIDERMOID,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,2,2,Lung Mucoepidermoid Carcinoma,0.9679,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.9590,Mucoepidermoid Carcinoma,0.9492,Lung Mucinous Adenocarcinoma,0.9427,Lung Non-Mucinous Adenocarcinoma,0.9399
NSCLC_SQUAMOUS,Lung Squamous Cell Carcinoma,1,2,Lung Squamous Cell Carcinoma,0.9667,Squamous Cell Carcinoma,0.9528,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9528,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9495,Lung Adenosquamous Carcinoma,0.9492
NUP98 TRANSLOCATION,NUP98 Gene<;>Chromosomal Translocation,1,2,NUP98 Gene<;>Chromosomal Translocation,0.9676,Translocation,0.9351,MLL Gene Translocation,0.9233,MLL Gene Translocation<;>Low Risk,0.9003,MiT Family Translocation-Associated Renal Cell Carcinoma,0.8981
OCCULT,Occult Stage,1,2,Occult Stage,0.9619,Meningioma,0.8987,Overt Primary Myelofibrosis,0.8944,Melanoma of Unknown Primary,0.8936,Extrahepatic,0.8921
OCULAR MELANOMA,Ocular Melanoma,1,2,Ocular Melanoma,1.0000,Uveal Melanoma,0.9498,Melanoma,0.9475,Cutaneous Melanoma,0.9396,Mucosal Melanoma of the Head and Neck,0.9363
ODONTOGENIC CARCINOMA,Odontogenic Carcinoma,1,2,Odontogenic Carcinoma,1.0000,Clear Cell Odontogenic Carcinoma,0.9630,Gingival Carcinoma,0.9457,Oropharyngeal Squamous Cell Carcinoma,0.9450,Salivary Gland Carcinoma,0.9430
OESOPHAGEAL SQUAMOUS CELL CARCINOMA,Esophageal Squamous Cell Carcinoma,1,2,Esophageal Squamous Cell Carcinoma,0.9816,Squamous Cell Carcinoma,0.9791,Laryngeal Squamous Cell Carcinoma,0.9734,Lung Squamous Cell Carcinoma,0.9728,Oral Cavity Squamous Cell Carcinoma,0.9725
OLFACTORY NEUROBLASTOMA,Olfactory Neuroblastoma,1,2,Olfactory Neuroblastoma,1.0000,Neuroblastoma,0.9632,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9195,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9118,Anaplastic Oligoastrocytoma,0.9117
OLIGOASTROCYTOMA,Oligoastrocytoma,1,2,Oligoastrocytoma,1.0000,Anaplastic Oligoastrocytoma,0.9771,Oligodendroglioma,0.9339,Anaplastic Oligodendroglioma,0.9274,Kidney Oncocytoma,0.9262
OLIGODENDROGLIOMA,Oligodendroglioma,1,2,Oligodendroglioma,1.0000,Anaplastic Oligodendroglioma,0.9677,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9480,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9453,Anaplastic Oligoastrocytoma,0.9370
"OLIGODENDROGLIOMA, IDH-MUTANT AND 1P/19Q-CODELETED","Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1,2,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1.0000,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9949,"Astrocytoma, IDH-Mutant, Grade 2",0.9576,"Astrocytoma, IDH-Mutant, Grade 4",0.9571,"Astrocytoma, IDH-Mutant, Grade 3",0.9570
OMENTUM,Omentum,1,2,Omentum,1.0000,Peritoneum,0.9221,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.9057,Abdominal Wall,0.9054,Peritoneal Mesothelioma,0.9036
ONCOCYTIC,Oncocytic Neoplasm,1,2,Oncocytic Neoplasm,0.9809,Thyroid Gland Oncocytic Carcinoma,0.9605,Thyroid Gland Oncocytic Adenoma,0.9528,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.9501,Kidney Oncocytoma,0.9464
ONCOCYTIC ADENOMA OF THE THYROID,Thyroid Gland Oncocytic Adenoma,1,2,Thyroid Gland Oncocytic Adenoma,0.9954,Thyroid Gland Oncocytic Carcinoma,0.9790,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.9695,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.9631,Oncocytic Neoplasm,0.9596
ONCOCYTOMA,Oncocytic Neoplasm,2,2,Kidney Oncocytoma,0.9793,Oncocytic Neoplasm,0.9710,Thyroid Gland Oncocytic Carcinoma,0.9564,Thyroid Gland Oncocytic Adenoma,0.9536,Adrenal Cortical Oncocytic Carcinoma,0.9530
OPTIC NERVE GLIOMA,Optic Nerve Glioma,1,2,Optic Nerve Glioma,1.0000,Glioma,0.9470,Visual Pathway Glioma,0.9338,Oligodendroglioma,0.9233,Low Grade Glioma,0.9196
OPTIC PATHWAY GLIOMA,Visual Pathway Glioma,1,2,Visual Pathway Glioma,0.9688,Optic Nerve Glioma,0.9681,Glioma,0.9359,Low Grade Glioma,0.9197,Low Grade Glioma<;>IDH Gene Family Mutation,0.9190
ORAL,Oral,1,2,Oral,1.0000,Oral Cavity Squamous Cell Carcinoma,0.9084,Buccal Mucosa,0.9067,Alveolar,0.9038,Buccal Mucosa Squamous Cell Carcinoma,0.9003
ORAL CAVITY SQUAMOUS CELL CARCINOMA,Oral Cavity Squamous Cell Carcinoma,1,2,Oral Cavity Squamous Cell Carcinoma,1.0000,Buccal Mucosa Squamous Cell Carcinoma,0.9793,Tongue Squamous Cell Carcinoma,0.9782,Squamous Cell Carcinoma,0.9777,Laryngeal Squamous Cell Carcinoma,0.9753
ORAL DYSPLASIA,Oral Epithelial Dysplasia,1,2,Oral Epithelial Dysplasia,0.9827,Dysplastic Nevus,0.9283,Odontogenic Carcinoma,0.9269,Oral Cavity Squamous Cell Carcinoma,0.9220,Myelodysplastic Syndrome with Multilineage Dysplasia,0.9203
ORGANOID,Organoid,1,2,Organoid,1.0000,Ovary,0.9044,Kidney,0.8955,Kidney Oncocytoma,0.8913,Adrenal Gland,0.8906
OROPHARYNX SQUAMOUS CELL CARCINOMA,Oropharyngeal Squamous Cell Carcinoma,1,2,Oropharyngeal Squamous Cell Carcinoma,0.9929,Pharyngeal Squamous Cell Carcinoma,0.9793,Hypopharyngeal Squamous Cell Carcinoma,0.9694,Head and Neck Squamous Cell Carcinoma,0.9691,Oral Cavity Squamous Cell Carcinoma,0.9685
OS,Osteosarcoma,1,2,Osteosarcoma,0.9269,Ovarian Serous Adenocarcinoma,0.9113,Osteoblastic Osteosarcoma,0.9110,Ovarian Seromucinous Carcinoma,0.9083,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.9080
OSSIFYING FIBROMYXOID TUMOR,Ossifying Fibromyxoid Tumor,1,2,Ossifying Fibromyxoid Tumor,1.0000,Plexiform Fibrohistiocytic Tumor,0.9339,Malignant Soft Tissue Neoplasm,0.9311,Low Grade Fibromyxoid Sarcoma,0.9291,Malignant Bone Neoplasm,0.9276
OSTEOBLASTIC OSTEOSARCOMA,Osteoblastic Osteosarcoma,1,2,Osteoblastic Osteosarcoma,1.0000,Osteosarcoma,0.9780,Chondroblastic Osteosarcoma,0.9625,Periosteal Osteosarcoma,0.9587,Fibroblastic Osteosarcoma,0.9450
OSTEOSARCOMA,Osteosarcoma,1,2,Osteosarcoma,1.0000,Osteoblastic Osteosarcoma,0.9780,Chondroblastic Osteosarcoma,0.9640,Periosteal Osteosarcoma,0.9630,Parosteal Osteosarcoma,0.9546
OTHER UTERINE TUMOR,Uterine Neoplasm,1,2,Uterine Neoplasm,0.9561,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,0.9406,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.9385,Endometrial Carcinoma<;>Uterine Corpus Cancer,0.9384,Uterine Carcinosarcoma,0.9323
OV,Ovarian Carcinoma,99,2,Ovary,0.9234,Organoid,0.8996,Omentum,0.8951,Vulvar Carcinoma<;>Vaginal Carcinoma,0.8941,Hemangioma,0.8890
OVARIAN ADENOCARCINOMA,Ovarian Adenocarcinoma,1,2,Ovarian Adenocarcinoma,1.0000,Ovarian Serous Adenocarcinoma,0.9788,Ovarian Carcinoma,0.9735,Ovarian Endometrioid Adenocarcinoma,0.9712,Ovarian High Grade Serous Adenocarcinoma,0.9640
OVARIAN CANCER,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.9807,Ovarian Adenocarcinoma,0.9685,Ovarian Epithelial Tumor,0.9618,Metastatic Ovarian Carcinoma,0.9536,Ovarian Serous Adenocarcinoma,0.9533
"OVARIAN CANCER, OTHER",Ovarian Carcinoma,2,2,Ovarian Adenocarcinoma,0.9490,Ovarian Carcinoma,0.9485,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.9455,Ovarian Epithelial Tumor,0.9443,Ovarian Serous Adenocarcinoma,0.9392
OVARIAN CARCINOMA,Ovarian Carcinoma,1,2,Ovarian Carcinoma,1.0000,Ovarian Adenocarcinoma,0.9735,Metastatic Ovarian Carcinoma,0.9658,Ovarian Epithelial Tumor,0.9654,Ovarian Small Cell Carcinoma,0.9626
OVARIAN CARCINOMA OTHER,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.9625,Ovarian Adenocarcinoma,0.9537,Metastatic Ovarian Carcinoma,0.9470,Ovarian Epithelial Tumor,0.9466,Ovarian Small Cell Carcinoma,0.9453
OVARIAN CARCINOSARCOMA/MALIGNANT MIXED MESODERMAL TUMOR,Ovarian Carcinosarcoma,99,2,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9807,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9790,Malignant Mixed Mesodermal (Mullerian) Tumor<;>Carcinosarcoma<;>Yolk Sac Tumor,0.9789,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9778,Malignant Mixed Mesodermal (Mullerian) Tumor,0.9654
OVARIAN CLEAR CELL,Malignant Ovarian Clear Cell Tumor,3,2,Ovarian Clear Cell Tumor,0.9866,Ovarian Clear Cell Cystadenocarcinoma,0.9778,Malignant Ovarian Clear Cell Tumor,0.9716,Borderline Ovarian Clear Cell Tumor,0.9593,Clear Cell Renal Cell Carcinoma,0.9592
OVARIAN EPITHELIAL CARCINOMA OVCA,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.9671,Ovarian Epithelial Tumor,0.9637,ovary mixed epithelial carcinoma,0.9501,Malignant Ovarian Clear Cell Tumor,0.9468,Ovarian Adenocarcinoma,0.9462
OVARIAN EPITHELIAL TUMOR,Ovarian Epithelial Tumor,1,2,Ovarian Epithelial Tumor,1.0000,Ovarian Carcinoma,0.9654,Ovarian Granulosa Cell Tumor,0.9596,Malignant Ovarian Clear Cell Tumor,0.9564,ovary mixed epithelial carcinoma,0.9560
OVARIAN FIBROTHECOMA,Ovarian Fibrothecoma,1,2,Ovarian Fibrothecoma,1.0000,Fibrothecoma,0.9729,Fibromatosis,0.9300,Ovarian Dysgerminoma,0.9180,Desmoid Fibromatosis,0.9179
OVARIAN GERM CELL TUMOR,Ovarian Germ Cell Tumor,1,2,Ovarian Germ Cell Tumor,1.0000,Germ Cell Tumor,0.9765,Ovarian Granulosa Cell Tumor,0.9749,Testicular Germ Cell Tumor,0.9680,Ovarian Sertoli-Leydig Cell Tumor,0.9597
OVARIAN GRANULOSA CELL TUMOR,Ovarian Granulosa Cell Tumor,1,2,Ovarian Granulosa Cell Tumor,1.0000,Granulosa Cell Tumor,0.9879,Ovarian Germ Cell Tumor,0.9749,Ovarian Sertoli-Leydig Cell Tumor,0.9639,Ovarian Epithelial Tumor,0.9596
OVARIAN HIGH-GRADE SEROUS,Ovarian High Grade Serous Adenocarcinoma,1,2,Ovarian High Grade Serous Adenocarcinoma,0.9890,Ovarian Low Grade Serous Adenocarcinoma,0.9807,Serous Adenocarcinoma<;>High Grade,0.9749,Cystadenocarcinoma<;>High Grade<;>Serous,0.9675,Fallopian Tube High Grade Serous Adenocarcinoma,0.9670
OVARIAN LOW-GRADE SEROUS,Ovarian Low Grade Serous Adenocarcinoma,1,2,Ovarian Low Grade Serous Adenocarcinoma,0.9880,Ovarian High Grade Serous Adenocarcinoma,0.9764,Serous Adenocarcinoma<;>High Grade,0.9631,Cystadenocarcinoma<;>High Grade<;>Serous,0.9589,Fallopian Tube High Grade Serous Adenocarcinoma,0.9582
OVARIAN SEROMUCINOUS CARCINOMA,Ovarian Seromucinous Carcinoma,1,2,Ovarian Seromucinous Carcinoma,1.0000,Ovarian Serous Adenocarcinoma,0.9529,Ovarian Carcinoma,0.9472,Serous Cystadenocarcinoma,0.9418,Serous Adenocarcinoma,0.9414
OVARIAN SEROUS CARCINOMA,Ovarian Serous Adenocarcinoma,1,2,Ovarian Serous Adenocarcinoma,0.9833,Ovarian Carcinoma,0.9761,Serous Adenocarcinoma,0.9688,Ovarian High Grade Serous Adenocarcinoma,0.9688,Ovarian Low Grade Serous Adenocarcinoma,0.9655
"OVARIAN/FALLOPIAN TUBE CANCER, NOS",Fallopian Tube Carcinoma<;>Ovarian Carcinoma,1,2,Fallopian Tube Carcinoma<;>Ovarian Carcinoma,0.9760,Fallopian Tube High Grade Serous Adenocarcinoma,0.9526,Ovarian Carcinoma,0.9517,Ovarian Small Cell Carcinoma,0.9480,Malignant Ovarian Clear Cell Tumor,0.9450
OVARIAN_CANCER,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.9774,Ovarian Adenocarcinoma,0.9675,Ovarian Epithelial Tumor,0.9604,Fallopian Tube Carcinoma<;>Ovarian Carcinoma,0.9537,Metastatic Ovarian Carcinoma,0.9529
OVARIAN_CARCINOMA,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.9933,Ovarian Adenocarcinoma,0.9709,Metastatic Ovarian Carcinoma,0.9628,Ovarian Epithelial Tumor,0.9620,Fallopian Tube Carcinoma<;>Ovarian Carcinoma,0.9610
OVARY,Ovary,1,2,Ovary,1.0000,Ovarian Adenocarcinoma,0.9316,Ovarian Germ Cell Tumor,0.9269,ovary mixed epithelial carcinoma,0.9266,Ovarian Granulosa Cell Tumor,0.9262
OVARY/FALLOPIAN TUBE,Appendage of the Uterus,99,2,Fallopian Tube Carcinoma<;>Ovarian Carcinoma,0.9552,Ovary,0.9507,Fallopian Tube High Grade Serous Adenocarcinoma,0.9332,ovary mixed epithelial carcinoma,0.9178,Ovarian Adenocarcinoma,0.9168
OVARY_ADENOCARCINOMA,Ovarian Adenocarcinoma,1,2,Ovarian Adenocarcinoma,0.9828,Ovarian Serous Adenocarcinoma,0.9651,Ovarian Endometrioid Adenocarcinoma,0.9599,Adenocarcinoma,0.9563,Ovarian Carcinoma,0.9561
OVARY_CARCINOMA,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.9804,Ovarian Adenocarcinoma,0.9613,ovary mixed epithelial carcinoma,0.9558,Carcinoma,0.9553,Fallopian Tube Carcinoma<;>Ovarian Carcinoma,0.9525
PAAD,Pancreatic Adenocarcinoma,99,2,Pharynx,0.8996,Angiosarcoma,0.8993,"Posterior Fossa Ependymoma, Group A (PFA)",0.8982,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.8981,Adenosarcoma,0.8975
PAGET DISEASE OF THE NIPPLE,Nipple Paget Disease,1,2,Nipple Paget Disease,0.9916,Extramammary Paget Disease,0.9378,Breast Inflammatory Carcinoma,0.9075,Erdheim-Chester Disease,0.9055,Acute Myeloid Leukemia with Mutated NPM1,0.9050
PAIRED PRIMARY TUMOR,Primary Neoplasm<;>Paired,1,2,Primary Neoplasm<;>Paired,0.9780,Primary Neoplasm<;>Unpaired,0.9531,Primary Neoplasm,0.9444,Gastroesophageal Cancer<;>Primary Neoplasm,0.9296,Metastatic Colorectal Carcinoma<;>Primary,0.9287
PANCREAS,Pancreas,1,2,Pancreas,1.0000,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.9362,Pancreatic Adenocarcinoma,0.9306,Pancreatic Insulinoma<;>Benign,0.9264,Pancreatic Ductal Adenocarcinoma,0.9236
PANCREAS-ADENOCARCINOMA DUCTAL TYPE,Pancreatic Ductal Adenocarcinoma,1,2,Pancreatic Ductal Adenocarcinoma,0.9724,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.9661,Pancreatic Adenocarcinoma<;>Poorly Differentiated Adenocarcinoma Cell,0.9619,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.9599,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9593
PANCREAS-ADENOCARCINOMA-OTHER SUBTYPE,Pancreatic Adenocarcinoma,2,2,Pancreatic Adenocarcinoma<;>Poorly Differentiated Adenocarcinoma Cell,0.9635,Pancreatic Adenocarcinoma,0.9613,Pancreatic Ductal Adenocarcinoma,0.9537,"Lung Adenocarcinoma, Mixed Subtype",0.9511,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.9510
PANCREAS-COLLOID MUCINOUS NON-CYSTIC CARCINOMA,Pancreatic Colloid Carcinoma,1,2,Pancreatic Colloid Carcinoma,0.9670,Pancreatic Mucinous-Cystic Neoplasm,0.9627,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.9464,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9456,Mucinous Cystadenocarcinoma,0.9436
PANCREAS-UNDIFFERENTIATED CARCINOMA,Pancreatic Undifferentiated Carcinoma,1,2,Pancreatic Undifferentiated Carcinoma,0.9883,Carcinoma<;>Undifferentiated,0.9695,Adenocarcinoma<;>Undifferentiated Carcinoma,0.9686,Adenocarcinoma<;>Undifferentiated,0.9661,Undifferentiated Carcinoma,0.9642
PANCREATIC ADENOCARCINOMA,Pancreatic Adenocarcinoma,1,2,Pancreatic Adenocarcinoma,1.0000,Pancreatic Ductal Adenocarcinoma,0.9810,Pancreatic Carcinoma,0.9738,Adenocarcinoma,0.9699,Prostate Adenocarcinoma,0.9670
PANCREATIC CANCER,Pancreatic Carcinoma,1,2,Pancreatic Carcinoma,0.9795,Pancreatic Adenocarcinoma,0.9703,Pancreatic Acinar Cell Carcinoma,0.9553,Pancreatic Ductal Adenocarcinoma,0.9531,Pancreatobiliary Carcinoma,0.9461
PANCREATIC CANCER OTHER,Pancreatic Carcinoma,2,2,Pancreatic Adenocarcinoma,0.9494,Pancreatic Carcinoma,0.9449,Pancreatic Adenocarcinoma<;>Poorly Differentiated Adenocarcinoma Cell,0.9354,Pancreatic Ductal Adenocarcinoma,0.9341,Pancreatic Insulinoma<;>Benign,0.9319
"PANCREATIC CANCER, NOS",Pancreatic Carcinoma,1,2,Pancreatic Carcinoma,0.9569,Pancreatic Adenocarcinoma,0.9471,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.9458,Pancreatic Adenosquamous Carcinoma,0.9438,Pancreatic Adenosquamous Carcinoma<;>Ductal,0.9434
PANCREATIC DUCTAL ADENOCARCINOMA,Pancreatic Ductal Adenocarcinoma,1,2,Pancreatic Ductal Adenocarcinoma,1.0000,Prostate Ductal Adenocarcinoma,0.9813,Pancreatic Adenocarcinoma,0.9810,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.9722,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.9673
PANCREATIC NEUROENDOCRINE,Pancreatic Neuroendocrine Tumor,1,2,Pancreatic Neuroendocrine Tumor,0.9704,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.9478,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9467,Pancreas,0.9461,Pituitary Neuroendocrine Tumor,0.9409
PANCREATIC NEUROENDOCRINE TUMOR,Pancreatic Neuroendocrine Tumor,1,2,Pancreatic Neuroendocrine Tumor,1.0000,Neuroendocrine Tumor,0.9799,Pituitary Neuroendocrine Tumor,0.9769,Neuroendocrine Neoplasm,0.9674,Gastric Neuroendocrine Tumor,0.9657
PANCREATIC_CANCER,Pancreatic Carcinoma,1,2,Pancreatic Carcinoma,0.9758,Pancreatic Adenocarcinoma,0.9687,Pancreatic Acinar Cell Carcinoma,0.9542,Pancreatic Ductal Adenocarcinoma,0.9529,Pancreatic Neuroendocrine Tumor,0.9447
PANCREATOBILIARY,Pancreatobiliary Carcinoma,1,2,Pancreatobiliary Carcinoma,0.9622,Pancreas,0.9439,Pancreatoblastoma,0.9333,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma,0.9208,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.9194
PANCREATOBILIARY AMPULLARY CARCINOMA,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma,2,2,Pancreatobiliary Carcinoma,0.9876,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma,0.9561,Pancreatic Carcinoma,0.9550,Pancreatic Adenocarcinoma,0.9515,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9506
PANCREATOBLASTOMA,Pancreatoblastoma,1,2,Pancreatoblastoma,1.0000,Pancreatobiliary Carcinoma,0.9500,Solid Pseudopapillary Neoplasm of the Pancreas,0.9332,Congenital Peribronchial Myofibroblastic Tumor,0.9328,Pancreatic Carcinoma,0.9293
PANET,Pancreatic Neuroendocrine Tumor,99,2,Central Nervous System<;>Brain,0.8921,Central Nervous System Germinoma,0.8873,Solid Pseudopapillary Neoplasm of the Pancreas,0.8871,Pancreas,0.8865,Acute Myeloid Leukemia with Mutated NPM1,0.8857
PAPILLARY,Papillary,1,2,Papillary,1.0000,Papillary Carcinoma,0.9605,Papillary Adenocarcinoma,0.9554,Papillary Renal Cell Carcinoma,0.9520,Acinar Cell Carcinoma<;>Papillary,0.9510
PAPILLARY ADENOCARCINOMA 82603,Papillary Adenocarcinoma,1,2,Papillary Adenocarcinoma,0.9664,Lung Papillary Adenocarcinoma,0.9638,Gastric Papillary Adenocarcinoma,0.9506,Digital Papillary Adenocarcinoma,0.9505,Acinar Cell Carcinoma<;>Papillary,0.9500
PAPILLARY CARCINOMA,Papillary Carcinoma,1,2,Papillary Carcinoma,1.0000,Papillary Renal Cell Carcinoma,0.9790,Thyroid Gland Papillary Carcinoma,0.9778,Papillary Adenocarcinoma,0.9774,Papillary Transitional Cell Carcinoma,0.9725
"PAPILLARY CARCINOMA, DIFFUSE SCLEROSING VARIANT",Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,1,2,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,0.9906,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.9532,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9492,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.9468,Follicular Variant Thyroid Gland Papillary Carcinoma,0.9450
PAPILLARY CARCINOMA: MIXED PAPILLARY AND FOLLICULAR VARIANT,Follicular Variant Thyroid Gland Papillary Carcinoma,1,2,Follicular Variant Thyroid Gland Papillary Carcinoma,0.9729,Thyroid Gland Papillary and Follicular Carcinoma,0.9707,Papillary Carcinoma,0.9539,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.9532,Classic Thyroid Gland Papillary Carcinoma,0.9528
PAPILLARY INFILTRATING DUCTAL CARCINOMA-MAMMARY GLAND,Breast Papillary Ductal Carcinoma with Invasion,1,2,Breast Papillary Ductal Carcinoma with Invasion,0.9846,Papillary Carcinoma,0.9648,Breast Solid Papillary Carcinoma,0.9644,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9617,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9608
PAPILLARY INFILTRATING DUCTAL CARCINOMA-MAMMARY GLAND; BREAST,Breast Papillary Ductal Carcinoma with Invasion,1,2,Breast Papillary Ductal Carcinoma with Invasion,0.9831,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9639,Breast Solid Papillary Carcinoma,0.9624,Papillary Carcinoma,0.9622,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9614
PAPILLARY KIDNEY RENAL CELL CARCINOMA,Papillary Renal Cell Carcinoma,1,2,Papillary Renal Cell Carcinoma,0.9977,Clear Cell Papillary Renal Neoplasm,0.9795,Papillary Carcinoma,0.9727,Papillary Transitional Cell Carcinoma,0.9691,Renal Cell Carcinoma,0.9680
PAPILLARY RENAL CELL CARCINOMA,Papillary Renal Cell Carcinoma,1,2,Papillary Renal Cell Carcinoma,1.0000,Papillary Carcinoma,0.9790,Clear Cell Papillary Renal Neoplasm,0.9790,Papillary Transitional Cell Carcinoma,0.9729,Renal Cell Carcinoma,0.9666
PAPILLARY STOMACH ADENOCARCINOMA,Gastric Papillary Adenocarcinoma,1,2,Gastric Papillary Adenocarcinoma,0.9898,Papillary Adenocarcinoma,0.9786,Lung Papillary Adenocarcinoma,0.9709,Papillary Carcinoma,0.9551,Thyroid Gland Papillary Carcinoma,0.9512
PAPILLARY THROID CARCINOMA,Thyroid Gland Papillary Carcinoma,4,2,Papillary Carcinoma,0.9625,Papillary Renal Cell Carcinoma,0.9538,Papillary Transitional Cell Carcinoma,0.9527,Thyroid Gland Papillary Carcinoma,0.9518,Papillary Adenocarcinoma,0.9460
PAPILLARY THYROID CANCER,Thyroid Gland Papillary Carcinoma,1,2,Thyroid Gland Papillary Carcinoma,0.9861,Papillary Carcinoma,0.9757,Classic Thyroid Gland Papillary Carcinoma,0.9701,Thyroid Gland Papillary and Follicular Carcinoma,0.9668,Papillary Adenocarcinoma,0.9612
"PAPILLARY, FOLLICULAR",Thyroid Gland Papillary and Follicular Carcinoma,2,2,Papillary,0.9649,Thyroid Gland Papillary and Follicular Carcinoma,0.9549,Follicular Variant Thyroid Gland Papillary Carcinoma,0.9501,Papillary Carcinoma,0.9373,Acinar Cell Carcinoma<;>Papillary,0.9367
"PAPILLARY, TALL CELL VARIANT",Tall Cell Variant Thyroid Gland Papillary Carcinoma,1,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.9825,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.9528,Follicular Variant Thyroid Gland Papillary Carcinoma,0.9426,Papillary,0.9395,Papillary Transitional Cell Carcinoma,0.9342
PAPILLARY_ADENOCARCINOMA,Papillary Adenocarcinoma,1,2,Papillary Adenocarcinoma,0.9937,Lung Papillary Adenocarcinoma,0.9827,Papillary Carcinoma,0.9738,Gastric Papillary Adenocarcinoma,0.9703,Acinar Cell Carcinoma<;>Papillary,0.9686
PAPILLARY_CARCINOMA,Papillary Carcinoma,1,2,Papillary Carcinoma,0.9942,Papillary Adenocarcinoma,0.9763,Papillary Renal Cell Carcinoma,0.9753,Thyroid Gland Papillary Carcinoma,0.9750,Acinar Cell Carcinoma<;>Papillary,0.9702
PAPILLARY_TRANSITIONAL_CELL_CARCINOMA,Papillary Transitional Cell Carcinoma,1,2,Papillary Transitional Cell Carcinoma,0.9928,Papillary Carcinoma,0.9715,Transitional Cell Carcinoma,0.9699,Papillary Renal Cell Carcinoma,0.9684,Acinar Cell Carcinoma<;>Papillary,0.9609
PAPILLOMA,Papilloma,1,2,Papilloma,1.0000,Urothelial Papilloma,0.9624,Choroid Plexus Papilloma,0.9540,Papillary Carcinoma,0.9466,Papillary,0.9426
PARAGANGLIOMA,Paraganglioma,1,2,Paraganglioma,1.0000,Adrenal Gland Pheochromocytoma<;>Paraganglioma,0.9640,Extra-Adrenal Sympathetic Paraganglioma,0.9583,Craniopharyngioma,0.9234,Adrenal Gland Pheochromocytoma,0.9227
PARAGANGLIOMA; EXTRA-ADRENAL PHEOCHROMOCYTOMA,Extra-Adrenal Sympathetic Paraganglioma,1,2,Extra-Adrenal Sympathetic Paraganglioma,0.9842,Extra-Adrenal Pheochromocytoma,0.9783,Adrenal Gland Pheochromocytoma<;>Paraganglioma,0.9780,Paraganglioma,0.9610,Adrenal Gland Pheochromocytoma,0.9559
PARAOSTEAL OSTEOSARCOMA,Parosteal Osteosarcoma,2,2,Periosteal Osteosarcoma,0.9545,Parosteal Osteosarcoma,0.9528,Osteosarcoma,0.9464,Osteoblastic Osteosarcoma,0.9388,Extraskeletal Osteosarcoma,0.9358
PARASPIL MASS,Neoplasm<;>Paraspinal,1,2,Neoplasm<;>Paraspinal,0.9445,Solid Pseudopapillary Neoplasm of the Pancreas,0.9078,Paraganglioma,0.9038,Pilocytic Astrocytoma,0.8998,Pilomatrical Carcinoma,0.8992
PAST,Pilocytic Astrocytoma,99,2,Gingiva,0.8705,Proximal Bile Duct,0.8700,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.8681,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.8653,Myelodysplastic Syndrome with Isolated del(5q),0.8652
PAX3/FOXO1-FUSION,PAX3/FOXO1 Fusion Gene,1,2,PAX3/FOXO1 Fusion Gene,0.9907,Fusion-Positive Rhabdomyosarcoma,0.9269,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9227,CBFB-MYH11 Fusion Protein Expression,0.9201,MLL Gene Translocation,0.9184
PCPG,Adrenal Gland Pheochromocytoma<;>Paraganglioma,99,2,"Posterior Fossa Ependymoma, Group B (PFB)",0.9033,Pharynx,0.9008,"Posterior Fossa Ependymoma, Group A (PFA)",0.8984,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.8953,Plasmacytoma,0.8952
PDA -  SIGNET RING,Pancreatic Signet Ring Cell Carcinoma,1,2,Pancreatic Signet Ring Cell Carcinoma,0.9282,Signet Ring Cell,0.9252,Signet Ring Adenocarcinoma Cell,0.9210,Signet Ring Cell Carcinoma,0.9151,Gastric Signet Ring Cell Adenocarcinoma,0.9146
PDA - ADENOSQUAMOUS CARCINOMA,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,1,2,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.9770,Pancreatic Adenosquamous Carcinoma<;>Ductal,0.9721,Pancreatic Adenosquamous Carcinoma,0.9682,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland<;>Ductal,0.9610,Adenosquamous Carcinoma,0.9572
PDA - MIXED DUCTAL ENDOCRINE CARCINOMA,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,2,2,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9726,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9707,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9690,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.9588,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.9510
PDA - MUCINOUS NON-CYSTIC CARCINOMA,Pancreatic Colloid Carcinoma,99,2,Pancreatic Mucinous-Cystic Neoplasm,0.9613,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9563,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9517,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.9512,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9508
PDA - UNDIFFERENTIATED ANAPLASTIC CARCINOMA,Pancreatic Undifferentiated Carcinoma,3,2,Adenocarcinoma<;>Undifferentiated Carcinoma,0.9631,Adenocarcinoma<;>Undifferentiated,0.9630,Pancreatic Undifferentiated Carcinoma,0.9573,Carcinoma<;>Undifferentiated,0.9547,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,0.9532
PDA - UNDIFFERENTIATED CARCINOMA SOME MULTINUCLEATED BUT NOT OSTEOCLAST,Pancreatic Undifferentiated Carcinoma,99,2,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.9569,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.9556,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells<;>Sarcomatoid Carcinoma,0.9534,Adenocarcinoma<;>Undifferentiated,0.9472,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9456
PDA - UNDIFFERENTIATED CARCINOMA WITH OSTEOCLAST LIKE GIANT CELLS,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,1,2,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.9684,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.9645,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells<;>Sarcomatoid Carcinoma,0.9634,Pancreatic Adenocarcinoma<;>Poorly Differentiated Adenocarcinoma Cell,0.9485,Adenocarcinoma<;>Undifferentiated,0.9465
PDA - UNDIFFERENTIATED CARCINOMA WITH SPINDLING AND OSTEOCLAST LIKE GIANT CELLS,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells<;>Sarcomatoid Carcinoma,3,2,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.9599,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.9588,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells<;>Sarcomatoid Carcinoma,0.9554,Pancreatic Adenocarcinoma<;>Poorly Differentiated Adenocarcinoma Cell,0.9506,Adenocarcinoma<;>Undifferentiated,0.9477
PDAC-CLEAR CELL,Clear Cell,3,2,Adenocarcinoma Clear Cell,0.9658,Clear Cell Adenocarcinoma,0.9597,Clear Cell,0.9541,"Lung Large Cell Carcinoma, Clear Cell Variant",0.9509,Clear Cell Renal Cell Carcinoma,0.9496
PEDIATRIC HIGH GRADE GLIOMAS,Malignant Glioma<;>Pediatric,2,2,Low Grade Glioma<;>Pediatric,0.9829,Malignant Glioma<;>Pediatric,0.9673,High Grade Astrocytic Tumor,0.9532,Low Grade Glioma,0.9515,Low Grade Glioma<;>Low Grade Astrocytoma,0.9474
PEDIATRIC LOW GRADE GLIOMAS,Low Grade Glioma<;>Pediatric,1,2,Low Grade Glioma<;>Pediatric,0.9925,Low Grade Glioma,0.9689,Malignant Glioma<;>Pediatric,0.9585,Low Grade Glioma<;>Low Grade Astrocytoma,0.9583,Low Grade Glioma<;>IDH Gene Family Mutation,0.9428
PENILE CANCER,Penile Carcinoma,1,2,Penile Carcinoma,0.9773,Squamous Cell Carcinoma of the Penis,0.9503,Basaloid Squamous Cell Carcinoma of the Penis,0.9446,Prostate Carcinoma,0.9354,Prostate Squamous Cell Carcinoma,0.9310
PENILE SQUAMOUS CELL CARCINOMA,Squamous Cell Carcinoma of the Penis,1,2,Squamous Cell Carcinoma of the Penis,0.9935,Prostate Squamous Cell Carcinoma,0.9807,Basaloid Squamous Cell Carcinoma of the Penis,0.9753,Penile Carcinoma,0.9734,Squamous Cell Carcinoma,0.9728
PERIHILAR CHOLANGIOCARCINOMA,Hilar Cholangiocarcinoma,3,2,Intrahepatic Cholangiocarcinoma,0.9359,Cholangiocarcinoma,0.9355,Hilar Cholangiocarcinoma,0.9344,Cholangiocarcinoma<;>Extrahepatic,0.9292,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9286
PERIOSTEAL OSTEOSARCOMA,Periosteal Osteosarcoma,1,2,Periosteal Osteosarcoma,1.0000,Osteosarcoma,0.9630,Osteoblastic Osteosarcoma,0.9587,Parosteal Osteosarcoma,0.9580,Chondroblastic Osteosarcoma,0.9534
PERIPHERAL MEDULLOEPITHELIOMA,Central Nervous System Medulloepithelioma,1,2,Central Nervous System Medulloepithelioma,0.9644,Peripheral Primitive Neuroectodermal Tumor,0.9482,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.9370,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9345,Peripheral Nervous System,0.9294
PERIPHERAL NERVOUS SYSTEM,Peripheral Nervous System,1,2,Peripheral Nervous System,1.0000,Central Nervous System<;>Brain,0.9363,Peripheral Primitive Neuroectodermal Tumor,0.9348,Central Nervous System Melanoma,0.9320,Central Nervous System Medulloepithelioma,0.9264
PERIPHERAL NEUROECTODERMAL TUMOR,Peripheral Primitive Neuroectodermal Tumor,1,2,Peripheral Primitive Neuroectodermal Tumor,0.9895,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.9717,Primitive Neuroectodermal Tumor,0.9692,Malignant Peripheral Nerve Sheath Tumor,0.9558,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9532
"PERIPHERAL T-CELL LYMPHOMA, NOS","Peripheral T-Cell Lymphoma, Not Otherwise Specified",1,2,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.9793,T-Cell Non-Hodgkin Lymphoma,0.9547,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9468,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9457,Angioimmunoblastic T-Cell Lymphoma,0.9447
PERIPHERAL_T_CELL_LYMPHOMA_UNSPECIFIED,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",1,2,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.9821,T-Cell Non-Hodgkin Lymphoma,0.9508,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9438,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.9427,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.9425
"PERITONEAL CANCER, NOS",Malignant Peritoneal Neoplasm,1,2,Malignant Peritoneal Neoplasm,0.9518,Peritoneal Mesothelioma,0.9455,Malignant Ovarian Clear Cell Tumor,0.9336,Ovarian Carcinoma,0.9332,Ovarian Small Cell Carcinoma,0.9319
PERITONEAL MESOTHELIOMA,Peritoneal Mesothelioma,1,2,Peritoneal Mesothelioma,1.0000,Pleural Mesothelioma,0.9677,Mesothelioma,0.9657,Peritoneum,0.9486,Testicular mesothelioma,0.9444
PERITONEAL SEROUS CARCINOMA,Malignant Peritoneal Neoplasm,4,2,Serous Adenocarcinoma,0.9565,Ovarian Serous Adenocarcinoma,0.9563,Endometrial Serous Adenocarcinoma,0.9508,Malignant Peritoneal Neoplasm,0.9475,Serous Cystadenocarcinoma,0.9468
PERITONEUM,Peritoneum,1,2,Peritoneum,1.0000,Peritoneal Mesothelioma,0.9486,Omentum,0.9221,Abdominal Wall,0.9210,Abdomen,0.9208
PERIVASCULAR EPITHELIOID CELL TUMOR,PEComa,99,2,Epithelioid Trophoblastic Tumor,0.9563,Epithelioid Cell<;>Spindle Cell Neoplasm,0.9548,Epithelioid Cell,0.9500,Epithelioid Sarcoma,0.9452,Epithelioid Hemangioendothelioma,0.9421
PFA,"Posterior Fossa Ependymoma, Group A (PFA)",1,2,"Posterior Fossa Ependymoma, Group A (PFA)",0.9253,"Posterior Fossa Ependymoma, Group B (PFB)",0.9170,Fibromatosis,0.9090,FOXA1 Gene,0.9062,immortal embryo-derived fibroblast cell line cell,0.9059
PFB,"Posterior Fossa Ependymoma, Group B (PFB)",1,2,"Posterior Fossa Ependymoma, Group B (PFB)",0.9462,"Posterior Fossa Ependymoma, Group A (PFA)",0.9143,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9112,Fibromatosis,0.9091,FOXA1 Gene,0.9090
PH+-ALL,B Acute Lymphoblastic Leukemia with t(9<;>22)(q34.1<;>q11.2)<;> BCR-ABL1,99,2,"Astrocytoma, IDH-Mutant, Grade 3",0.8969,"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",0.8958,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.8956,"Astrocytoma, IDH-Mutant, Grade 4",0.8953,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.8947
PH-LIKEALL,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,99,2,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.9031,Normal Breast-Like Subtype of Breast Carcinoma,0.9020,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9017,Poorly Differentiated,0.8999,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.8973
PHARYNX,Pharynx,1,2,Pharynx,1.0000,Pharyngeal Squamous Cell Carcinoma,0.9048,Stomach,0.9040,Head and Neck,0.9038,Fibroblast<;>upper aerodigestive tract,0.9030
PHEOCHROMOCYTOMA,Adrenal Gland Pheochromocytoma,1,2,Adrenal Gland Pheochromocytoma,0.9778,Adrenal Gland Pheochromocytoma<;>Paraganglioma,0.9631,Extra-Adrenal Pheochromocytoma,0.9572,Extra-Adrenal Sympathetic Paraganglioma,0.9408,Adrenal Gland Neoplasm,0.9347
PHYLLODES,Phyllodes Tumor,1,2,Phyllodes Tumor,0.9604,Benign Breast Phyllodes Tumor,0.9481,Malignant Breast Phyllodes Tumor,0.9477,Borderline Breast Phyllodes Tumor,0.9388,Linitis Plastica,0.9049
PH_POSITIVE,Philadelphia Chromosome Positive,1,2,Philadelphia Chromosome Positive,0.9271,Estrogen Receptor Positive,0.9226,HER2/Neu Positive,0.9223,Estrogen Receptor Negative<;>HER2/Neu Positive,0.9187,Estrogen Receptor Positive<;>HER2/Neu Positive,0.9175
PILOCYTIC ASTROCYTOMA,Pilocytic Astrocytoma,1,2,Pilocytic Astrocytoma,1.0000,Pilomyxoid Astrocytoma,0.9666,Astrocytoma,0.9484,Pilomatrical Carcinoma,0.9381,Anaplastic Astrocytoma,0.9322
PILOMATRIX CARCINOMA,Pilomatrical Carcinoma,1,2,Pilomatrical Carcinoma,0.9847,Penile Carcinoma,0.9391,Papillary Carcinoma,0.9358,Prostate Carcinoma,0.9356,Squamous Cell Carcinoma of the Penis,0.9345
PILOMYXOID ASTROCYTOMA,Pilomyxoid Astrocytoma,1,2,Pilomyxoid Astrocytoma,1.0000,Pilocytic Astrocytoma,0.9666,Astrocytoma,0.9344,Pilomatrical Carcinoma,0.9220,Myxopapillary Ependymoma,0.9202
PINEAL GERM CELL TUMOR,Pineal Region Germ Cell Tumor,1,2,Pineal Region Germ Cell Tumor,0.9835,Germ Cell Tumor,0.9745,Testicular Germ Cell Tumor,0.9649,Ovarian Germ Cell Tumor,0.9615,Childhood Brain Germ Cell Tumor,0.9581
PINEAL PARENCHYMAL TUMOR OF INTERMEDIATE DIFFERENTIATION,Pineal Parenchymal Tumor of Intermediate Differentiation,1,2,Pineal Parenchymal Tumor of Intermediate Differentiation,1.0000,Pineal Region Germ Cell Tumor,0.9407,Pineal Region Neoplasm,0.9374,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.9295,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.9245
PINEAL TUMOR,Pineal Region Neoplasm,1,2,Pineal Region Neoplasm,0.9654,Pineal Region Germ Cell Tumor,0.9619,Pineal Parenchymal Tumor of Intermediate Differentiation,0.9511,Pituitary Neuroendocrine Tumor,0.9414,Rhabdoid Tumor,0.9404
PINEOBLASTOMA,Pineoblastoma,1,2,Pineoblastoma,1.0000,Hemangioblastoma,0.9353,Hepatoblastoma,0.9323,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9300,Medulloblastoma,0.9243
PITUICYTOMA,Pituicytoma,1,2,Pituicytoma,1.0000,Pleomorphic Xanthoastrocytoma,0.9247,Anaplastic Pleomorphic Xanthoastrocytoma,0.9198,Plasmacytoma,0.9172,Chondroblastoma,0.9162
PITUITARY ADENOMA,Pituitary Neuroendocrine Tumor,1,2,Pituitary Neuroendocrine Tumor,0.9498,Adrenal Cortical Adenoma,0.9446,Hepatocellular Adenoma,0.9439,Adrenal Gland Neoplasm,0.9329,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9322
PLASMA CELL MYELOMA,Plasma Cell Myeloma,1,2,Plasma Cell Myeloma,1.0000,Plasma Cell Myeloma<;>Plasmacytoma,0.9800,Plasma Cell Leukemia,0.9731,Plasmacytoma,0.9642,plasmacytoid variant infiltrating bladder urothelial carcinoma,0.9454
PLASMACYTOID/SIGNET RING CELL BLADDER CARCINOMA,plasmacytoid variant infiltrating bladder urothelial carcinoma,3,2,Pancreatic Signet Ring Cell Carcinoma,0.9685,Signet Ring Cell Carcinoma,0.9658,plasmacytoid variant infiltrating bladder urothelial carcinoma,0.9605,Appendix Signet Ring Cell Carcinoma,0.9569,Signet Ring Adenocarcinoma Cell,0.9556
PLASMACYTOID/SIGNET RING CELL BLADDER CARCINOMA,plasmacytoid variant infiltrating bladder urothelial carcinoma,3,2,Pancreatic Signet Ring Cell Carcinoma,0.9652,Signet Ring Cell Carcinoma,0.9620,plasmacytoid variant infiltrating bladder urothelial carcinoma,0.9606,Appendix Signet Ring Cell Carcinoma,0.9539,Rectal Signet Ring Cell Adenocarcinoma<;>Colon Signet Ring Cell Adenocarcinoma,0.9525
PLASMACYTOMA,Plasmacytoma,1,2,Plasmacytoma,1.0000,Plasma Cell Myeloma<;>Plasmacytoma,0.9713,Plasma Cell Myeloma,0.9642,Plasma Cell Leukemia,0.9533,plasmacytoid variant infiltrating bladder urothelial carcinoma,0.9500
PLASMA_CELL_LEUKEMIA,Plasma Cell Leukemia,1,2,Plasma Cell Leukemia,0.9914,Plasma Cell Myeloma,0.9637,Plasma Cell Myeloma<;>Plasmacytoma,0.9556,Leukemia,0.9462,Plasmacytoma,0.9455
PLASMA_CELL_MYELOMA,Plasma Cell Myeloma,1,2,Plasma Cell Myeloma,0.9910,Plasma Cell Myeloma<;>Plasmacytoma,0.9806,Plasma Cell Leukemia,0.9637,Plasmacytoma,0.9591,Smoldering Plasma Cell Myeloma,0.9468
PLEOMORPHIC 'MFH' / UNDIFFERENTIATED PLEOMORPHIC SARCOMA,Undifferentiated Pleomorphic Sarcoma,2,2,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.9664,Undifferentiated Pleomorphic Sarcoma,0.9603,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.9585,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.9433,Pleomorphic Rhabdomyosarcoma,0.9432
PLEOMORPHIC CARCINOMA OF THE LUNG,Lung Pleomorphic Carcinoma,1,2,Lung Pleomorphic Carcinoma,0.9950,Pleomorphic Hepatocellular Carcinoma,0.9783,Pleomorphic Liposarcoma,0.9678,Pleomorphic Rhabdomyosarcoma,0.9613,Lung Carcinoma,0.9551
PLEOMORPHIC HEPATOCELLULAR CARCINOMA,Pleomorphic Hepatocellular Carcinoma,1,2,Pleomorphic Hepatocellular Carcinoma,1.0000,Lung Pleomorphic Carcinoma,0.9732,Pleomorphic Liposarcoma,0.9592,Pleomorphic Rhabdomyosarcoma,0.9586,Hepatocellular Carcinoma,0.9515
PLEOMORPHIC LIPOSARCOMA,Pleomorphic Liposarcoma,1,2,Pleomorphic Liposarcoma,1.0000,Pleomorphic Rhabdomyosarcoma,0.9751,Lung Pleomorphic Carcinoma,0.9634,Pleomorphic Hepatocellular Carcinoma,0.9592,Liposarcoma,0.9587
PLEOMORPHIC RHABDOMYOSARCOMA,Pleomorphic Rhabdomyosarcoma,1,2,Pleomorphic Rhabdomyosarcoma,1.0000,Pleomorphic Liposarcoma,0.9751,Pleomorphic Hepatocellular Carcinoma,0.9586,Rhabdomyosarcoma,0.9546,Undifferentiated Pleomorphic Sarcoma,0.9542
PLEOMORPHIC SARCOMA,Undifferentiated Pleomorphic Sarcoma,3,2,Pleomorphic Liposarcoma,0.9751,Pleomorphic Rhabdomyosarcoma,0.9746,Undifferentiated Pleomorphic Sarcoma,0.9678,Lung Pleomorphic Carcinoma,0.9608,Pleomorphic Hepatocellular Carcinoma,0.9570
PLEOMORPHIC XANTHOASTROCYTOMA,Pleomorphic Xanthoastrocytoma,1,2,Pleomorphic Xanthoastrocytoma,1.0000,Anaplastic Pleomorphic Xanthoastrocytoma,0.9822,Pleomorphic Rhabdomyosarcoma,0.9404,Pleomorphic Hepatocellular Carcinoma,0.9399,Pleomorphic Liposarcoma,0.9388
PLEOMORPHIC_SARCOMA,Undifferentiated Pleomorphic Sarcoma,3,2,Pleomorphic Rhabdomyosarcoma,0.9692,Pleomorphic Liposarcoma,0.9681,Undifferentiated Pleomorphic Sarcoma,0.9638,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.9560,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.9549
PLEURA,Pleura,1,2,Pleura,1.0000,Pleural Mesothelioma,0.9433,Pleural Fluid,0.9421,Pleomorphic Rhabdomyosarcoma,0.9264,Pleuropulmonary Blastoma,0.9233
"PLEURAL CANCER, NOS",Malignant Pleural Neoplasm,1,2,Malignant Pleural Neoplasm,0.9578,Pleural Mesothelioma,0.9499,Pleural Sarcomatoid Mesothelioma,0.9433,Breast Ductal Carcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9404,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9384
PLEURAL FLUID,Pleural Fluid,1,2,Pleural Fluid,1.0000,Pleural Mesothelioma,0.9441,Pleura,0.9421,Breast Ductal Carcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9195,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9183
PLEURAL MESOTHELIOMA,Pleural Mesothelioma,1,2,Pleural Mesothelioma,1.0000,Mesothelioma,0.9769,Peritoneal Mesothelioma,0.9677,Pleural Sarcomatoid Mesothelioma,0.9634,Pleural Epithelioid Mesothelioma,0.9587
"PLEURAL MESOTHELIOMA, BIPHASIC TYPE",Pleural Biphasic Mesothelioma,1,2,Pleural Biphasic Mesothelioma,0.9825,Biphasic Mesothelioma,0.9701,Pleural Mesothelioma,0.9454,Pleural Sarcomatoid Mesothelioma,0.9404,Pleural Epithelioid Mesothelioma,0.9384
"PLEURAL MESOTHELIOMA, EPITHELIOID TYPE",Pleural Epithelioid Mesothelioma,1,2,Pleural Epithelioid Mesothelioma,0.9763,Epithelioid Mesothelioma,0.9652,Pleural Mesothelioma,0.9546,Pleural Sarcomatoid Mesothelioma,0.9426,Mesothelioma,0.9423
"PLEURAL MESOTHELIOMA, SARCOMATOID TYPE",Pleural Sarcomatoid Mesothelioma,1,2,Pleural Sarcomatoid Mesothelioma,0.9818,Sarcomatoid Mesothelioma,0.9704,Pleural Mesothelioma,0.9565,Lung Sarcomatoid Carcinoma,0.9520,Pleural Epithelioid Mesothelioma,0.9476
PLEUROPULMONARY BLASTOMA,Pleuropulmonary Blastoma,1,2,Pleuropulmonary Blastoma,1.0000,Malignant Pleural Neoplasm,0.9363,Blastic Plasmacytoid Dendritic Cell Neoplasm,0.9334,Undifferentiated Pleomorphic Sarcoma,0.9264,Lung Pleomorphic Carcinoma,0.9261
PLEUROPULMONARY BLASTOMA PPB,Pleuropulmonary Blastoma,1,2,Pleuropulmonary Blastoma,0.9863,Blastic Plasmacytoid Dendritic Cell Neoplasm,0.9293,Malignant Pleural Neoplasm,0.9264,Lung Pleomorphic Carcinoma,0.9194,Acute Promyelocytic Leukemia with PML-RARA,0.9173
PLEUROPULMORY BLASTOMA PPB,Pleuropulmonary Blastoma,1,2,Pleuropulmonary Blastoma,0.9759,Blastic Plasmacytoid Dendritic Cell Neoplasm,0.9297,Malignant Pleural Neoplasm,0.9233,Malignant PEComa,0.9200,Pleural Biphasic Mesothelioma,0.9184
PLEXIFORM FIBROHISTIOCYTIC TUMOR,Plexiform Fibrohistiocytic Tumor,1,2,Plexiform Fibrohistiocytic Tumor,1.0000,Plexiform Neurofibroma,0.9540,Plexiform Schwannoma,0.9539,Ossifying Fibromyxoid Tumor,0.9339,Fibrolamellar Carcinoma,0.9327
PLEXIFORM NEUROFIBROMA,Plexiform Neurofibroma,1,2,Plexiform Neurofibroma,1.0000,Plexiform Schwannoma,0.9809,Neurofibroma,0.9542,Plexiform Fibrohistiocytic Tumor,0.9540,Melanotic Schwannoma,0.9195
PLEXIFORM SCHWANNOMA,Plexiform Schwannoma,1,2,Plexiform Schwannoma,1.0000,Plexiform Neurofibroma,0.9809,Plexiform Fibrohistiocytic Tumor,0.9539,Schwannoma,0.9429,Melanotic Schwannoma,0.9400
PLMESO,Pleural Mesothelioma,99,2,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.8955,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.8908,"Posterior Fossa Ependymoma, Group A (PFA)",0.8903,Linitis Plastica,0.8894,Plasmacytoma,0.8886
PML-RARA,PML-RARA Fusion Protein Expression,1,2,PML-RARA Fusion Protein Expression,0.9643,Acute Promyelocytic Leukemia with PML-RARA,0.9623,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.9256,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9186,Acute Myeloid Leukemia with MLL Rearrangement,0.9173
PNET,Primitive Neuroectodermal Tumor,4,2,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.9144,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9093,Peripheral Nervous System,0.9083,Primitive Neuroectodermal Tumor,0.9058,Peripheral Primitive Neuroectodermal Tumor,0.9057
POLE ULTRA-MUTATED,POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma,1,2,POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma,0.9519,Colon Adenocarcinoma<;>POLE Gene Mutation,0.9410,Endometrial Carcinoma<;>POLE Gene Mutation,0.9395,Rectal Adenocarcinoma<;>POLE Gene Mutation,0.9372,Esophageal Adenocarcinoma<;>POLE Gene Mutation,0.9351
POLYCYTHAEMIA VERA MYELOFIBROSIS,Polycythemia Vera<;>Myelofibrosis,1,2,Polycythemia Vera<;>Myelofibrosis,0.9915,Polycythemia Vera,0.9690,Essential Thrombocythemia<;>Myelofibrosis,0.9415,Myelodysplastic/Myeloproliferative Neoplasm,0.9382,Primary Myelofibrosis,0.9350
POLYCYTHEMIA VERA,Polycythemia Vera,1,2,Polycythemia Vera,1.0000,Polycythemia Vera<;>Myelofibrosis,0.9637,Erythroleukemia,0.9145,Hemangioma,0.9034,Hemangioblastoma,0.8977
POOR RISK CYTOGENETIC ABNORMALITY,Cytogenetic Abnormality<;>Low Risk,1,2,Cytogenetic Abnormality<;>Low Risk,0.9742,Cytogenetic Abnormality<;>Intermediate Risk,0.9616,MLL Gene Translocation<;>Low Risk,0.9371,"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",0.9312,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.9264
POORLY DIFFERENTIATED,Poorly Differentiated,1,2,Poorly Differentiated,1.0000,Poorly Differentiated Adenocarcinoma,0.9697,Carcinoma<;>Poorly Differentiated,0.9631,Adenocarcinoma<;>Poorly Differentiated,0.9609,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9567
POORLY DIFFERENTIATED ADENOCARCINOMA,Poorly Differentiated Adenocarcinoma,1,2,Poorly Differentiated Adenocarcinoma,1.0000,Adenocarcinoma<;>Poorly Differentiated,0.9916,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9852,Carcinoma<;>Poorly Differentiated,0.9769,Adenocarcinoma<;>Well Differentiated,0.9756
POORLY DIFFERENTIATED CARCINOMA,Carcinoma<;>Poorly Differentiated,1,2,Carcinoma<;>Poorly Differentiated,0.9913,Poorly Differentiated Adenocarcinoma,0.9857,Poorly Differentiated Thyroid Gland Carcinoma,0.9773,Adenocarcinoma<;>Poorly Differentiated,0.9765,Gastric Carcinoma<;>Poorly Differentiated,0.9724
POORLY DIFFERENTIATED CARCINOMA OF THE STOMACH,Gastric Carcinoma<;>Poorly Differentiated,1,2,Gastric Carcinoma<;>Poorly Differentiated,0.9888,Carcinoma<;>Poorly Differentiated,0.9770,Poorly Differentiated Adenocarcinoma,0.9769,Adenocarcinoma<;>Poorly Differentiated,0.9725,Poorly Differentiated Thyroid Gland Carcinoma,0.9703
"POORLY DIFFERENTIATED CARCINOMA, NOS",Carcinoma<;>Poorly Differentiated,1,2,Carcinoma<;>Poorly Differentiated,0.9777,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9674,Poorly Differentiated Adenocarcinoma,0.9669,Poorly Differentiated Thyroid Gland Carcinoma,0.9655,Squamous Cell Carcinoma<;>Poorly Differentiated,0.9649
POORLY DIFFERENTIATED NEC,Neuroendocrine Carcinoma<;>Poorly Differentiated,2,2,Poorly Differentiated,0.9516,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.9511,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9400,Carcinoma<;>Poorly Differentiated,0.9326,Poorly Differentiated Adenocarcinoma,0.9320
POORLY DIFFERENTIATED NON-SMALL CELL LUNG CANCER,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,1,2,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9920,Lung Non-Small Cell Carcinoma,0.9789,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9779,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9720,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9698
POORLY DIFFERENTIATED ONCOCYTIC CARCINOMA,Oncocytic Variant Thyroid Gland Papillary Carcinoma,3,2,Carcinoma<;>Poorly Differentiated,0.9638,Thyroid Gland Oncocytic Carcinoma,0.9628,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.9623,Poorly Differentiated Adenocarcinoma,0.9607,Oncocytic Neoplasm,0.9602
POORLY DIFFERENTIATED OR PLEOMORPHIC OR EPITHELIOID LEIOMYOSARCOMA,Leiomyosarcoma,99,2,Well Differentiated Leiomyosarcoma,0.9605,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.9566,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9539,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.9535,Squamous Cell Carcinoma<;>Poorly Differentiated,0.9501
POORLY DIFFERENTIATED PANCREATIC ADENOCARCINOMA,Pancreatic Adenocarcinoma<;>Poorly Differentiated Adenocarcinoma Cell,1,2,Pancreatic Adenocarcinoma<;>Poorly Differentiated Adenocarcinoma Cell,0.9875,Poorly Differentiated Adenocarcinoma,0.9865,Adenocarcinoma<;>Poorly Differentiated,0.9810,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9773,Adenocarcinoma<;>Well Differentiated,0.9694
POORLY DIFFERENTIATED THYROID CANCER,Poorly Differentiated Thyroid Gland Carcinoma,1,2,Poorly Differentiated Thyroid Gland Carcinoma,0.9929,Differentiated Thyroid Gland Carcinoma,0.9678,Carcinoma<;>Poorly Differentiated,0.9654,Poorly Differentiated Adenocarcinoma,0.9622,Thyroid Gland Carcinoma,0.9610
POORLY DIFFERENTIATED THYROID CARCINOMA,Poorly Differentiated Thyroid Gland Carcinoma,1,2,Poorly Differentiated Thyroid Gland Carcinoma,0.9970,Carcinoma<;>Poorly Differentiated,0.9739,Differentiated Thyroid Gland Carcinoma,0.9719,Thyroid Gland Carcinoma,0.9654,Poorly Differentiated Adenocarcinoma,0.9650
POORLY_COHESIVE,Gastric Poorly Cohesive Adenocarcinoma,1,2,Gastric Poorly Cohesive Adenocarcinoma,0.9457,Poorly Differentiated,0.9330,Carcinoma<;>Poorly Differentiated,0.9239,Squamous Cell Carcinoma<;>Poorly Differentiated,0.9178,Poorly Differentiated Adenocarcinoma,0.9173
POORLY_DIFFERENTIATED_GASTRIC CARCINOMA,Gastric Carcinoma<;>Poorly Differentiated,1,2,Gastric Carcinoma<;>Poorly Differentiated,0.9925,Carcinoma<;>Poorly Differentiated,0.9717,Poorly Differentiated Adenocarcinoma,0.9695,Adenocarcinoma<;>Poorly Differentiated,0.9661,Poorly Differentiated Thyroid Gland Carcinoma,0.9639
POROCARCINOMA/SPIROADENOCARCINOMA,Porocarcinoma,1,2,Porocarcinoma,0.9689,Papillary Serous Cystadenocarcinoma,0.9305,Serous Cystadenocarcinoma,0.9268,Cystadenocarcinoma,0.9266,Cystadenocarcinoma<;>Endometrioid Adenocarcinoma,0.9264
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS,Post-Transplant Lymphoproliferative Disorder,1,2,Post-Transplant Lymphoproliferative Disorder,0.9806,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.9595,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.9294,Angioimmunoblastic T-Cell Lymphoma,0.9198,Monoclonal B-Cell Lymphocytosis,0.9176
PRAD,Prostate Adenocarcinoma,99,2,Prostate Acinar Adenocarcinoma<;>Cribriform,0.9010,Peritoneum,0.8962,Gastric Adenocarcinoma<;>POLE Gene Mutation,0.8960,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.8958,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.8954
PRE-T,T Lymphoblastic Leukemia/Lymphoma,99,2,T-Lymphocyte,0.9118,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.9086,Post-Transplant Lymphoproliferative Disorder,0.9059,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.9041,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9035
PRIMARY,Primary,1,2,Primary,1.0000,Primary Myelofibrosis,0.9259,Limited Stage<;>Primary,0.9240,Primary Neoplasm,0.9214,Primary Effusion Lymphoma,0.9201
PRIMARY CNS MELANOMA,Central Nervous System Melanoma,3,2,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9499,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9426,Central Nervous System Melanoma,0.9422,Melanoma of Unknown Primary,0.9414,Primary Neoplasm,0.9376
PRIMARY CUTANEOUS CD30 POSITIVE T-CELL LYMPHOPROLIFERATIVE DISORDERS,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,1,2,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.9991,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9675,Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma,0.9671,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9513,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9471
PRIMARY CUTANEOUS CD8 POSITIVE AGGRESSIVE EPIDERMOTROPIC CYTOTOXIC T-CELL LYMPHOMA,Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma,1,2,Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma,0.9997,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.9664,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9647,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9541,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9424
PRIMARY DLBCL OF THE CNS,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1,2,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9701,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9534,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9477,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.9458,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9424
PRIMARY EFFUSION LYMPHOMA,Primary Effusion Lymphoma,1,2,Primary Effusion Lymphoma,1.0000,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.9808,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9501,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9410,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9396
PRIMARY ESOPHAGUS,Gastroesophageal Cancer<;>Primary Neoplasm,3,2,Primary,0.9551,Esophagus,0.9412,Gastroesophageal Cancer<;>Primary Neoplasm,0.9294,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9227,Primary Effusion Lymphoma,0.9220
PRIMARY MEDIASTINAL THYMIC DLBCL,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,1,2,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9771,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9705,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9391,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9388,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.9315
PRIMARY MEDIASTINAL THYMIC LARGE B-CELL LYMPHOMA,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,1,2,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9973,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9849,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9628,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9591,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.9554
PRIMARY MYELOFIBROSIS,Primary Myelofibrosis,1,2,Primary Myelofibrosis,1.0000,Secondary Myelofibrosis,0.9679,Overt Primary Myelofibrosis,0.9622,Polycythemia Vera<;>Myelofibrosis,0.9349,Essential Thrombocythemia<;>Myelofibrosis,0.9345
"PRIMARY MYELOFIBROSIS,OVERT FIBROTIC STAGE",Overt Primary Myelofibrosis,1,2,Overt Primary Myelofibrosis,0.9739,Primary Myelofibrosis,0.9616,Secondary Myelofibrosis,0.9411,Polycythemia Vera<;>Myelofibrosis,0.9325,Essential Thrombocythemia<;>Myelofibrosis,0.9310
PRIMARY NEUROEPITHELIAL TUMOR,Neuroepithelial Neoplasm,1,2,Neuroepithelial Neoplasm,0.9608,Neuroepithelial Neoplasm<;>High Grade,0.9587,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.9472,Dysembryoplastic Neuroepithelial Tumor,0.9460,Primary Neoplasm,0.9433
PRIMARY RESIDUAL,Primary Neoplasm,99,2,Primary,0.9397,Limited Stage<;>Primary,0.9148,Residual Nodal Disease,0.9072,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9043,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9029
PRIMARY TUMOR UNPAIRED,Primary Neoplasm<;>Unpaired,1,2,Primary Neoplasm<;>Unpaired,0.9798,Primary Neoplasm<;>Paired,0.9568,Primary Neoplasm,0.9442,Melanoma of Unknown Primary,0.9308,Gastroesophageal Cancer<;>Primary Neoplasm,0.9277
PRIMARY TUMOUR,Primary Neoplasm,1,2,Primary Neoplasm,0.9748,Primary Neoplasm<;>Paired,0.9507,Gastroesophageal Cancer<;>Primary Neoplasm,0.9475,Metastatic Colorectal Carcinoma<;>Primary,0.9466,Primary Neoplasm<;>Unpaired,0.9464
PRIMITIVE NEUROECTODERMAL TUMOR,Primitive Neuroectodermal Tumor,1,2,Primitive Neuroectodermal Tumor,1.0000,Peripheral Primitive Neuroectodermal Tumor,0.9840,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9773,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.9771,Dysembryoplastic Neuroepithelial Tumor,0.9399
PRIMITIVE NEUROECTODERMAL TUMOR PNET,Primitive Neuroectodermal Tumor,1,2,Primitive Neuroectodermal Tumor,0.9832,Peripheral Primitive Neuroectodermal Tumor,0.9743,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.9686,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9654,Pancreatic Neuroendocrine Tumor,0.9407
PRIMITIVE NEUROECTODERMAL TUMOUR-MEDULLOBLASTOMA,Primitive Neuroectodermal Tumor<;>Medulloblastoma,1,2,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9909,Primitive Neuroectodermal Tumor,0.9751,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.9685,Peripheral Primitive Neuroectodermal Tumor,0.9626,Dysembryoplastic Neuroepithelial Tumor,0.9428
PRO MYELOCYTIC LEUKEMIA,Acute Promyelocytic Leukemia with PML-RARA,99,2,Myeloproliferative Neoplasm,0.9448,Myelodysplastic/Myeloproliferative Neoplasm,0.9425,Acute Myelomonocytic Leukemia,0.9348,Acute Myeloid Leukemia with Mutated CEBPA,0.9340,Acute Myeloid Leukemia with Mutated NPM1,0.9336
PROGRESSIVE FIRST HGG RECORD,Malignant Glioma<;>Progressive,1,2,Malignant Glioma<;>Progressive,0.9189,Low Grade Glioma<;>IDH Gene Family Mutation,0.8901,Solid<;>High Grade Transformation,0.8862,"Diffuse Midline Glioma, H3 K27M-Mutant",0.8853,Glioblastoma<;>IDH Gene Family Mutation,0.8852
PROSTATE,Prostate Gland,1,2,Prostate Gland,0.9801,Prostate Adenocarcinoma,0.9467,Prostate Carcinoma,0.9387,Prostate Acinar Adenocarcinoma,0.9348,Bone<;>Site of Metastasis<;>Prostate Adenocarcinoma,0.9328
PROSTATE ADENOCARCINOMA,Prostate Adenocarcinoma,1,2,Prostate Adenocarcinoma,1.0000,Prostate Ductal Adenocarcinoma,0.9735,Prostate Carcinoma,0.9726,Adenocarcinoma,0.9717,Prostate Acinar Adenocarcinoma,0.9716
PROSTATE ADENOCARCINOMA ACINAR TYPE,Prostate Acinar Adenocarcinoma,1,2,Prostate Acinar Adenocarcinoma,0.9759,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.9690,Pancreatic Acinar Cell Carcinoma,0.9565,Lung Acinar Adenocarcinoma,0.9559,Acinar Cell Carcinoma,0.9544
"PROSTATE ADENOCARCINOMA, NOT OTHERWISED SPECIFIED, WITH DUCTAL FEATUES",Prostate Ductal Adenocarcinoma,1,2,Prostate Ductal Adenocarcinoma,0.9522,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.9486,Pancreatic Ductal Adenocarcinoma,0.9433,Prostate Adenocarcinoma,0.9422,Pancreatic Adenocarcinoma<;>Poorly Differentiated Adenocarcinoma Cell,0.9416
"PROSTATE ADENOCARCINOMA, OTHER SUBTYPE",Prostate Adenocarcinoma,1,2,Prostate Adenocarcinoma,0.9657,"Lung Adenocarcinoma, Mixed Subtype",0.9568,Prostate Ductal Adenocarcinoma,0.9547,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.9537,Pancreatic Adenocarcinoma<;>Poorly Differentiated Adenocarcinoma Cell,0.9517
PROSTATE CANCER,Prostate Carcinoma,1,2,Prostate Carcinoma,0.9763,Prostate Adenocarcinoma,0.9659,Prostate Squamous Cell Carcinoma,0.9531,Prostate Neuroendocrine Carcinoma,0.9503,Castration-Resistant Prostate Carcinoma<;>Prostate Adenocarcinoma,0.9435
"PROSTATE CANCER, NOS",Prostate Carcinoma,1,2,Prostate Carcinoma,0.9484,Prostate Squamous Cell Carcinoma,0.9414,Prostate Adenocarcinoma,0.9398,Squamous Cell Carcinoma of the Penis,0.9378,Prostate Neuroendocrine Carcinoma,0.9374
PROSTATE HYPERPLASIA,Benign Prostatic Hyperplasia,1,2,Benign Prostatic Hyperplasia,0.9724,Prostate Adenocarcinoma,0.9395,Prostate Gland,0.9356,Prostate Carcinoma,0.9328,Prostate Ductal Adenocarcinoma,0.9289
PROSTATE NEUROENDOCRINE CARCINOMA,Prostate Neuroendocrine Carcinoma,1,2,Prostate Neuroendocrine Carcinoma,1.0000,Prostate Small Cell Neuroendocrine Carcinoma,0.9774,Neuroendocrine Carcinoma,0.9770,Castration-Resistant Prostate Carcinoma<;>Prostate Neuroendocrine Neoplasm,0.9679,Prostate Carcinoma,0.9667
PROSTATE SMALL CELL CARCINOMA,Prostate Small Cell Neuroendocrine Carcinoma,1,2,Prostate Small Cell Neuroendocrine Carcinoma,0.9809,Small Cell Adenocarcinoma,0.9750,Lung Small Cell Carcinoma,0.9734,Ovarian Small Cell Carcinoma,0.9650,Small Cell Neuroendocrine Carcinoma,0.9640
PROSTATE SQUAMOUS CELL CARCINOMA,Prostate Squamous Cell Carcinoma,1,2,Prostate Squamous Cell Carcinoma,1.0000,Squamous Cell Carcinoma of the Penis,0.9834,Squamous Cell Carcinoma,0.9795,Lung Squamous Cell Carcinoma,0.9764,Salivary Gland Squamous Cell Carcinoma,0.9740
PROSTATE; METASTATIC SITE: BRAIN; CARCINOMA PATIENT WITH METASTATIC CARCINOMA OF THE PROSTATE AND A 3 YEAR HISTORY OF LYMPHOCYTIC LEUKEMIA.,Brain<;>Site of Metastasis<;>Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,1,2,Brain<;>Site of Metastasis<;>Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,0.9747,Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,0.9629,Brain<;>Site of Metastasis,0.9465,Breast Ductal Carcinoma<;>Pleural Effusion<;>Site of Metastasis,0.9430,Bone<;>Site of Metastasis<;>Prostate Adenocarcinoma,0.9429
PROSTATE_ADENOCARCINOMA,Prostate Adenocarcinoma,1,2,Prostate Adenocarcinoma,0.9928,Prostate Ductal Adenocarcinoma,0.9695,Adenocarcinoma,0.9679,Prostate Carcinoma,0.9668,Prostate Acinar Adenocarcinoma,0.9666
PROSTATE_CANCER,Prostate Carcinoma,1,2,Prostate Carcinoma,0.9723,Prostate Adenocarcinoma,0.9644,Prostate Squamous Cell Carcinoma,0.9504,Prostate Neuroendocrine Carcinoma,0.9489,Prostate Ductal Adenocarcinoma,0.9421
PROSTATE_HYPERPLASIA,Benign Prostatic Hyperplasia,1,2,Benign Prostatic Hyperplasia,0.9692,Prostate Adenocarcinoma,0.9399,Prostate Gland,0.9354,Prostate Carcinoma,0.9330,Prostate Carcinoma<;>Incidental Finding,0.9327
PROSTATE_SMALL_CELL,Prostate Small Cell Neuroendocrine Carcinoma,2,2,Small Cell,0.9641,Prostate Small Cell Neuroendocrine Carcinoma,0.9609,Small Cell Adenocarcinoma,0.9522,"Malignant Tumor, Small Cell Type",0.9430,Lung Small Cell Carcinoma,0.9398
PROSTATIC ADENOCARCINOMA ACINAR TYPE MIXED WITH PROSTATIC DUCT ADENOCARCINOMA,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,1,2,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.9722,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9680,Prostate Acinar Adenocarcinoma,0.9631,Prostate Ductal Adenocarcinoma,0.9624,Pancreatic Ductal Adenocarcinoma,0.9553
PROXIMAL-TYPE EPITHELIOID SARCOMA,Proximal-Type Epithelioid Sarcoma,1,2,Proximal-Type Epithelioid Sarcoma,1.0000,Epithelioid Sarcoma,0.9532,Epithelioid Cell<;>Spindle Cell Neoplasm,0.9399,Epithelioid Mesothelioma,0.9334,Epithelioid Cell,0.9318
PROXIMAL-TYPE EPITHELIOID SARCOMA PTES,Proximal-Type Epithelioid Sarcoma,1,2,Proximal-Type Epithelioid Sarcoma,0.9824,Epithelioid Sarcoma,0.9330,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.9255,Epithelioid Cell<;>Spindle Cell Neoplasm,0.9253,Epithelioid Trophoblastic Tumor,0.9218
PSEUDOMYOGENIC HEMANGIOENDOTHELIOMA,Pseudomyogenic Hemangioendothelioma,1,2,Pseudomyogenic Hemangioendothelioma,1.0000,Epithelioid Hemangioendothelioma,0.9447,Hemangioma,0.9260,Malignant Myoepithelioma,0.9143,Hemangioblastoma,0.9142
PURE ERYTHROID LEUKEMIA,Pure Erythroid Leukemia,1,2,Pure Erythroid Leukemia,1.0000,Acute Erythroid Leukemia,0.9555,Erythroleukemia,0.9375,Acute Megakaryoblastic Leukemia,0.9285,Leukemia,0.9274
RA,Refractory Anemia,99,2,Acute Promyelocytic Leukemia with PML-RARA,0.9146,PML-RARA Fusion Protein Expression,0.9137,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9077,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9056,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.9051
RAEB,Myelodysplastic Syndrome with Excess Blasts,99,2,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.9071,Acute Promyelocytic Leukemia with PML-RARA,0.9067,PML-RARA Fusion Protein Expression,0.9060,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.9035,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9025
RAEB1,Myelodysplastic Syndrome with Excess Blasts-1,99,2,Acute Promyelocytic Leukemia with PML-RARA,0.9094,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.9080,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.9070,PML-RARA Fusion Protein Expression,0.9058,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9050
RARS,Myelodysplastic Syndrome with Ring Sideroblasts,99,2,PML-RARA Fusion Protein Expression,0.9226,Acute Promyelocytic Leukemia with PML-RARA,0.9167,Cribriform,0.9048,Rectum,0.9041,Prostate Acinar Adenocarcinoma<;>Cribriform,0.8942
RARS-T,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,99,2,PML-RARA Fusion Protein Expression,0.9164,Acute Promyelocytic Leukemia with PML-RARA,0.9138,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9068,T-Lymphocyte,0.9050,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9041
RBL,Retinoblastoma,1,2,Retinoblastoma,0.9273,EBV-Related Lymphoma,0.9085,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9049,B-Lymphocyte,0.8999,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.8954
RCMD,Myelodysplastic Syndrome with Multilineage Dysplasia,99,2,Rosai-Dorfman Disease,0.9034,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.8996,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.8973,Myelodysplastic Syndrome with Ring Sideroblasts,0.8963,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.8963
RCMD-RS,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,1,2,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.9021,Myelodysplastic Syndrome with Ring Sideroblasts,0.9006,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.8995,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.8994,Chondrosarcoma,0.8989
READ,Rectal Adenocarcinoma,99,2,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.8868,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.8843,Acute Myeloid Leukemia with Mutated RUNX1,0.8816,Cecum,0.8814,Ascending Colon,0.8785
READ_CIN,Rectal Adenocarcinoma<;>Chromosomal Instability,99,2,uterine corpus endometrial carcinoma<;>Copy Number<;>Low,0.9050,uterine corpus endometrial carcinoma<;>Copy Number<;>High,0.9047,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,0.9028,Human Papillomavirus Positive<;>Squamous Cell Carcinoma,0.9028,NUP98 Gene<;>Chromosomal Translocation,0.9006
READ_GS,Rectal Adenocarcinoma,99,2,Germ Cell,0.8946,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.8901,Nongerminomatous Germ Cell Tumor<;>Yolk Sac Tumor,0.8882,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.8873,Glioma,0.8867
READ_MSI,Rectal Adenocarcinoma<;>Microsatellite Instability,99,2,Adenocarcinoma<;>Well Differentiated<;>Rectum,0.8993,Mucosal Melanoma<;>Anorectal,0.8986,Colon Adenocarcinoma<;>POLE Gene Mutation,0.8984,Colon Carcinoma<;>Melanoma,0.8982,Rectal Adenocarcinoma<;>POLE Gene Mutation,0.8979
READ_POLE,Rectal Adenocarcinoma<;>POLE Gene Mutation,2,2,Endometrial Carcinoma<;>POLE Gene Mutation,0.9145,Rectal Adenocarcinoma<;>POLE Gene Mutation,0.9130,POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma,0.9123,Colon Adenocarcinoma<;>POLE Gene Mutation,0.9079,Esophageal Adenocarcinoma<;>POLE Gene Mutation,0.9044
RECTAL ADENOCARCINOMA,Rectal Adenocarcinoma,1,2,Rectal Adenocarcinoma,1.0000,Rectal Mucinous Adenocarcinoma,0.9730,Colorectal Adenocarcinoma,0.9669,Adenocarcinoma<;>Well Differentiated<;>Rectum,0.9600,Colon Adenocarcinoma,0.9578
RECTAL MUCINOUS ADENOCARCINOMA,Rectal Mucinous Adenocarcinoma,1,2,Rectal Mucinous Adenocarcinoma,1.0000,Rectal Mucinous Adenocarcinoma<;>Colon Mucinous Adenocarcinoma,0.9824,Mucinous Adenocarcinoma,0.9748,Colon Mucinous Adenocarcinoma,0.9744,Rectal Adenocarcinoma,0.9730
RECTOSIGMOID JUNCTION,Rectosigmoid Region,1,2,Rectosigmoid Region,0.9585,Rectum,0.9198,Rectal Mucinous Adenocarcinoma<;>Colon Mucinous Adenocarcinoma,0.9148,Rectal Mucinous Adenocarcinoma,0.9131,Hemangioblastoma<;>Cervicomedullary Junction,0.9106
RECTUM,Rectum,1,2,Rectum,1.0000,Rectal Adenocarcinoma,0.9490,Adenocarcinoma<;>Well Differentiated<;>Rectum,0.9371,Rectal Mucinous Adenocarcinoma,0.9279,Rectal Adenocarcinoma<;>POLE Gene Mutation,0.9262
RECTUM; ADENOCARCINOMA; WELL DIFFERENTIATED,Adenocarcinoma<;>Well Differentiated<;>Rectum,1,2,Adenocarcinoma<;>Well Differentiated<;>Rectum,0.9910,Adenocarcinoma<;>Well Differentiated,0.9784,Endometrial Adenocarcinoma<;>Well Differentiated,0.9665,Adenocarcinoma<;>Poorly Differentiated,0.9662,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9657
RECURRENCE,Recurrence,1,2,Recurrence,1.0000,Recurrent,0.9719,Regional<;>Recurrence,0.9609,Anastomosis<;>Recurrence,0.9570,Recurrent Endometrial Carcinoma,0.9439
RECURRENCE FIRST HGG RECORD,Recurrent Malignant Glioma,1,2,Recurrent Malignant Glioma,0.9140,First Relapse,0.9056,Low Grade Glioma<;>IDH Gene Family Mutation,0.9051,Recurrence,0.9026,Glioblastoma<;>IDH Gene Family Mutation,0.9014
RECURRENCE/PERSISTENT METASTASIC TUMOR TO LYMPH NODE,Metastatic Malignant Neoplasm in the Lymph Nodes<;>Recurrent,1,2,Metastatic Malignant Neoplasm in the Lymph Nodes<;>Recurrent,0.9784,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,0.9687,Metastatic Lesion<;>Recurrent,0.9644,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9604,"Neoplasm Recurrence, Local",0.9543
RECURRENT,Recurrent,1,2,Recurrent,1.0000,Recurrence,0.9719,Recurrent Endometrial Carcinoma,0.9499,Recurrent Malignant Glioma,0.9490,Recurrent Acute Myeloid Leukemia,0.9479
RECURRENT METASTATIC DISEASE,Metastatic Lesion<;>Recurrent,1,2,Metastatic Lesion<;>Recurrent,0.9844,Metastatic Malignant Neoplasm in the Lymph Nodes<;>Recurrent,0.9701,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9601,Locally Recurrent Malignant Neoplasm,0.9585,Recurrent Endometrial Carcinoma,0.9539
RECURRENT_ENDOMETRIAL_CARCINOMA,Recurrent Endometrial Carcinoma,1,2,Recurrent Endometrial Carcinoma,0.9949,Endometrial Carcinoma,0.9521,Locally Recurrent Malignant Neoplasm,0.9493,Recurrent,0.9459,Metastatic Lesion<;>Recurrent,0.9450
REFRACTORY ANAEMIA WITH EXCESS BLASTS,Myelodysplastic Syndrome with Excess Blasts,1,2,Myelodysplastic Syndrome with Excess Blasts,0.9577,Myelodysplastic Syndrome with Excess Blasts-2,0.9515,Myelodysplastic Syndrome with Excess Blasts-1,0.9508,Refractory Anemia,0.9445,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.9304
REFRACTORY ANEMIA,Refractory Anemia,1,2,Refractory Anemia,1.0000,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.8985,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.8975,Therapy-Related Myelodysplastic Syndrome,0.8964,Hypodiploidy,0.8937
REFRACTORY ANEMIA WITH EXCESS BLASTS-1,Myelodysplastic Syndrome with Excess Blasts-1,1,2,Myelodysplastic Syndrome with Excess Blasts-1,0.9655,Myelodysplastic Syndrome with Excess Blasts-2,0.9639,Myelodysplastic Syndrome with Excess Blasts,0.9563,Refractory Anemia,0.9470,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.9332
REFRACTORY ANEMIA WITH EXCESS BLASTS-2,Myelodysplastic Syndrome with Excess Blasts-2,1,2,Myelodysplastic Syndrome with Excess Blasts-2,0.9683,Myelodysplastic Syndrome with Excess Blasts-1,0.9618,Myelodysplastic Syndrome with Excess Blasts,0.9556,Refractory Anemia,0.9473,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.9362
REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA,Myelodysplastic Syndrome with Multilineage Dysplasia,2,2,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.9548,Myelodysplastic Syndrome with Multilineage Dysplasia,0.9541,Acute Myeloid Leukemia with Multilineage Dysplasia,0.9528,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.9477,Myelodysplastic Syndrome with Ring Sideroblasts,0.9359
REGIONAL CUTANEOUS OR SUBCUTANEOUS METASTASIS,Melanoma Involvement of Regional Cutaneous or Subcutaneous Tissue,1,2,Melanoma Involvement of Regional Cutaneous or Subcutaneous Tissue,0.9672,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,0.9558,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9521,Metastatic Lesion<;>Recurrent,0.9478,Metastatic Malignant Neoplasm in the Lymph Nodes<;>Recurrent,0.9472
REGIONAL LYMPH NODE METASTASIS,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,1,2,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,0.9751,Metastatic Malignant Neoplasm in the Lymph Nodes<;>Recurrent,0.9578,Regional<;>Recurrence,0.9479,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9383,Metastatic Lesion<;>Recurrent,0.9330
REGIONAL NODES,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,2,2,Regional<;>Recurrence,0.9384,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,0.9374,Metastatic Malignant Neoplasm in the Lymph Nodes<;>Recurrent,0.9230,Lymph Node,0.9224,Local-Regional,0.9215
REGIONAL RECURRENCE,Regional<;>Recurrence,1,2,Regional<;>Recurrence,0.9922,Recurrence,0.9636,"Neoplasm Recurrence, Local",0.9453,Anastomosis<;>Recurrence,0.9443,Recurrent,0.9438
REL CELL CARCINOMA,Renal Cell Carcinoma,99,2,Lung Large Cell Carcinoma,0.9325,Anal Squamous Cell Carcinoma,0.9306,Large Cell Carcinoma,0.9298,Carcinoma,0.9293,Lung Carcinoma,0.9291
"REL ONCOCYTIC NEOPLASM, FAVOR CHROMOPHOBE, EOSINOPHILIC",Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,1,2,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.9651,Chromophobe Renal Cell Carcinoma,0.9392,Oncocytic Neoplasm,0.9380,Classic Variant of Chromophobe Renal Cell Carcinoma,0.9379,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.9334
"REL ONCOCYTIC NEOPLASM, FAVOR ONCOCYTOMA",Kidney Oncocytoma,2,2,Oncocytic Neoplasm,0.9570,Kidney Oncocytoma,0.9435,Thyroid Gland Oncocytic Carcinoma,0.9401,Adrenal Cortical Oncocytic Carcinoma,0.9382,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.9379
RELA-FUSION,"Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive",1,2,"Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive",0.9343,PML-RARA Fusion Protein Expression,0.9148,PAX3/FOXO1 Fusion Gene,0.9131,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9130,CBFB-MYH11 Fusion Protein Expression,0.9120
RELAPSE,Relapse,1,2,Relapse,1.0000,First Relapse,0.9463,Recurrence,0.9417,Recurrent,0.9223,Anastomosis<;>Recurrence,0.9196
RELAPSED_AML,Recurrent Acute Myeloid Leukemia,3,2,Relapse,0.9465,Acute Lymphoblastic Leukemia<;>Recurrent Disease,0.9457,Recurrent Acute Myeloid Leukemia,0.9443,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.9378,Acute Myeloid Leukemia with Mutated RUNX1,0.9362
RENAL ANGIOMYOLIPOMA,Kidney Angiomyolipoma,1,2,Kidney Angiomyolipoma,0.9921,Renal Cell Carcinoma,0.9356,Breast Angiosarcoma,0.9319,Renal Cell Carcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9315,Renal Cell Carcinoma<;>Poorly Differentiated,0.9288
RENAL CANCER,Kidney Carcinoma,2,2,Renal Cell Carcinoma,0.9806,Kidney Carcinoma,0.9710,Clear Cell Renal Cell Carcinoma,0.9578,Kidney Medullary Carcinoma,0.9526,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.9493
"RENAL CARCINOMA, CLEAR CELL",Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.9951,Renal Cell Carcinoma,0.9809,Clear Cell Papillary Renal Neoplasm,0.9790,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9784,Clear Cell Adenocarcinoma,0.9734
"RENAL CARCINOMA, TRANSITIONAL CELL","Kidney Carcinoma, Transitional Cells",1,2,"Kidney Carcinoma, Transitional Cells",0.9902,Transitional Cell Carcinoma,0.9736,Renal Cell Carcinoma,0.9731,Clear Cell Renal Cell Carcinoma,0.9620,Papillary Transitional Cell Carcinoma,0.9582
RENAL CELL CARCINOMA,Renal Cell Carcinoma,1,2,Renal Cell Carcinoma,1.0000,Clear Cell Renal Cell Carcinoma,0.9807,Kidney Carcinoma,0.9799,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9675,Papillary Renal Cell Carcinoma,0.9666
RENAL CELL CARCINOMA-P/MD,Renal Cell Carcinoma<;>Poorly Differentiated<;>Moderately Differentiated,2,2,Renal Cell Carcinoma,0.9564,Renal Cell Carcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9542,Renal Cell Carcinoma<;>Poorly Differentiated,0.9528,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9498,Kidney Carcinoma,0.9481
RENAL CELL CARCINOMA-PD,Renal Cell Carcinoma<;>Poorly Differentiated,2,2,Renal Cell Carcinoma,0.9655,Renal Cell Carcinoma<;>Poorly Differentiated,0.9589,Renal Cell Carcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9572,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9570,Clear Cell Papillary Renal Neoplasm,0.9539
RENAL CELL CARCINOMA-VPD,Renal Cell Carcinoma<;>Poorly Differentiated,4,2,Renal Cell Carcinoma,0.9615,Papillary Renal Cell Carcinoma,0.9544,Renal Cell Carcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9523,Renal Cell Carcinoma<;>Poorly Differentiated,0.9505,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9472
RENAL CLEAR CELL,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.9809,Clear Cell Papillary Renal Neoplasm,0.9672,Clear Cell,0.9669,Renal Cell Carcinoma,0.9650,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9601
RENAL CLEAR CELL CARCINOMA,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.9968,Renal Cell Carcinoma,0.9875,Clear Cell Papillary Renal Neoplasm,0.9779,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9744,Kidney Carcinoma,0.9705
RENAL CLEAR CELL CARCINOMA WITH SARCOMATOID FEATURES,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,1,2,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.9861,Sarcomatoid Renal Cell Carcinoma,0.9806,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9647,Renal Cell Carcinoma,0.9641,Clear Cell Renal Cell Carcinoma,0.9632
RENAL LEIOMYOBLASTOMA,Bizarre Leiomyoma<;>Kidney Leiomyoma,99,2,Leiomyosarcoma,0.9471,Renal Cell Carcinoma,0.9461,Kidney Angiomyolipoma,0.9416,Sarcomatoid Renal Cell Carcinoma,0.9370,Renal Cell Carcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9368
RENAL MEDULLARY CARCINOMA,Kidney Medullary Carcinoma,1,2,Kidney Medullary Carcinoma,0.9921,Medullary Carcinoma,0.9780,Renal Cell Carcinoma,0.9693,Colon Medullary Carcinoma,0.9660,Breast Medullary Carcinoma,0.9651
RENAL MUCINOUS TUBULAR SPINDLE CELL CARCINOMA,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1,2,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,0.9892,Renal Cell Carcinoma,0.9624,Sarcomatoid Renal Cell Carcinoma,0.9521,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.9512,"Kidney Carcinoma, Transitional Cells",0.9497
RENAL NON-CLEAR CELL CARCINOMA,Renal Cell Carcinoma,2,2,Clear Cell Renal Cell Carcinoma,0.9783,Renal Cell Carcinoma,0.9749,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9725,Clear Cell Papillary Renal Neoplasm,0.9681,Non-Small Cell Carcinoma,0.9630
RENAL ONCOCYTOMA,Kidney Oncocytoma,1,2,Kidney Oncocytoma,0.9909,Oncocytic Neoplasm,0.9567,Adrenal Cortical Oncocytic Carcinoma,0.9555,Renal Cell Carcinoma,0.9485,Thyroid Gland Oncocytic Carcinoma,0.9442
RENAL SPINDLE CELL CARCINOMA,Sarcomatoid Carcinoma,99,2,Renal Cell Carcinoma,0.9688,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,0.9677,Lung Spindle Cell Carcinoma,0.9644,Sarcomatoid Renal Cell Carcinoma,0.9627,Spindle Cell Neoplasm,0.9606
RENAL_CELL_CARCINOMA,Renal Cell Carcinoma,1,2,Renal Cell Carcinoma,0.9948,Clear Cell Renal Cell Carcinoma,0.9761,Kidney Carcinoma,0.9748,Renal Cell Carcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9682,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9679
RENAL_LEIOMYOBLASTOMA,Bizarre Leiomyoma<;>Kidney Leiomyoma,99,2,Leiomyosarcoma,0.9459,Renal Cell Carcinoma,0.9445,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.9411,Sarcomatoid Renal Cell Carcinoma,0.9384,Renal Cell Carcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9381
RESECTION,Resection,1,2,Resection,1.0000,Transurethral Resection of Bladder Tumor,0.9198,Surgical Procedure,0.9178,Anastomosis<;>Recurrence,0.9130,Cystectomy,0.9040
RESIDUAL NODAL DISEASE,Residual Nodal Disease,1,2,Residual Nodal Disease,1.0000,Metastatic Malignant Neoplasm in the Lymph Nodes<;>Recurrent,0.9309,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,0.9285,"Neoplasm Recurrence, Local",0.9204,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9174
RETINOBLASTOMA,Retinoblastoma,1,2,Retinoblastoma,1.0000,Rhabdomyosarcoma,0.9323,Medulloblastoma,0.9283,Trilateral Retinoblastoma,0.9238,Botryoid-Type Embryonal Rhabdomyosarcoma,0.9185
RHABDOID CANCER,Rhabdoid Tumor,1,2,Rhabdoid Tumor,0.9782,Rhabdoid Tumor<;>Extracranial,0.9371,Atypical Teratoid/Rhabdoid Tumor,0.9277,Extrarenal Rhabdoid Tumor,0.9212,Renal Cell Carcinoma,0.9168
RHABDOID TUMOR,Rhabdoid Tumor,1,2,Rhabdoid Tumor,1.0000,Rhabdoid Tumor<;>Extracranial,0.9566,Atypical Teratoid/Rhabdoid Tumor,0.9491,Extrarenal Rhabdoid Tumor,0.9465,Pituitary Neuroendocrine Tumor,0.9270
RHABDOID TUMOUR,Rhabdoid Tumor,1,2,Rhabdoid Tumor,0.9935,Rhabdoid Tumor<;>Extracranial,0.9547,Atypical Teratoid/Rhabdoid Tumor,0.9456,Extrarenal Rhabdoid Tumor,0.9453,Rhabdomyosarcoma,0.9260
RHABDOID_TUMOUR,Rhabdoid Tumor,1,2,Rhabdoid Tumor,0.9877,Rhabdoid Tumor<;>Extracranial,0.9571,Atypical Teratoid/Rhabdoid Tumor,0.9480,Extrarenal Rhabdoid Tumor,0.9456,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.9301
RHABDOMYOSARCOMA,Rhabdomyosarcoma,1,2,Rhabdomyosarcoma,1.0000,Embryonal Rhabdomyosarcoma,0.9559,Pleomorphic Rhabdomyosarcoma,0.9546,Leiomyosarcoma,0.9533,Alveolar Rhabdomyosarcoma,0.9503
"RHABDOMYOSARCOMA, ALVEOLAR",Alveolar Rhabdomyosarcoma,1,2,Alveolar Rhabdomyosarcoma,0.9883,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.9695,Rhabdomyosarcoma,0.9538,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.9431,Pleomorphic Rhabdomyosarcoma,0.9393
"RHABDOMYOSARCOMA, ALVEOLAR SUBTYPE",Alveolar Rhabdomyosarcoma,1,2,Alveolar Rhabdomyosarcoma,0.9805,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.9703,Rhabdomyosarcoma,0.9494,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.9415,Botryoid-Type Embryonal Rhabdomyosarcoma,0.9379
"RHABDOMYOSARCOMA, EMBRYONAL",Embryonal Rhabdomyosarcoma,1,2,Embryonal Rhabdomyosarcoma,0.9879,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.9659,Botryoid-Type Embryonal Rhabdomyosarcoma,0.9595,Rhabdomyosarcoma,0.9558,Embryonal Carcinoma<;>Seminoma,0.9514
RMS,Rhabdomyosarcoma,1,2,Rhabdomyosarcoma,0.9242,Alveolar Rhabdomyosarcoma,0.9096,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.9081,Medulloblastoma,0.9066,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.9028
ROSAI-DORFMAN DISEASE,Rosai-Dorfman Disease,1,2,Rosai-Dorfman Disease,1.0000,Erdheim-Chester Disease,0.9167,Myelodysplastic Syndrome with Isolated del(5q),0.9072,Castleman Disease,0.9065,Myelodysplastic Syndrome with del(5q),0.9058
ROSETTE-FORMING GLIONEURONAL TUMOR OF THE FOURTH VENTRICLE,Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle,1,2,Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle,1.0000,Glioneuronal Tumor,0.9452,Embryonal Tumor with Multilayered Rosettes,0.9312,Diffuse Leptomeningeal Glioneuronal Tumor,0.9281,Central Nervous System Medulloepithelioma,0.9263
"ROUND CELL SARCOMA, NOS",Undifferentiated Round Cell Sarcoma,2,2,Round Cell Sarcoma,0.9856,Undifferentiated Round Cell Sarcoma,0.9642,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.9570,myxoid/round cell liposarcoma,0.9568,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.9485
"ROUND CELL SARCOMA, OTHER",Round Cell Sarcoma,1,2,Round Cell Sarcoma,0.9844,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.9616,Undifferentiated Round Cell Sarcoma,0.9608,myxoid/round cell liposarcoma,0.9510,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.9473
RT,Rhabdoid Tumor,99,2,Adult T-Cell Leukemia/Lymphoma,0.9071,T Lymphoblastic Leukemia/Lymphoma,0.9037,Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,0.9025,B Acute Lymphoblastic Leukemia with t(9<;>22)(q34.1<;>q11.2)<;> BCR-ABL1,0.8997,Transurethral Resection of Bladder Tumor,0.8995
RUNX1-RUNX1T1,AML1-ETO Fusion Protein Expression,99,2,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9402,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9368,Acute Myeloid Leukemia with Mutated RUNX1,0.9343,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9188,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9188
SALIVARY ADENOCARCINOMA,Salivary Gland Adenocarcinoma,1,2,Salivary Gland Adenocarcinoma,0.9932,Salivary Gland Carcinoma,0.9706,Salivary Gland Secretory Carcinoma,0.9639,Adenocarcinoma,0.9610,Salivary Duct Carcinoma,0.9592
SALIVARY ADENOCARCINOMA NOS,Salivary Gland Adenocarcinoma,1,2,Salivary Gland Adenocarcinoma,0.9741,Salivary Gland Carcinoma,0.9627,Salivary Gland Secretory Carcinoma,0.9592,Salivary Duct Carcinoma,0.9545,Salivary Gland Squamous Cell Carcinoma,0.9541
SALIVARY CANCER,Salivary Gland Carcinoma,1,2,Salivary Gland Carcinoma,0.9726,Salivary Gland Adenocarcinoma,0.9627,Salivary Gland Secretory Carcinoma,0.9613,Salivary Gland Squamous Cell Carcinoma,0.9593,Salivary Duct Carcinoma,0.9569
SALIVARY CARCINOMA,Salivary Gland Carcinoma,1,2,Salivary Gland Carcinoma,0.9925,Salivary Gland Secretory Carcinoma,0.9784,Salivary Duct Carcinoma,0.9769,Salivary Gland Squamous Cell Carcinoma,0.9722,Salivary Gland Adenocarcinoma,0.9653
"SALIVARY CARCINOMA, OTHER",Salivary Gland Carcinoma,1,2,Salivary Gland Carcinoma,0.9675,Salivary Gland Squamous Cell Carcinoma,0.9559,Salivary Gland Secretory Carcinoma,0.9553,Salivary Duct Carcinoma,0.9543,Salivary Gland Adenocarcinoma,0.9531
SALIVARY DUCT CARCINOMA,Salivary Duct Carcinoma,1,2,Salivary Duct Carcinoma,1.0000,Salivary Gland Carcinoma,0.9767,Salivary Gland Secretory Carcinoma,0.9625,Salivary Gland Squamous Cell Carcinoma,0.9584,Salivary Gland Adenocarcinoma,0.9579
SALIVARY GLAND CANCER,Salivary Gland Carcinoma,1,2,Salivary Gland Carcinoma,0.9810,Salivary Gland Adenocarcinoma,0.9735,Salivary Gland Secretory Carcinoma,0.9667,Salivary Gland Squamous Cell Carcinoma,0.9648,Salivary Duct Carcinoma,0.9573
SALIVARY GLAND-TYPE TUMOR OF THE LUNG,Malignant Mixed Tumor of the Salivary Gland<;>Lung Neoplasm,1,2,Malignant Mixed Tumor of the Salivary Gland<;>Lung Neoplasm,0.9703,Salivary Gland Adenocarcinoma,0.9547,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9543,Salivary Gland Carcinoma,0.9525,Lung Adenosquamous Carcinoma,0.9517
SALIVARY_GLAND,Salivary Gland,1,2,Salivary Gland,0.9846,Salivary Gland Adenocarcinoma,0.9419,Salivary Gland Secretory Carcinoma,0.9372,Salivary Gland Carcinoma,0.9359,Prostate Gland,0.9276
SARC,Sarcoma,2,2,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.9092,Sarcoma,0.9088,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.9069,Rhabdomyosarcoma,0.9054,Fibrosarcoma,0.9023
SARC LMS,Uterine Corpus Leiomyosarcoma,99,2,Leiomyosarcoma,0.9159,Muscle,0.9094,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.9065,Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma,0.9038,Rhabdomyosarcoma,0.9036
SARC LS,Liposarcoma,99,2,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.9087,Sarcoma,0.9074,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.9063,Leiomyosarcoma,0.9046,Angiosarcoma,0.9021
SARC UPSMFS,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,99,2,Extramammary Paget Disease,0.9035,Muscle,0.8986,Plasma Cell Myeloma,0.8985,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.8980,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.8975
SARCOMA,Sarcoma,1,2,Sarcoma,1.0000,Bone Sarcoma,0.9725,Breast Sarcoma,0.9663,Synovial Sarcoma,0.9628,Soft Tissue Sarcoma,0.9596
SARCOMA LEIOMYO,Uterine Corpus Leiomyosarcoma,99,2,Leiomyosarcoma,0.9766,Sarcoma,0.9684,Sarcomatoid Mesothelioma,0.9513,Breast Sarcoma,0.9503,Lung Sarcomatoid Carcinoma,0.9484
SARCOMA LIPO,Liposarcoma,1,2,Liposarcoma,0.9707,Sarcoma,0.9592,Sarcomatoid Carcinoma,0.9401,Pleomorphic Liposarcoma,0.9400,Breast Sarcoma,0.9398
SARCOMA UPS/MXF,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,99,2,Sarcoma,0.9369,Myxoinflammatory Fibroblastic Sarcoma,0.9248,Bone Sarcoma,0.9241,Breast Sarcoma,0.9219,Malignant Soft Tissue Neoplasm,0.9214
"SARCOMA, NOS",Sarcoma,1,2,Sarcoma,0.9701,Sarcomatoid Mesothelioma,0.9448,Sarcomatoid Carcinoma,0.9444,Bone Sarcoma,0.9440,Breast Sarcoma,0.9432
SARCOMA; SYNOVIAL; POORLY DIFFERENTIATED,Synovial Sarcoma<;>Poorly Differentiated,1,2,Synovial Sarcoma<;>Poorly Differentiated,0.9855,Squamous Cell Carcinoma<;>Poorly Differentiated,0.9528,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9513,Synovial Sarcoma,0.9509,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.9504
SARCOMATOID,Sarcomatoid Carcinoma,1,2,Sarcomatoid Carcinoma,0.9774,Sarcomatoid Mesothelioma,0.9745,Sarcoma,0.9721,Lung Sarcomatoid Carcinoma,0.9636,Sarcomatoid Renal Cell Carcinoma,0.9584
SARCOMATOID CARCINOMA OF THE LUNG,Lung Sarcomatoid Carcinoma,1,2,Lung Sarcomatoid Carcinoma,0.9944,Sarcomatoid Carcinoma,0.9879,Sarcomatoid Renal Cell Carcinoma,0.9730,Sarcomatoid Mesothelioma,0.9680,Sarcoma,0.9587
SARCOMATOID CARCINOMA OF THE URINARY BLADDER,infiltrating bladder urothelial carcinoma sarcomatoid variant,3,2,Sarcomatoid Carcinoma,0.9763,Sarcomatoid Renal Cell Carcinoma,0.9748,infiltrating bladder urothelial carcinoma sarcomatoid variant,0.9727,Lung Sarcomatoid Carcinoma,0.9659,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.9599
SARCOMATOID MESOTHELIOMA,Sarcomatoid Mesothelioma,1,2,Sarcomatoid Mesothelioma,1.0000,Pleural Sarcomatoid Mesothelioma,0.9867,Sarcomatoid Carcinoma,0.9636,Lung Sarcomatoid Carcinoma,0.9614,Sarcoma,0.9592
SARCOMATOID RENAL CELL CARCINOMA,Sarcomatoid Renal Cell Carcinoma,1,2,Sarcomatoid Renal Cell Carcinoma,1.0000,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.9842,Sarcomatoid Carcinoma,0.9762,Lung Sarcomatoid Carcinoma,0.9675,Renal Cell Carcinoma,0.9618
SARC_DDLPS,Dedifferentiated Liposarcoma,1,2,Dedifferentiated Liposarcoma,0.9010,Dedifferentiated Chondrosarcoma,0.8963,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.8958,Histiocytic and Dendritic Cell Neoplasm,0.8957,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.8950
SARC_LMS,Leiomyosarcoma,1,2,Leiomyosarcoma,0.9139,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.9045,Muscle,0.9032,Atypical Spindle Melanocyte<;>Epithelioid Melanocyte,0.9002,Rhabdomyosarcoma,0.8993
SARC_MFS/UPS,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,99,2,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9119,Ewing Sarcoma<;>ERG Gene Rearrangement,0.9070,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.9068,Plasma Cell Myeloma<;>Plasmacytoma,0.9030,Epithelioid Cell<;>Spindle Cell Neoplasm,0.9025
SARC_OTHER,Sarcoma,99,2,Extraskeletal Myxoid Chondrosarcoma,0.9037,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.9015,Extraskeletal Osteosarcoma,0.8994,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8974,T-Cell Non-Hodgkin Lymphoma,0.8974
SBS,Small Intestinal Carcinoma,99,2,B-Lymphocyte,0.8995,Sigmoid Colon,0.8954,Biliary Tract,0.8931,Pineoblastoma,0.8919,Activated B-Cell Positive,0.8904
SCC HEAD AND NECK,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,0.9662,Head and Neck Carcinoma,0.9588,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,0.9529,Head and Neck,0.9503,Head and Neck Squamous Cell Carcinoma<;>Spindle Cell Squamous Cell Carcinoma,0.9502
SCCOHT,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",99,2,Squamous Cell Carcinoma<;>Poorly Differentiated,0.9157,Head and Neck Squamous Cell Carcinoma,0.9117,Chondrosarcoma,0.9101,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9090,Oral Cavity Squamous Cell Carcinoma,0.9087
SCHMINKE TUMOR/LYMPHOEPITHELIAL CARCINOMA,Nasopharyngeal-Type Undifferentiated Carcinoma,99,2,Thyroid Gland Medullary Carcinoma,0.9397,Lung Lymphoepithelial Carcinoma,0.9379,Sebaceous Carcinoma,0.9378,Salivary Gland Carcinoma,0.9357,Medullary Carcinoma,0.9338
SCHWANNOMA,Schwannoma,1,2,Schwannoma,1.0000,Nerve Sheath Neoplasm,0.9435,Melanotic Schwannoma,0.9431,Plexiform Schwannoma,0.9429,Cellular Schwannoma,0.9409
SCLC,Lung Small Cell Carcinoma,3,2,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9313,Lung Non-Small Cell Carcinoma,0.9309,Lung Small Cell Carcinoma,0.9283,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9281,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9263
SCLEROSING EPITHELIOID FIBROSARCOMA,Sclerosing Epithelioid Fibrosarcoma,1,2,Sclerosing Epithelioid Fibrosarcoma,1.0000,Epithelioid Sarcoma,0.9480,Fibrosarcoma,0.9466,Sclerosing Rhabdomyosarcoma,0.9380,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9362
SCLEROSING RHABDOMYOSARCOMA,Sclerosing Rhabdomyosarcoma,1,2,Sclerosing Rhabdomyosarcoma,1.0000,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.9640,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.9447,Rhabdomyosarcoma,0.9417,Sclerosing Epithelioid Fibrosarcoma,0.9380
SEBACEOUS CARCINOMA,Sebaceous Carcinoma,1,2,Sebaceous Carcinoma,1.0000,Sweat Gland Carcinoma,0.9566,Skin Carcinoma,0.9517,Skin Squamous Cell Carcinoma,0.9487,skin appendage carcinoma,0.9480
SECOND MALIGNANCY,Secondary Malignant Neoplasm,1,2,Secondary Malignant Neoplasm,0.9459,Malignant Glioma<;>Secondary Malignant Neoplasm,0.9320,Primary Neoplasm,0.9239,Primary Neoplasm<;>Paired,0.9231,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9220
SECOND MALIGNANCY FIRST HGG RECORD,Malignant Glioma<;>Secondary Malignant Neoplasm,1,2,Malignant Glioma<;>Secondary Malignant Neoplasm,0.9254,Gastroesophageal Cancer<;>Primary Neoplasm,0.9166,Low Grade Glioma<;>IDH Gene Family Mutation,0.9121,Malignant Head and Neck Neoplasm,0.9099,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9096
SECOND RECURRENCE,Recurrence,1,2,Recurrence,0.9478,Recurrent,0.9352,Regional<;>Recurrence,0.9304,First Relapse,0.9300,Metastatic Lesion<;>Recurrent,0.9224
SECONDARY MYELOFIBROSIS,Secondary Myelofibrosis,1,2,Secondary Myelofibrosis,1.0000,Primary Myelofibrosis,0.9679,Overt Primary Myelofibrosis,0.9393,Secondary Osteosarcoma,0.9326,Secondary Malignant Neoplasm,0.9324
SECONDARY OSTEOSARCOMA,Secondary Osteosarcoma,1,2,Secondary Osteosarcoma,1.0000,Osteosarcoma,0.9502,Secondary Malignant Neoplasm,0.9495,Secondary Myelofibrosis,0.9326,Extraskeletal Osteosarcoma,0.9302
SELLAR TUMOR,Sellar Region Neoplasm,1,2,Sellar Region Neoplasm,0.9590,Pituitary Neuroendocrine Tumor,0.9367,Brain Neoplasm,0.9279,Ovarian Sertoli-Leydig Cell Tumor,0.9215,Rhabdoid Tumor,0.9207
SEMINAL VESICLE CARCINOMA,Malignant Seminal Vesicle Neoplasm,1,2,Malignant Seminal Vesicle Neoplasm,0.9729,Vaginal Carcinoma,0.9521,Vulvar Carcinoma,0.9501,Vulvar Carcinoma<;>Vaginal Carcinoma,0.9497,Vaginal Squamous Cell Carcinoma,0.9442
SEMINOMA,Seminoma,1,2,Seminoma,1.0000,Testicular Seminoma,0.9811,Seminoma<;>Mature Teratoma,0.9558,Embryonal Carcinoma<;>Seminoma,0.9469,Testicular Non-Seminomatous Germ Cell Tumor,0.9444
SEMINOMA; NOS,Seminoma,1,2,Seminoma,0.9696,Testicular Seminoma,0.9664,Seminoma<;>Mature Teratoma,0.9567,Testicular Non-Seminomatous Germ Cell Tumor,0.9535,Embryonal Carcinoma<;>Seminoma,0.9489
SEMINOMA; NOSNON-SEMINOMA; CHORIOCARCINOMA,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,2,2,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9653,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,0.9650,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9525,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,0.9495,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.9476
SEMINOMA; NOSNON-SEMINOMA; EMBRYONAL CARCINOMA,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,2,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9653,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.9640,Embryonal Carcinoma<;>Seminoma,0.9630,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9591,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9550
SEMINOMA; NOSNON-SEMINOMA; TERATOMA MATURE,Nonseminomatous<;>Mature Teratoma<;>Seminoma,2,2,Seminoma<;>Mature Teratoma,0.9642,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9570,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9529,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9528,Nonseminomatous<;>Mature Teratoma,0.9479
SEMINOMA; NOSNON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; EMBRYONAL CARCINOMA,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,1,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9686,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9640,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9589,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9570,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9570
SEMINOMA; NOSNON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9651,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9598,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9593,Seminoma<;>Mature Teratoma,0.9558,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9552
SEMINOMA; NOSNON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,5,2,Seminoma<;>Mature Teratoma,0.9579,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9546,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9545,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9532,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.9491
SEMINOMA; NOSNON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA IMMATURE,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9644,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9633,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,0.9631,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9630,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9630
SEMINOMA; NOSNON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURE,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma<;>Seminoma,99,2,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9625,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9619,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.9619,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor,0.9605,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9604
SEROUS,Serous,1,2,Serous,1.0000,Serous Adenocarcinoma,0.9597,Serous Cystadenocarcinoma,0.9518,Ovarian Serous Adenocarcinoma,0.9437,Pancreatic Serous Cystadenoma,0.9422
SEROUS BORDERLINE OVARIAN TUMOR,Borderline Ovarian Serous Tumor,1,2,Borderline Ovarian Serous Tumor,0.9974,Borderline Ovarian Clear Cell Tumor,0.9692,Borderline Ovarian Serous Tumor-Micropapillary Variant,0.9656,Ovarian Serous Adenocarcinoma,0.9579,Ovarian Low Grade Serous Adenocarcinoma,0.9566
"SEROUS BORDERLINE OVARIAN TUMOR, MICROPAPILLARY",Borderline Ovarian Serous Tumor-Micropapillary Variant,1,2,Borderline Ovarian Serous Tumor-Micropapillary Variant,0.9918,Borderline Ovarian Serous Tumor,0.9663,Papillary Serous Cystadenocarcinoma,0.9522,Borderline Ovarian Clear Cell Tumor,0.9519,Borderline Breast Phyllodes Tumor,0.9472
SEROUS CYSTADENOCARCINOMA,Serous Cystadenocarcinoma,1,2,Serous Cystadenocarcinoma,1.0000,Papillary Serous Cystadenocarcinoma,0.9794,Pancreatic Serous Cystadenoma,0.9760,Cystadenocarcinoma,0.9742,Mucinous Cystadenocarcinoma,0.9701
SEROUS CYSTADENOMA OF THE PANCREAS,Pancreatic Serous Cystadenoma,1,2,Pancreatic Serous Cystadenoma,0.9921,Serous Cystadenocarcinoma,0.9801,Papillary Serous Cystadenocarcinoma,0.9688,Cystadenocarcinoma<;>High Grade<;>Serous,0.9571,Mucinous Cystadenocarcinoma,0.9561
SEROUS ENDOMETRIAL ADENOCARCINOMA,Endometrial Serous Adenocarcinoma,1,2,Endometrial Serous Adenocarcinoma,0.9981,Serous Adenocarcinoma,0.9867,Ovarian Serous Adenocarcinoma,0.9804,Endometrial Endometrioid Adenocarcinoma,0.9673,Endometrial Adenocarcinoma,0.9664
SEROUS OVARIAN CANCER,Ovarian Serous Adenocarcinoma,1,2,Ovarian Serous Adenocarcinoma,0.9775,Serous Adenocarcinoma,0.9724,Ovarian High Grade Serous Adenocarcinoma,0.9635,Ovarian Low Grade Serous Adenocarcinoma,0.9621,Endometrial Serous Adenocarcinoma,0.9607
SEROUS_CARCINOMA,Ovarian Serous Adenocarcinoma,2,2,Serous Adenocarcinoma,0.9796,Ovarian Serous Adenocarcinoma,0.9689,Endometrial Serous Adenocarcinoma,0.9666,Serous Cystadenocarcinoma,0.9664,Serous Adenocarcinoma<;>High Grade,0.9607
SERTOLI-LEYDIG CELL TUMOR,Ovarian Sertoli-Leydig Cell Tumor,1,2,Ovarian Sertoli-Leydig Cell Tumor,0.9887,Testicular Germ Cell Tumor,0.9569,Testicular Non-Seminomatous Germ Cell Tumor,0.9432,Granulosa Cell Tumor,0.9431,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,0.9423
SEX CORD STROMAL TUMOR,Sex Cord-Stromal Tumor,1,2,Sex Cord-Stromal Tumor,0.9982,Gastrointestinal Stromal Tumor,0.9290,Ovarian Sertoli-Leydig Cell Tumor,0.9281,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.9260,Endometrioid Stromal Sarcoma,0.9235
SEX CORD-STROMAL TUMOUR,Sex Cord-Stromal Tumor,1,2,Sex Cord-Stromal Tumor,0.9927,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9264,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.9238,Breast Carcinoma with Chondroid Metaplasia,0.9237,Uterine Corpus Sarcoma<;>Mesenchymal,0.9222
SEZARY SYNDROME,Sezary Syndrome,1,2,Sezary Syndrome,1.0000,Mycosis Fungoides and Sezary Syndrome,0.9717,Synovial Sarcoma,0.8993,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.8987,Myelodysplastic Syndrome with Excess Blasts-1,0.8986
SEZARY_SYNDROME,Sezary Syndrome,1,2,Sezary Syndrome,0.9860,Mycosis Fungoides and Sezary Syndrome,0.9690,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9127,Ewing Sarcoma<;>ERG Gene Rearrangement,0.9101,Central Nervous System Ewing Sarcoma<;>CIC Gene Rearrangement,0.9095
SIGMOID COLON,Sigmoid Colon,1,2,Sigmoid Colon,1.0000,Colon,0.9567,Ascending Colon,0.9547,Descending Colon,0.9376,Transverse Colon,0.9371
SIGNET RING,Signet Ring Cell,1,2,Signet Ring Cell,0.9671,Signet Ring Cell Carcinoma,0.9533,Signet Ring Adenocarcinoma Cell,0.9481,Appendix Signet Ring Cell Carcinoma,0.9433,Pancreatic Signet Ring Cell Carcinoma,0.9405
SIGNET RING CELL,Signet Ring Cell,1,2,Signet Ring Cell,1.0000,Signet Ring Cell Carcinoma,0.9733,Signet Ring Adenocarcinoma Cell,0.9716,Appendix Signet Ring Cell Carcinoma,0.9643,Signet Ring Cell<;>Mucinous,0.9605
SIGNET RING CELL ADENOCARCINOMA OF THE COLON AND RECTUM,Rectal Signet Ring Cell Adenocarcinoma<;>Colon Signet Ring Cell Adenocarcinoma,1,2,Rectal Signet Ring Cell Adenocarcinoma<;>Colon Signet Ring Cell Adenocarcinoma,0.9910,Signet Ring Adenocarcinoma Cell,0.9893,Signet Ring Cell Carcinoma,0.9862,Appendix Signet Ring Cell Carcinoma,0.9833,Gastric Signet Ring Cell Adenocarcinoma,0.9829
SIGNET RING CELL CARCINOMA OF THE STOMACH,Gastric Signet Ring Cell Adenocarcinoma,1,2,Gastric Signet Ring Cell Adenocarcinoma,0.9905,Signet Ring Cell Carcinoma,0.9899,Signet Ring Adenocarcinoma Cell,0.9849,Appendix Signet Ring Cell Carcinoma,0.9848,Pancreatic Signet Ring Cell Carcinoma,0.9840
SIGNET RING CELL TYPE OF THE APPENDIX,Appendix Signet Ring Cell Carcinoma,1,2,Appendix Signet Ring Cell Carcinoma,0.9756,Signet Ring Cell,0.9742,Signet Ring Adenocarcinoma Cell,0.9679,Signet Ring Cell Carcinoma,0.9657,Signet Ring Cell<;>Mucinous,0.9627
"SIGNET RING, MUCINOUS FEATURES",Signet Ring Cell<;>Mucinous,1,2,Signet Ring Cell<;>Mucinous,0.9724,Pancreatic Signet Ring Cell Carcinoma,0.9561,Rectal Signet Ring Cell Adenocarcinoma<;>Colon Signet Ring Cell Adenocarcinoma,0.9555,Signet Ring Cell Carcinoma,0.9545,Signet Ring Adenocarcinoma Cell,0.9538
SIGNET_RING_ADENOCARCINOMA,Signet Ring Adenocarcinoma Cell,1,2,Signet Ring Adenocarcinoma Cell,0.9854,Signet Ring Cell Carcinoma,0.9790,Rectal Signet Ring Cell Adenocarcinoma<;>Colon Signet Ring Cell Adenocarcinoma,0.9764,Gastric Signet Ring Cell Adenocarcinoma,0.9750,Pancreatic Signet Ring Cell Carcinoma,0.9729
SIGNET_RING_CELL,Signet Ring Cell,1,2,Signet Ring Cell,0.9940,Signet Ring Cell Carcinoma,0.9683,Signet Ring Adenocarcinoma Cell,0.9667,Signet Ring Cell<;>Mucinous,0.9583,Appendix Signet Ring Cell Carcinoma,0.9582
SINONASAL ADENOCARCINOMA,Sinonasal Adenocarcinoma,1,2,Sinonasal Adenocarcinoma,1.0000,Sinonasal Squamous Cell Carcinoma,0.9631,Sinonasal Undifferentiated Carcinoma,0.9537,Salivary Gland Adenocarcinoma,0.9468,Adenocarcinoma,0.9458
SINONASAL SQUAMOUS CELL CARCINOMA,Sinonasal Squamous Cell Carcinoma,1,2,Sinonasal Squamous Cell Carcinoma,1.0000,Salivary Gland Squamous Cell Carcinoma,0.9671,Squamous Cell Carcinoma,0.9663,Sinonasal Adenocarcinoma,0.9631,Head and Neck Squamous Cell Carcinoma,0.9614
SINONASAL UNDIFFERENTIATED CARCINOMA,Sinonasal Undifferentiated Carcinoma,1,2,Sinonasal Undifferentiated Carcinoma,1.0000,Undifferentiated Carcinoma,0.9673,Sinonasal Squamous Cell Carcinoma,0.9609,Nasopharyngeal-Type Undifferentiated Carcinoma,0.9603,Gastric Undifferentiated Carcinoma,0.9601
SKCM,Cutaneous Melanoma,99,2,Low-CSD Melanoma,0.9095,Sigmoid Colon,0.9078,Angiosarcoma,0.9073,Colon,0.9065,Hemangioma,0.9063
SKIN,Skin,1,2,Skin,1.0000,Skin Squamous Cell Carcinoma,0.9326,Skin Fibrous Histiocytoma,0.9307,Skin Carcinoma,0.9293,Cutaneous Melanoma,0.9267
SKIN ADNEXAL CARCINOMA,skin appendage carcinoma,2,2,Skin Carcinoma,0.9586,skin appendage carcinoma,0.9570,Skin Squamous Cell Carcinoma,0.9541,Skin Acantholytic Squamous Cell Carcinoma,0.9462,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9434
SKIN CANCER,Malignant Skin Neoplasm,3,2,Skin Carcinoma,0.9741,Skin Squamous Cell Carcinoma,0.9689,Malignant Skin Neoplasm,0.9516,Skin Acantholytic Squamous Cell Carcinoma,0.9477,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9473
"SKIN CANCER, NON-MELANOMA",Skin Carcinoma,99,2,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9532,Melanoma,0.9481,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9473,Skin Squamous Cell Carcinoma,0.9451,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9432
SKIN_CANCER,Malignant Skin Neoplasm,3,2,Skin Carcinoma,0.9712,Skin Squamous Cell Carcinoma,0.9664,Malignant Skin Neoplasm,0.9531,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9493,Skin Acantholytic Squamous Cell Carcinoma,0.9462
SKIN_SQUAMOUS,Skin Squamous Cell Carcinoma,1,2,Skin Squamous Cell Carcinoma,0.9667,Skin Acantholytic Squamous Cell Carcinoma,0.9501,Skin,0.9497,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9470,Squamous Cell Carcinoma,0.9468
SMALL BOWEL ADENOCARCINOMA,Small Intestinal Adenocarcinoma,1,2,Small Intestinal Adenocarcinoma,0.9906,Small Intestinal Carcinoma,0.9755,Small Cell Adenocarcinoma,0.9625,Cecum Adenocarcinoma,0.9564,Colon Adenocarcinoma,0.9527
SMALL BOWEL CANCER,Small Intestinal Carcinoma,1,2,Small Intestinal Carcinoma,0.9744,Small Intestinal Adenocarcinoma,0.9687,Small Cell Adenocarcinoma,0.9449,Small Intestinal Neuroendocrine Neoplasm,0.9444,Ovarian Small Cell Carcinoma,0.9429
SMALL BOWEL CARCINOMA,Small Intestinal Carcinoma,1,2,Small Intestinal Carcinoma,0.9884,Small Intestinal Adenocarcinoma,0.9706,Ovarian Small Cell Carcinoma,0.9528,Lung Small Cell Carcinoma,0.9525,Small Cell Adenocarcinoma,0.9515
SMALL BOWEL NEUROENDOCRINE TUMOR,Small Intestinal Neuroendocrine Neoplasm,1,2,Small Intestinal Neuroendocrine Neoplasm,0.9837,Small Intestinal Neuroendocrine Neoplasm<;>Well Differentiated,0.9722,Neuroendocrine Tumor,0.9642,Colorectal Neuroendocrine Tumor,0.9639,Appendix Neuroendocrine Tumor,0.9629
SMALL BOWEL WELL-DIFFERENTIATED NEUROENDOCRINE TUMOR,Small Intestinal Neuroendocrine Neoplasm<;>Well Differentiated,1,2,Small Intestinal Neuroendocrine Neoplasm<;>Well Differentiated,0.9847,Small Intestinal Neuroendocrine Neoplasm,0.9742,Rectal Neuroendocrine Tumor<;>Well Differentiated,0.9687,Gastric Small Cell Neuroendocrine Carcinoma,0.9617,Small Cell Neuroendocrine Carcinoma,0.9614
SMALL CELL,Small Cell,1,2,Small Cell,1.0000,Small Cell Adenocarcinoma,0.9573,Small Cell Osteosarcoma,0.9569,"Malignant Tumor, Small Cell Type",0.9469,Small Cell Neuroendocrine Carcinoma,0.9432
SMALL CELL BLADDER CANCER,Bladder Small Cell Neuroendocrine Carcinoma,1,2,Bladder Small Cell Neuroendocrine Carcinoma,0.9719,Small Cell Adenocarcinoma,0.9647,Lung Small Cell Carcinoma,0.9618,"Malignant Tumor, Small Cell Type",0.9580,Ovarian Small Cell Carcinoma,0.9574
SMALL CELL BRONCHIOALVEOLAR CARCINOMA,Lung Small Cell Carcinoma,1,2,Lung Small Cell Carcinoma,0.9779,Small Cell Adenocarcinoma,0.9710,Lung Non-Small Cell Carcinoma,0.9633,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9623,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9613
SMALL CELL CARCINOMA,Small Cell Neuroendocrine Carcinoma,3,2,Lung Small Cell Carcinoma,0.9864,Small Cell Adenocarcinoma,0.9848,Small Cell Neuroendocrine Carcinoma,0.9782,Ovarian Small Cell Carcinoma,0.9750,Non-Small Cell Carcinoma,0.9705
SMALL CELL CARCINOMA OF  GALLBLADDER,Gallbladder Small Cell Neuroendocrine Carcinoma,1,2,Gallbladder Small Cell Neuroendocrine Carcinoma,0.9837,Gastric Small Cell Neuroendocrine Carcinoma,0.9692,Gallbladder Large Cell Neuroendocrine Carcinoma,0.9671,Small Cell Adenocarcinoma,0.9641,Lung Small Cell Carcinoma,0.9639
SMALL CELL CARCINOMA OF THE CERVIX,Cervical Small Cell Neuroendocrine Carcinoma,4,2,Lung Small Cell Carcinoma,0.9773,Small Cell Adenocarcinoma,0.9771,Ovarian Small Cell Carcinoma,0.9749,Cervical Small Cell Neuroendocrine Carcinoma,0.9747,Small Cell Neuroendocrine Carcinoma,0.9663
SMALL CELL CARCINOMA OF THE OVARY,Ovarian Small Cell Carcinoma,1,2,Ovarian Small Cell Carcinoma,0.9945,Small Cell Adenocarcinoma,0.9693,Lung Small Cell Carcinoma,0.9693,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.9646,Ovarian Small Cell Carcinoma<;>Dermoid Cyst,0.9626
SMALL CELL CARCINOMA OF THE OVARY HYPERCALCEMIC TYPE SCCOHT,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",1,2,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.9866,Ovarian Small Cell Carcinoma,0.9588,"Malignant Tumor, Small Cell Type",0.9511,Ovarian Small Cell Carcinoma<;>Dermoid Cyst,0.9478,Cervical Small Cell Neuroendocrine Carcinoma,0.9473
SMALL CELL CARCINOMA OF THE STOMACH,Gastric Small Cell Neuroendocrine Carcinoma,1,2,Gastric Small Cell Neuroendocrine Carcinoma,0.9774,Small Cell Adenocarcinoma,0.9750,Lung Small Cell Carcinoma,0.9724,Gallbladder Small Cell Neuroendocrine Carcinoma,0.9661,Small Cell Neuroendocrine Carcinoma,0.9653
SMALL CELL CARCINOMA OF UNKNOWN PRIMARY,Small Cell Neuroendocrine Carcinoma,99,2,Non-Small Cell Carcinoma,0.9641,Lung Small Cell Carcinoma,0.9630,Small Cell Adenocarcinoma,0.9606,Lung Non-Small Cell Carcinoma,0.9597,"Malignant Tumor, Small Cell Type",0.9590
SMALL CELL LUNG CANCER,Lung Small Cell Carcinoma,1,2,Lung Small Cell Carcinoma,0.9899,Small Cell Adenocarcinoma,0.9777,Lung Non-Small Cell Carcinoma,0.9692,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9654,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9620
SMALL CELL LUNG CANCER SCLC,Lung Small Cell Carcinoma,1,2,Lung Small Cell Carcinoma,0.9793,Small Cell Adenocarcinoma,0.9646,Lung Non-Small Cell Carcinoma,0.9643,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9614,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9597
SMALL CELL NEUROENDOCRINE CARCINOMA OF GALLBLADDER,Gallbladder Small Cell Neuroendocrine Carcinoma,1,2,Gallbladder Small Cell Neuroendocrine Carcinoma,0.9984,Gallbladder Large Cell Neuroendocrine Carcinoma,0.9858,Gastric Small Cell Neuroendocrine Carcinoma,0.9832,Small Cell Neuroendocrine Carcinoma,0.9767,Bladder Small Cell Neuroendocrine Carcinoma,0.9758
SMALL CELL OSTEOSARCOMA,Small Cell Osteosarcoma,1,2,Small Cell Osteosarcoma,1.0000,Small Cell,0.9569,Small Cell Adenocarcinoma,0.9546,Ovarian Small Cell Carcinoma,0.9490,"Malignant Tumor, Small Cell Type",0.9441
SMALL INTESTINAL CARCINOMA,Small Intestinal Carcinoma,1,2,Small Intestinal Carcinoma,1.0000,Small Intestinal Adenocarcinoma,0.9825,Small Intestinal Neuroendocrine Neoplasm,0.9603,Ovarian Small Cell Carcinoma,0.9517,Small Intestinal Neuroendocrine Neoplasm<;>Well Differentiated,0.9508
SMALL ROUND BLUE CELL TUMOR,Desmoplastic Small Round Cell Tumor,2,2,Round Cell Sarcoma,0.9475,Desmoplastic Small Round Cell Tumor,0.9462,"Malignant Tumor, Small Cell Type",0.9393,Lung Small Cell Carcinoma,0.9348,Small Cell,0.9341
SMALL ROUND BLUE CELL TUMOR/ EWING SARCOMA,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,1,2,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.9629,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.9522,Round Cell Sarcoma,0.9519,Desmoplastic Small Round Cell Tumor,0.9447,Undifferentiated Round Cell Sarcoma,0.9431
SMALL_CELL_ADENOCARCINOMA,Small Cell Adenocarcinoma,1,2,Small Cell Adenocarcinoma,0.9923,Lung Small Cell Carcinoma,0.9698,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9676,"Malignant Tumor, Small Cell Type",0.9620,Small Cell Neuroendocrine Carcinoma,0.9605
SMALL_CELL_CARCINOMA,Small Cell Neuroendocrine Carcinoma,3,2,Lung Small Cell Carcinoma,0.9820,Small Cell Adenocarcinoma,0.9796,Small Cell Neuroendocrine Carcinoma,0.9765,Non-Small Cell Carcinoma,0.9711,Ovarian Small Cell Carcinoma,0.9705
SMOLDERING MYELOMA,Smoldering Plasma Cell Myeloma,1,2,Smoldering Plasma Cell Myeloma,0.9852,Monoclonal Gammopathy of Undetermined Significance,0.9079,Plasma Cell Myeloma,0.9044,Myelodysplastic/Myeloproliferative Neoplasm,0.9022,Plasma Cell Myeloma<;>Plasmacytoma,0.9007
SOFT TISSUE,Soft Tissue,1,2,Soft Tissue,1.0000,Soft Tissue Sarcoma,0.9608,Fibroblast<;>Soft Tissue,0.9599,Soft Tissue Neoplasm,0.9553,Malignant Soft Tissue Neoplasm,0.9367
"SOFT TISSUE CANCER, NOS",Malignant Soft Tissue Neoplasm,3,2,Soft Tissue Neoplasm,0.9675,Soft Tissue Sarcoma,0.9615,Malignant Soft Tissue Neoplasm,0.9600,Clear Cell Sarcoma of Soft Tissue,0.9516,Soft Tissue,0.9471
SOFT TISSUE MYOEPITHELIAL CARCINOMA,Malignant Myoepithelioma,99,2,Malignant Soft Tissue Neoplasm,0.9584,Soft Tissue Neoplasm,0.9539,Epithelial-Myoepithelial Carcinoma,0.9510,Soft Tissue Sarcoma,0.9424,Undifferentiated Soft Tissue Sarcoma,0.9337
SOFT TISSUE SARCOMA,Soft Tissue Sarcoma,1,2,Soft Tissue Sarcoma,1.0000,Soft Tissue Neoplasm,0.9778,Malignant Soft Tissue Neoplasm,0.9648,Undifferentiated Soft Tissue Sarcoma,0.9622,Soft Tissue,0.9608
SOFT TISSUE SARCOMA OTHER,Soft Tissue Sarcoma,1,2,Soft Tissue Sarcoma,0.9712,Soft Tissue Neoplasm,0.9553,Undifferentiated Soft Tissue Sarcoma,0.9482,Malignant Soft Tissue Neoplasm,0.9457,Sarcoma,0.9405
SOFT TISSUE TUMOR,Soft Tissue Neoplasm,1,2,Soft Tissue Neoplasm,0.9833,Soft Tissue Sarcoma,0.9783,Malignant Soft Tissue Neoplasm,0.9705,Soft Tissue,0.9628,Clear Cell Sarcoma of Soft Tissue,0.9493
SOFT_TISSUE,Soft Tissue,1,2,Soft Tissue,0.9847,Fibroblast<;>Soft Tissue,0.9625,Soft Tissue Sarcoma,0.9555,Soft Tissue Neoplasm,0.9531,Malignant Soft Tissue Neoplasm,0.9396
SOLID,Solid,1,2,Solid,1.0000,Cribriform<;>Solid,0.9474,Solid Lung Adenocarcinoma,0.9357,Cribriform<;>Solid<;>Tubular,0.9295,Solid<;>High Grade Transformation,0.9189
SOLID >30%,Solid,1,2,Solid,0.9592,Solid<;>High Grade Transformation,0.9330,Cribriform<;>Solid,0.9305,Cribriform<;>Solid<;>Tubular,0.9205,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,0.9167
SOLID >50%,Solid,1,2,Solid,0.9595,Solid<;>High Grade Transformation,0.9331,Cribriform<;>Solid,0.9309,Cribriform<;>Solid<;>Tubular,0.9209,Solid Lung Adenocarcinoma,0.9200
SOLID ADENOCARCINOMA 82303,Solid Lung Adenocarcinoma,1,2,Solid Lung Adenocarcinoma,0.9643,Adenocarcinoma<;>Well Differentiated,0.9320,Breast Solid Papillary Carcinoma,0.9308,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,0.9307,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.9304
SOLID PAPILLARY CARCINOMA OF THE BREAST,Breast Solid Papillary Carcinoma,1,2,Breast Solid Papillary Carcinoma,0.9962,Papillary Carcinoma,0.9685,Breast Papillary Ductal Carcinoma with Invasion,0.9612,Papillary Serous Cystadenocarcinoma,0.9554,Solid Pseudopapillary Neoplasm of the Pancreas,0.9553
SOLID PSEUDOPAPILLARY NEOPLASM OF THE PANCREAS,Solid Pseudopapillary Neoplasm of the Pancreas,1,2,Solid Pseudopapillary Neoplasm of the Pancreas,1.0000,Pancreatic Mucinous-Cystic Neoplasm,0.9501,Breast Solid Papillary Carcinoma,0.9466,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.9449,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.9433
SOLID/DEDIFFERENTIATED,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,1,2,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,0.9697,Solid Lung Adenocarcinoma,0.9416,Solid,0.9397,Dedifferentiated Chondrosarcoma,0.9352,Solid<;>High Grade Transformation,0.9308
SOLID/HIGH-GRADE TRANSFORMATION,Solid<;>High Grade Transformation,1,2,Solid<;>High Grade Transformation,0.9939,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,0.9337,High Grade Astrocytic Tumor,0.9320,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.9292,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9272
SOLITARY FIBROUS TUMOR,Solitary Fibrous Tumor,1,2,Solitary Fibrous Tumor,1.0000,Meningeal Solitary Fibrous Tumor,0.9783,Central Nervous System Solitary Fibrous Tumor,0.9688,Skin Fibroblastic Neoplasm,0.9234,Synovial Neoplasm,0.9197
SOLITARY FIBROUS TUMOR OF THE CENTRAL NERVOUS SYSTEM,Central Nervous System Solitary Fibrous Tumor,1,2,Central Nervous System Solitary Fibrous Tumor,0.9956,Meningeal Solitary Fibrous Tumor,0.9808,Solitary Fibrous Tumor,0.9780,Central Nervous System Neoplasm,0.9486,Malignant Central Nervous System Neoplasm,0.9411
SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA,Solitary Fibrous Tumor,1,2,Solitary Fibrous Tumor,0.9704,Meningeal Solitary Fibrous Tumor,0.9630,Central Nervous System Solitary Fibrous Tumor,0.9615,Hemangioma,0.9497,Hemangioblastoma,0.9433
SOMATOSTATINOMA,Somatostatin-Producing Neuroendocrine Tumor,1,2,Somatostatin-Producing Neuroendocrine Tumor,0.9616,Pituitary Neuroendocrine Tumor,0.9315,Schwannoma,0.9311,Small Intestinal Neuroendocrine Neoplasm,0.9242,Pancreatic Insulinoma<;>Benign,0.9238
SPECIFIC DX AT ACQUISITION MDSMPN,Myelodysplastic/Myeloproliferative Neoplasm,99,2,Myelodysplastic Syndrome with Isolated del(5q),0.9133,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.9112,Myelodysplastic Syndrome with del(5q),0.9110,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.9093,Myelodysplastic Syndrome with Multilineage Dysplasia,0.9089
SPECIFIC_DX_AT_ACQUISITION_MDSMPN,Myelodysplastic/Myeloproliferative Neoplasm,99,2,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.9128,Myelodysplastic Syndrome with Isolated del(5q),0.9102,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.9102,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.9082,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.9078
SPINDLE CELL,Spindle Cell Neoplasm,1,2,Spindle Cell Neoplasm,0.9642,Spindle Cell Sarcoma,0.9585,Spindle Cell Rhabdomyosarcoma,0.9564,Lung Spindle Cell Carcinoma,0.9468,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.9392
SPINDLE CELL CARCINOMA OF THE LUNG,Lung Spindle Cell Carcinoma,1,2,Lung Spindle Cell Carcinoma,0.9956,Spindle Cell Neoplasm,0.9743,Spindle Cell Sarcoma,0.9661,Lung Squamous Cell Carcinoma,0.9609,Head and Neck Squamous Cell Carcinoma<;>Spindle Cell Squamous Cell Carcinoma,0.9607
SPINDLE CELL RHABDOMYOSARCOMA,Spindle Cell Rhabdomyosarcoma,1,2,Spindle Cell Rhabdomyosarcoma,1.0000,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.9797,Spindle Cell Sarcoma,0.9722,Spindle Cell Neoplasm,0.9616,Lung Spindle Cell Carcinoma,0.9509
SPINDLE CELL SARCOMA,Spindle Cell Sarcoma,1,2,Spindle Cell Sarcoma,1.0000,Spindle Cell Neoplasm,0.9785,Spindle Cell Rhabdomyosarcoma,0.9722,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.9653,Lung Spindle Cell Carcinoma,0.9623
SPINDLE CELL/SCLEROSING RHABDOMYOSARCOMA,Spindle Cell/Sclerosing Rhabdomyosarcoma,1,2,Spindle Cell/Sclerosing Rhabdomyosarcoma,1.0000,Spindle Cell Rhabdomyosarcoma,0.9797,Spindle Cell Sarcoma,0.9653,Sclerosing Rhabdomyosarcoma,0.9640,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.9633
SPINDLE CELLEPITHELIOID CELL,Epithelioid Cell<;>Spindle Cell Neoplasm,2,2,Spindle Cell Neoplasm,0.9513,Epithelioid Cell<;>Spindle Cell Neoplasm,0.9507,Spindle Cell Rhabdomyosarcoma,0.9446,Spindle Cell Sarcoma,0.9415,Lung Spindle Cell Carcinoma,0.9372
SPINDLED/SCLEROSING/DIFFUSE ANAPLASIA,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,1,2,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.9698,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.9532,Anaplastic Lesion<;>Diffuse,0.9452,"Malignant Lymphoma, Histiocytic, Diffuse",0.9451,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,0.9432
SPINE,Vertebral Column,1,2,Vertebral Column,0.9118,Sacral Chordoma,0.9115,Neoplasm<;>Paraspinal,0.9001,Bone Sarcoma,0.8947,Sarcoma,0.8945
SPITZOID MELANOMA,Spitz Melanoma,1,2,Spitz Melanoma,0.9964,Melanoma,0.9107,Melanotic Schwannoma,0.9097,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9054,Skin Fibroblastic Neoplasm,0.9050
SPLENIC FLEXURE,Splenic Flexure,1,2,Splenic Flexure,1.0000,Hepatic Flexure,0.9631,Sigmoid Colon,0.9020,Cecum,0.9008,Follicular Lymphoma,0.9006
SQUAMOUS CELL CARCINOMA,Squamous Cell Carcinoma,1,2,Squamous Cell Carcinoma,1.0000,Lung Squamous Cell Carcinoma,0.9902,Laryngeal Squamous Cell Carcinoma,0.9847,Skin Squamous Cell Carcinoma,0.9816,Esophageal Squamous Cell Carcinoma,0.9816
SQUAMOUS CELL CARCINOMA ARISING IN A MATURE CYSTIC TERATOMA OF THE OVARY,Ovarian Small Cell Carcinoma<;>Dermoid Cyst,5,2,Teratoma with Somatic-Type Malignancy,0.9548,Lung Squamous Cell Carcinoma,0.9525,Squamous Cell Carcinoma<;>Poorly Differentiated,0.9515,Squamous Cell Carcinoma of the Penis,0.9510,Ovarian Small Cell Carcinoma<;>Dermoid Cyst,0.9497
SQUAMOUS CELL CARCINOMA OF GALLBLADDER,Gallbladder Squamous Cell Carcinoma,1,2,Gallbladder Squamous Cell Carcinoma,0.9975,Squamous Cell Carcinoma,0.9720,Bladder Squamous Cell Carcinoma,0.9695,Salivary Gland Squamous Cell Carcinoma,0.9693,thyroid gland squamous cell carcinoma,0.9683
SQUAMOUS CELL CARCINOMA OF THE VULVA/VAGINA,Vaginal Squamous Cell Carcinoma,2,2,Vulvar Squamous Cell Carcinoma,0.9886,Vaginal Squamous Cell Carcinoma,0.9866,Squamous Cell Carcinoma,0.9723,Cervical Squamous Cell Carcinoma,0.9715,Vulvar Carcinoma<;>Vaginal Carcinoma,0.9702
"SQUAMOUS CELL CARCINOMA, BASALOID",Squamous Cell Carcinoma<;>Basaloid Cell,1,2,Squamous Cell Carcinoma<;>Basaloid Cell,0.9888,Basal Cell Carcinoma,0.9810,Basaloid Squamous Cell Carcinoma of the Penis,0.9742,Head and Neck Basaloid Carcinoma,0.9717,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9670
"SQUAMOUS CELL CARCINOMA, BUCCAL MUCOSA",Buccal Mucosa Squamous Cell Carcinoma,1,2,Buccal Mucosa Squamous Cell Carcinoma,0.9942,Oral Cavity Squamous Cell Carcinoma,0.9773,Squamous Cell Carcinoma,0.9750,Salivary Gland Squamous Cell Carcinoma,0.9732,Tongue Squamous Cell Carcinoma,0.9705
"SQUAMOUS CELL CARCINOMA, HYPOPHARYNGEAL",Hypopharyngeal Squamous Cell Carcinoma,1,2,Hypopharyngeal Squamous Cell Carcinoma,0.9920,Head and Neck Squamous Cell Carcinoma,0.9803,Salivary Gland Squamous Cell Carcinoma,0.9707,Squamous Cell Carcinoma,0.9703,Laryngeal Squamous Cell Carcinoma,0.9697
"SQUAMOUS CELL CARCINOMA, LARYNGEAL",Laryngeal Squamous Cell Carcinoma,1,2,Laryngeal Squamous Cell Carcinoma,0.9933,Squamous Cell Carcinoma,0.9827,Lung Squamous Cell Carcinoma,0.9802,Head and Neck Squamous Cell Carcinoma,0.9769,Salivary Gland Squamous Cell Carcinoma,0.9749
"SQUAMOUS CELL CARCINOMA, NOS",Squamous Cell Carcinoma,1,2,Squamous Cell Carcinoma,0.9784,Lung Squamous Cell Carcinoma,0.9740,Salivary Gland Squamous Cell Carcinoma,0.9678,Laryngeal Squamous Cell Carcinoma,0.9664,Esophageal Squamous Cell Carcinoma,0.9663
"SQUAMOUS CELL CARCINOMA, ORAL",Oral Cavity Squamous Cell Carcinoma,1,2,Oral Cavity Squamous Cell Carcinoma,0.9862,Squamous Cell Carcinoma,0.9821,Buccal Mucosa Squamous Cell Carcinoma,0.9793,Tongue Squamous Cell Carcinoma,0.9772,Salivary Gland Squamous Cell Carcinoma,0.9768
"SQUAMOUS CELL CARCINOMA, PHARYNX",Pharyngeal Squamous Cell Carcinoma,1,2,Pharyngeal Squamous Cell Carcinoma,0.9826,Head and Neck Squamous Cell Carcinoma,0.9739,Hypopharyngeal Squamous Cell Carcinoma,0.9722,Squamous Cell Carcinoma of the Penis,0.9720,Lung Squamous Cell Carcinoma,0.9712
"SQUAMOUS CELL CARCINOMA, SALIVARY GLAND",Salivary Gland Squamous Cell Carcinoma,1,2,Salivary Gland Squamous Cell Carcinoma,0.9943,Squamous Cell Carcinoma,0.9803,Head and Neck Squamous Cell Carcinoma,0.9764,thyroid gland squamous cell carcinoma,0.9743,Lung Squamous Cell Carcinoma,0.9736
"SQUAMOUS CELL CARCINOMA, TONGUE",Tongue Squamous Cell Carcinoma,1,2,Tongue Squamous Cell Carcinoma,0.9931,Squamous Cell Carcinoma,0.9789,Salivary Gland Squamous Cell Carcinoma,0.9780,Oral Cavity Squamous Cell Carcinoma,0.9777,Head and Neck Squamous Cell Carcinoma,0.9762
"SQUAMOUS CELL CARCINOMA, VULVAR",Vulvar Squamous Cell Carcinoma,1,2,Vulvar Squamous Cell Carcinoma,0.9937,Vaginal Squamous Cell Carcinoma,0.9798,Vulvar Carcinoma,0.9728,Squamous Cell Carcinoma,0.9705,Cervical Squamous Cell Carcinoma,0.9673
SQUAMOUS CELL CARCINOMA-VPD,Squamous Cell Carcinoma<;>Poorly Differentiated,99,2,Prostate Squamous Cell Carcinoma,0.9678,Vulvar Squamous Cell Carcinoma,0.9659,Squamous Cell Carcinoma of the Penis,0.9643,Oropharyngeal Squamous Cell Carcinoma,0.9632,Oral Cavity Squamous Cell Carcinoma,0.9621
SQUAMOUS_CELL_CARCINOMA,Squamous Cell Carcinoma,1,2,Squamous Cell Carcinoma,0.9937,Lung Squamous Cell Carcinoma,0.9868,Laryngeal Squamous Cell Carcinoma,0.9814,Skin Squamous Cell Carcinoma,0.9779,Salivary Gland Squamous Cell Carcinoma,0.9778
ST-RELPOS,"Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive",99,2,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.8986,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.8925,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.8902,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.8899,NUP98 Gene<;>Chromosomal Translocation,0.8899
ST-SE,Supratentorial Ependymoma<;>Subependymoma,2,2,Sezary Syndrome,0.9112,Supratentorial Ependymoma<;>Subependymoma,0.9100,Mycosis Fungoides and Sezary Syndrome,0.9077,Synovial Sarcoma<;>Poorly Differentiated,0.9000,ETV1 Gene,0.8998
ST-YAP,Supratentorial Ependymoma YAP1 Fusion-Positive,3,2,NUP98 Gene<;>Chromosomal Translocation,0.9008,"Astrocytoma, IDH-Mutant, Grade 2",0.8957,Supratentorial Ependymoma YAP1 Fusion-Positive,0.8949,"Anaplastic Astrocytoma, IDH-Wildtype",0.8947,"Astrocytoma, IDH-Mutant, Grade 3",0.8935
STAD,Gastric Adenocarcinoma,99,2,Angiosarcoma,0.9051,Adamantinoma,0.8991,Breast Angiosarcoma,0.8968,Chondroblastoma,0.8900,Adamantinomatous Craniopharyngioma,0.8899
STAD_CIN,Gastric Adenocarcinoma<;>Chromosomal Instability,99,2,Angiosarcoma,0.8980,Colon Adenocarcinoma<;>Microsatellite Instability,0.8954,Colon Adenocarcinoma<;>Chromosomal Instability,0.8948,Endometrial Carcinoma<;>Microsatellite Instability,0.8940,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.8933
STAD_EBV,Gastric Adenocarcinoma<;>Epstein-Barr Virus,2,2,EBV-Related Lymphoma,0.9148,Gastric Adenocarcinoma<;>Epstein-Barr Virus,0.9133,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.9061,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9055,Activated B-Cell Positive,0.9033
STAD_GS,Gastric Adenocarcinoma,99,2,Adamantinoma,0.8921,Activated B-Cell Positive,0.8907,"Astrocytoma, IDH-Mutant, Grade 4",0.8902,Glioblastoma<;>IDH Gene Family Mutation,0.8886,Adamantinomatous Craniopharyngioma,0.8873
STAD_MSI,Gastric Adenocarcinoma<;>Microsatellite Instability,3,2,Colon Adenocarcinoma<;>Microsatellite Instability,0.9223,Rectal Adenocarcinoma<;>Microsatellite Instability,0.9192,Gastric Adenocarcinoma<;>Microsatellite Instability,0.9143,Esophageal Adenocarcinoma<;>Microsatellite Instability,0.9119,Microsatellite Instability,0.9094
STAD_POLE,Gastric Adenocarcinoma<;>POLE Gene Mutation,99,2,Colon Adenocarcinoma<;>POLE Gene Mutation,0.9096,Rectal Adenocarcinoma<;>POLE Gene Mutation,0.9070,Endometrial Carcinoma<;>POLE Gene Mutation,0.9056,POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma,0.9044,Esophageal Adenocarcinoma<;>POLE Gene Mutation,0.9036
"STEROID CELL TUMOR, NOS","Ovarian Steroid Cell Tumor, Not Otherwise Specified",1,2,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.9645,Ovarian Sertoli-Leydig Cell Tumor,0.9363,"Malignant Tumor, Small Cell Type",0.9344,Sinonasal Squamous Cell Carcinoma,0.9315,Testicular Non-Seminomatous Germ Cell Tumor,0.9307
STOMACH,Stomach,1,2,Stomach,1.0000,Gastric,0.9564,Abdomen,0.9233,Gastric Adenocarcinoma,0.9150,Colon,0.9094
STOMACH ADENOCARCINOMA,Gastric Adenocarcinoma,1,2,Gastric Adenocarcinoma,0.9840,Gallbladder Adenocarcinoma,0.9659,Adenocarcinoma,0.9614,Salivary Gland Adenocarcinoma,0.9561,Gastric Tubular Adenocarcinoma,0.9556
"STOMACH ADENOCARCINOMA, SIGNET RING TYPE",Gastric Signet Ring Cell Adenocarcinoma,1,2,Gastric Signet Ring Cell Adenocarcinoma,0.9850,Signet Ring Adenocarcinoma Cell,0.9760,Rectal Signet Ring Cell Adenocarcinoma<;>Colon Signet Ring Cell Adenocarcinoma,0.9743,Pancreatic Signet Ring Cell Carcinoma,0.9697,Signet Ring Cell Carcinoma,0.9688
STOMACH ADENOCARINOMA,Gastric Adenocarcinoma,99,2,Gastric Adenosquamous Carcinoma,0.9486,Adenosarcoma,0.9483,Uterine Corpus Adenosarcoma,0.9443,Adenoid Cystic Carcinoma,0.9384,Gallbladder Adenosquamous Carcinoma,0.9381
STOMACH CANCER,Gastric Carcinoma,1,2,Gastric Carcinoma,0.9530,Gastric Adenocarcinoma,0.9523,Stomach,0.9445,Gallbladder Squamous Cell Carcinoma,0.9386,Gallbladder Carcinoma,0.9374
"STOMACH, ADENOCARCINOMA, DIFFUSE TYPE",Gastric Diffuse Adenocarcinoma,1,2,Gastric Diffuse Adenocarcinoma,0.9728,Gastric Intestinal-Type Adenocarcinoma,0.9627,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.9498,Gastric Adenocarcinoma,0.9493,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9487
"STOMACH, ADENOCARCINOMA, NOT OTHERWISE SPECIFIED NOS",Gastric Adenocarcinoma,99,2,Not Otherwise Specified,0.9512,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9497,Adenocarcinoma<;>Well Differentiated,0.9487,Lung Adenocarcinoma In Situ<;>Lung Non-Small Cell Carcinoma,0.9478,Adenocarcinoma<;>Poorly Differentiated,0.9475
"STOMACH, INTESTINAL ADENOCARCINOMA, MUCINOUS TYPE",Gastric Mucinous Adenocarcinoma,4,2,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.9779,Gastric Intestinal-Type Adenocarcinoma,0.9770,"Mucinous Adenocarcinoma, Endocervical Type",0.9662,Gastric Mucinous Adenocarcinoma,0.9655,Colon Mucinous Adenocarcinoma,0.9580
"STOMACH, INTESTINAL ADENOCARCINOMA, NOT OTHERWISE SPECIFIED NOS",Gastric Intestinal-Type Adenocarcinoma,1,2,Gastric Intestinal-Type Adenocarcinoma,0.9581,Lung Adenocarcinoma In Situ<;>Lung Non-Small Cell Carcinoma,0.9498,Adenocarcinoma<;>Well Differentiated<;>Rectum,0.9482,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9476,Adenocarcinoma<;>Well Differentiated,0.9470
"STOMACH, INTESTINAL ADENOCARCINOMA, PAPILLARY TYPE",Gastric Papillary Adenocarcinoma,2,2,Gastric Intestinal-Type Adenocarcinoma,0.9746,Gastric Papillary Adenocarcinoma,0.9675,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.9601,Papillary Adenocarcinoma,0.9527,Lung Papillary Adenocarcinoma,0.9523
"STOMACH, INTESTINAL ADENOCARCINOMA, TUBULAR TYPE",Gastric Tubular Adenocarcinoma,2,2,Gastric Intestinal-Type Adenocarcinoma,0.9806,Gastric Tubular Adenocarcinoma,0.9708,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.9594,Tubular Adenocarcinoma<;>Well Differentiated Adenocarcinoma Cell,0.9582,Tubular Adenocarcinoma<;>Moderately Differentiated,0.9579
SUN-EXPOSED,Sun-exposed Site,1,2,Sun-exposed Site,0.9674,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.8992,Skin,0.8927,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.8915,Head and Neck Squamous Cell Carcinoma<;>Spindle Cell Squamous Cell Carcinoma,0.8913
SUPERFICIAL,Superficial,1,2,Superficial,1.0000,Melanoma Involvement of Regional Cutaneous or Subcutaneous Tissue,0.8985,Synovial Sarcoma<;>Poorly Differentiated,0.8954,Skin,0.8924,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.8921
SUPERFICIAL SPREADING,Low-CSD Melanoma,99,2,Superficial,0.9637,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9124,Skin Squamous Cell Carcinoma,0.9081,Melanoma Involvement of Regional Cutaneous or Subcutaneous Tissue,0.9035,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.9034
SUPERFICIAL SPREADING MELANOMA,Low-CSD Melanoma,99,2,Superficial,0.9464,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9362,Cutaneous Nodular Melanoma,0.9317,Skin Squamous Cell Carcinoma,0.9306,Melanoma Involvement of Regional Cutaneous or Subcutaneous Tissue,0.9273
SURGERY,Surgical Procedure,1,2,Surgical Procedure,0.9719,Resection,0.9217,Cystectomy,0.9012,Transurethral Resection of Bladder Tumor,0.9009,Anastomosis<;>Recurrence,0.8940
SWEAT GLAND ADENOCARCINOMA,Eccrine Carcinoma,99,2,Sweat Gland Carcinoma,0.9809,Salivary Gland Adenocarcinoma,0.9678,Adenocarcinoma,0.9591,Breast Adenocarcinoma,0.9566,Anal Glands Adenocarcinoma,0.9565
SWEAT GLAND CARCINOMA/APOCRINE ECCRINE CARCINOMA,Sweat Gland Carcinoma,1,2,Sweat Gland Carcinoma,0.9795,Eccrine Carcinoma,0.9648,Adrenal Gland Carcinoma,0.9546,Sebaceous Carcinoma,0.9533,Salivary Gland Carcinoma,0.9508
SYNOVIAL,Synovial Neoplasm,2,2,Synovial Sarcoma,0.9498,Synovial Neoplasm,0.9375,Synovial Sarcoma<;>Poorly Differentiated,0.9367,Biphasic Synovial Sarcoma,0.9195,Monophasic Synovial Sarcoma,0.9179
SYNOVIAL SARCOMA,Synovial Sarcoma,1,2,Synovial Sarcoma,1.0000,Synovial Neoplasm,0.9641,Sarcoma,0.9628,Bone Sarcoma,0.9622,Synovial Sarcoma<;>Poorly Differentiated,0.9621
SYNOVIAL SARCOMA - BIPHASIC,Biphasic Synovial Sarcoma,1,2,Biphasic Synovial Sarcoma,0.9945,Monophasic Synovial Sarcoma,0.9639,Synovial Sarcoma,0.9582,Synovial Sarcoma<;>Poorly Differentiated,0.9581,Sarcoma,0.9472
SYNOVIAL SARCOMA - MONOPHASIC,Monophasic Synovial Sarcoma,1,2,Monophasic Synovial Sarcoma,0.9939,Biphasic Synovial Sarcoma,0.9631,Synovial Sarcoma,0.9511,Synovial Sarcoma<;>Poorly Differentiated,0.9498,Synovial Neoplasm,0.9349
SYNOVIAL_SARCOMA,Synovial Sarcoma,1,2,Synovial Sarcoma,0.9902,Synovial Sarcoma<;>Poorly Differentiated,0.9598,Synovial Neoplasm,0.9579,Sarcoma,0.9569,Bone Sarcoma,0.9514
SYSTEMIC MASTOCYTOSIS,Systemic Mastocytosis,1,2,Systemic Mastocytosis,1.0000,Mastocytosis,0.9570,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.9086,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9076,"Malignant Lymphoma, Histiocytic, Diffuse",0.9067
S_T_MDS,Myelodysplastic Syndrome,99,2,Myelodysplastic Syndrome with del(5q),0.9111,Myelodysplastic Syndrome with Isolated del(5q),0.9109,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9088,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9088,T-Cell Non-Hodgkin Lymphoma,0.9086
T-ALL,T Acute Lymphoblastic Leukemia,5,2,T-Lymphocyte,0.9354,T Lymphoblastic Leukemia/Lymphoma,0.9334,Adult T-Cell Leukemia/Lymphoma,0.9322,T-Cell Non-Hodgkin Lymphoma,0.9301,T Acute Lymphoblastic Leukemia,0.9230
T-CELL,T-Lymphocyte,1,2,T-Lymphocyte,0.9843,T-Cell Non-Hodgkin Lymphoma,0.9526,B-Lymphocyte,0.9439,Adult T-Cell Leukemia/Lymphoma,0.9406,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9360
T-CELL ACUTE LYMPHOID LEUKEMIA,T Acute Lymphoblastic Leukemia,1,2,T Acute Lymphoblastic Leukemia,0.9820,T Lymphoblastic Leukemia/Lymphoma,0.9739,B Acute Lymphoblastic Leukemia,0.9662,Adult T-Cell Leukemia/Lymphoma,0.9657,Acute Lymphoblastic Leukemia,0.9639
T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA,T-Cell Large Granular Lymphocyte Leukemia,1,2,T-Cell Large Granular Lymphocyte Leukemia,0.9969,T Lymphoblastic Leukemia/Lymphoma,0.9524,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9518,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.9482,T Acute Lymphoblastic Leukemia,0.9461
"T-CELL, NON-HODGKINS, ANAPLASTIC LARGE CELL ALCL",Anaplastic Large Cell Lymphoma,1,2,Anaplastic Large Cell Lymphoma,0.9673,T-Cell Non-Hodgkin Lymphoma,0.9632,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.9615,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.9611,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9595
"T-CELL, NON-HODGKINS, CUTANEOUS",Cutaneous T-Cell Non-Hodgkin Lymphoma,1,2,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9885,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9784,T-Cell Non-Hodgkin Lymphoma,0.9673,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9546,B-Cell Non-Hodgkin Lymphoma,0.9533
"T-CELL, NON-HODGKINS, CUTANEOUS, SEZARY SYNDROME",Sezary Syndrome,2,2,Mycosis Fungoides and Sezary Syndrome,0.9635,Sezary Syndrome,0.9569,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9556,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9546,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.9441
T-CELL_ALL,T Acute Lymphoblastic Leukemia,99,2,T-Lymphocyte,0.9489,T-Cell Non-Hodgkin Lymphoma,0.9389,Adult T-Cell Leukemia/Lymphoma,0.9298,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.9249,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9227
T-CELL_LYMPHOMA_OTHER,T-Cell Non-Hodgkin Lymphoma,1,2,T-Cell Non-Hodgkin Lymphoma,0.9737,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.9580,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9529,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9496,Adult T-Cell Leukemia/Lymphoma,0.9489
T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,T Lymphoblastic Leukemia/Lymphoma,1,2,T Lymphoblastic Leukemia/Lymphoma,0.9990,B Lymphoblastic Leukemia/Lymphoma,0.9832,T Acute Lymphoblastic Leukemia,0.9775,Adult T-Cell Leukemia/Lymphoma,0.9686,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.9677
TALL,T Acute Lymphoblastic Leukemia,99,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.9100,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.8820,Ascending Colon,0.8784,Overt Primary Myelofibrosis,0.8762,Solid<;>High Grade Transformation,0.8754
TALL CELL,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.9499,Cell Line,0.9036,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9013,Columnar Cell,0.9010,Transitional Cells,0.8997
TALL CELL VARIANT,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.9655,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.9104,Cell Line,0.9061,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9046,Large Cell Carcinoma<;>Undifferentiated,0.9025
TALL CELL VARIANT  PHENOTYPE CHANGED AFTER CONSENSUS UPSTAGED T,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.9483,Squamous Cell Carcinoma<;>Poorly Differentiated,0.9190,T-Cell Non-Hodgkin Lymphoma,0.9166,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9142,Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma,0.9135
TC: UNDIFERENTIATED,Thymic Carcinoma<;>Undifferentiated,99,2,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,0.9237,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.9219,Adenocarcinoma<;>Undifferentiated,0.9193,Carcinoma<;>Undifferentiated,0.9179,Adenocarcinoma<;>Undifferentiated Carcinoma,0.9167
TC: UNDIFFERENTIATED,Thymic Carcinoma<;>Undifferentiated,3,2,Carcinoma<;>Undifferentiated,0.9470,Undifferentiated,0.9418,Thymic Carcinoma<;>Undifferentiated,0.9415,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.9412,Glioblastoma<;>Undifferentiated,0.9361
TC: UNDIFFERENZIATED,Thymic Carcinoma<;>Undifferentiated,99,2,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.9221,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.9155,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9135,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.9126,Adenocarcinoma<;>Undifferentiated,0.9125
TC:NEC,Thymic Neuroendocrine Carcinoma,99,2,Central Nervous System<;>Brain,0.9043,Mature T-Cell and NK-Cell Neoplasm,0.8999,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8991,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.8988,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.8985
TC:SCC,Thymic Squamous Cell Carcinoma,99,2,Carcinoma,0.9173,Tongue Squamous Cell Carcinoma,0.9155,Oral Cavity Squamous Cell Carcinoma,0.9148,thyroid gland squamous cell carcinoma,0.9143,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9143
TC:UNDIFFERENTIATED,Thymic Carcinoma<;>Undifferentiated,3,2,Carcinoma<;>Undifferentiated,0.9470,Undifferentiated,0.9418,Thymic Carcinoma<;>Undifferentiated,0.9415,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.9412,Glioblastoma<;>Undifferentiated,0.9361
TELANGIECTATIC OSTEOSARCOMA,Telangiectatic Osteosarcoma,1,2,Telangiectatic Osteosarcoma,1.0000,Osteosarcoma,0.9426,Osteoblastic Osteosarcoma,0.9307,Chondroblastic Osteosarcoma,0.9301,Periosteal Osteosarcoma,0.9276
TERATOMA,Teratoma,1,2,Teratoma,1.0000,Immature Teratoma,0.9589,Mature Teratoma,0.9581,Seminoma<;>Mature Teratoma,0.9547,Teratoma with Somatic-Type Malignancy,0.9542
TERATOMA IMMATURE,Immature Teratoma,1,2,Immature Teratoma,0.9936,Teratoma,0.9649,Mature Teratoma,0.9569,Seminoma<;>Mature Teratoma,0.9466,Nonseminomatous<;>Immature Teratoma,0.9416
TERATOMA IMMATURENON-SEMINOMA,Nonseminomatous<;>Immature Teratoma,99,2,Seminoma<;>Mature Teratoma,0.9772,Immature Teratoma,0.9715,Teratoma,0.9603,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9589,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9585
TERATOMA IMMATURESEMINOMA,Nonseminomatous<;>Immature Teratoma,4,2,Immature Teratoma,0.9762,Teratoma,0.9565,Seminoma<;>Mature Teratoma,0.9513,Nonseminomatous<;>Immature Teratoma,0.9512,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.9511
TERATOMA MATURE,Mature Teratoma,1,2,Mature Teratoma,0.9857,Teratoma,0.9646,Seminoma<;>Mature Teratoma,0.9622,Immature Teratoma,0.9519,Mature,0.9422
TERATOMA MATURENON-SEMINOMA,Nonseminomatous<;>Mature Teratoma,99,2,Seminoma<;>Mature Teratoma,0.9883,Mature Teratoma,0.9717,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9618,Teratoma,0.9610,Testicular Seminoma,0.9580
TERATOMA MATURESEMINOMA,Seminoma<;>Mature Teratoma,2,2,Mature Teratoma,0.9726,Seminoma<;>Mature Teratoma,0.9684,Teratoma,0.9572,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9524,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9519
TERATOMA MATURE[NOT AVAILABLE]NON-SEMINOMA,Nonseminomatous<;>Mature Teratoma,3,2,Seminoma<;>Mature Teratoma,0.9711,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9701,Nonseminomatous<;>Mature Teratoma,0.9644,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9639,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9622
TERATOMA WITH MALIGNANT TRANSFORMATION,Teratoma with Somatic-Type Malignancy,2,2,Teratoma,0.9624,Teratoma with Somatic-Type Malignancy,0.9579,Malignant Neoplasm,0.9445,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9430,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.9417
TESTICULAR CARCINOMA,Testicular Carcinoma,1,2,Testicular Carcinoma,1.0000,Testicular Germ Cell Tumor,0.9609,Penile Carcinoma,0.9557,Breast Carcinoma,0.9491,Carcinoma,0.9479
TESTICULAR MESOTHELIOMA,Testicular mesothelioma,1,2,Testicular mesothelioma,1.0000,Mesothelioma,0.9520,Testicular Seminoma,0.9448,Peritoneal Mesothelioma,0.9444,Pleural Mesothelioma,0.9432
TESTICULAR NON-SEMINOMA,Testicular Non-Seminomatous Germ Cell Tumor,1,2,Testicular Non-Seminomatous Germ Cell Tumor,0.9756,Testicular Seminoma,0.9652,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9581,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,0.9546,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.9508
TESTICULAR SEMINOMA,Testicular Seminoma,1,2,Testicular Seminoma,1.0000,Seminoma,0.9811,Testicular Non-Seminomatous Germ Cell Tumor,0.9611,Seminoma<;>Mature Teratoma,0.9599,Embryonal Carcinoma<;>Seminoma,0.9550
TGCT,Testicular Germ Cell Tumor,1,2,Testicular Germ Cell Tumor,0.9234,Testicular Non-Seminomatous Germ Cell Tumor,0.9215,Testicular Seminoma,0.9205,Glioblastoma,0.9152,Childhood Brain Germ Cell Tumor,0.9141
TGCT NON-SEM,Testicular Non-Seminomatous Germ Cell Tumor,1,2,Testicular Non-Seminomatous Germ Cell Tumor,0.9218,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,0.9204,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9167,Choriocarcinoma<;>Nonseminomatous,0.9160,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9143
TGCT SEM,Testicular Seminoma,1,2,Testicular Seminoma,0.9036,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9028,Testicular Non-Seminomatous Germ Cell Tumor,0.9011,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,0.9003,Testicular Germ Cell Tumor,0.8962
TGCT_NON-SEMINOMA,Testicular Non-Seminomatous Germ Cell Tumor,1,2,Testicular Non-Seminomatous Germ Cell Tumor,0.9681,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,0.9513,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9481,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.9455,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.9432
TGCT_SEMINOMA,Testicular Seminoma,1,2,Testicular Seminoma,0.9653,Seminoma,0.9613,Testicular Non-Seminomatous Germ Cell Tumor,0.9544,Testicular Germ Cell Tumor,0.9519,Embryonal Carcinoma<;>Seminoma,0.9444
THCA,Thyroid Gland Carcinoma,99,2,Meningioma,0.9025,Hemangioma,0.8989,Adult T-Cell Leukemia/Lymphoma,0.8978,Brain,0.8975,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.8909
THERAPY-RELATED MYELODYSPLASTIC SYNDROME,Therapy-Related Myelodysplastic Syndrome,1,2,Therapy-Related Myelodysplastic Syndrome,1.0000,Therapy-Related Myeloid Neoplasm,0.9692,Myelodysplastic Syndrome,0.9660,Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,0.9557,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.9549
THERAPY-RELATED MYELOID NEOPLASMS,Therapy-Related Myeloid Neoplasm,1,2,Therapy-Related Myeloid Neoplasm,0.9989,Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,0.9723,Therapy-Related Myelodysplastic Syndrome,0.9711,Myeloid Neoplasm,0.9541,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.9452
THIGH,Thigh,1,2,Thigh,1.0000,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.9045,Fibrosarcoma,0.9015,Muscle,0.8977,fibroblast of breast,0.8963
THIRD RECURRENCE,Recurrence,1,2,Recurrence,0.9299,Recurrent,0.9231,Regional<;>Recurrence,0.9152,Locally Recurrent Malignant Neoplasm,0.9144,First Relapse,0.9119
THPA,Thyroid Gland Papillary Carcinoma,99,2,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.9048,Hemangioma,0.9048,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.9043,Acute Promyelocytic Leukemia with PML-RARA,0.9042,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9033
THPD,Poorly Differentiated Thyroid Gland Carcinoma,99,2,Hemangioma,0.9061,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.9056,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9049,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.9041,Acute Promyelocytic Leukemia with PML-RARA,0.9034
THRBCL,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1,2,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9084,Hemangioma,0.9015,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.9003,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.8999,Chordoma,0.8990
THYM,Thymoma,1,2,Thymoma,0.9564,Thymoma Type A,0.9296,Thymoma Type A<;>Thymoma Type AB,0.9267,Thymoma Type AB,0.9266,T-Lymphocyte,0.9245
THYMIC CARCINOMA,Thymic Carcinoma,1,2,Thymic Carcinoma,1.0000,Thymic Squamous Cell Carcinoma,0.9784,Thymic Neuroendocrine Carcinoma,0.9740,Thymic Epithelial Neoplasm,0.9651,thymic neuroendocrine tumor,0.9548
THYMIC EPITHELIAL TUMOR,Thymic Epithelial Neoplasm,1,2,Thymic Epithelial Neoplasm,0.9880,Thymic Carcinoma,0.9668,thymic neuroendocrine tumor,0.9657,Thymic Squamous Cell Carcinoma,0.9577,Thymic Neuroendocrine Carcinoma,0.9570
THYMIC NEUROENDOCRINE TUMOR,thymic neuroendocrine tumor,1,2,thymic neuroendocrine tumor,1.0000,Thymic Neuroendocrine Carcinoma,0.9860,Neuroendocrine Tumor,0.9658,Thymic Epithelial Neoplasm,0.9621,Appendix Neuroendocrine Tumor,0.9549
THYMIC TUMOR,Thymus Neoplasm,4,2,Thymic Carcinoma,0.9780,thymic neuroendocrine tumor,0.9715,Thymic Epithelial Neoplasm,0.9673,Thymus Neoplasm,0.9651,Thymic Squamous Cell Carcinoma,0.9587
THYMOMA,Thymoma,1,2,Thymoma,1.0000,Thymoma Type A,0.9526,Thymus Neoplasm,0.9475,Thymic Carcinoma,0.9447,Thymoma Type AB,0.9416
THYMOMA; TYPE A,Thymoma Type A,1,2,Thymoma Type A,0.9936,Thymoma Type A<;>Thymoma Type AB,0.9848,Thymoma Type AB,0.9804,Thymoma Type B1<;>Thymoma Type B2,0.9764,Thymoma Type B1,0.9715
THYMOMA; TYPE AB,Thymoma Type AB,1,2,Thymoma Type AB,0.9943,Thymoma Type A<;>Thymoma Type AB,0.9916,Thymoma Type A,0.9804,Thymoma Type B1<;>Thymoma Type B2,0.9724,Thymoma Type B2<;>Thymoma Type B3,0.9692
THYMOMA; TYPE ATHYMOMA; TYPE AB,Thymoma Type A<;>Thymoma Type AB,1,2,Thymoma Type A<;>Thymoma Type AB,0.9784,Thymoma Type AB,0.9783,Thymoma Type A,0.9635,Thymoma Type B1<;>Thymoma Type B2,0.9612,Thymoma Type B2<;>Thymoma Type B3,0.9549
THYMOMA; TYPE B1,Thymoma Type B1,1,2,Thymoma Type B1,0.9951,Thymoma Type B1<;>Thymoma Type B2,0.9860,Thymoma Type A,0.9745,Thymoma Type B2,0.9724,Thymoma Type B2<;>Thymoma Type B3,0.9724
THYMOMA; TYPE B1THYMOMA; TYPE B2,Thymoma Type B1<;>Thymoma Type B2,1,2,Thymoma Type B1<;>Thymoma Type B2,0.9863,Thymoma Type B2<;>Thymoma Type B3,0.9793,Thymoma Type B2,0.9760,Thymoma Type B1,0.9752,Thymoma Type A<;>Thymoma Type AB,0.9690
THYMOMA; TYPE B2,Thymoma Type B2,1,2,Thymoma Type B2,0.9952,Thymoma Type B2<;>Thymoma Type B3,0.9877,Thymoma Type B1<;>Thymoma Type B2,0.9864,Thymoma Type B3,0.9724,Thymoma Type B1,0.9708
THYMOMA; TYPE B2THYMOMA; TYPE B3,Thymoma Type B2<;>Thymoma Type B3,1,2,Thymoma Type B2<;>Thymoma Type B3,0.9855,Thymoma Type B1<;>Thymoma Type B2,0.9784,Thymoma Type B3,0.9765,Thymoma Type B2,0.9749,Thymoma Type A<;>Thymoma Type AB,0.9643
THYMOMA; TYPE B3,Thymoma Type B3,1,2,Thymoma Type B3,0.9956,Thymoma Type B2<;>Thymoma Type B3,0.9855,Thymoma Type B2,0.9708,Thymoma Type B1<;>Thymoma Type B2,0.9706,Thymoma Type B1,0.9660
THYMOMA; TYPE C,Thymic Carcinoma,99,2,Thymoma Type A,0.9778,Thymoma Type A<;>Thymoma Type AB,0.9726,Thymoma Type B1<;>Thymoma Type B2,0.9693,Thymoma Type AB,0.9667,Thymoma Type B2<;>Thymoma Type B3,0.9658
THYROID,Thyroid Gland,1,2,Thyroid Gland,0.9869,Thyroid Gland Sarcoma,0.9428,Thyroid Gland Carcinoma,0.9390,Differentiated Thyroid Gland Carcinoma,0.9277,Thyroid Gland Papillary and Follicular Carcinoma,0.9275
THYROID CANCER,Thyroid Gland Carcinoma,1,2,Thyroid Gland Carcinoma,0.9740,Thyroid Gland Papillary Carcinoma,0.9543,thyroid gland squamous cell carcinoma,0.9517,Thyroid Gland Follicular Carcinoma,0.9500,Thyroid Gland Medullary Carcinoma,0.9497
"THYROID CANCER, NOS",Thyroid Gland Carcinoma,1,2,Thyroid Gland Carcinoma,0.9570,thyroid gland squamous cell carcinoma,0.9483,Thyroid Gland Oncocytic Carcinoma,0.9430,Poorly Differentiated Thyroid Gland Carcinoma,0.9425,Thyroid Gland Medullary Carcinoma,0.9397
THYROID CARCINOMA,Thyroid Gland Carcinoma,1,2,Thyroid Gland Carcinoma,0.9932,Thyroid Gland Papillary Carcinoma,0.9709,Thyroid Gland Medullary Carcinoma,0.9705,Thyroid Gland Anaplastic Carcinoma,0.9668,Thyroid Gland Follicular Carcinoma,0.9653
THYROID CARCINOMA OTHER,Thyroid Gland Carcinoma,1,2,Thyroid Gland Carcinoma,0.9596,Poorly Differentiated Thyroid Gland Carcinoma,0.9515,Thyroid Gland Papillary and Follicular Carcinoma,0.9497,Classic Thyroid Gland Papillary Carcinoma,0.9472,Thyroid Gland Medullary Carcinoma,0.9460
THYROID PAPILLARY,Thyroid Gland Papillary Carcinoma,1,2,Thyroid Gland Papillary Carcinoma,0.9721,Papillary,0.9697,Thyroid Gland Papillary and Follicular Carcinoma,0.9612,Classic Thyroid Gland Papillary Carcinoma,0.9577,Follicular Variant Thyroid Gland Papillary Carcinoma,0.9531
THYROID PAPILLARY CARCINOMA - CLASSICAL/USUAL,Classic Thyroid Gland Papillary Carcinoma,1,2,Classic Thyroid Gland Papillary Carcinoma,0.9800,Thyroid Gland Papillary Carcinoma,0.9649,Thyroid Gland Papillary and Follicular Carcinoma,0.9629,Follicular Variant Thyroid Gland Papillary Carcinoma,0.9627,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.9565
THYROID PAPILLARY CARCINOMA - FOLLICULAR >= 99% FOLLICULAR PATTERNED,Follicular Variant Thyroid Gland Papillary Carcinoma,2,2,Thyroid Gland Papillary and Follicular Carcinoma,0.9696,Follicular Variant Thyroid Gland Papillary Carcinoma,0.9672,Thyroid Gland Papillary Carcinoma,0.9591,Classic Thyroid Gland Papillary Carcinoma,0.9562,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.9551
THYROID PAPILLARY CARCINOMA - TALL CELL >= 50% TALL CELL FEATURES,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.9773,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.9527,Thyroid Gland Papillary and Follicular Carcinoma,0.9515,Classic Thyroid Gland Papillary Carcinoma,0.9468,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.9463
THYROID POORLY DIFFERENTIATED,Poorly Differentiated Thyroid Gland Carcinoma,1,2,Poorly Differentiated Thyroid Gland Carcinoma,0.9806,Poorly Differentiated,0.9592,Differentiated Thyroid Gland Carcinoma,0.9589,Carcinoma<;>Poorly Differentiated,0.9506,Thyroid Gland,0.9436
THYROID SARCOMA,Thyroid Gland Sarcoma,1,2,Thyroid Gland Sarcoma,0.9879,Thyroid Gland Carcinoma,0.9475,Sarcoma,0.9439,Thyroid Gland,0.9418,thyroid gland squamous cell carcinoma,0.9414
THYROID_CARCINOMA,Thyroid Gland Carcinoma,1,2,Thyroid Gland Carcinoma,0.9888,Thyroid Gland Medullary Carcinoma,0.9692,Thyroid Gland Papillary Carcinoma,0.9680,Thyroid Gland Papillary and Follicular Carcinoma,0.9648,Thyroid Gland Follicular Carcinoma,0.9637
THYROID_SARCOMA,Thyroid Gland Sarcoma,1,2,Thyroid Gland Sarcoma,0.9814,Thyroid Gland Carcinoma,0.9446,Sarcoma,0.9420,thyroid gland squamous cell carcinoma,0.9414,Thyroid Gland,0.9402
THYROID_SQUAMOUS,thyroid gland squamous cell carcinoma,1,2,thyroid gland squamous cell carcinoma,0.9755,Thyroid Gland Carcinoma,0.9442,Thymic Squamous Cell Carcinoma,0.9418,Thyroid Gland Papillary and Follicular Carcinoma,0.9412,Thyroid Gland Follicular Carcinoma,0.9401
THYROID_SQUAMOUS_CELL_CARCINOMA,thyroid gland squamous cell carcinoma,1,2,thyroid gland squamous cell carcinoma,0.9939,Squamous Cell Carcinoma,0.9698,Laryngeal Squamous Cell Carcinoma,0.9679,Tongue Squamous Cell Carcinoma,0.9677,Thyroid Gland Carcinoma,0.9672
TISSUE NOS,Tissue,1,2,Tissue,0.9530,Brain,0.8978,Central Nervous System<;>Brain,0.8975,Soft Tissue,0.8949,Mucosa,0.8934
TLL,T Lymphoblastic Leukemia/Lymphoma,2,2,Adult T-Cell Leukemia/Lymphoma,0.9007,T Lymphoblastic Leukemia/Lymphoma,0.9001,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.8979,T-Lymphocyte,0.8938,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.8911
TN,Triple-Negative Breast Cancer Finding,99,2,Cecum,0.9065,Nephroblastomatosis,0.9014,nan,0.8992,T-Lymphocyte,0.8989,NTRK-Rearranged Spindle Cell Neoplasm,0.8984
TONGUE,Tongue,1,2,Tongue,1.0000,Tongue Squamous Cell Carcinoma,0.9315,Head and Neck,0.9052,Thymoma,0.9036,thyroid gland squamous cell carcinoma,0.9034
TRANSITIONAL CELL CARCINOMA,Transitional Cell Carcinoma,1,2,Transitional Cell Carcinoma,1.0000,Papillary Transitional Cell Carcinoma,0.9745,"Kidney Carcinoma, Transitional Cells",0.9702,Transitional Cells,0.9689,Breast Tubular Carcinoma,0.9482
TRANSITIONAL_CELL,Transitional Cells,1,2,Transitional Cells,0.9905,Transitional Cell Carcinoma,0.9641,"Kidney Carcinoma, Transitional Cells",0.9503,Papillary Transitional Cell Carcinoma,0.9382,Bladder Urothelial Cell,0.9190
TRANSITIONAL_CELL_CARCINOMA,Transitional Cell Carcinoma,1,2,Transitional Cell Carcinoma,0.9945,"Kidney Carcinoma, Transitional Cells",0.9705,Papillary Transitional Cell Carcinoma,0.9689,Transitional Cells,0.9679,Breast Tubular Carcinoma,0.9490
TRANSLOCATION,Translocation,1,2,Translocation,1.0000,MLL Gene Translocation,0.9263,NUP98 Gene<;>Chromosomal Translocation,0.9210,MiT Family Translocation-Associated Renal Cell Carcinoma,0.9051,MLL Gene Translocation<;>Low Risk,0.9042
TRANSLOCATION-ASSOCIATED RENAL CELL CARCINOMA,MiT Family Translocation-Associated Renal Cell Carcinoma,1,2,MiT Family Translocation-Associated Renal Cell Carcinoma,0.9700,Renal Cell Carcinoma,0.9536,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.9481,"Kidney Carcinoma, Transitional Cells",0.9473,Sarcomatoid Renal Cell Carcinoma,0.9455
TRANSVERSE COLON,Transverse Colon,1,2,Transverse Colon,1.0000,Ascending Colon,0.9378,Sigmoid Colon,0.9371,Descending Colon,0.9351,Colon,0.9345
TREATED PRIMARY GBM,Glioblastoma,99,2,Malignant Glioma<;>Secondary Malignant Neoplasm,0.9227,Primary,0.9176,Malignant Glioma<;>Progressive,0.9122,Glioblastoma<;>De Novo,0.9118,Primary Myelofibrosis,0.9114
TRILATERAL,Trilateral Retinoblastoma,1,2,Trilateral Retinoblastoma,0.9525,T-Lymphocyte,0.8931,Adult T-Cell Leukemia/Lymphoma,0.8879,Angioimmunoblastic T-Cell Lymphoma,0.8842,T Lymphoblastic Leukemia/Lymphoma,0.8813
TUBULAR,Tubular,1,2,Tubular,1.0000,Tubular Adenocarcinoma,0.9411,Breast Tubular Carcinoma,0.9329,Tubular Adenocarcinoma<;>Moderately Differentiated,0.9326,Gastric Tubular Adenocarcinoma,0.9303
TUBULAR STOMACH ADENOCARCINOMA,Gastric Tubular Adenocarcinoma,1,2,Gastric Tubular Adenocarcinoma,0.9922,Tubular Adenocarcinoma,0.9817,Tubular Adenocarcinoma<;>Moderately Differentiated,0.9597,Gastric Adenocarcinoma,0.9595,Tubular Adenocarcinoma<;>Well Differentiated Adenocarcinoma Cell,0.9559
TUBULAR/ CRIBRIFORM,Breast Tubular Carcinoma<;>Cribriform Pattern,3,2,Cribriform<;>Solid<;>Tubular,0.9764,Breast Tubular Carcinoma<;>Cribriform,0.9629,Breast Tubular Carcinoma<;>Cribriform Pattern,0.9554,Cribriform,0.9530,Tubular,0.9453
TUBULAR_ADENOCARCINOMA,Tubular Adenocarcinoma,1,2,Tubular Adenocarcinoma,0.9951,Gastric Tubular Adenocarcinoma,0.9754,Tubular Adenocarcinoma<;>Moderately Differentiated,0.9727,Tubular Adenocarcinoma<;>Well Differentiated Adenocarcinoma Cell,0.9692,Breast Tubular Carcinoma,0.9658
TUMOR FREE,Tumor Free,1,2,Tumor Free,1.0000,With Tumor,0.9209,Transurethral Resection of Bladder Tumor,0.9174,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9145,Fumarate Hydratase-Deficient Renal Cell Carcinoma,0.9137
TUMOR PRIMARY,Primary Neoplasm,1,2,Primary Neoplasm,0.9742,Metastatic Colorectal Carcinoma<;>Primary,0.9476,Primary,0.9447,Gastroesophageal Cancer<;>Primary Neoplasm,0.9445,Primary Neoplasm<;>Paired,0.9443
TUMOR_FREE,Tumor Free,1,2,Tumor Free,0.9928,Transurethral Resection of Bladder Tumor,0.9248,With Tumor,0.9238,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.9232,Malignant Brain Neoplasm,0.9226
TURBT,Transurethral Resection of Bladder Tumor,99,2,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9024,Myxoma,0.9004,Testicular Seminoma,0.8999,Thymoma,0.8988,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.8987
TYPE A,Thymoma Type A,1,2,Thymoma Type A,0.9339,Thymoma Type A<;>Thymoma Type AB,0.9303,Thymoma Type AB,0.9286,Thymoma Type B1<;>Thymoma Type B2,0.9252,Thymoma Type B1,0.9211
TYPE AB,Thymoma Type AB,1,2,Thymoma Type AB,0.9538,Thymoma Type A<;>Thymoma Type AB,0.9453,Thymoma Type B1<;>Thymoma Type B2,0.9252,Thymoma Type B2<;>Thymoma Type B3,0.9210,Thymoma Type B1,0.9203
TYPE ATHYMOMA,Thymoma Type A,3,2,Thymoma Type AB,0.9099,Thymoma Type A<;>Thymoma Type AB,0.9077,Thymoma Type A,0.9064,Botryoid-Type Embryonal Rhabdomyosarcoma,0.9058,Thymoma Type B1<;>Thymoma Type B2,0.9049
TYPE B1,Thymoma Type B1,1,2,Thymoma Type B1,0.9527,Thymoma Type B1<;>Thymoma Type B2,0.9366,Thymoma Type B2<;>Thymoma Type B3,0.9161,Thymoma Type B2,0.9158,Thymoma Type AB,0.9144
TYPE B1THYMOMA,Thymoma Type B1,1,2,Thymoma Type B1,0.9544,Thymoma Type B1<;>Thymoma Type B2,0.9427,Thymoma Type B3,0.9302,Thymoma Type B2<;>Thymoma Type B3,0.9292,Thymoma Type AB,0.9276
TYPE B2,Thymoma Type B2,1,2,Thymoma Type B2,0.9536,Thymoma Type B1<;>Thymoma Type B2,0.9444,Thymoma Type B2<;>Thymoma Type B3,0.9435,Thymoma Type B1,0.9277,Thymoma Type B3,0.9252
TYPE B2THYMOMA,Thymoma Type B2,1,2,Thymoma Type B2,0.9532,Thymoma Type B2<;>Thymoma Type B3,0.9479,Thymoma Type B1<;>Thymoma Type B2,0.9471,Thymoma Type B3,0.9377,Thymoma Type B1,0.9356
TYPE B3,Thymoma Type B3,1,2,Thymoma Type B3,0.9574,Thymoma Type B2<;>Thymoma Type B3,0.9429,Thymoma Type B1<;>Thymoma Type B2,0.9240,Thymoma Type B2,0.9229,Thymoma Type B1,0.9205
TYPE C,Thymic Carcinoma,99,2,Thymoma Type B1<;>Thymoma Type B2,0.9153,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9152,Cytology Specimen Type,0.9133,Thymoma Type A<;>Thymoma Type AB,0.9126,"Non-B, Non-C Hepatitis",0.9119
T_CELL,T-Lymphocyte,1,2,T-Lymphocyte,0.9731,T-Cell Non-Hodgkin Lymphoma,0.9454,Adult T-Cell Leukemia/Lymphoma,0.9364,B-Lymphocyte,0.9332,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.9294
T_CELL_ALCL,Anaplastic Large Cell Lymphoma,99,2,T-Lymphocyte,0.9508,T-Cell Non-Hodgkin Lymphoma,0.9468,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9399,Adult T-Cell Leukemia/Lymphoma,0.9377,T Lymphoblastic Leukemia/Lymphoma,0.9332
T_CELL_CUTANEOUS,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,2,2,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9669,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9567,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.9474,T-Lymphocyte,0.9465,Cutaneous Melanoma,0.9419
T_CELL_LARGE_GRANULAR_LYMPHOCYTIC_LEUKAEMIA,T-Cell Large Granular Lymphocyte Leukemia,1,2,T-Cell Large Granular Lymphocyte Leukemia,0.9806,T Lymphoblastic Leukemia/Lymphoma,0.9522,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.9522,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.9467,T-Cell Non-Hodgkin Lymphoma,0.9447
UCEC,Endometrial Carcinoma<;>Uterine Corpus Cancer,99,2,Colon,0.9078,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.9039,Bladder Urothelial Carcinoma,0.9004,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.9000,Bladder Urothelial Cell,0.8998
UCEC CSRC,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,1,2,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.9052,Colon,0.9029,uterine corpus endometrial carcinoma<;>Copy Number<;>Low,0.9003,Carcinosarcoma,0.8988,uterine corpus endometrial carcinoma<;>Copy Number<;>High,0.8973
UCEC ENDO,Endometrial Endometrioid Adenocarcinoma,99,2,Esophagus,0.8959,Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma,0.8928,Extrahepatic,0.8917,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.8911,Calcifying Nested Stromal-Epithelial Tumor of the Liver,0.8909
UCEC HM,Endometrial Carcinoma<;>Microsatellite Instability,99,2,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.9031,Colon,0.9025,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.8995,Hypermutated Colorectal Carcinoma,0.8985,Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma,0.8985
UCEC SEROUS,Endometrial Serous Adenocarcinoma,3,2,Serous,0.9288,Mixed<;>Serous<;>Clear Cells,0.9221,Endometrial Serous Adenocarcinoma,0.9185,Serous Cystadenocarcinoma,0.9185,Pancreatic Serous Cystadenoma,0.9166
UCEC_CN_HIGH,uterine corpus endometrial carcinoma<;>Copy Number<;>High,1,2,uterine corpus endometrial carcinoma<;>Copy Number<;>High,0.9305,uterine corpus endometrial carcinoma<;>Copy Number<;>Low,0.9256,High Grade<;>Small Cell Neuroendocrine Carcinoma<;>Small Cell Adenocarcinoma,0.9101,Claudin-Low,0.9095,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.9007
UCEC_CN_LOW,uterine corpus endometrial carcinoma<;>Copy Number<;>Low,1,2,uterine corpus endometrial carcinoma<;>Copy Number<;>Low,0.9331,Claudin-Low,0.9306,uterine corpus endometrial carcinoma<;>Copy Number<;>High,0.9252,Low-CSD Melanoma,0.9142,Cytogenetic Abnormality<;>Low Risk,0.9087
UCEC_MSI,Endometrial Carcinoma<;>Microsatellite Instability,1,2,Endometrial Carcinoma<;>Microsatellite Instability,0.9140,Colon Adenocarcinoma<;>Microsatellite Instability,0.9140,Esophageal Adenocarcinoma<;>Microsatellite Instability,0.9098,Colon,0.9097,Fibroblast<;>Colorectal,0.9074
UCEC_POLE,Endometrial Carcinoma<;>POLE Gene Mutation,2,2,POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma,0.9238,Endometrial Carcinoma<;>POLE Gene Mutation,0.9186,Colon Adenocarcinoma<;>POLE Gene Mutation,0.9080,Esophageal Adenocarcinoma<;>POLE Gene Mutation,0.9074,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.9002
UCS,Uterine Carcinosarcoma,99,2,Uveal Tract,0.8874,Bladder Urachal Adenocarcinoma,0.8824,"Myelodysplastic Syndrome, Unclassifiable",0.8822,Uterine Corpus Undifferentiated Sarcoma,0.8821,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.8816
UM,Uveal Melanoma,1,2,Uveal Melanoma,0.9120,Unclassified,0.9067,Undifferentiated,0.9026,Mucosal Melanoma of the Head and Neck,0.9002,Melanoma of Unknown Primary,0.8998
UNCLASSIFIED,Unclassified,1,2,Unclassified,1.0000,Unclassified Renal Cell Carcinoma,0.9409,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",0.9324,"Myelodysplastic Syndrome, Unclassifiable",0.9304,Undifferentiated,0.9149
UNCLASSIFIED KIDNEY RENAL CELL CARCINOMA,Renal Cell Carcinoma,2,2,Unclassified Renal Cell Carcinoma,0.9961,Renal Cell Carcinoma,0.9593,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9557,Kidney Carcinoma,0.9539,Renal Cell Carcinoma<;>Poorly Differentiated,0.9526
UNCLASSIFIED RENAL CELL CARCINOMA,Unclassified Renal Cell Carcinoma,1,2,Unclassified Renal Cell Carcinoma,1.0000,Renal Cell Carcinoma,0.9542,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.9536,Renal Cell Carcinoma<;>Poorly Differentiated,0.9516,Renal Cell Carcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.9493
UNCLASSIFIED SARCOMA,Sarcoma,99,2,Unclassified Renal Cell Carcinoma,0.9603,Unclassified,0.9483,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",0.9461,undifferentiated sarcoma,0.9442,Undifferentiated Soft Tissue Sarcoma,0.9441
UNDIFFERENTIATED,Undifferentiated,1,2,Undifferentiated,1.0000,Undifferentiated Carcinoma,0.9591,undifferentiated sarcoma,0.9562,Carcinoma<;>Undifferentiated,0.9538,Acute Undifferentiated Leukemia,0.9505
UNDIFFERENTIATED B LYMPHOMA,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,1,2,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.9792,Acute Undifferentiated Leukemia,0.9545,Undifferentiated,0.9500,Undifferentiated Carcinoma,0.9499,Carcinoma<;>Undifferentiated,0.9495
UNDIFFERENTIATED CARCINOMA,Undifferentiated Carcinoma,1,2,Undifferentiated Carcinoma,1.0000,Carcinoma<;>Undifferentiated,0.9862,Adenocarcinoma<;>Undifferentiated Carcinoma,0.9789,Gastric Undifferentiated Carcinoma,0.9777,Pancreatic Undifferentiated Carcinoma,0.9768
UNDIFFERENTIATED CARCINOMA OF THE PANCREAS,Pancreatic Undifferentiated Carcinoma,1,2,Pancreatic Undifferentiated Carcinoma,0.9936,Undifferentiated Carcinoma,0.9773,Carcinoma<;>Undifferentiated,0.9729,Adenocarcinoma<;>Undifferentiated Carcinoma,0.9727,Gastric Undifferentiated Carcinoma,0.9697
UNDIFFERENTIATED MALIGNANT NEOPLASM,Undifferentiated Malignant Neoplasm,1,2,Undifferentiated Malignant Neoplasm,1.0000,Undifferentiated Carcinoma,0.9760,Carcinoma<;>Undifferentiated,0.9716,Adenocarcinoma<;>Undifferentiated Carcinoma,0.9685,Adenocarcinoma<;>Undifferentiated,0.9640
UNDIFFERENTIATED PLEOMORPHIC SARCOMA MALIGNANT FIBROUS HISTIOCYTOMA,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.9791,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.9686,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.9684,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.9597,Pleomorphic Rhabdomyosarcoma,0.9515
UNDIFFERENTIATED PLEOMORPHIC SARCOMA UPS,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.9790,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.9679,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.9618,undifferentiated sarcoma,0.9568,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.9507
UNDIFFERENTIATED PLEOMORPHIC SARCOMA/MALIGANT FIBROUS HISTIOCYTOMA/HIGH-GRADE SPINDLE CELL SARCOMA,Undifferentiated Pleomorphic Sarcoma,3,2,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.9711,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.9660,Undifferentiated Pleomorphic Sarcoma,0.9603,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.9555,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.9491
UNDIFFERENTIATED PLEOMORPHIC SARCOMA/MALIGNANT FIBROUS HISTIOCYTOMA/HIGH-GRADE SPINDLE CELL SARCOMA,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.9816,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.9741,Undifferentiated Pleomorphic Sarcoma,0.9688,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.9663,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells<;>Sarcomatoid Carcinoma,0.9488
UNDIFFERENTIATED SARCOMA,Undifferentiated Soft Tissue Sarcoma,2,2,undifferentiated sarcoma,1.0000,Undifferentiated Soft Tissue Sarcoma,0.9803,Undifferentiated Pleomorphic Sarcoma,0.9712,Uterine Corpus Undifferentiated Sarcoma,0.9668,Undifferentiated Round Cell Sarcoma,0.9665
UNDIFFERENTIATED STOMACH ADENOCARCINOMA,Gastric Undifferentiated Carcinoma,1,2,Gastric Undifferentiated Carcinoma,0.9794,Adenocarcinoma<;>Undifferentiated,0.9723,Adenocarcinoma<;>Undifferentiated Carcinoma,0.9702,Undifferentiated Carcinoma,0.9616,Pancreatic Undifferentiated Carcinoma,0.9591
UNDIFFERENTIATED UTERINE SARCOMA,Uterine Corpus Undifferentiated Sarcoma,1,2,Uterine Corpus Undifferentiated Sarcoma,0.9862,undifferentiated sarcoma,0.9842,undifferentiated carcinoma of the corpus uteri,0.9667,Undifferentiated Soft Tissue Sarcoma,0.9654,Undifferentiated Pleomorphic Sarcoma,0.9614
UNDIFFERENTIATED_ADENOCARCINOMA,Adenocarcinoma<;>Undifferentiated Carcinoma,2,2,Adenocarcinoma<;>Undifferentiated,0.9901,Adenocarcinoma<;>Undifferentiated Carcinoma,0.9867,Carcinoma<;>Undifferentiated,0.9762,Undifferentiated Carcinoma,0.9758,Undifferentiated Malignant Neoplasm,0.9686
UNDIFFERENTIATED_CARCINOMA,Undifferentiated Carcinoma,1,2,Undifferentiated Carcinoma,0.9939,Carcinoma<;>Undifferentiated,0.9901,Adenocarcinoma<;>Undifferentiated Carcinoma,0.9813,undifferentiated carcinoma of the corpus uteri,0.9749,Undifferentiated Malignant Neoplasm,0.9744
UNDIFFERENTIATED_SARCOMA,undifferentiated sarcoma,1,2,undifferentiated sarcoma,0.9929,Undifferentiated Soft Tissue Sarcoma,0.9762,Undifferentiated Pleomorphic Sarcoma,0.9662,Undifferentiated Round Cell Sarcoma,0.9643,Uterine Corpus Undifferentiated Sarcoma,0.9642
UNILATERAL,Unilateral,1,2,Unilateral,1.0000,Bilateral,0.9241,Lobular,0.9033,Local-Regional,0.8915,Localized,0.8903
UNKNOWN TUMOR,Neoplasm,99,2,Melanoma of Unknown Primary,0.9546,Unclassified Renal Cell Carcinoma,0.9306,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,0.9231,Primary Neoplasm<;>Unpaired,0.9209,"Malignant Tumor, Small Cell Type",0.9175
UNTREATED PRIMARY DE NOVO GBM,Glioblastoma<;>De Novo,1,2,Glioblastoma<;>De Novo,0.9563,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.9212,Melanoma of Unknown Primary,0.9140,Malignant Glioma<;>Secondary Malignant Neoplasm,0.9132,Glioblastoma<;>Undifferentiated,0.9128
UPPER AERODIGESTIVE,upper aerodigestive tract neoplasm,2,2,Fibroblast<;>upper aerodigestive tract,0.9630,upper aerodigestive tract neoplasm,0.9535,upper aerodigestive tract neoplasm<;>Oral Cavity Squamous Cell Carcinoma,0.9370,upper tract urothelial carcinoma,0.9037,Adenocarcinoma<;>Undifferentiated,0.9005
UPPER TRACT UROTHELIAL,upper tract urothelial carcinoma,1,2,upper tract urothelial carcinoma,0.9752,Urothelial Papilloma,0.9321,Bladder Urothelial Cell,0.9316,upper aerodigestive tract neoplasm,0.9290,Urothelial Carcinoma,0.9271
UPPER TRACT UROTHELIAL CARCINOMA,upper tract urothelial carcinoma,1,2,upper tract urothelial carcinoma,1.0000,Urothelial Carcinoma,0.9690,Bladder Urothelial Carcinoma,0.9648,Urethral Urothelial Carcinoma,0.9599,upper aerodigestive tract neoplasm,0.9502
UPPER_AERODIGESTIVE,upper aerodigestive tract neoplasm,2,2,Fibroblast<;>upper aerodigestive tract,0.9661,upper aerodigestive tract neoplasm,0.9544,upper aerodigestive tract neoplasm<;>Oral Cavity Squamous Cell Carcinoma,0.9397,Adenocarcinoma<;>Undifferentiated,0.9059,upper tract urothelial carcinoma,0.9058
UPPER_AERODIGESTIVE_CARCINOMA,upper aerodigestive tract neoplasm,1,2,upper aerodigestive tract neoplasm,0.9845,upper aerodigestive tract neoplasm<;>Oral Cavity Squamous Cell Carcinoma,0.9789,Fibroblast<;>upper aerodigestive tract,0.9558,upper tract urothelial carcinoma,0.9474,Adenocarcinoma<;>Undifferentiated Carcinoma,0.9391
UPPER_AERODIGESTIVE_SQUAMOUS,upper aerodigestive tract neoplasm<;>Oral Cavity Squamous Cell Carcinoma,1,2,upper aerodigestive tract neoplasm<;>Oral Cavity Squamous Cell Carcinoma,0.9698,Fibroblast<;>upper aerodigestive tract,0.9652,upper aerodigestive tract neoplasm,0.9613,Squamous Cell Carcinoma<;>Poorly Differentiated,0.9392,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9371
URACHAL ADENOCARCINOMA,Bladder Urachal Adenocarcinoma,1,2,Bladder Urachal Adenocarcinoma,0.9890,Bladder Urachal Carcinoma,0.9747,Urethral Adenocarcinoma,0.9307,Adenocarcinoma,0.9248,Bladder Adenocarcinoma,0.9241
URACHAL CARCINOMA,Bladder Urachal Carcinoma,1,2,Bladder Urachal Carcinoma,0.9880,Bladder Urachal Adenocarcinoma,0.9744,Urothelial Carcinoma,0.9391,upper tract urothelial carcinoma,0.9326,Bladder Urothelial Carcinoma,0.9321
URETHRAL ADENOCARCINOMA,Urethral Adenocarcinoma,1,2,Urethral Adenocarcinoma,1.0000,Urethral Carcinoma,0.9727,Urethral Urothelial Carcinoma,0.9645,Bladder Adenocarcinoma,0.9576,Urethral Squamous Cell Carcinoma,0.9570
URETHRAL CANCER,Urethral Carcinoma,1,2,Urethral Carcinoma,0.9818,Urethral Urothelial Carcinoma,0.9750,Urethral Adenocarcinoma,0.9672,Urethral Squamous Cell Carcinoma,0.9625,Urothelial Carcinoma,0.9506
URETHRAL SQUAMOUS CELL CARCINOMA,Urethral Squamous Cell Carcinoma,1,2,Urethral Squamous Cell Carcinoma,1.0000,Urethral Carcinoma,0.9753,Squamous Cell Carcinoma,0.9727,Bladder Squamous Cell Carcinoma,0.9723,Squamous Cell Carcinoma of the Penis,0.9717
URETHRAL UROTHELIAL CARCINOMA,Urethral Urothelial Carcinoma,1,2,Urethral Urothelial Carcinoma,1.0000,Urethral Carcinoma,0.9878,Urothelial Carcinoma,0.9829,Bladder Urothelial Carcinoma,0.9761,Urethral Squamous Cell Carcinoma,0.9673
URINARY_TRACT,Urinary System,1,2,Urinary System,0.9533,Fibroblast<;>Urinary System,0.9458,Uveal Tract,0.9239,Biliary Tract,0.9215,Bladder,0.9191
UROTHELIAL CARCINOMA,Urothelial Carcinoma,1,2,Urothelial Carcinoma,1.0000,Bladder Urothelial Carcinoma,0.9900,Urethral Urothelial Carcinoma,0.9829,upper tract urothelial carcinoma,0.9690,Urethral Carcinoma,0.9689
UROTHELIAL CARCINOMA OTHER,Urothelial Carcinoma,1,2,Urothelial Carcinoma,0.9647,Bladder Urothelial Carcinoma,0.9567,upper tract urothelial carcinoma,0.9534,Urethral Urothelial Carcinoma,0.9526,Urothelial Papilloma,0.9462
UROTHELIAL PAPILLOMA,Urothelial Papilloma,1,2,Urothelial Papilloma,1.0000,Papilloma,0.9624,Urothelial Carcinoma,0.9584,Urethral Urothelial Carcinoma,0.9560,Bladder Urothelial Carcinoma,0.9519
UTERINE ADENOSARCOMA,Uterine Corpus Adenosarcoma,1,2,Uterine Corpus Adenosarcoma,0.9873,Adenosarcoma,0.9810,Endometrial Adenosquamous Carcinoma,0.9512,Breast Angiosarcoma,0.9511,Chondrosarcoma,0.9476
UTERINE CARCINOSARCOMA,Uterine Carcinosarcoma,1,2,Uterine Carcinosarcoma,1.0000,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.9782,Carcinosarcoma,0.9750,Ovarian Carcinosarcoma,0.9693,Carcinoid Tumor,0.9555
UTERINE CARCINOSARCOMA/ MALIGNANT MIXED MULLERIAN TUMOR MMMT: NOS,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,1,2,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9755,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9681,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9677,Malignant Mixed Mesodermal (Mullerian) Tumor<;>Carcinosarcoma<;>Yolk Sac Tumor,0.9657,Malignant Mixed Mesodermal (Mullerian) Tumor,0.9628
UTERINE CARCINOSARCOMA/ MMMT: HETEROLOGOUS TYPE,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",1,2,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9774,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9705,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9632,Malignant Mixed Mesodermal (Mullerian) Tumor<;>Carcinosarcoma<;>Yolk Sac Tumor,0.9497,Uterine Corpus Sarcoma<;>Mesenchymal,0.9443
UTERINE CARCINOSARCOMA/MMMT: HOMOLOGOUS TYPE,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",1,2,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9764,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9690,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9624,Malignant Mixed Mesodermal (Mullerian) Tumor<;>Carcinosarcoma<;>Yolk Sac Tumor,0.9455,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.9452
UTERINE CARCINOSARCOMA/UTERINE MALIGNANT MIXED MULLERIAN TUMOR,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,1,2,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9893,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9838,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9818,Malignant Mixed Mesodermal (Mullerian) Tumor<;>Carcinosarcoma<;>Yolk Sac Tumor,0.9675,Endometrial Carcinoma<;>Mixed,0.9661
UTERINE CLEAR CELL CARCINOMA,Endometrial Clear Cell Adenocarcinoma,1,2,Endometrial Clear Cell Adenocarcinoma,0.9786,Clear Cell Renal Cell Carcinoma,0.9738,Clear Cell Adenocarcinoma,0.9683,Adenocarcinoma Clear Cell,0.9648,Ovarian Clear Cell Tumor,0.9640
UTERINE CORPUS ENDOMETRIAL CARCINOMA,uterine corpus endometrial carcinoma,1,2,uterine corpus endometrial carcinoma,1.0000,Endometrial Carcinoma<;>Uterine Corpus Cancer,0.9899,Endometrial Carcinoma,0.9797,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.9773,Uterine Corpus Sarcoma,0.9655
UTERINE CORPUS ENDOMETRIAL CARCINOMA OTHER,uterine corpus endometrial carcinoma,2,2,Endometrial Carcinoma<;>Uterine Corpus Cancer,0.9718,uterine corpus endometrial carcinoma,0.9708,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.9640,Uterine Corpus Sarcoma,0.9499,Uterine Corpus Leiomyosarcoma,0.9495
UTERINE DEDIFFERENTIATED CARCINOMA,Endometrial Dedifferentiated Carcinoma,1,2,Endometrial Dedifferentiated Carcinoma,0.9887,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,0.9534,undifferentiated carcinoma of the corpus uteri,0.9533,Dedifferentiated Liposarcoma,0.9504,Adenocarcinoma<;>Undifferentiated Carcinoma,0.9503
UTERINE ENDOMETRIOID,Endometrial Endometrioid Adenocarcinoma,1,2,Endometrial Endometrioid Adenocarcinoma,0.9710,Endometrioid Adenocarcinoma,0.9655,Ovarian Endometrioid Adenocarcinoma,0.9646,Endometrioid Tumor,0.9640,Cervical Endometrioid Adenocarcinoma,0.9626
UTERINE ENDOMETRIOID CARCINOMA,Endometrial Endometrioid Adenocarcinoma,1,2,Endometrial Endometrioid Adenocarcinoma,0.9808,Endometrioid Tumor,0.9797,Endometrioid Adenocarcinoma,0.9789,Cervical Endometrioid Adenocarcinoma,0.9761,Ovarian Endometrioid Adenocarcinoma,0.9745
UTERINE EPITHELIOID LEIOMYOSARCOMA,Uterine Corpus Epithelioid Leiomyosarcoma,1,2,Uterine Corpus Epithelioid Leiomyosarcoma,0.9863,Epithelioid Sarcoma,0.9639,Epithelioid Mesothelioma,0.9559,Epithelioid Trophoblastic Tumor,0.9550,Uterine Corpus Myxoid Leiomyosarcoma,0.9535
UTERINE HYPERMUTATED,Endometrial Carcinoma<;>Microsatellite Instability,99,2,Hypermutated Colorectal Carcinoma,0.9456,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9072,Endometrial Carcinoma<;>POLE Gene Mutation,0.9058,Uterine Corpus Sarcoma<;>Mesenchymal,0.9046,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9044
UTERINE LEIOMYOSARCOMA,Uterine Corpus Leiomyosarcoma,2,2,Leiomyosarcoma,0.9805,Uterine Corpus Leiomyosarcoma,0.9768,Uterine Carcinosarcoma,0.9648,Uterine Corpus Myxoid Leiomyosarcoma,0.9644,Uterine Corpus Epithelioid Leiomyosarcoma,0.9585
UTERINE MIXED ENDOMETRIAL CARCINOMA,Endometrial Carcinoma<;>Mixed,1,2,Endometrial Carcinoma<;>Mixed,0.9870,Mixed Carcinoma,0.9655,Cervical Carcinoma<;>Mixed,0.9646,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9577,Endometrial Clear Cell Adenocarcinoma<;>Mixed,0.9568
UTERINE MYXOID LEIOMYOSARCOMA,Uterine Corpus Myxoid Leiomyosarcoma,1,2,Uterine Corpus Myxoid Leiomyosarcoma,0.9797,Myxoid Liposarcoma,0.9646,Leiomyosarcoma,0.9562,Uterine Corpus Epithelioid Leiomyosarcoma,0.9548,Uterine Corpus Leiomyosarcoma,0.9519
UTERINE NEUROENDOCRINE CARCINOMA,Endometrial Neuroendocrine Carcinoma,1,2,Endometrial Neuroendocrine Carcinoma,0.9833,Neuroendocrine Carcinoma,0.9744,Cervical Neuroendocrine Tumor,0.9612,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.9595,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.9571
UTERINE PERIVASCULAR EPITHELIOID CELL TUMOR,Uterine Corpus PEComa,99,2,Epithelioid Trophoblastic Tumor,0.9612,Uterine Corpus Epithelioid Leiomyosarcoma,0.9526,Epithelioid Cell<;>Spindle Cell Neoplasm,0.9497,Epithelioid Cell,0.9443,Epithelioid Sarcoma,0.9432
UTERINE SARCOMA,Uterine Corpus Sarcoma,1,2,Uterine Corpus Sarcoma,0.9738,Uterine Corpus Undifferentiated Sarcoma,0.9641,Uterine Neoplasm,0.9624,Uterine Carcinosarcoma,0.9594,Sarcoma,0.9559
"UTERINE SARCOMA, OTHER",Uterine Corpus Sarcoma,1,2,Uterine Corpus Sarcoma,0.9568,Uterine Corpus Undifferentiated Sarcoma,0.9538,Uterine Corpus Sarcoma<;>Mesenchymal,0.9498,Uterine Neoplasm,0.9479,Uterine Carcinosarcoma,0.9446
UTERINE SARCOMA/MESENCHYMAL,Uterine Corpus Sarcoma<;>Mesenchymal,1,2,Uterine Corpus Sarcoma<;>Mesenchymal,0.9777,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9571,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9546,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9535,Uterine Corpus Sarcoma,0.9502
UTERINE SEROUS,Endometrial Serous Adenocarcinoma,2,2,Serous,0.9705,Endometrial Serous Adenocarcinoma,0.9533,Serous Adenocarcinoma,0.9442,Ovarian Serous Adenocarcinoma,0.9398,Serous Cystadenocarcinoma,0.9363
UTERINE SEROUS CARCINOMA,Endometrial Serous Adenocarcinoma,1,2,Endometrial Serous Adenocarcinoma,0.9715,Serous Adenocarcinoma,0.9624,uterine corpus endometrial carcinoma,0.9615,Ovarian Serous Adenocarcinoma,0.9600,Endometrial Carcinoma<;>Uterine Corpus Cancer,0.9593
UTERINE SEROUS CARCINOMA/UTERINE PAPILLARY SEROUS CARCINOMA,Endometrial Serous Adenocarcinoma,2,2,Endometrial Carcinoma<;>Uterine Corpus Cancer,0.9623,Endometrial Serous Adenocarcinoma,0.9620,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.9588,uterine corpus endometrial carcinoma,0.9562,Papillary Serous Cystadenocarcinoma,0.9546
UTERINE SMOOTH MUSCLE TUMOR OF UNCERTAIN MALIGNANT POTENTIAL,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,1,2,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,0.9935,Uterine Neoplasm,0.9521,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9463,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9441,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9425
UTERINE UNDIFFERENTIATED CARCINOMA,undifferentiated carcinoma of the corpus uteri,1,2,undifferentiated carcinoma of the corpus uteri,0.9869,Undifferentiated Carcinoma,0.9822,Uterine Corpus Undifferentiated Sarcoma,0.9736,Carcinoma<;>Undifferentiated,0.9713,Gastric Undifferentiated Carcinoma,0.9709
UTERINE_SARCOMA,Uterine Corpus Sarcoma,1,2,Uterine Corpus Sarcoma,0.9678,Uterine Corpus Undifferentiated Sarcoma,0.9611,Uterine Corpus Sarcoma<;>Mesenchymal,0.9592,Uterine Neoplasm,0.9553,Uterine Carcinosarcoma,0.9541
UTUC,upper tract urothelial carcinoma,1,2,upper tract urothelial carcinoma,0.9175,Uveal Tract,0.9160,Urethral Urothelial Carcinoma,0.9084,Bladder Urachal Carcinoma,0.9069,Bladder Urachal Adenocarcinoma,0.9056
UVEAL,Uveal Tract,2,2,Uveal Melanoma,0.9783,Uveal Tract,0.9703,Ocular Melanoma,0.9150,Retinoblastoma,0.9006,Urethral Melanoma,0.8966
UVEAL MELANOMA,Uveal Melanoma,1,2,Uveal Melanoma,1.0000,Uveal Tract,0.9533,Ocular Melanoma,0.9498,Melanoma,0.9361,Melanoma of Unknown Primary,0.9306
UVEAL_MELANOMA,Uveal Melanoma,1,2,Uveal Melanoma,0.9916,Ocular Melanoma,0.9501,Uveal Tract,0.9483,Melanoma,0.9412,Melanoma of Unknown Primary,0.9363
UVM,Uveal Melanoma,4,2,Sun-exposed Site,0.9100,Urethral Melanoma,0.9060,Urethral Squamous Cell Carcinoma,0.8967,Uveal Melanoma,0.8966,Keratoacanthoma,0.8961
VAGINAL ADENOCARCINOMA,Vaginal Adenocarcinoma,1,2,Vaginal Adenocarcinoma,1.0000,Vaginal Carcinoma,0.9721,Vaginal Squamous Cell Carcinoma,0.9573,Cervical Adenocarcinoma,0.9557,Vulvar Carcinoma<;>Vaginal Carcinoma,0.9554
VAGINAL CANCER,Vaginal Carcinoma,1,2,Vaginal Carcinoma,0.9800,Vaginal Adenocarcinoma,0.9658,Vulvar Carcinoma<;>Vaginal Carcinoma,0.9638,Vaginal Squamous Cell Carcinoma,0.9637,Vaginal Melanoma,0.9474
VULVA/VAGINA,Vulvar Carcinoma<;>Vaginal Carcinoma,1,2,Vulvar Carcinoma<;>Vaginal Carcinoma,0.9532,Vulvar Carcinoma,0.9388,Vulvar Squamous Cell Carcinoma,0.9333,Vaginal Melanoma,0.9283,Vaginal Squamous Cell Carcinoma,0.9248
"VULVAR/VAGINAL CANCER, NOS",Vulvar Carcinoma<;>Vaginal Carcinoma,1,2,Vulvar Carcinoma<;>Vaginal Carcinoma,0.9748,Vulvar Carcinoma,0.9666,Vulvar Squamous Cell Carcinoma,0.9627,Vaginal Carcinoma,0.9569,Vaginal Squamous Cell Carcinoma,0.9567
WALDENSTROM MACROGLOBULINEMIA,Waldenstrom Macroglobulinemia,1,2,Waldenstrom Macroglobulinemia,1.0000,Monoclonal B-Cell Lymphocytosis,0.9106,Monoclonal Gammopathy of Undetermined Significance,0.9062,Diabetes Mellitus,0.9021,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.9001
WDLPS,Well Differentiated Liposarcoma,99,2,Descending Colon,0.8870,"Myelodysplastic Syndrome, Unclassifiable",0.8857,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",0.8795,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.8794,Dedifferentiated Liposarcoma,0.8793
WELL DIFFERENTIATED,Well Differentiated,1,2,Well Differentiated,1.0000,Poorly Differentiated,0.9496,Adenocarcinoma<;>Well Differentiated,0.9490,Well Differentiated Liposarcoma,0.9477,Well Differentiated Leiomyosarcoma,0.9427
WELL DIFFERENTIATED ENDOMETRIAL ADENOCARCINOMA,Endometrial Adenocarcinoma<;>Well Differentiated,1,2,Endometrial Adenocarcinoma<;>Well Differentiated,0.9934,Adenocarcinoma<;>Well Differentiated,0.9740,Adenocarcinoma<;>Well Differentiated<;>Rectum,0.9663,Endometrial Adenocarcinoma,0.9598,Poorly Differentiated Adenocarcinoma,0.9598
WELL DIFFERENTIATED INVASIVE EOSPHAGEAL SQUAMOUS CELL CARCINOMA,Esophageal Well Differentiated Squamous Cell Carcinoma<;>Invasive,1,2,Esophageal Well Differentiated Squamous Cell Carcinoma<;>Invasive,0.9775,Squamous Cell Carcinoma<;>Poorly Differentiated,0.9523,Well Differentiated Lesion<;>Invasive,0.9484,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9481,Esophageal Squamous Cell Carcinoma,0.9474
WELL DIFFERENTIATED LIPOSARCOMA,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,3,2,Well Differentiated Liposarcoma,1.0000,Well Differentiated Leiomyosarcoma,0.9692,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.9610,Liposarcoma,0.9519,Well Differentiated,0.9477
WELL DIFFERENTIATED TUBULAR ADENOCARCINOMA,Tubular Adenocarcinoma<;>Well Differentiated Adenocarcinoma Cell,1,2,Tubular Adenocarcinoma<;>Well Differentiated Adenocarcinoma Cell,0.9877,Tubular Adenocarcinoma<;>Moderately Differentiated,0.9840,Tubular Adenocarcinoma,0.9699,Adenocarcinoma<;>Well Differentiated,0.9661,Gastric Tubular Adenocarcinoma,0.9594
WELL-DIFFERENTIATED LEIOMYOSARCOMA RESEMBLING LEIOMYOMA,Well Differentiated Leiomyosarcoma,1,2,Well Differentiated Leiomyosarcoma,0.9856,Leiomyosarcoma,0.9637,Well Differentiated Liposarcoma,0.9523,Uterine Corpus Myxoid Leiomyosarcoma,0.9449,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.9448
WELL-DIFFERENTIATED LIPOSARCOMA,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,3,2,Well Differentiated Liposarcoma,0.9983,Well Differentiated Leiomyosarcoma,0.9702,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.9630,Liposarcoma,0.9540,Well Differentiated,0.9471
WELL-DIFFERENTIATED NEUROENDOCRINE TUMOR OF THE APPENDIX,Appendix Neuroendocrine Tumor,1,2,Appendix Neuroendocrine Tumor,0.9746,Small Intestinal Neuroendocrine Neoplasm<;>Well Differentiated,0.9683,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.9675,Rectal Neuroendocrine Tumor<;>Well Differentiated,0.9664,Adenocarcinoma with Neuroendocrine Differentiation,0.9599
WELL-DIFFERENTIATED NEUROENDOCRINE TUMOR OF THE RECTUM,Rectal Neuroendocrine Tumor<;>Well Differentiated,1,2,Rectal Neuroendocrine Tumor<;>Well Differentiated,0.9913,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.9683,Small Intestinal Neuroendocrine Neoplasm<;>Well Differentiated,0.9659,Adenocarcinoma<;>Well Differentiated<;>Rectum,0.9626,Adenocarcinoma with Neuroendocrine Differentiation,0.9619
WELL-DIFFERENTIATED NEUROENDOCRINE TUMORS OF THE STOMACH,Gastric Neuroendocrine Tumor,1,2,Gastric Neuroendocrine Tumor,0.9712,Small Intestinal Neuroendocrine Neoplasm<;>Well Differentiated,0.9657,Rectal Neuroendocrine Tumor<;>Well Differentiated,0.9650,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.9649,Gastric Small Cell Neuroendocrine Carcinoma,0.9626
WELL-DIFFERENTIATED THYROID CANCER,Differentiated Thyroid Gland Carcinoma,2,2,Poorly Differentiated Thyroid Gland Carcinoma,0.9729,Differentiated Thyroid Gland Carcinoma,0.9697,Thyroid Gland Carcinoma,0.9564,Adenocarcinoma<;>Well Differentiated,0.9517,Classic Thyroid Gland Papillary Carcinoma,0.9494
WILMS,Wilms Tumor,1,2,Wilms Tumor,0.9630,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.9033,Kidney,0.9022,Hemangioma,0.9013,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.9000
WILMS TUMOR,Wilms Tumor,1,2,Wilms Tumor,1.0000,Rhabdoid Tumor,0.9249,Testicular Germ Cell Tumor,0.9231,Ovarian Epithelial Tumor,0.9168,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9166
WILMS' TUMOR,Wilms Tumor,1,2,Wilms Tumor,0.9980,Testicular Germ Cell Tumor,0.9250,Rhabdoid Tumor,0.9245,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9187,Ovarian Epithelial Tumor,0.9174
WILMS' TUMORS,Wilms Tumor,1,2,Wilms Tumor,0.9956,Testicular Germ Cell Tumor,0.9247,Rhabdoid Tumor,0.9236,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9194,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9177
WITH DUCTAL AND LOBULAR PHENOTYPES,Breast Mixed Ductal and Lobular Carcinoma,1,2,Breast Mixed Ductal and Lobular Carcinoma,0.9432,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9419,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9415,Ductal,0.9354,Lobular,0.9325
WITH TUMOR,With Tumor,1,2,With Tumor,1.0000,Neoplasm,0.9210,Tumor Free,0.9209,Brain Neoplasm,0.9194,Breast Neoplasm,0.9126
WITH_TUMOR,With Tumor,1,2,With Tumor,0.9821,Tumor Free,0.9218,Neoplasm,0.9162,Brain Neoplasm,0.9158,Primary Neoplasm<;>Paired,0.9113
WT,Wilms Tumor,99,2,Low Grade Glioma<;>IDH Family Wildtype,0.8988,"Glioblastoma, IDH-Wildtype",0.8981,"Astrocytoma, IDH-Mutant, Grade 4",0.8918,Glioblastoma<;>IDH Family Wildtype,0.8915,"Astrocytoma, IDH-Mutant, Grade 2",0.8915
YOLK SAC TUMOR,Yolk Sac Tumor,1,2,Yolk Sac Tumor,1.0000,Yolk Sac Tumor<;>Seminoma,0.9745,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9601,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,0.9551,Malignant Mixed Mesodermal (Mullerian) Tumor<;>Carcinosarcoma<;>Yolk Sac Tumor,0.9534
YOLK SAC TUMORNON-SEMINOMA,Nonseminomatous<;>Yolk Sac Tumor,99,2,Yolk Sac Tumor<;>Seminoma,0.9888,Yolk Sac Tumor,0.9720,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9627,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor,0.9587,Embryonal Carcinoma<;>Seminoma,0.9586
YOLK SAC TUMORSEMINOMA,Yolk Sac Tumor<;>Seminoma,2,2,Yolk Sac Tumor,0.9845,Yolk Sac Tumor<;>Seminoma,0.9729,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.9679,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,0.9640,Nonseminomatous<;>Yolk Sac Tumor,0.9622
